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Abstract 
 
Chagas disease remains the most important parasitic infection in Latin America. The 
aetiological agent, Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae), is a complex 
vector-borne zoonosis transmitted in the faeces of hematophagous triatomine bugs 
(Hemiptera: Reduviidae: Triatominae), and maintained by mammalian reservoir hosts 
ranging from the southern United States to Argentinean Patagonia. In the absence of 
chemotherapy, infection is life-long and can lead to a spectrum of pathological sequelae 
ranging from subclinical to lethal cardiac and/or gastrointestinal complications in up to 30% 
of patients.  
T. cruzi displays remarkable genetic diversity, which has long been suspected to contribute to 
the considerable variation in clinical symptoms observed between endemic regions. 
Currently, isolates of T. cruzi can be assigned to a minimum of six stable genetic lineages or 
discrete typing units (DTUs) (TcI-TcVI), which are broadly associated with disparate 
ecologies, transmission cycles and geographical distributions. The principal mode of 
reproduction among T. cruzi strains is the subject of an intense, decades-old debate. Despite 
the existence of two recent natural hybrid lineages (TcV and TcVI), which resemble meiotic 
F1 progeny, a pervasive view is that recombination has been restrained at an evolutionary 
scale and is of little epidemiological relevance to contemporary parasite populations. 
 The aim of this PhD project was to investigate T. cruzi genetic diversity through significant 
development of phylogenetic markers and their application to the characterization of natural 
parasite population structures and genetic exchange mechanisms. Multiple, single-copy, 
chromosomally-independent, nuclear housekeeping genes were assessed initially for their 
ability to allocate isolates to DTU-level, to facilitate higher resolution intra-lineage analyses 
and finally for their inclusion alongside additional targets in a standardized T. cruzi 
multilocus sequence typing (nMLST) scheme. For the immediate future, nuclear MLST, 
using a panel of four to seven nuclear loci, is a robust, reproducible and highly discriminatory 
method that has potential to become the new gold standard for T. cruzi DTU assignment.  
To investigate natural parasite population structures and uncover evidence of genetic 
exchange, a high resolution mitochondrial MLST (mtMLST) scheme, based on ten gene 
fragments, was developed and evaluated against current nuclear markers (multilocus 
microsatellite typing; MLMT) using isolates belonging to the oldest and most widely 
distributed lineage (TcI). Observations of gross nuclear-mitochondrial phylogenetic 
incongruence indicate that recombination is ongoing, geographically widespread and 
continues to influence natural populations, challenging the traditional paradigm of clonality 
in T. cruzi.  
Application of this combined nuclear-mitochondrial methodology to intensively sampled, 
minimally-subdivided TcI populations revealed extensive mitochondrial introgression within 
a disease focus in North-East Colombia as well as among arboreal transmission cycles in 
Bolivia. Failure to detect any reciprocal nuclear hybridization among recombinant strains 
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may be indicative of alternate, cryptic mating strategies in T. cruzi, which are challenging to 
reconcile with both in vitro parasexual mechanisms of genetic exchange described, and 
patterns of Mendelian allele inheritance among natural hybrid DTUs.  
High resolution genotyping of TcI populations was also undertaken to explore the interaction 
between parasite genetic heterogeneity and ecological biodiversity, exposing the significant 
impact human activity has had on T. cruzi evolution. Reduced genetic diversity, accelerated 
parasite dissemination between densely populated areas and mitochondrial gene flow 
between domestic and sylvatic populations, suggests humans may have played a crucial role 
in T. cruzi dispersal across the Bolivian highlands. Parallel reductions in genetic diversity 
were observed among isolates from the Brazilian Atlantic Forest, attributable to ongoing 
anthropogenic habitat fragmentation. By comparison domestic TcI isolates (TcIDOM) are 
divergent from their sylvatic counterparts, but also genetically homogeneous, and likely to 
have originated in North/Central America before distribution southwards. Molecular dating 
of Colombian TcIDOM clones confirmed that this clade emerged 23,000 ± 12,000 years, 
coinciding with the earliest human migration into South America. 
Lastly, Illumina amplicon deep sequencing markers were developed to explore the interaction 
between parasite multiclonality and clinical status of chronic Chagas disease. An 
unprecedented level of intra-host genetic diversity was detected, highlighting putative 
diversifying selection affecting antigenic surface proteases, which may facilitate survival in 
the mammalian host. In lieu of comparative genomics of representative T. cruzi field isolates, 
not yet a reality, as is the case with other more experimentally-tractable trypanosomatids, 
presented herein are some of the highest resolution genotyping techniques developed in T. 
cruzi to date, which have the potential to expand our current understanding of parasite 
genetic diversity and its relevance to clinical outcome of Chagas disease.  
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1. Introduction 
1.1 Trypanosoma cruzi life cycle and transmission 
Trypanosoma cruzi, the aetiological agent of Chagas disease (American trypanosomiasis) is a 
hemoflagellate protozoan parasite belonging to the genus Trypanosoma within the class 
Kinetoplastida. This group also includes other human pathogens of public health importance, 
notably Trypanosoma brucei, the causative agent of sleeping sickness (African 
trypanosomiasis), and Leishmania species.  Kinetoplastids are characterized by a number of 
unique biological features including, extra-nuclear DNA (kDNA) in the form of minicircles 
and maxicircles (functionally equivalent to eukaryotic mitochondria), RNA editing and 
almost exclusive post-transcriptional gene regulation (Simpson et al., 1988; Lukes et al., 
2002; Clayton and Shapira, 2007).  
T. cruzi is a complex vector-borne zoonosis transmitted by hematophagous triatomine bugs 
(Hemiptera: Reduviidae: Triatominae) and maintained by a wide range of mammalian 
reservoirs. In order to successfully colonize both the mammalian host and insect vector, T. 
cruzi assumes three distinct morphological forms at different developmental stages of its life 
cycle (Figure 1.1) (Tyler and Engman, 2001; 2003). 
 
 
 
 
 
Figure 1.1. Trypanosoma cruzi morphological forms: A – intracellular amastigotes; B – bloodstream 
form trypomastigotes; C – epimastigotes in axenic culture. Sources: http://www.stanford.edu, 
http://winona.edu, http://www.dpd.cdc.gov.  
Amastigote and epimastigote forms (Figure 1.1 A and C) replicate by binary fission within 
phagocytic and non-phagocytic mammalian cells and in the hindgut of the triatomine bug 
vector, respectively. Trypomastigote forms (Figure 1.1 B) are non-replicative and are present 
at two distinct life cycle stages: (i) in the bloodstream of the mammalian host (bloodstream 
form trypomastigotes) and (ii) in the rectum and faeces of triatomine bug vectors (infective 
metacyclic trypomastigotes). 
The life cycle of T. cruzi is illustrated in Figure 1.2.  Infective metacyclic trypomastigotes are 
deposited on the skin of the mammalian host in faecal droplets extruded by a blood-feeding 
triatomine bug. Parasites enter the host via contamination of the bite wound or alternatively 
through skin abrasions, exposed mucous membranes or the conjunctiva. Once inside the host, 
motile trypomastigotes are able to invade a range of phagocytic and non-phagocytic 
nucleated cells via both lysosomal-dependent and independent mechanisms (reviewed by 
Epting et al., 2010; Caradonna and Burleigh, 2011).   
A B C 
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Upon cell entry, the parasite is taken up into a membrane-bound (parasitophorous) vacuole 
which subsequently fuses with a lysosome; exposure to decreasing pH stimulates parasite 
differentiation to the intracellular amastigote form and its concomitant release into the 
cytosol. Here, amastigotes multiply asexually to form pseudocysts, which can arise in a 
variety of host tissues but predominate in cardiac, smooth and skeletal muscles and 
reticuloendothelial cells in the liver, spleen and lymphatic system. Within pseudocysts, 
amastigotes differentiate into non-replicative, flagellated trypomastigotes that, upon cell 
lysis, can either infect adjacent tissues or disseminate throughout the bloodstream or lymph.   
Triatomine bugs feeding on an infected mammal may ingest extracellular trypomastigotes, 
which pass to the midgut where transformation to the amastigote form occurs. Differentiation 
of amastigotes into epimastigotes occurs in response to decreasing environmental glucose 
levels from the mammalian host to the insect vector (Tyler and Engman, 2000).  
Epimastigotes multiply by binary fission in the hindgut and migrate to the rectum where they 
attach hydrophobically to the waxy gut cuticle by their flagella and transform into infective 
metacyclic trypomastigotes, thus completing the life cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. The life cycle of T. cruzi.  Red and blue arrows indicate parasite developmental stages in 
the insect vector and human host, respectively. Source: http://www.dpd.cdc.gov/dpdx. 
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1.2 Epidemiology and public health importance of Chagas disease  
Chagas disease remains the most important parasitic infection in Latin America. It is 
estimated that 8-10 million individuals are infected, with a further 90 million at risk (Hotez et 
al., 2008; Rassi Jr et al., 2010). T. cruzi has a broad geographical range that extends from the 
southern United States to Argentinean Patagonia (latitude 42oN to latitude 40oS; Figure 1.3).  
However, human disease transmission is principally restricted to areas where individuals are 
exposed to the infected faeces of domiciliated or invasive triatomine bugs. In endemic 
countries, Chagas disease disproportionally affects impoverished communities resulting in 
the loss of 0.7 million Disability Adjusted Life Years (DALYs) (WHO, 2008) and 12,500 
deaths per annum (Lescure et al., 2010).   
 
 
 
 
 
 
 
 
 
 
Figure 1.3. The distribution of endemic (light grey) and non-endemic Chagas disease (see colour key) 
estimated by Rassi Jr et al., 2010. Source: Rassi Jr et al., 2010. 
While the majority of T. cruzi cases are vector-borne, oral infection is an important secondary 
transmission route which is often responsible for regional microepidemics of acute Chagas 
disease in areas devoid of domestic triatomine species, such as the Amazon Basin (recently 
reviewed by Shikanai-Yasuda and Carvalho, 2012). Ingestion of food/drink, contaminated 
with triatomine faeces, is generally associated with massive parasitic infection resulting in 
more severe acute clinical presentations and higher mortality rates (Yoshida, 2009; Alarcón 
de Noya et al., 2010).  
In recent years, a significant proportion of the infected population has emigrated from rural 
areas, leading to the urbanization of Chagas disease in endemic countries as well as 
internationally (Gürtler, 2009). Chagas disease is now considered an emergent global public 
health problem associated with congenital transmission (Bern et al., 2011a), blood 
transfusions (Jackson et al., 2010a) and organ transplantations (Centers of Disease Control, 
2006; Kransdorf et al., 2013) (reviewed by Schmunis and Yadon, 2010; Gascon et al., 2010). 
Current estimates indicate 1-26% of migrants are T. cruzi seropositive, depending on the 
 
!
23 
country and/or the migrants’ nationality (Jackson et al., 2009). In the United States over 
300,000 individuals are estimated to harbor T. cruzi, forming a potential parasite reservoir for 
autochthonous transmission (Bern and Montgomery, 2009; Bern et al., 2011b) (Figure 1.3).  
Lastly, T. cruzi infection can also result from occupational exposure, with at least sixty-five 
cases of laboratory-acquired Chagas disease reported to date (Herwaldt, 2001).  
 
1.3 Diagnosis and clinical manifestations of vector-borne Chagas disease  
In the absence of chemotherapy, infection with T. cruzi is life-long and can lead to a 
spectrum of pathological sequelae ranging from subclinical to debilitation and death (Prata, 
2001).  Disease progression and clinical outcome are determined by a number of factors 
including host (recently reviewed by Ayo et al., 2013) and parasite genetics (Campbell et al., 
2004), mixed/super-infections (Bustamente et al., 2002; Torrico et al., 2006; Schofield et al., 
2006) and geographical strain variation (Miles et al., 1981a; reviewed by Macedo et al., 
2004).  
Chagas disease can typically be categorized into three stages (Figure 1.4).  An initial acute 
phase begins 4-15 days after infection and lasts up to 8 weeks, during which bloodstream 
form trypomastigotes are detectable in the peripheral blood.  Most individuals remain 
asymptomatic, while 15-30% present overt clinical manifestations including prolonged fever, 
malaise, lymphadenopathy and hepatosplenomegaly. Inflammation and parasite 
multiplication at the site of inoculation can develop into an oedematous nodule or chagoma 
(Figure 1.5). In addition, up to 50% of cases present with conjunctivitis and unilateral 
palperbral oedema (Romaňa’s sign). Mortality during the acute stage is low (<5-10% of 
cases) and predominates in children under five and immunocompromised individuals, usually 
resulting from severe myocarditis, meningoencephalitis, or both (Rassi Jr et al., 2010). The 
acute phase resolves spontaneously in approximately 90% of patients, even if the infection is 
left untreated.  
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Figure 1.4. Schematic of the clinical progression of Chagas disease. Adapted from Rassi Jr et al., 
2010. 
 
Following the acute phase, 60-70% of infected individuals progress to an asymptomatic or 
indeterminate period of clinical latency, which can persist indefinitely. Indeterminate Chagas 
disease is characterized by T. cruzi seropositivity, a normal 12-lead electrocardiogram (ECG) 
and normal radiological examination of the chest, oesophagus and colon (Rassi Jr et al., 
2010). During this stage parasitaemia is undetectable by direct microscopy and diagnosis is 
reliant on high levels of circulating anti-T. cruzi IgG detected by at least  two different 
serological methods (usually enzyme-linked immunosorbent assay; ELISA, indirect 
immunofluorescence; IFA or indirect haemagglutination; IHA) (Duarte et al., 2014).  
The remaining 30-40% of patients develop chronic Chagas disease within 10-30 years post-
infection at a rate of approximately 2% per year (Prata, 2001). Direct progression from the 
acute phase to the chronic form of Chagas disease has been reported in a minority of 
individuals. In addition, reactivation of Chagas disease can occur in chronically infected 
patients who become immunocompromised by immunosuppressive treatment or co-infection 
with HIV (Bern, 2012).  
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Chronic Chagas disease is characterised by irreversible lesions to the cardiac or digestive 
tissues or, in rare cases, to both. Early chagasic cardiomyopathy typically presents as 
conduction system abnormalities, particularly right bundle branch block, left anterior 
fascicular block and premature left ventricular wall contractions (Maguire et al., 1987). More 
advanced manifestations include ventricular tachycardia, high degree atrioventricular block 
and progressive dilated cardiomyopathy with congestive heart failure (Rassi Jr et al., 2000). 
Sudden death accounts for nearly two-thirds of chagasic cardiomyopathy-related mortality 
and can affect both patients with end-stage heart disease, as well as those who were 
previously asymptomatic (Rassi Jr et al., 2001). Denervation, muscular hypertrophy and 
luminal dilatation of the upper and lower alimentary tract can lead to the development of 
megaoesophagus or megacolon, respectively (De Oliveira et al., 1998) (Figure 1.5).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Acute and chronic clinical symptoms of Chagas disease: A – Romaňa’s sign; B – 
Chagoma; C – Apical aneurysm; D – Chagasic megaoesophagus; E – Chagasic megacolon.   
Sources: WHO, 2002; Kinoshita-Yanaga et al., 2009; Coura and Vinas, 2010 and Rassi Jr et al., 2010. 
 
In general, chagasic megasyndromes are rarer than cardiac but the prevalence of different 
clinical forms of Chagas disease varies considerably between individuals and endemic 
regions (Miles et al., 1981a; Rezende, 1976). Chronic Chagas disease pathology 
demonstrates geographically-restricted clinical profiles; cardiomyopathies occur throughout 
Central and South America, whereas gastrointestinal complications are reported almost 
A B 
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exclusively from south of the Amazon Basin. It has been suggested that this geographical 
heterogeneity is associated with genetic variation among parasite strains (section 1.13) (Miles 
et al., 1981a; reviewed by Campbell et al., 2004; Macedo et al., 2004). However, the 
relationship between parasite genotype and clinical outcome remains elusive.   
1.4 Diagnosis and clinical manifestations of congenital Chagas disease 
With improved vector control, congenital transmission is becoming proportionately more 
important among chronically-infected populations and now accounts for 25% of new Chagas 
disease cases (Jannin and Salvatella, 2006). In certain areas of Bolivia, which has the highest 
T. cruzi seroprevalence (~6.75% of the population), between 72.7-97.1% of adults are 
infected, including 20-50% of women of child-bearing age (Samuels et al., 2013). Women 
infected as children remain at risk of vertical transmission for at least 30 years, even if 
vector-borne transmission were interrupted today (Schmunis and Cruz, 2005). Congenitally 
infected women can also transmit to their children, sustaining the cycle across generations in 
the absence of the vector (Carlier and Torrico, 2003).  
Diagnosis of congenital Chagas disease involves microscopic observation of trypomastigotes 
in cord or peripheral blood by microhaematocrit during the first month of life (Freilij et al., 
1983; La Fuente et al., 1984) and/or serological detection of anti-T. cruzi IgG at 6-9 months, 
once maternal antibodies have cleared (Freilij and Altcheh, 1995; Gomes et al., 2009).  PCR-
based detection of T. cruzi DNA is highly sensitive and can facilitate earlier diagnosis (Diez 
et al., 2008), but remains only a research tool in endemic areas, due to the need for 
specialized laboratory capacity, high cost reagents and problems of standardization between 
laboratories and countries. Although many hospitals have now initiated congenital screening, 
current diagnostic methods, even when optimally executed, fail to detect over half of infected 
neonates (Bern et al., 2009) and <20% of at risk infants complete the requisite 9 month 
follow-ups in programme evaluations (Blanco et al., 2000; Carlier and Torrico, 2003; 
Alonso-Vega et al., 2013). 
Congenital T. cruzi infection causes a spectrum of clinical manifestations. Disease severity 
may be related in part to the period of pregnancy during which transmission occurs; 
transmission early in pregnancy appears to increase risk of spontaneous abortion (Bittencourt 
and Barbosa 1972), while infection after 22 weeks of gestation is more likely to result in a 
late stillbirth or an infected live-born infant (Bittencourt et al., 1974; Azogue et al., 1985). 
For the latter, clinical symptoms range from low birth weight, prematurity and low Apgar 
scores to meningoencephalitis, hepatosplenomegaly, anaemia, thrombocytopenia and 
respiratory distress syndrome; mortality occurs in <5-20% of live-born symptomatic infants 
(Bittencourt et al., 1981; Torrico et al., 2004). Congenital infection also carries a 20-30% risk 
of chronic cardiac and/or gastrointestinal disease decades later.  
Treatment during infancy is significantly more effective and better tolerated than later 
(Schijman, 2006), but paediatric diagnosis and allocation of finite disease management 
resources are further complicated by highly variable congenital transmission rates, ranging 
between 1% to >15% among study populations (Mora et al., 2005; Torrico et al., 2004; 2006; 
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Bern et al., 2009; De Rissio et al., 2010). Factors associated with higher risk of congenital 
transmission include younger maternal age (presumed to reflect more recent maternal 
infection) (Torrico et al., 2004), maternal and neonatal immunological responses (Vekemans 
et al., 2000; Hermann et al., 2004), higher maternal parasitaemia (Bern et al., 2009), HIV and 
other immunodeficiencies (Freilij and Altcheh, 1995) and in some animal models, parasite 
strain (Andrade, 1982); evidence for the latter in humans is more equivocal (Virreira et al., 
2006; 2007; Corrales et al., 2009).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Venous blood draw from a one month year old participant enrolled in an ongoing 
congenital Chagas disease surveillance study in Hospital Municipal Camiri, Santa Cruz department, 
Bolivia. Source: L.A. Messenger (LSHTM).  
1.5 Pathogenesis and immunology of Chagas disease 
Historically, the pathogenesis of Chagas disease, particularly the relative involvement of the 
parasite and the host immune system to pathology during the chronic stage, have been widely 
debated (reviewed by Machado et al. 2012). Failure to observe parasites in chronic tissue 
lesions and the presence of auto-antibodies (Cunha-Neto et al., 1995), potentially resulting 
from bystander activation and/or molecular mimicry to parasite antigens (Leon and Engman, 
2003), led to the ‘autoimmunity hypothesis’ of Chagas disease (Kierszenbaum, 1999) and 
called into question the benefit of anti-parasitic treatment for disease management 
(Kierszenbaum, 2005).  
This theory has been subsequently challenged by many, based on failure to reproduce 
chagasic pathology by passive autoantibody transfer and detection of T. cruzi in tissue lesions 
by PCR (Kierszenbaum, 2003; 2005); although recent mouse data still suggest that pathology 
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can proceed in the absence of detectable local parasite load (Lewis et al., 2014). Current 
knowledge indicates that parasite persistence, coupled with an unbalanced immune response 
in some individuals (which can include autoimmune reactions), is responsible for prolonged 
inflammatory responses in chronically-infected tissues and resulting pathology, implying 
elimination of T. cruzi may be prerequisite to arrest irreversible disease progression (Dutra 
and Gollob, 2008).  
During the acute phase, tissue damage directly results from the parasite and the host’s robust 
immunoinflammatory response to its presence (reviewed by Talvani and Teixeira, 2011; 
Andrade et al., 2014). Macrophages and dendritic cells are activated by pathogen-associated 
molecular patterns (PAMPs) to secrete interleukin-12 (Campos and Gazzinelli, 2004). IL-12 
induces interferon (IFN)-γ synthesis, which augments the production of IL-12 itself and 
tumor necrosis factor (TNF)-α and polarizes CD4+ and CD8+ T-cells to produce interferon 
(IFN)-γ  (Martin and Tarleton, 2004). Macrophages activated by TNF-α and IFN-γ play a 
protective role through the synthesis of trypanocidal nitric oxide (NO) (Chandra et al., 2002; 
Silva et al., 2003). IFN-γ also stimulates the recruitment of T-cells by inducing expression of 
pro-inflammatory chemokines and adhesion molecules (reviewed by Teixeira et al., 2002). 
The acute Th1-predominant immune response is modulated by the production of IL-10 and 
IL-17 (Hölscher et al., 2000; da Matta Guedes et al., 2010). Acute symptoms resolve 
spontaneously as parasitaemia decreases to subpatent levels, but without treatment, total 
parasite clearance virtually never occurs (Rassi Jr et al., 2010).  
 
Figure 1.7. Immune responses in acute Chagas disease. Source: Andrade et al., 2014. 
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During chronic infection, adequate T-cell-mediated immunity is essential to control 
parasitaemia (Reis et al., 1993; Dutra et al., 1994; da Silveira et al., 2007); 
immunosuppression can lead to lethal reactivation (Cordova et al., 2008; Bacal et al., 2010; 
Bern, 2012). However, concomitant failure to downregulate the inflammatory response, 
triggered by parasite persistence, plays a key role in cardiac pathogenesis (Dutra et al., 2005; 
Martin-Neto et al., 2007; Dutra and Gollob, 2008) (Figure 1.8). Comparisons between 
asymptomatic and cardiac patients, indicate the former display higher expressions of IL-10 
(Souza et al., 2004), CD25HighCD4+ regulatory T-cells (de Araújo et al., 2011) and surface 
expression of CTLA-4 by CD8+ T-cells (Souza et al., 2007), which may all contribute to 
control of cytolytic action and tissue destruction (Dutra and Gollob, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8. Immunoregulatory model in chronic indeterminate and cardiac Chagas disease. Source: 
Dutra and Gollob, 2008. 
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1.6 Current treatment and management of Chagas disease 
There are currently two chemotherapies available to treat T. cruzi infection: nifurtimox 
(Bayer, Leverkusen, Germany) and benznidazole (LAFEPE, Recife, Brazil), of which the 
latter is the first-line treatment with the superior safety profile (Viotti et al., 2009). In general, 
anti-trypanosomal treatment is strongly recommended for all acute, congenital and 
reactivated cases and all children and patients up to 18 years of age with chronic disease 
(Rassi Jr et al., 2010). The treatment regimens for children are benznidazole (5-10 mg/kg 
daily) in two or three divided doses for 60 days, or nifurtimox (15 mg/kg daily) in three 
divided doses for 60-90 days. For adults, daily treatment with 5 mg/kg benznidazole or 8-10 
mg/kg nifurtimox is recommended for the same duration as children (Rassi Jr et al., 2010). 
Treatment is contraindicated during pregnancy and in patients with severe renal or hepatic 
insufficiency or advanced chagasic cardiomyopathy or megaoesophagus.  
The major limitations associated with both drugs are significant side effects (ranging from 
mild hypersensitivity and polyneuropathy to Stevens-Johnson syndrome or toxic epidermal 
necrolysis) (Yun et al., 2009; Jackson et al., 2010b; Pinazo et al., 2010), prolonged treatment 
regimens, lack of paediatric formulations (Rassi Jr et al., 2009) and considerable supply 
problems in endemic countries (Burki, 2011). 
Both drugs have significant activity in the acute phase with over 80% success rates in treated 
patients (Pinto et al., 2009). Efficacy during the chronic phase is much lower and varies with 
geographical location, which may reflect different methods of treatment evaluation, 
incomplete treatment administration, variable drug susceptibility among distinct T. cruzi 
strains or characteristics of the host’s immune response (Andrade et al., 1992; Toledo et al., 
2003; Urbina, 2010; Zingales et al., 2014). The benefits of benznidazole treatment to halt 
Chagas disease progression in adults aged 19-50 without advanced cardiomyopathy, is 
presently debated, and the subject of two ongoing multi-centre, double-blind, placebo-
controlled clinical trials (BENEFIT and TRAENA) (Marin-Neto et al., 2009).  
For symptomatic cardiac patients with sustained ventricular tachycardia and myocardial 
dysfunction, who are at high risk of death from arrhythmias, amiodarone treatment may be 
recommended (Scanavacca et al., 1990). Patients with refractory or unstable ventricular 
tachycardia can also be treated with implantable cardioverter defibrillators (ICDs) (Martinelli 
et al., 2012) or pacemakers (Clark et al., 2014). However, these options are often 
prohibitively expensive for local indigenous populations (Clark et al., 2014). Future 
prospects for Chagas disease management include the identification of biomarker predictors 
of progression, allowing treatment, surgical interventions etc., to be targeted to the subset of 
chronically-infected patients with the highest risk of morbidity and mortality (Requena-
Méndez et al., 2013). 
1.7 Prospective treatment of Chagas disease  
Recent impetus from international agencies has made significant achievements in advancing 
the evaluation of novel chemical classes for Chagas disease (Buckner, 2011). Two phase II 
clinical trials assessing the activity of ergosterol biosynthesis inhibitors, posaconazole 
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(Molina et al., 2014) and ravuconazole E1224 pro-drug (DNDi, 2013), were recently 
completed, demonstrating no significant improvement over the current gold standard 
benznidazole. Additional drugs in the research and development pipeline include 
flexinidazole (5-nitroimidazole) (Bahia et al., 2012; 2014), vinyl sulfone derivative K777 
(cysteine protease inhibitor) and fenarimol (fungicide) (Keenan et al., 2013a; 2013b; 2012). 
Alternate strategies also under investigation in mouse models are combination or sequential 
therapy with the aim of reducing drug dosage and/or duration of treatment (Benaim et al., 
2006; Bustamante et al., 2013; Diniz et al., 2013).  
 
1.8 Vector species, behaviours and ecologies 
The triatomine bugs responsible for T. cruzi transmission represent a diverse taxonomic 
group encompassing at least 140 species belonging to six tribes and 19 genera (Lent and 
Wygodzinsky, 1979; Galvão, 2003). T. cruzi is principally transmitted by five domestic 
vector species, belonging to three genera: Triatoma infestans, Rhodnius prolixus, 
Panstrongylus megistus, Triatoma brasiliensis and Triatoma dimidiata (Figure 1.9 and 1.10).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9. Major triatomine bug species responsible for T. cruzi transmission. Top row from left: 
adults of Triatoma infestans, Rhodnius prolixus and Panstrongylus megistus. Bottom row from left: 
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nymphs of Triatoma infestans and Rhodnius prolixus and Rhodnius egg. Source: L.A. Messenger and 
C. Whitehorn (LSHTM). 
Triatomine bugs are nocturnal, obligate haematophages, which require at least one blood 
meal to develop through each of five nymphal instars. All developmental stages and adults of 
both sexes can transmit T. cruzi. The probability that a triatomine is infected is directly 
proportional to number of blood meals taken, thus older instars and adults tend to have the 
highest infection rates. Paradoxically, stecorarian transmission of T. cruzi to humans is highly 
inefficient, estimated to occur every 900-4000 infected contacts (Nouvellet et al., 2013). 
 
 
Figure 1.10. Geographical distribution of the 14 most important vector species of Chagas disease. 
Source: Patterson and Guhl, 2010. 
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The triatomine bug species responsible for T. cruzi transmission are restricted to the 
Americas, with the exception of Triatoma rubrofasciata, which has a global tropicopolitan 
distribution in association with Rattus rattus (Patterson and Guhl, 2010). In general, the 
major taxonomic groups are broadly correlated with distinct geographies and many display 
evolutionary adaptations to specific ecological niches (Gaunt and Miles, 2000) (section 1.13) 
(Figure 1.10).  
Rhodnius species primarily inhabit Attalea palm trees (Gaunt and Miles, 2000) across the 
Amazon (Abad-Franch and Monteiro, 2007), the northern Andean countries, and parts of 
Central America. Triatoma species principally colonize terrestrial, rocky habitats, 
concentrated around southern and central Brazil and neighbouring countries, with a few 
species extending into the southern United States, where they have been implicated in 
sporadic autochthonous transmission of T. cruzi (Stevens et al., 2012; Garcia et al., 2014). 
Historically the maximum distribution of the principal domestic vector in South America, 
Triatoma infestans, ranged from the 12 most populated states of Brazil across vast areas of 
Bolivia, Argentina, southern Peru, northern Chile, Paraguay and Uruguay (Schofield et al., 
2006). Nowadays, domestic T. infestans is confined to the Andean valleys of Bolivia and the 
Gran Chaco region in sympatry with several wild populations (Cortez et al., 2007; 2008; 
Buitrago et al., 2010; Ceballos et al., 2011; Waleckx et al., 2012).  
Panstrongylus species, found predominantly in burrows and tree cavities, can be divided into 
two phylogenetically defined groups (Lent and Wygodzinsky, 1979; Marcilla et al., 2002) 
which correspond to regions north and south of the Amazon and East and West of the Andes 
(Patterson et al., 2009). P. geniculatus has the most extensive uninterrupted distribution of 
any triatomine species, ranging from the Atlantic to Pacific coasts and from mid-Central 
America to northern Argentina (Abad-Franch and Monteiro, 2007). 
Dispersal of triatomines can be active or passive. Active transportation among domestic 
species is facilitated by walking, and less frequently by flying (Noireau and Dujardin, 2001); 
the average dispersal range of T. infestans is <500m (Richer et al., 2007). Passive dispersion 
involves transportation of usually immature stages by sylvatic vertebrate hosts (e.g. eggs 
glued to feathers (Forattini et al., 1971)) or attached to familiar objects carried or worn by 
humans and is the most important in the context of Chagas disease epidemiology (Noireau 
and Dujardin, 2010). Phylogenetic studies suggest that historically the main domestic 
populations of T. infestans were passively distributed by anthropogenic migration (Dujardin, 
1998; Bargues et al., 2006; Piccinali et al., 2009; Cortez et al., 2010). This dependency on 
human hosts and domestic animals, overall lack of intra-species genetic diversity and loss of 
genetic resources from sylvatic populations (Panzera et al., 2004), would theoretically render 
this species highly susceptible to chemical control measures. These observations formed part 
of the rationale for the large trans-national vector control initiatives conducted during the 
1990s (section 1.10). In practice, contemporary insecticide resistance threatens the success of 
local control programmes in areas of residual vector transmission, such as the Bolivian Chaco 
region (Germano et al., 2010; Lardeux et al., 2010).  
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1.9 Mammalian reservoir hosts and transmission cycle dynamics 
More than 150 species of domestic (e.g., dogs, cats and guinea pigs), peridomestic (e.g. 
rodents, goats and pigs) and wild mammals (e.g., bats, marsupials and primates), from eight 
different orders, have been reported as infected with T. cruzi, although it is widely believed 
that all mammals are susceptible (Noireau et al., 2009a). Birds and cold-blooded vertebrates 
are refractory to infection (Kierszenbaum et al., 1981). While prevalence rates are not well 
established, certain species, particularly Dasypus novemcinctus (nine-banded armadillo), 
Didelphis marsupialis and D. albiventris (opossums), appear to be prominent sylvatic 
reservoirs of infection (Figure 1.11) (Yeo et al., 2005). T. cruzi is able to colonize almost all 
tissues in its mammalian hosts, including unconventional sites such as the cornea of 
Thrichomys apereoides (Herrera et al., 2007a) and the anal scent glands of Didelphis species 
(Deane et al., 1984a), enabling the latter species to function as both a host and vector of T. 
cruzi. 
 
Figure 1.11.  Examples of important sylvatic reservoirs of T. cruzi infection: Didelphis albiventris 
(left) and Dasypus novemcinctus (right). Source: Noireau et al., 2009a. 
In addition to vector-borne infection, many sylvatic mammals are prone to alternate 
transmission routes, including oral infection via predation of infected vectors or mammals 
(Jansen and Roque, 2010) and exposure to contaminated anal scent gland secretions (Deane 
et al., 1984a; Carreira et al., 2001). These biological features may predispose such hosts to 
multiplicity of infection which is directly related to intensity and efficiency of parasite 
transmission and duration and course of disease (Roellig et al., 2010; Nouvellet et al., 2013). 
In terms of T. cruzi transmission, ‘maintenance reservoirs’ are considered to be those that are 
able to be infected and retain the infection, while ‘amplifier reservoirs’ are those that display 
characteristics of infection that favour parasite transmission, e.g. high parasitaemia levels 
(Jansen and Roque, 2010). 
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Chagas disease transmission cycles can be described as domestic, peridomestic or sylvatic 
and separate or overlapping in their ecology (Miles et al., 2009). Domestic transmission 
arises when triatomine vector species colonise human settlements, feeding exclusively on the 
inhabitants (Figure 1.12).   
 
Figure 1.12. Example of domestic transmission in an endemic region of the Gran Chaco, Santa Cruz 
department, Bolivia. A: Gutierrez municipality, Cordillera province, where the rural population is 
almost exclusively of Guarani ethnicity and Chagas disease seroprevalence is 97% in adults older 
than 30 years. B: Typical house constructed from mud and sticks (tabique). C: T. infestans collected 
from inside B. D. Triatomine faeces stains, indicative of heavy house infestation. Source: L.A. 
Messenger (LSHTM). 
Peridomestic foci, including chicken coops, goat corrals and pigsties, act as sites of 
triatomine re-invasion following the eradication of domestic populations (Cecere et al., 2006; 
Breniere et al., 2007) (Figure 1.13). Infection restricted to wild triatomines and reservoir 
hosts is termed sylvatic (or enzootic) transmission. Direct human infection is rare but 
sporadic cases can arise when adventitious sylvatic vectors, such as T. sordida, R. pictipes 
and P. geniculatus, fly into human settlements attracted by light (Miles et al., 1981b), R. 
brethesi attacks workers harvesting piassaba palms (Coura et al., 2002) or through oral 
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transmission when infected bugs enter juice presses, such as those used for açaí palm or sugar 
cane (section 1.2).   
 
Figure 1.13. Example of potential peridomestic reservoir hosts in an endemic region of the Gran 
Chaco, Santa Cruz department, Bolivia. A: Goats. B: Pigs. C: Dogs. D: Ducks and ducklings. All 
photos were taken either inside or less than 10 m from a house.  Source: L.A. Messenger (LSHTM).  
Separate transmission cycles are the most feasible to interrupt as there is limited potential for 
vector migration from the surrounding environment. However, in some epidemiological 
settings, domestic and sylvatic transmission cycles overlap, threatening the success of control 
programmes, specifically by the re-invasion of sylvatic vectors after the elimination of 
domestic colonies (Fitzpatrick et al., 2008) and/or the adaptation of sylvatic species to inhabit 
the domestic or peridomestic niche (Matias et al., 2003; Carrasco et al., 2005; Noireau et al., 
2005; 2009b). 
1.10 Control of Chagas disease 
Considering the limited success of chemotherapy and absence of a prophylactic vaccine for 
Chagas disease (Vazquez-Chagoyan et al., 2011), control strategies have traditionally 
concentrated on interrupting vector-borne transmission through the elimination of 
domiciliary triatomine species. Since 1990, case reporting of Chagas disease has decreased 
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by ~70%, following the success of coordinated multi-country vector control programmes, 
most notably the Southern Cone Initiative (INCOSUR) (Figure 1.14) (Moncayo, 2003).   
In 1991, the governments of Argentina, Bolivia, Brazil, Chile, Paraguay and Uruguay, under 
the auspices of the Pan American Health Organization (PAHO; http://www.paho.org), 
initiated a trans-national control programme aimed at the total eradication of the principal 
domestic vector T. infestans, the suppression of secondary vector species and compulsory 
blood-bank screening (Schofield and Dias, 1999).  The basic preventive strategies consisted 
of chemical control of vectors and screening of blood donors using serology, supported by 
health education, community participation, improved housing construction and 
epidemiological surveillance. As of 2006, Uruguay, Chile and Brazil have been declared free 
of active transmission, while a number of provinces in Argentina, Bolivia and Paraguay have 
also reported disease interruption (Moncayo and Silveira, 2009).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14. The seroprevalence of Chagas disease and geographical distribution of control 
programmes. Data according to the PAHO, 2006. Source: Coura and Vinas, 2010. 
In light of these achievements, several other programmes, including the Andean Initiative 
(IPA, 1996) (Guhl, 2007), the Central American Initiative (IPCA, 1997) (Ponce, 2007) and 
the Amazon Initiative (AMCHA, 2004) (Aguilar et al., 2007) have been implemented with 
the goal of interrupting Chagas disease transmission through the establishment of nationwide 
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blood screening programmes and vector control, with an emphasis on preventing domestic 
re-infestation from sylvatic foci, as vectors in these areas are not solely domiciliated.   
Whilst the progress made over the last 20 years to control Chagas disease is indisputable, 
major challenges remain to ensure the sustainability and prioritization of these programmes 
in areas with very low residual disease prevalence and negligible house infestation rates 
(Schofield et al., 2006).  
More recently, initiatives in countries of non-endemicity have also been introduced to control 
the transmission of Chagas disease by blood transfusion and transplantations of organs from 
infected migrant donors. For example, the USA, Spain and France have established measures 
to minimize transfusional risk through screening of blood donors and deferral strategies 
(Castro, 2009). 
 
1.11 The origins of T. cruzi 
Two theories have been proposed to explain the origins of T. cruzi (Stevens et al., 1999; 
Hamilton et al., 2012). Phylogenetic analysis of 18S rRNA sequences suggested that 
salivarian trypanosomes (members of the T. brucei clade, transmitted in saliva) diverged 
from stercorarian trypanosomes (members of the T. cruzi clade, transmitted in faeces) 
approximately 100 million years ago (MYA), which coincided with the breakup of 
Gondwana, the continental landmass that included Africa, South America, Antarctica and 
Australia (Stevens et al., 1999; Stevens and Gibson, 1999; Stevens et al., 2001) (“southern 
super-continent hypothesis”) (Figure 1.15a). Based on this hypothesis, considerable species 
diversity would be expected within the T. cruzi clade, assuming its members co-evolved with 
South American terrestrial mammals since the separation of South America from Antarctica 
and Australia ~40 MYA (Hamilton et al., 2012). However, no additional ‘bona fide’ T. cruzi 
clade species have been isolated from South American mammals, while T. cruzi clade 
trypanosomes have been identified in African terrestrial mammals, implying geographical 
isolation may not have been entirely responsible for the evolution of the T. cruzi clade 
(Hamilton et al., 2009).!
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Figure 1.15. Two hypotheses for the evolution of the T. cruzi clade: (a) the southern super-continent 
hypothesis and (b) the bat seeding hypothesis. Source: Hamilton et al., 2012. 
 
Recent molecular analyses favour the premise that T. c. cruzi evolved from a bat 
trypanosome (“bat seeding hypothesis”), given that it is most closely related to T. cruzi 
marinkellei (from South American bats) (Hamilton et al., 2007; Cavazzana et al., 2010), 
Trypanosoma erneyi (Lima et al., 2012), Trypanosoma livingstonei (Lima et al., 2013) (both 
from bats in Mozambique) and Trypanosoma dionisii (from Old and New World bats) 
(Hamilton et al., 2007; Hamilton et al., 2012), and is frequently isolated from bats (Lisboa et 
al., 2008; Marcili et al., 2009a; Pinto et al., 2012; Ramírez et al., 2014) (Hamilton et al., 
2012) (Figure 1.15b). The “bat seeding hypothesis” proposes that various lineages of bat 
trypanosomes have independently switched hosts into terrestrial mammals, facilitated by 
invertebrate vectors feeding on both bats and mammals occupying the same ecological niche 
(Hamilton et al., 2012).  
T. c. cruzi has subsequently undergone major genetic diversification and dispersal across 
Central and South America. Current international consensus recognizes a minimum of six 
stable genetic lineages or discrete typing units (DTUs): TcI-TcVI (Zingales et al., 2009), 
which have distributions loosely defined by geography, ecology and transmission cycle 
(Miles et al., 2009) (section 1.13).  
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1.12 Contemporary population structure of T. cruzi  
T. cruzi displays remarkable genetic diversity and this has long been implicated as one of the 
principal factors underlying the major geographical, biology, epidemiological and clinical 
variation observed in Chagas disease (Miles et al., 1981a; Miles et al., 2009). Molecular 
analyses indicate that T. cruzi has a predominantly clonal population structure, interspersed 
with infrequent genetic exchange events. DTUs TcI-TcIV form monophyletic clades and TcV 
and TcVI are known to be recent natural inter-lineage hybrids (Machado and Ayala, 2001; 
Lewis et al., 2011). Multilocus sequence typing (MLST) supports these designations with 
TcI-TcIV characterized by substantial allelic homozygosity, likely resulting from recurrent, 
genome-wide and dispersed gene conversion, while TcV and TcVI display natural 
heterozygosity and minimal distinction, sharing intact alleles from their parental progenitors 
(TcII and TcIII) (Machado and Ayala, 2001; Brisse et al., 2003; Barnabé et al., 2011; Lewis 
et al., 2011; Yeo et al., 2011).  
The origin(s) of these hybrid DTUs is unresolved and it is presently contested whether they 
arose from two independent genetic exchange events (Figure 1.16b) (de Freitas et al., 2006; 
Lewis et al., 2011) or a single incidence of hybridization followed by clonal divergence 
(Figure 1.16a) (Westenberger et al., 2005; Sturm and Campbell, 2010; Flores-López and 
Machado, 2011). It has also been suggested that TcIII and TcIV are the products of a more 
ancient recombination event between TcI and TcII, which have subsequently undergone 
extensive loss of heterozygosity (LOH) (Figure 1.16a) (Westenberger et al., 2005).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.16. Comparison of the two-hybridization (a) and three ancestor (b) models which describe 
the role of genetic exchange during the evolution of T. cruzi.  Rectangles represent the six T. cruzi 
DTUs. Genetic exchange is indicated by ovals, with parental contributions designated by red arrows.  
The three mitochondrial clades identified by de Freitas et al., are highlighted in different colours: blue 
= clade A; green = clade B; orange = clade C. Source: Zingales et al., 2012.  
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1.13 Molecular epidemiology of T. cruzi 
The epidemiological relevance of the T. cruzi DTUs has also been the subject of considerable 
debate, with evidence emerging to support historical and contemporary associations of 
particular lineages with different transmission ecologies (Figure 1.17) (Table 1.1).  In 
general, TcI, TcII, TcV and TcVI are frequently isolated from domestic cycles and are 
responsible for the majority of human infections. The distribution of domestic TcI extends 
from the Amazon Basin northwards, where it is the principal cause of Chagas disease in 
Venezuela and Colombia (Anez et al., 2004; Ramírez et al., 2010; Carrasco et al., 2012). TcI 
is also ubiquitous in arboreal sylvatic transmission cycles throughout Latin America 
(Barnabé et al., 2000; Roellig et al., 2008), primarily circulating in arboreal ecotopes 
between Didelphis species and the triatomine tribe Rhodniini (Gaunt and Miles, 2000), with 
secondary terrestrial cycles among rodents and sylvatic Triatoma species in the inter-Andean 
valleys of Bolivia, Peru and Chile (Cortez et al., 2006; Barnabé et al., 2011; Arenas et al., 
2012; Breniere et al., 2012). Multiple molecular markers consistently identify high levels of 
genetic diversity within sylvatic TcI populations (Herrera et al., 2007b; 2009; O’Connor et 
al., 2007; Falla et al., 2009; Llewellyn et al., 2009a; Ocaña-Mayorga et al., 2010; Lima et al., 
2014), and divergent, but genetically homogeneous, strains associated with human infections 
(Llewellyn et al., 2009a; Cura et al., 2010; Ramírez et al., 2012; Zumaya-Estrada et al., 
2012). 
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By contrast, TcII, TcV and TcVI are less genetically diverse overall (Lewis et al., 2011) and 
appear confined to domestic transmission cycles in southern parts of South America (Miles et 
al., 2009). The sylvatic reservoirs of these three DTUs are not fully defined, although TcII 
has been increasingly isolated from primates in Brazil (Fernandes et al., 1999; Lisboa et al., 
2007; Araújo et al., 2011); peridomestic dogs are emerging as potential hosts of TcV and 
TcVI (Maffey et al., 2012; Enriquez et al., 2013; Fernandez et al., 2014). The geographical 
range of TcV and TcVI appears to be more extensive than previously suggested, with reports 
of these hybrid DTUs as far north as Colombia (Guhl and Ramírez, 2013; Messenger et al., 
submitted).  
 
. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17. Approximate geographical distributions of T. cruzi lineages and transmission cycles.  
Source: M. Llewellyn (LSHTM). 
 
TcIII has a dispersed terrestrial distribution that ranges from Amazonia to Argentina, where it 
is primarily transmitted by P. geniculatus to D. novemcinctus and other burrowing mammals 
(Yeo et al., 2005; Marcili et al., 2009b; Llewellyn et al., 2009b). TcIV is poorly understood, 
principally because several genotyping methods fail to distinguish this lineage from others, 
particularly from TcIII (Fernandes et al., 1998a; Lewis et al., 2009a). However, TcIV is 
known to circulate sympatrically with TcI in wild primates (Marcili et al., 2009c) and 
racoons and dogs (Roellig et al., 2013), in the Amazon and North America, respectively. 
TcIV is also increasing in importance to human disease; it is a secondary agent of Chagas 
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disease in Venezuela (Miles et al., 1981a; Carrasco et al., 2012) and has been isolated from 
recent oral outbreaks in the Brazilian Amazon (Roque et al., 2008; Marcili et al., 2009c; 
Valente et al., 2009; Monteiro et al., 2010; 2012) and Colombia (Ramírez et al., 2013a). As 
yet, TcIII and TcIV only sporadically invade domestic transmission cycles, but this may 
reflect the relative paucity of available samples and the insensitivity of conventional 
genotyping methods. Finally, TcBat, a new genetically-distinct and potentially human-
infective lineage (Ramírez et al., 2013b) has been isolated from Chiroptera species across 
Brazil (Marcili et al., 2009a), Panama (Pinto et al., 2012) and Colombia (Ramírez et al., 
2014). 
 
1.14 Genetic exchange in kinetoplastid protozoa and its phenotypic implications 
Many eukaryotic pathogenic microorganisms (both fungal and protozoan) that were 
previously assumed to reproduce clonally have non-obligate cryptic sexual cycles (Heitman, 
2010). Genetic exchange has the potential to drive the evolution of novel recombinant strains 
with epidemiologically significant traits, including increased pathogenicity, transmissibility 
and drug resistance (Awadalla, 2003). However, limiting sexual reproduction allows the 
generation of host-adapted clonal populations that retain the ability to hybridize in response 
to selective pressures (Heitman, 2006). The conservation of meiotic gene orthologues among 
several basally divergent protists, including Giardia (Poxleitner et al., 2008), Entamoeba 
(Ramesh et al., 2005) and Trichomonas (Malik et al., 2008) suggests that the common 
ancestor of all eukaryotes was capable of meiotic recombination.  
Evidence of linkage disequilibrium (non-random association of genotypes at different loci) 
and deviations from Hardy-Weinberg expectations among various parasitic protozoa, 
including T. cruzi, T. brucei and Leishmania species, has reinforced the pervasive view that 
these pathogens rarely engage in sexual reproduction if even at all (Smith et al., 1993; 
Tibayrenc et al., 1986; 1990; reviewed by Tibayrenc and Ayala, 2012; 2013). However, the 
generation of in vitro experimental hybrids in each of these species indicates that all have 
retained their capacity for genetic exchange (Jenni et al., 1986; Gaunt et al., 2003; Akopyants 
et al., 2009; Calvo-Álvarez et al., 2014).  
Molecular analyses of representative field isolates now suggest that a variety of population 
structures exists among natural geographical foci, ranging from endogamy/inbreeding 
(Rougeron et al., 2009; 2011) to epidemics (MacLeod et al., 2000) and exogamy/outbreeding 
(Morrison et al., 2009), which do not conform to traditional models of strict clonality or 
panmixia (Smith et al., 1993; Ramírez and Llewellyn, 2014) (Figure 1.18).  The existence of 
natural hybrid strains has also been reported in T. cruzi (section 1.12) and between a number 
of different Leishmania sub-species (Belli et al., 1994; Dujardin et al., 1995; Ravel et al., 
2006; Nolder et al., 2007; Rougeron et al., 2009; Chargui et al., 2009; Odiwuor et al., 2011; 
Gelanew et al., 2014; Rogers et al., 2014).  
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Figure 1.18. Mechanisms of genetic exchange among selected parasitic protozoa, predicted 
implications for population structure and observed population structures in the field. Source: Ramírez 
and Llewellyn, 2014. 
 
In T. brucei brucei and L. major, genetic exchange is non-obligatory, occurs in their insect 
vectors (tsetse flies and sandflies, respectively) and involves Mendelian segregation of 
parental alleles (Jenni et al., 1986; Akopyants et al., 2009 Peacock et al., 2011; Inbar et al., 
2013), and in the former, the production of putative haploid life cycle stages (Peacock et al., 
2014). By comparison, characterization of experimental intra-TcI hybrids indicates that for T. 
cruzi recombination may arise within the mammalian host and is analogous to the parasexual 
cycle of Candida albicans (Bennett and Johnson, 2003); nuclear fusion creates a tetraploid 
intermediate, followed by homologous recombination, gradual genome erosion and reversion 
to aneuploidy (Gaunt et al., 2003; Lewis et al., 2009b). This unusual mating system differs 
from canonical meiosis and is challenging to reconcile with both the presence of highly 
conserved meiosis-specific orthologues within the T. cruzi genome and the existence of 
natural diploid heterozygous lineages, which resemble Mendelian F1 progeny (TcV and 
TcVI) (Lewis et al., 2009b; 2011). These hybrid strains are found almost exclusively in 
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domestic transmission cycles and are associated with human disease in Paraguay, Chile, 
Argentina, Bolivia and Southern Brazil, despite the abundance of other genotypes in these 
regions. Molecular dating indicates that these DTUs evolved recently, which suggests there is 
continuous risk of genetic exchange driving the emergence of novel recombinant genotypes 
(Lewis et al., 2011).   
Importantly, the effect of hybridization on T. cruzi phenotype remains unresolved. The 
phenomenon of hybrid vigour (heterosis), whereby recombinants display novel, often 
enhanced phenotypes compared to parental strains, is well documented among parasitic 
protozoa (reviewed by Detwiler and Criscione, 2010). Preliminary reports of heterosis in T. 
cruzi, manifesting as different temperature stabilities of glucosephosphate isomerase 
isoenzymes, were described by Widmer et al., 1987. More recent observations of natural 
Leishmania hybrids indicate that genetic exchange can alter vector permissibility (Volf et al., 
2007), increase virulence (Akopyants et al., 2009; Cortes et al., 2012) and generate 
successful variants which are capable of widespread clonal dissemination (Schwenkenbecher 
et al., 2006; Nolder et al., 2007), a scenario reminiscent of the dispersal of TcV and TcVI 
throughout the Southern Cone countries.   
Detecting genetic exchange among natural T. cruzi populations is of profound importance 
considering the expansion of the hybrid lineages within the domestic niche, their association 
with clinical disease and the capacity for recombination to accelerate the evolution of novel 
strains with potentially important phenotypes. Furthermore, understanding the impact of 
hybridization on parasite genetic diversity and population structure is crucial to provide an 
accurate assessment of the epidemiological risk associated with recombinant T. cruzi 
genotypes.  
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1.15 PhD aims, biological objectives and milestones 
The overall aim of this PhD project was to investigate genetic diversity in T. cruzi through 
significant development of phylogenetic markers and their application to the characterization 
of natural parasite population structures and genetic exchange mechanisms. 
Biological objectives were: 
- To contribute to the characterization of inter- and intra-DTU T. cruzi genetic diversity 
among natural parasite populations.  
- To investigate intra-host T. cruzi multiclonality and its association with transmission 
and the clinical status of Chagas disease. 
- To explore the interaction between parasite genetic heterogeneity and ecological 
biodiversity. 
- To examine the frequency and mechanisms of genetic exchange among natural 
parasite populations. 
Specific milestones included to: 
1. Evaluate nuclear housekeeping genes as MLST candidates for T. cruzi DTU-level 
assignment. 
2. Optimize nuclear targets for inclusion in a standardized MLST scheme for wider use 
by the T. cruzi research community. 
3. Develop mitochondrial phylogenetic markers to describe intra-lineage genetic 
diversity in combination with multilocus microsatellite typing (MLMT). 
4. Investigate intra-host parasite multiclonality through the application of Illumina 
amplicon deep sequencing markers. 
5. Exploit high resolution nuclear and mitochondrial genotyping to identify ecological 
determinants of sylvatic parasite diversification and to detect incidences of natural 
genetic exchange occurring among putative parasite contact zones.  
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2. Materials and methods  
!
2.1 Ethics statements 
All molecular analyses in chapters 3-5 were performed at the London School of Hygiene and 
Tropical Medicine (LSHTM) following approval from the Ethics Committee (document No 
5483 “Comparative epidemiology of genetic lineages of Trypanosoma cruzi”). All T. cruzi 
field strains were collected with permissions from local institutional review boards (IRBs). 
Written informed consent was obtained prior to isolating human-derived strains, under the 
supervision and approval of local IRBs. 
 
2.2 Parasite stocks 
T. cruzi strains used in chapters 3-5 were obtained from the LSHTM cryobanks or through 
members of the ChagasEpiNet EC consortium. Specific panels of strains are included in each 
individual study. 
 
2.3 Routine procedures 
2.3.1 Parasite (epimastigote) culture 
T. cruzi epimastigotes were cultivated in either biphasic or liquid growth medium.  Biphasic 
cultures consisted of 4% (w/v) blood agar base, 0.6% (w/v) agar, 0.6% (w/v) NaCl, 0.5% 
(w/v) tryptone (all Sigma-Aldrich, UK) and 10% (v/v) defibrinated rabbit blood, prepared in 
sterile NunclonTM Δ flat sided culture tubes (Nunc, Denmark) and overlaid with 0.9% NaCl 
(w/v) solution and 50µg/ml gentamycin (Sigma-Aldrich, UK). Liquid growth medium 
consisted of either RPMI-1640 (#R0883) or liver infusion tryptose (LIT). RPMI-1640 was 
supplemented with 0.5% (w/v) tryptone, 20mM HEPES buffer (pH 7.2), 30mM haemin, 10% 
(v/v) heat-inactivated fetal bovine serum (FBS), 2mM sodium glutamate, 2mM sodium 
pyruvate, 250µg/ml streptomycin, 250U/ml penicillin and 25µg/ml gentamycin (all Sigma-
Aldrich, UK). LIT was prepared by dissolving 25g liver infusion broth (DifcoTM, Becton 
Dickenson, USA), 5g tryptone, 4g NaCl, 2g glucose, 0.4g KCl and 3.15g Na2HPO4 in 900 ml 
ddH2O and adjusting the pH to 7.4 before adding 25g haemin dissolved in 1 ml 1N NaOH, 
100 ml heat inactivated FBS, 250µg/ml streptomycin, 250U/ml penicillin and 25µg/ml 
gentamycin (all Sigma-Aldrich, UK).  
Cultures in liquid medium were maintained in 25cm2 flasks (Becton Dickinson, USA) and 
incubated at 28oC in a humidified atmosphere of 5% CO2. Parasites were routinely 
maintained in logarithmic growth phase by re-passaging cultures at 1:20-1:50 dilutions every 
1-3 weeks, depending on strain growth rate.  
For long-term cryopreservation of parasites, late logarithmic phase cultures were 
supplemented with sterile 10% glycerol (v/v) (VWR, UK) and aliquots were prepared in 
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cryovials (Nunc, Denmark). Cryovials were stored at -70oC for 24 hours before transfer to 
liquid nitrogen containers in the LSHTM cryobank.   
To recover parasites from cryopreservation, cryovials were carefully thawed in a 37oC water 
bath and the contents aliquoted into a biphasic culture tube or 1 ml of liquid medium in a 24-
well culture plate (Becton Dickinson, USA).   
 
2.3.2 Isolating parasite field strains 
T. cruzi strains were isolated from Chagas seropositive patients or mammalian hosts by 
hemoculturing; isolation protocols had minor differences between studies. In general, 
between 0.5-20 ml venous blood was collected in a sterile BD Vacutainer® spray-coated K2 
EDTA tube (Becton Dickinson, USA) and either aliquoted directly into biphasic culture tubes 
or LIT medium, or inoculated following the removal of plasma by centrifugation. All 
procedures were performed under sterile conditions in a laminar flow hood and samples were 
processed less than 12 hours after blood draw.  
Hemocultures were maintained at 26-28oC and examined microscopically for motile 
trypanosomes fortnightly for up to six months. Positive primary cultures were allowed to 
grow to late logarithmic phase and preserved in 1:1 6M guanidine hydrochloride - 0.2M 
EDTA (GEB) (Sigma-Aldrich, UK). 
 
2.3.3 Biological cloning of parasites on solid media  
Solid phase cloning was undertaken at the LSHTM as described by Yeo et al., 2007. 
Uncloned culture density was measured using a disposable haemocytometer (Immune 
Systems, UK) and 102-103 logarithmic phase cells were mixed with 2.4 ml (w/v) 
supplemented RPMI-1640 medium and 0.6 ml molten 3% (w/v) low melting point (LMP) 
agarose containing 0.9% NaCl (w/v) and 50µg/ml gentamycin (all Sigma-Aldrich, UK).  This 
overlay was poured onto a blood agar plate (prepared by adding 10.8 ml biphasic medium, 
described in section 2.3.1, to a sterile 90mm petri dish (Sterilin, UK)) and allowed to set.  
Plates were sealed with parafilm (VWR, UK) and incubated at 28oC in a humidified 
atmosphere of 5% CO2.   
Once colonies became visible (2-4 weeks depending on strain growth rate), they were 
examined microscopically, picked using a 200µl sterile pipette tip and inoculated into 1 ml 
liquid growth medium in a 48-well culture plate (Becton Dickinson, USA). 
For studies in chapter 5, where parasite DNA was provided by Universidad de los Andes, 
biological clones were derived from primary parasite cultures by either limiting dilution 
(Ramírez et al., 2013c) or fluorescence activated cell sorting (FACS) (Valadares et al., 2012). 
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2.3.4 Extraction of parasite genomic DNA 
Total genomic DNA from late logarithmic phase cultures (~107-108 parasites) was prepared 
using a Gentra Puregene Tissue kit (Qiagen, UK), according to the manufacturer’s protocol. 
For field samples in GEB, DNA was extracted using either a DNeasy® Blood and Tissue kit 
(QIAGEN, UK) or a High Pure PCR template preparation kit (Roche, UK), according to the 
manufacturer’s protocol. 
 
2.3.5 Polymerase chain reaction (PCR)  
Unless otherwise specified, all PCR reactions contained: 1X NH4 reaction buffer, 1.5mM 
MgCl2 (Bioline, UK), 0.2mM dNTPs (New England Biolabs, UK), 10pmol of each primer, 
1U BIOTAQTM DNA polymerase (Bioline, UK) and 10-100ng of template DNA, diluted in 
ddH2O to a final volume of 20µl.  Depending on sample numbers, reactions were prepared in 
either 0.2 ml PCR tube strips (VWR, UK) or 96-well reaction plates (Fisher Scientific, UK). 
All PCR amplifications were performed in a G-Storm thermal cycler (G-Storm, UK).   
 
2.3.6 Agarose gel electrophoresis 
PCR products were routinely visualized by gel electrophoresis using agarose gels containing 
0.5µg/ml ethidium bromide (EtBr) (Sigma-Aldrich, UK).  For DNA fragments with sizes 
ranging from 0.5-10kb, 1.5% agarose gels (Bioline, UK) were used and run at 90V for 1-4 
hours in 1X TAE buffer, depending on the level of separation required.  
In some cases, to visualize small base pair differences (5-20 bp), PCR products were 
separated by gel electrophoresis using 3.5% NuSieveTM GTGTM low melting temperature 
agarose gels (Lonza, UK) containing 0.5µg/ml ethidium bromide (Sigma-Aldrich, UK).  
If PCR products required gel extraction, products were separated in 0.8% agarose gels 
(Bioline, UK). The following DNA molecular weight markers were used according to the 
range of size separation required: 0.1-1kb HyperladderTM IV; 0.2-10kb HyperladderTM I (both 
Bioline, UK).  All samples were loaded into agarose gel wells with 1µl of 5X DNA loading 
buffer (Bioline, UK). Following electrophoresis, gels were visualized using a UV 
transilluminator (UVP).  
 
2.3.7 PCR purification  
All PCR products were purified using QIAquick PCR Purification kits (Qiagen, UK), 
according to the manufacturer’s protocol.  When reactions produced multiple bands or a 
specific band was required for further analysis, the appropriate-sized band was excised with a 
sterile scalpel blade (SLS, UK) under UV illumination, and purified using a QIAquick Gel 
Extraction kit (Qiagen, UK).   
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2.3.8 Chain termination DNA sequencing 
Bi-directional sequencing was performed using a BigDyeTM Terminator v3.1 Cycle 
Sequencing kit (Applied Biosystems, UK), according to a modified version of the 
manufacturer’s protocol. Sequencing reactions contained 0.5µl Big Dye sequencing RR-100, 
1.7µl sequencing buffer, 3.2pmol of forward or reverse primer and 20-100ng of purified PCR 
product or plasmid DNA, diluted in ddH2O to a final volume of 10µl.  Reactions were 
subjected to 25 cycles of the following conditions: rapid thermal ramp to 96oC (1oC/second), 
96oC for 30 seconds, rapid thermal ramp to 55oC (1oC/second), 55oC for 20 seconds, rapid 
thermal ramp to 60oC (1oC/second) and 60oC for 4 minutes.  
Reactions were transferred to 96-well optical reaction plates with barcodes (Applied 
Biosystems, UK).  For each sample, DNA was precipitated by the addition of 8µl ddH2O 
followed by 32µl ice-cold 95% (v/v) ethanol. Samples were incubated at 4oC for 15 minutes 
and then centrifuged at 3000g for 45 minutes at 4oC. Supernatants were removed by inverting 
the plates onto absorbent paper and centrifuging at 20g for 10 seconds.  DNA pellets were 
washed by the addition of 50µl ice-cold 70% (v/v) ethanol and briefly vortexing.  Samples 
were then centrifuged at 3000g for 30 minutes at 4oC.  Supernatants were aspirated as 
previously and the DNA pellets left to dry at room temperature until no visible ethanol 
remained.  DNA pellets were then re-suspended in 10µl Hi-DiTM deionized formamide 
(Applied Biosystems, UK) and stored at -20oC. DNA sequences were analyzed on a 16-
capillary 3730 DNA Analyzer (Applied Biosystems, UK).   
!
2.3.9 Ligation reactions 
All ligation reactions were performed using reagents from the pGEM®-T Easy Vector System 
I kit (Promega, UK), according to the manufacturer’s instructions. Since TA cloning is 
dependent on the presence of a 3’terminal adenine base, added to amplicons during PCR 
amplification, all PCR products were first subjected to A-tailing by incubation for 30 minutes 
at 72oC in a reaction containing 1X NH4 reaction buffer, 2mM MgCl2, 10mM dATP and 2U 
BIOTAQTM DNA polymerase (all Bioline, UK) diluted in ddH2O to a final volume of 50µl.  
A-tailed PCR products were then gel purified (section 2.3.7) and cloned separately into the 
pGEM®-T Easy Vector (Promega, UK). 
 Ligation reactions contained insert and vector DNA in a 3:1 molar ratio, 2X rapid ligation 
buffer, 50ng pGEM®-T Easy Vector and 3U T4 DNA ligase, diluted in ddH2O to a final 
volume of 10µl.  Each set of reactions was accompanied by a self-ligation control (pGEM®-T 
Easy Vector with no insert) and two positive control reaction (control insert DNA with 
pGEM®-T Easy Vector or transformed whole plasmid DNA).  Ligations were incubated at 
room temperature overnight.   
 
2.3.10 Preparation of chemically competent bacterial cells  
Bacterial cells from a frozen glycerol stock were streaked onto a lysogeny broth (LB) agar 
plate with no antibiotic selection, using a sterile 200µl pipette tip, and incubated overnight at 
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37oC. A single colony from this plate was inoculated into 2 ml LB broth with no antibiotic 
selection in a sterile 30 ml universal tube (Sterilin, UK) and the culture was grown overnight 
in a shaking incubator at 37oC.  The following day 1 ml of the overnight culture was used to 
seed 100 ml of LB broth (no antibiotic selection) in a 2 L conical flask (Fisher, UK).  The 
culture was grown in a shaking incubator at 37oC until the optical density at 600nm 
(measured using a spectrophotometer and calibrated using a cuvette of LB) reached between 
0.6-0.8. Cells were transferred to a 50 ml centrifuge tube (Corning, UK) on ice and left to 
cool for 1 hour.  The culture was centrifuged at 3500 rpm for 15 minutes at 4oC, the 
supernatant discarded, and the pellet re-suspended in 30 ml ice-cold 100mM CaCl2 
(containing 15% glycerol, VWR, UK) and incubated on ice for 1 hour.  The cell suspension 
was centrifuged as previously and the pellet re-suspended in 8 ml ice-cold 100mM CaCl2 
(15% glycerol) and incubated on ice for 1 hour. Competent cells were aliquoted into sterile 
1.5 ml graduated microtubes (Anachem, UK) and flash-frozen by incubating in dry ice and 
absolute ethanol for 5 minutes. Aliquots were stored at -80oC. 
 
2.3.11 Bacterial transformations 
Completed ligation reactions were transformed into Escherichia coli strain XL1-Blue 
(Agilent Technologies, UK), according to the following procedure.  Sterile 1.5 ml graduated 
microtubes (Anachem, UK) were placed on ice and allowed to cool. To each tube 100µl of 
bacterial cell suspension was added, mixed with 5µl of ligation reaction, and incubated on ice 
for 30 minutes.  Each tube was then heat shocked by incubating in a water bath at 42oC for 1 
minute after which it was returned directly to ice and incubated for a further 2 minutes. 250µl 
of room temperature super optimal broth with catabolite repression (SOC) medium was 
added to each tube and reactions were incubated for 1-1.5 hours at 37oC in a shaking 
incubator. 100µl of each reaction was then spread aseptically onto the surface of a pre-
warmed LB agar plate supplemented with 100µg/ml ampicillin (Sigma-Aldrich, UK), 
80µg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) and 20mM isopropyl β-
D-1-thiogalactopyranoside (IPTG) (both Bioline, UK). Agar plates were incubated at 37oC 
for 16-24 hours and stored at 4oC to facilitate colour-based colony selection.   
Colonies were picked from agar plates using sterile 200µl pipette tips, which were then used 
to inoculate 5 ml cultures of fresh LB broth containing 100µg/ml ampicillin in sterile 30 ml 
universal tubes (Sterilin, UK).  Cultures were incubated overnight in a shaking incubator at 
37oC.   
Plasmid DNA was purified from 3 ml of each overnight culture using a QIAprep Spin 
Miniprep kit (Qiagen, UK), according to the manufacturer’s protocol.  Successful ligation of 
inserts into the pGEM®-T Easy Vector was confirmed by digestion of plasmid DNA with 
either EcoRI or NotI restriction enzymes, as described in section 2.3.12.   
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2.3.12 Restriction enzyme digests  
Restriction enzyme digestion reactions typically contained up to 100ng/µl DNA, 0.25U/µl of 
one or two restriction endonucleases, 100ng/µl bovine serum albumin (BSA) and 1X 
manufacturer’s recommended reaction buffer diluted in ddH2O (all New England Biolabs, 
UK). All reactions were incubated at 37oC for up to 24 hours and then visualized by agarose 
gel electrophoresis, as described in section 2.3.6.   
 
2.4 T. cruzi genotyping  
 
2.4.1 T. cruzi DTU assignment 
Strains were routinely assigned to DTU-level using a standardized triple-assay comprising 
PCR product size polymorphism analysis of the 24Sα rRNA gene (LSU rDNA) and PCR-
restriction fragment-length polymorphism analysis (PCR-RFLP) using heat shock protein 60 
(HSP60) and glucose-6-phosphate isomerase (GPI) (Lewis et al., 2009a).  
PCR amplifications were performed as described in section 2.3.5, using primers listed in 
Table 2.1. Reaction conditions for the 24Sα rRNA (LSU rDNA) PCR were an initial 
denaturation step of 94oC for 3 minutes and then 27 amplification cycles (94oC for 1 minute, 
60oC for 1 minute, 72oC for 1 minute), followed by a final elongation step at 72oC for 5 
minutes. Reaction conditions for both HSP60 and GPI used a touchdown PCR strategy 
comprising an initial denaturation step of 3 minutes at 94oC, followed by four cycles (94oC 
for 30 seconds, 64oC for 30 seconds, 72oC for 1 minute), followed by 28 cycles (94oC for 30 
seconds, 60oC for 30 seconds, 72oC for 1 minute), and then a final elongation step at 72oC for 
10 minutes.   
!
Table 2.1. PCR-RFLP gene fragments and primer details. 
PCR-RFLP 
Target 
Primer Name Primer Sequence (5’→3’) 
LSU rDNAa D71 AAGGTGCGTCGACAGTGTGG (20) 
 D72 TTTTCAGAATGGCCGAACAGT (21) 
HSP60b HSP60_for GTGGTATGGGTGACATGTAC (20) 
 HSP60_rev CGAGCAGCAGAGCGAAACAT (20) 
GPIc GPI_for GGCATGTGAAGCTTTGAGGCCTTTTTCAG (29) 
 GPI_rev TGTAAGGGCCCAGTGAGAGCGTTCGTTGAATAGC (34) 
 
a Primer sequences according to Brisse et al., 2001. 
b Primer sequences according to Strurm et al., 2003. 
c Primer sequences according to Gaunt et al., 2003. 
!
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Successful amplifications were confirmed by visualization of 24Sα rRNA PCR products on 
3.5% NuSieveTM GTGTM agarose gels (Lonza, UK) and HSP60 and GPI PCR products on 
1.5% agarose gels (Bioline, UK), as described in section 2.3.6.  
!
Table 2.2. T. cruzi genotype assignment of PCR amplification product sizes (bp). 
Target/ 
Enzyme 
Expected PCR product (digestion product) band size (bp) 
 TcI TcII TcIII TcIV TcV TcVI 
LSU 
rDNA  
110 125 110 117* or 120 or 
125§ or 130¶ 
110 or 110 + 
125** 
125 
HSP60/
EcoRV 
 
432 - 462 (432 
- 462) 
432 - 462 (432 - 
462) 
432 – 462 
(314 + 148 
- 118) 
432 - 462 (432 - 
462) 
432 - 462 (432 - 
462 + 314 +148 - 
118) 
432 - 462 (432 - 
462 + 314 + 148 - 
118) 
GPI/ 
HhaI 
 
1,264 (817 + 
447) 
1,264 (490 + 
447 + 253) 
1,264 (817 
+ 447) 
1,264 (490 + 
447 + 253) 
1, 264 (817 + 490 
+ 447 + 253) 
1,264 (817 + 490 
+ 447 + 253) 
*According to Kawashita et al., 2001. 
** Double band pattern observed for most isolates; 125bp band exhibits variable intensity 
§According to Brisse et al., 2001. 
¶For strains of North American origin, according to Brisse et al., 2001. 
 
 
HSP60 and GPI PCR products were purified according to section 2.3.7 and then subjected to 
restriction digest with EcoRV or HhaI restriction endonucleases (New England Biolabs, UK), 
respectively, as described in section 2.3.12. 10µl of each digest reaction was visualized using 
either 1.5% (GPI/HhaI) or 3% agarose gels (HSP60/EcoRV) (Bioline, UK), as described in 
section 2.3.6.  
T. cruzi strains were assigned to DTU-level based on the number and size of their restriction 
fragment bands, as shown in Table 2.2, Figure 2.1 and 2.2.  
 
 
 
 
 
55 
!
 
 
 
 
 
 
 
 
Figure 2.1. Recommended triple-assay for discriminating T. cruzi DTUs. Source: Lewis et al., 2009a. 
!
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Figure 2.2. Examples of PCR-RFLP genotyping profiles. 
A. LSU rDNA. B. HSP60/EcoRV digestion products are shown. C. GPI/HhaI digestion products are 
shown.  For all gels, Lanes: 1, Sylvio X10/1 (TcI); 2, Esm cl3 (TcII); 3, M5631 (TcIII); 4, CanIII cl1 
(TcIV); 5, 92122102R (TcIV NA); 6, Sc43 cl1(TcV); 7, CL Brener (TcVI); 8, negative control.   
!
!
2.4.2 Nuclear multilocus sequence typing (nMLST)  
A total of nine single-copy nuclear housekeeping gene fragments were chosen for initial 
MLST evaluation: dihydrofolate reductase-thymidylate synthase (DHFR-TS), LYT1, 
metacyclin-II (Met-II), metacyclin-III (Met-III), RNA-binding protein-19 (RB19), ascorbate-
dependent haemoperoxidase (TcAPX), glutathione-dependent peroxidase II (TcGPXII), 
mitochondrial peroxidase (TcMPX) and trypanothione reductase (TR). Primer sequences are 
given in Table 2.3. PCR reactions were performed as described in section 2.3.5.  
 
For DHFR-TS and TR, reaction conditions were an initial denaturation step for 3 minutes at 
94oC, followed by 30 amplification cycles (94oC for 30 seconds, 58oC for 1 minute, 72oC for 
2 minutes). Annealing temperatures were 55oC for TcAPX, 50oC for TcMPX and 62oC for 
TcGPXII. Reaction conditions for Met-II and RB19 were 3 minutes at 94oC, followed by 30 
amplification cycles (94oC for 30 seconds, 53oC for 30 seconds, 72oC for 45 seconds). 
Annealing temperatures were 51oC for Met-III and 56oC for LYT1. All reactions had a final 
ten minute elongation step at 72oC.  
 
Successful amplifications were confirmed by visualization of PCR products on 1.5% agarose 
gels, as described in section 2.3.6. PCR products were purified according to section 2.3.7 and 
sequenced according to section 2.3.8 using PCR primer pairs and additional internal primers, 
as indicated in Table 2.3. !
For optimization of MLST targets, PCR reactions contained: 10µl GoTaq® reaction buffer 
(Promega, UK), 0.2mM dNTPs (New England Biolabs, UK), 10pmol of each primer (Table 
57 
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2.3), 1U GoTaq® DNA polymerase (Promega, UK) and 100ng of template DNA, diluted in 
ddH2O to a final volume of 50µl.  
 
Amplification conditions for all targets were an initial denaturation step for 5 minutes at 
94oC, followed by 35 amplification cycles (94oC for 1 minute, 55oC for 1 minute, 72oC for 1 
minute) with a final extension step of 72oC for 5 minutes.  
 
Successful amplifications were confirmed by visualization of PCR products on 1.5% agarose 
gels, as described in section 2.3.6. PCR products were purified according to section 2.3.7 and 
sequenced according to section 2.3.8 using PCR primer pairs (Table 2.3). To assess 
reproducibility, each PCR amplification and subsequent sequencing reaction was repeated at 
least twice. 
 
Additional MLST targets from Diosque et al., 2014, were used in selected analyses in chapter 
5, as indicated.  
 
 
 
 
58
 
!T
ab
le
 2
.3
. T
. c
ru
zi
 n
uc
le
ar
 g
en
e 
fr
ag
m
en
ts
 a
nd
 p
rim
er
 d
et
ai
ls
.  
 
G
en
e 
Fr
ag
m
en
t 
G
en
e 
ID
 
G
en
om
e 
Po
si
tio
na
 
Pr
im
er
 S
eq
ue
nc
e 
(5
’→
3’
) 
A
m
pl
ic
on
 
Si
ze
 (b
p)
 
Se
qu
en
ce
  
St
ar
t 5
’ 
Se
qu
en
ce
 
St
ar
t 3
’ 
Fr
ag
m
en
t L
en
gt
h 
(b
p)
  
D
H
FR
-T
S 
Tc
00
.1
04
7
05
35
09
15
3.
90
 
27
 
C
G
C
TG
TT
TA
A
G
A
TC
C
G
N
A
TG
C
C
 (2
2)
 F
W
D
 
14
73
 
G
C
G
G
G
A
G
A
 
C
A
C
G
C
TC
T 
71
5 
C
G
C
A
TA
G
TC
A
A
TG
A
C
C
TC
C
A
TG
TC
 (2
4)
 R
EV
 
A
C
C
C
TG
TC
C
G
TC
A
TA
G
TT
G
 (1
9)
 IN
T*
 
LY
T1
 
Tc
00
.1
04
7
05
35
08
04
5.
40
 
22
 
C
A
A
C
TT
G
C
C
C
TT
TT
G
C
TC
TC
 (2
0)
 F
W
D
 
80
4 
TT
TG
TG
A
C
 
G
TG
G
TG
G
A
 
69
1 
G
TT
G
TT
G
TT
G
TT
G
C
C
C
TG
TG
 (2
0)
 R
EV
 
A
C
A
A
G
G
G
TG
TT
TC
C
G
TG
A
A
G
 (2
0)
 IN
T 
M
et
-I
I 
Tc
00
.1
04
7
05
35
10
88
9.
28
 
6 
TC
A
TC
TG
C
A
C
C
G
A
TG
A
G
TT
C
 (2
0)
 F
W
D
 
70
2 
C
A
TT
TT
C
A
 
TT
TT
G
C
C
A
 
 
39
0 
C
TC
C
A
TA
G
C
G
TT
G
A
C
G
A
A
C
A
 (2
0)
 R
EV
 
TG
TG
TC
C
A
C
A
A
TT
C
G
TC
G
TT
 (2
0)
 IN
T 
M
et
-I
II
 
 
Tc
00
.1
04
7
05
35
10
94
3.
44
 
36
 
G
TG
G
C
TC
C
A
A
A
G
G
C
A
TA
A
G
A
 (2
0)
 F
W
D
 
82
4 
TT
C
A
TC
C
G
 
TT
TC
TT
TG
 
61
9 
C
C
C
C
C
TT
C
TT
TG
C
C
A
A
TT
A
T 
(2
0)
 R
EV
 
C
A
C
A
TG
A
G
G
TC
G
TG
TT
G
TC
C
 (2
0)
 IN
T 
RB
19
 
Tc
00
.1
04
7
05
35
07
51
5.
60
 
29
 
G
C
C
TA
C
A
C
C
G
A
G
G
A
G
TA
C
C
A
 (2
0)
 F
W
D
 
40
8 
G
TC
G
TG
C
G
 
C
C
C
A
G
A
C
T 
35
0 
TT
C
TC
C
A
A
TC
C
C
C
A
G
A
C
TT
G
 (2
0)
 R
EV
 
Tc
AP
X 
Tc
00
.1
04
7
05
35
06
19
3.
60
 
36
 
G
G
G
A
A
G
C
TT
TC
A
C
TT
TG
C
C
TA
TT
TT
G
A
C
TC
 (3
0)
 F
W
D
 
15
00
 
G
C
G
A
G
TC
G
 
G
G
C
G
C
C
G
G
 
79
9 
G
G
G
G
G
A
TC
C
A
TG
G
C
TT
TT
TG
TT
TT
G
G
TT
C
A
 (3
0)
 R
EV
 
59
 
!Tc
G
PX
II
 
Tc
00
.1
04
7
05
35
11
01
9.
99
 
35
 
G
G
G
C
A
G
C
A
G
C
A
C
G
C
TG
TT
C
G
 (2
0)
 F
W
D
 
48
7 
TT
G
C
G
G
C
C
 
A
TC
C
G
G
C
C
 
43
7 
TC
A
TG
C
A
C
C
C
C
G
TT
G
C
G
G
C
C
C
 (2
1)
 R
EV
 
Tc
M
PX
 
Tc
00
.1
04
7
05
35
09
49
9.
14
 
22
 
A
TG
TT
TC
G
TC
G
TA
TG
G
C
C
 (1
8)
 F
W
D
 
67
8 
TA
C
A
TG
G
A
 
C
G
C
A
C
C
G
T 
50
5 
TG
C
G
TT
TT
TC
TC
A
A
A
A
TA
TT
C
 (2
1)
 R
EV
 
TR
 
Tc
00
.1
04
7
05
35
03
55
5.
30
 
37
 
A
C
TG
G
A
G
G
C
TG
C
TT
G
G
A
A
C
G
C
 (2
1)
 F
W
D
 
12
90
 
TG
TC
A
A
TG
 
TA
C
G
A
A
G
G
 
60
2 
G
G
A
TG
C
A
C
A
C
C
R
A
TR
G
TG
TT
G
T 
(2
2)
 R
EV
 
C
G
A
A
TG
A
R
G
C
A
TT
Y
TA
C
C
TG
 (2
0)
 IN
T 
TA
C
TC
G
TC
C
A
C
C
TG
C
A
C
A
C
C
A
C
 (2
2)
 IN
T 
 a C
hr
om
os
om
al
 a
ss
ig
nm
en
t b
as
ed
 o
n 
W
ea
th
er
ly
 e
t a
l.,
 2
00
9.
!
* 
In
di
ca
te
s i
nt
er
na
l p
rim
er
s u
se
d 
du
rin
g 
se
qu
en
ci
ng
 re
ac
tio
ns
. 
             
60 
!
2.4.3 Phylogenetic analysis of nMLST 
Nucleotide sequences were assembled manually in BioEdit v7.1.3.0 sequence alignment 
editor software (Ibis Biosciences, USA) (Hall, 1999) and unambiguous consensus sequences 
were produced for each isolate. Heterozygous SNPs were visually identified by the presence 
of two coincident peaks at the same locus (‘split peaks’), verified in forward and reverse 
sequences, and manually scored according to the one-letter nomenclature for nucleotides 
from the International Union of Pure and Applied Chemistry (IUPAC) (Figure 2.3).  !!
!
!
!
!
!
Figure 2.3. Example of a heterozygous sequence chromatogram. Four heterozygous SNPs in the 
coding region of Met-III from Sc43 cl1 (TcV) (heterozygous SNPs are indicated by arrows).  From 
left to right the heterozygotes are C/G (=S), A/G (=R), A/G (=R) and C/T (=Y).  This chromatogram 
emphasizes the importance of manually editing sequences as the first two split peaks have been 
incorrectly resolved by BioEdit and the latter two are ambiguous to the software.  
Initially, phylogenetic analysis was performed on modified sequences according to the 
methodology described by Tavanti et al., 2005, which renders diplotypic data suitable for the 
construction of distance-based dendrograms. Briefly, variable loci between isolates can be 
considered either homozygous or heterozygous, assuming that T. cruzi is minimally diploid. 
For each of the nine MLST targets, all SNPs were conjoined to derive a sequence type (ST) 
and each base in the sequence was duplicated, e.g. for homozygous variable loci (A, C, G or 
T) an “A” was rewritten as “AA”, while in the case of heterozygous loci, “Y” was scored as 
“CT” in accordance with IUPAC nomenclature (K=GT, M=AC, R=AG, S=CG, W=AT, 
Y=CT).  
 
ST data were used to assess the discriminatory power (number of STs identified per total 
number of isolates) and typing efficiency (number of STs identified per polymorphic site) of 
each gene fragment (Hunter, 1990). For each target, the ratio of non-synonymous to 
synonymous amino acid changes (dN/dS) was calculated according to the Nei-Gojobori 
method (Nei and Gojobori, 1986), using SNAP software (available at 
http://www.hiv.lanl.gov) (Korber, 2000) to infer relative selection pressures.    
 
Modified sequences were used to generate neighbour-joining (NJ) dendrograms in MEGA 
5.10 (Tamura et al., 2011), to assess the “usefulness” of individual gene fragments for 
lineage assignment, intra-lineage resolution and to reconstruct phylogenetic relationships.  
Finally, variable loci data for all nine genes were concatenated together to produce a diploid 
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sequence type (DST) for each strain and a NJ phylogeny to evaluate the overall resolutive 
power of the MLST scheme.  
 
!
2.4.4 Haplotype resolution 
To infer haplotypes for each gene in selected analyses, diploid sequence data were submitted 
to PHASE software version 2.1 (Stephens et al., 2001) implemented in DnaSP v5.10.1 
(Librado and Rozas, 2009). This program is based on a modified Markov chain-Monte Carlo 
(MCMC) algorithm which first assembles all unambiguous haplotypes, i.e. those observed in 
strains which are homozygous at all variable sites or heterozygous at only a single variable 
site. Haplotypes in the remaining isolates, which are heterozygous at multiple sites, (and 
therefore of ambiguous phase) are estimated using a Maximum-Likelihood (ML) approach, 
with the assumption that they are most likely to be either the same as, or closely related to, 
one of the known unambiguous haplotypes already sampled in the dataset. For each 
reconstructed haplotype, an estimation of the uncertainty associated with each phase call is 
also generated.   
For isolates, where PHASE was unable to adequately resolve haplotypes (uncertainty 
probability p<0.95), PCR products were cloned and sequenced to experimentally verify 
predicted gene phase. PCR products were cloned using the pGEM®-T Easy Vector system I 
(Promega, UK), according to section 2.3.9. Plasmids were isolated from a minimum of six 
bacterial colonies, according to section 2.3.11, and sequenced, according to section 2.3.8, 
using standard T Easy Vector primers T7 (5’-TAATACGACTCACTATAGGG-3’) and Sp6 
(5’-ATTTAGGTGACACTATAG-3’) (Promega, UK). In cases where haplotypes remained 
ambiguous a further six colonies were picked and processed, as described. 
!
2.4.5 Maxicircle multilocus sequence typing (mtMLST)  
Ten maxicircle gene fragments from eight coding regions were chosen for evaluation: ND4 
(NADH dehydrogenase subunit 4), ND1 (NADH dehydrogenase subunit 1), COII 
(cytochrome c oxidase subunit II), MURF1 (maxicircle unidentified reading frame 1, two 
fragments), CYT b (cytochrome b), 12S rRNA, 9S rRNA and ND5 (NADH dehydrogenase 
subunit 5, two fragments). An additional target (ND8; NADH dehydrogenase subunit 8) was 
also assessed and discarded due to poor PCR amplification. Degenerate primers were 
designed in primaclade (Gadberry et al., 2005) by reference to the complete maxicircle 
genomes from Sylvio X10/1 (TcI), Esm cl3 (TcII) and CL Brener (TcVI), available online at 
www.tritrypdb.org (Aslett et al., 2010). Primer sequences are given in Table 2.4.  
PCR amplification for all targets was performed as described in section 2.3.5.  Reaction 
conditions for all targets were an initial denaturation step of 3 minutes at 94oC, followed by 
30 amplification cycles (94oC for 30 seconds, 50oC for 30 seconds, 72oC for 30 seconds) and 
a final elongation step at 72oC for ten minutes. Successful amplification was confirmed by 
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visualization of PCR products on 1.5% agarose gels, as described in section 2.3.6. PCR 
products were purified according to section 2.3.7 and sequenced according to section 2.3.8. 
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2.4.6 Phylogenetic analysis of mtMLST !
Sequence data were assembled manually as described for nuclear loci (section 2.4.3). For 
each isolate, maxicircle sequences were concatenated according to their structural 
arrangement (12S rRNA, 9S rRNA, CYT b, MURF1, ND1, COII, ND4 and ND5) and in the 
correct coding direction.  
 
Phylogenetic analysis was performed using ML and Bayesian algorithms, implemented in 
PhyML (Guindon et al., 2010) or MEGA 5.10 (Tamura et al., 2011) and MrBAYES v3.1 
(Ronquist and Huelsenbeck, 2003), respectively. The appropriate nucleotide substitution 
model for each analysis was selected from 1,624 candidates, based on the Akaike 
Information Criterion (AIC) or the Bayesian Information Criterion (BIC), respectively, 
inferred in jMODELTEST 2.1.4 (Darriba et al., 2012). For ML phylogenies, bootstrap 
support for clade topologies was routinely estimated following the generation of 1000 
pseudo-replicated datasets. Bayesian posterior probabilities were derived from multiple 
independent runs with periodic sampling over a minimum of one million iterations. When 
molecular dating was undertaken, a Bayesian MCMC method was executed in the Bayesian 
evolutionary analysis by sampling trees (BEAST) software package (Drummond and 
Rambaut, 2007).  
 
In incidences when nuclear and mitochondrial phylogenetic incongruence was suspected, 
alternate tree topologies derived from each dataset were evaluated using Kishino-Hasegawa 
(KH) (Kishino and Hasegawa, 1989) (to compare two trees) or Shimodaira-Hasegawa 
likelihood tests (SH) (Shimodaira and Hasegawa, 1999) (to compare >2 trees) implemented 
in PAML v.4. (Yang, 2007). In selected analyses, haplotype diversity (Hd) was calculated 
using DnaSP v5.10.1 (Librado and Rozas, 2009).  
!
2.4.7 Multilocus microsatellite typing (MLMT)  
Twenty-eight microsatellite loci were routinely used for genotyping, as previously described 
by Llewellyn et al., 2009a. These markers were distributed across eleven putative 
chromosomes, including six groups of physically linked loci (Weatherly et al., 2009). Marker 
choice in each study was determined by amplification reliability and intra-lineage resolution 
depending on DTU of strains under study. 
A full list of microsatellite targets and primers are given in Table 2.5. Five fluorescent dyes 
were used to label the forward primers: 6-FAM and TET (Proligo, Germany) and NED, PET 
and VIC (Applied Biosystems, UK) (Figure 2.4).  
 
 
 
66!
!
Table 2.5. T. cruzi microsatellite loci and primer details.  
Chromosome** Primer code Repeat type Forward/Reverse Primer (5’-3’) 
6 6529(CA)a (CA)n TGTGAAATGATTTGACCCGA 
   AGAGTCACGCCGCAAAGTAT 
6 6529(TA)b (TA)n TGAAGGAGATTCTCTGCGGT 
   CTCTCATCTTTTGTTGTGTCCG 
6 mclf10 (CA)nA(CA)n GCGTAGCGATTCATTTCC 
   ATCCGCTACCACTATCCAC 
10 6855(TA)(GA) (TA)n(GA)n TGTGATCAACGCGCATAAAT 
   TTCCATTGCCTCGTTTTAGA 
15 11863(CA) (CA)n AGTTGACATCCCCAAGCAAG 
   CCCTGATGCTGCAGACTCTT 
19 TcUn3 Unknown CTTAAAGAGATACAAGAGGGAAGG 
   CTGTTATTTCAATAACACGGGG 
19 10101(TA) (TA)n AACCCGCGCAGATACATTAG 
   TTCATTTGCAGCAACACACA 
24 8741(TA) (TA)n TGTAACGGTAGGTCTCAATTGC 
   TTGCACTTGTGTATCTCGCC 
27 10101(TC) (TC)n CGTACGACGTGGACACAAAC 
   ACAAGTGGGTGAGCCAAAAG 
27 10101(CA)c (CA)n GTGTCGTTGCTCCCAAACTC 
   AAACTTGCCAAATGTGAGGG 
27 10101(CA)a (CA)n GTCGCCATCATGTACAAACG 
   CTGTTGGCGAATGGTCATAA 
34 6559(TC) (TC)n CGCTCTCAAAGGCACCTTAC 
   ATATGGACGCGTAGGAGTGC 
37 10187(TTA) (TTA)n GAGAGAGATTCGGAAACTAATAGC 
   CATGTCCCTTCCTCCGTAAA 
37 10187(CA)(TA) (CA)n(TA)n CATGTCATTAAGTGGCCACG 
   GCACATGTTGGTTGTTGGAA 
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37 10187(TA) (TA)n AGAAAAAGGTTTACAACGAGCG 
   CGATGGAGAACGTGAAACAA 
37 10187(GA) (GA)n GTCACACCACTAGCGATGACA 
   ACTGCACAATACCCCCTTTG 
37 TcUn2 Unknown AACAAAATCTAGCGTCTACCATCC 
   GGTGTTGGCGTGTATGATTG 
37 TcUn4 Unknown ATGCTCCGCAACATATTACTCA 
   GTCGAGCTTCTGTTGTTCCC 
39 6925(TG)b (TG)n GAAACGCACTCACCCACAC 
   GGTAGCAACGCCAAACTTTC 
39 7093(TA)b (TA)b GGAAACACATCACGCAAAGA 
   AGTGACAAAGGGGGACATTG 
39 7093(TC) (TC)n CCAACATTCAACAAGGGAAA 
   GCATGAATATTGCCGGATCT 
39 6925(CT) (CT)n CATCAAGGAAAAACGGAGGA 
   CGGTACCACCTCAAGGAAAG 
39 7093(TA)c (TA)n CGTGTGCACAGGAGAGAAAA 
   CGTTTGGAGGAGGATTGAGA 
39 6925(TG)a (TG)n TCGTTCTCTTTACGCTTGCA 
   TAGCAGCACCAAACAAAACG 
39 7093(TCC) (TCC)n AGACGTTCATATTCGCAGCC 
   AGCCACATCCACATTTCCTC 
40 11283(TCG) (TCG)n ACCACCAGGAGGACATGAAG 
   TGTACACGGAACAGCGAAG 
40 11283(TA)b (TA)n AACATCCTCCACCTCACAGG 
   TTTGAATGCGAGGTGGTACA 
41 10359 (CA)(GA) (CA)n(GA)n AGTCCTACTGCCTCCTTGCA 
   CTGTTGGCGAATGGTCATAA 
* Chromosomal alignment based on Weatherly et al., 2009. 
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Figure 2.4. Microsatellite primer positions in a 96-well plate. 
 
Amplification reactions were achieved in a final volume of 10µl containing: 1X ThermoPol® 
Reaction Buffer (New England Biolabs, UK), 4mM MgCl2 (Bioline, UK), 34µM dNTPs 
(New England Biolabs, UK), 0.75pmol of each primer, 1U Taq DNA polymerase (New 
England Biolabs, UK) and 1ng of genomic DNA.  
 
PCR reaction conditions for all loci were an initial denaturation step of 4 minutes at 95oC, 
followed by 30 amplification cycles (95oC for 20 seconds, 57oC for 20 seconds, 72oC for 20 
seconds) and a final elongation step at 72oC for 20 minutes. Following amplification, 
microsatellite products were multiplexed according to Figure 2.5. Allele sizes were 
determined using a 16-capillary 3730 DNA Analyzer (Applied Biosystems, UK), in 
conjunction with a fluorescently-tagged size standard (GeneScanTM – 500 LIZ®, Applied 
Biosystems, UK) and were manually checked for errors in GeneMapper® software v3.7. All 
isolates were typed ‘blind’ to control for subjective user bias (Figure 2.6). Additional meta-
data from previous microsatellite publications were included in selected analyses. 
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Figure 2.5. Schematic of multiplexing microsatellite PCR products.   
 
 
 
 
Figure 2.6. Example of an ambiguous microsatellite profile for strains from different T. cruzi DTUs 
(A: Arma13 cl1; TcIII and B: Bug2148 cl1; TcV). In A the second peak was ambiguous according to 
the software and manually edited by the user.  
 
 
70!
!
2.4.8 Phylogenetic analysis of MLMT 
Individual-level sample clustering was routinely defined using a NJ tree based on pair-wise 
distances (DAS: 1 – proportion of shared alleles at all loci/n) between microsatellite genotypes 
calculated in MICROSAT v1.5d (Minch et al., 1997) under the infinite-alleles model (IAM).  
To accommodate multi-allelic genotypes (≥3 alleles per locus), a script (kindly provided by 
M. Llewellyn) was written in Microsoft Visual Basic to generate random multiple diploid re-
samplings of each multilocus profile. For each microsatellite dataset, a NJ phylogenetic tree 
was constructed in PHYLIP v3.67 (Felsenstein, 1989) using a pair-wise distance matrix 
derived from the mean across multiple re-sampled datasets. Majority rule consensus analysis 
of 10,000 bootstrap trees was performed in PHYLIP v3.67 by combining 100 bootstraps 
generated in MICROSAT v1.5d, each drawn from 100 respective randomly re-sampled 
datasets. 
In selected studies, putative subpopulations were defined using a nonparametric approach 
(free from Hardy-Weinberg assumptions). A K-means clustering algorithm, implemented in 
adegenet (Jombart et al., 2008), was used to determine the optimal number of ‘true’ 
populations, by reference to the BIC, which reaches a minimum when approaching the best 
supported assignment of individuals to the appropriate number of clusters.  The relationship 
between these clusters and the individuals within them was then evaluated via a discriminant 
analysis of principal components (DAPC) according to Jombart et al., 2010.   
Population-level genetic diversity was evaluated using sample size corrected allelic richness 
(Ar) in FSTAT 2.9.3.2 (Goudet, 1995). Mean FIS, which measures the distribution of 
heterozygosity within and between individuals, was calculated per population in FSTAT 
2.9.3.2. FIS can vary between -1 (all loci heterozygous for the same alleles) and +1 (all loci 
are homozygous for different alleles). FIS = 0 indicates Hardy-Weinberg allele frequencies.  
Sample size corrected private (population-specific) allele frequency per locus (PA/L) was 
calculated in HP-Rare (Kalinowski, 2005).   
Population subdivision was estimated using pair-wise FST, linearised with Slatkin’s 
correction, in ARLEQUIN v3.11 (Excoffier et al., 2005).  Statistical significance was 
assessed via 10,000 random permutations of alleles between populations. Within population 
subdivision was evaluated in ARLEQUIN v3.11 using a hierarchal Analysis of Molecular 
Variance (AMOVA).  Population-level heterozygosity indices were calculated in 
ARLEQUIN v3.11 and associated significance levels for p-values derived after performing a 
sequential Bonferroni correction to minimise the likelihood of Type 1 errors (Rice, 1989).   
Multilocus linkage disequilibrium, estimated by the Index of Association (IA) was calculated 
in MULTILOCUS 1.3b (Agapow and Burt, 2001) and statistical significance evaluated by 
comparison to a null distribution of 1000 randomisations. Mantel’s tests for the effect of 
isolation by distance within populations (pair-wise genetic vs. geographic distance) were 
implemented in GenAIEx 6.5 using 10,000 random permutations (Peakall and Smouse, 
2012), as indicated. 
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2.4.9 Illumina amplicon sequencing 
Two 450 bp multi-copy polymorphic sequence markers (TcGP63 and ND5) were chosen to 
investigate intra-host parasite multiclonality. Degenerate primers were designed for TcGP63 
family surface proteases (Cuevas et al., 2003) by reference to sequences retrieved from 
TriTypDB for Sylvio X10/1 (TcI), JR cl4 (TcI), Esm cl3 (TcII) and CL Brener (TcVI) (Aslett 
et al., 2010). TcGP63 sequences were aligned in MUSCLE (Edgar, 2004) and primers were 
manually designed to target an invariable flanking region (TcGP63_F 
CCAGYTGGTGTAATRCTGCYGCC and TcGP63_R RGAACCGATGTCATGGGGCAA). 
Degenerate primers to amplify ND5 (fragment b) were previously designed by Messenger et 
al., 2012 (Table 2.4). 
PCR reactions were performed using the FastStart High Fidelity PCR System (Roche, UK), 
according to the manufacturer’s instructions. Amplifications were undertaken using the 
Fluidigm® platform with a reduction of the manufacturer’s recommended number of cycles 
to 26 to minimise PCR amplification bias.  
PCR reactions were performed in triplicate for each patient sample and pooled, prior to 
sequencing. Negative controls were included in all PCR and sequencing steps. Equimolar 
concentrations of ND5 and TcGP63 amplicons from 96 DNA samples were multiplexed on 
Illumina runs using dual index sequence tags (Illumina Inc). Sequencing was undertaken 
using a MiSeq platform with 2 x 250 bp read lengths (Reagent Kit version 2), according to 
the manufacturer’s protocol.  
In addition to clinical isolates, a dilution series of control samples were also sequenced. 
Controls comprised artificial mixes of DTUs I-VI genomic DNA at equimolar 
concentrations.  
 
2.4.10 Illumina amplicon sequence data analysis 
De-multiplexed paired-end sequences were submitted to quality control and trimming in 
Sickle (Joshi and Fass, 2011) and mate pairs were trimmed in FASTX Toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/). ND5, TcGP63 and contaminating sequences were 
then sorted against a reference using Bowtie 2 (Langmead and Salzberg, 2012). Individual 
paired reads were found to be overlapping in only a minority of cases; a truncated central 
fragment was used in all downstream analyses. 
 
Further sequence manipulations were undertaken using FASTX Toolkit and custom awk 
scripts (kindly provided by M. Llewellyn) to parse files and concatenate mate pairs for 
downstream analysis. MUSCLE (Edgar, 2004) was used for alignment of sequences in each 
sample. Next, analysis was undertaken in the Mothur software package (Schloss et al., 2009) 
to eliminate putative PCR chimeras and examine clustering of individual sequences.  
 
The Shannon index of diversity was calculated at the intra-patient level based on STs defined 
at 97% and 99% identity cut-offs in Mothur. Comparisons among patient cohorts were made 
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via analyses of covariance and linear regression in R (http://CRAN.R-project.org). Sequence 
datasets for patients from each cohort were then merged and analyses conducted using 97% 
(ND5) and 99% (TcGP63) sequence clusters defined with UPARSE (Edgar, 2013). Weighted 
UniFrac distances between STs among samples were generated and subsequently clustered 
via a principal coordinates analysis in QIIME (Caporaso et al., 2010). Estimates of 
diversifying selection among TcGP63 STs were made in KaKs Calculator (Zhang et al., 
2006) using Yang and Neilson’s 2000 approximate method (Yang and Nielsen, 2000) and 
tested for significance using a Fisher’s exact test. To test across putative TcGP63 gene 
families (97% cut-off), 99% STs within each cohort population were pooled. Secondly, tests 
were conducted among STs within each 97% category per cohort. 
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3. Development and evaluation of T. cruzi phylogenetic markers for DTU-level 
genotyping and higher resolution population genetics 
 
3.1 Background 
3.1.1 A brief history of T. cruzi taxonomy 
Elucidating the complex epidemiology, clinical variability and phylogeography underlying 
Chagas disease requires a clear understanding of the parasite’s genetic diversity (Campbell et 
al., 2004; Miles et al., 2009). Historically, the taxonomy of T. cruzi has been hindered by a 
lack of standardized molecular typing methods and the use of various alternative 
nomenclatures (recently reviewed by Zingales et al., 2012). The earliest attempts to 
characterize T. cruzi strain variation, based on multilocus enzyme electrophoresis (MLEE), 
classified isolates into three major groups or ‘zymodemes I, II and III’ (Miles et al., 1977; 
1978), which were later subdivided into 43 ‘clonets’ (Tibayrenc and Ayala, 1988) (Table 
3.1). 
Subsequent genotyping of additional strains using MLEE (Tibayrenc et al., 1993), random 
amplification of polymorphic DNA (RAPD) (Steindel et al., 1993) and nuclear loci (Souto et 
al., 1996; Fernandes et al., 1998a, 1998b), grouped isolates into two major lineages, 
designated T. cruzi I and T. cruzi II (Anonymous, 1999) (Table 3.1). More recently, using 
MLST, TcII was divided into TcIIa-e (Brisse et al., 2000, 2001), which were latterly renamed 
to TcII-TcVI by international consensus to remove any presumptive sub-lineage designations 
(Zingales et al., 2009).  
Each of the six T. cruzi lineages is considered a discrete typing unit (DTU), defined as “a 
collection of strains that are genetically more closely related to each other than to any other 
strain and that share one or several specific characters” (Tibayrenc, 1998). However, the 
criteria for division, number of subgroups, and their precise biological and evolutionary 
relevance are still a popular subject for debate (Devera et al., 2003; Herrera et al., 2007b; 
Guhl and Ramirez, 2011). For example, there has been significant interest in classifying TcI 
isolates on the basis of either transmission cycle (TcIa-e) (Herrera et al., 2007b, 2009; Falla 
et al., 2009; Cura et al., 2010) or association with human infection (TcIDOM) (Zumaya-
Estrada et al., 2012; Ramírez et al., 2012). Furthermore, a potential seventh DTU (TcBat) has 
recently been identified from Chiroptera species in northern South and Central America 
(Marcili et al., 2009; Pinto et al., 2012; Ramírez et al., 2014). 
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3.1.2 Contemporary T. cruzi genotyping: perils and pitfalls 
Establishing any relationship between T. cruzi genotype and clinical outcome, ecological 
niche, host association, geographical distribution etc., is complicated by a number of inherent 
biological features relating to both parasite infection dynamics and our current repertoire of 
genotyping techniques. In humans (Vago et al., 2000; Burgos et al., 2008; 2010; Ramírez et 
al., 2012), triatomine bugs (Bosseno et al., 1996; Yeo et al., 2007; Cardinal et al., 2008) and 
mammalian reservoir hosts (Yeo et al., 2005; Llewellyn et al., 2011; Rocha et al., 2013), 
mixed infections of distinct parasite clones are not exceptional but inevitable. Among highly 
endemic areas, long-term inhabitants are repeatedly infected by multiple contacts with 
different triatomines (Nouvellet et al., 2013), which in turn have fed on various infected 
humans and/or mammals, depending on the local disease ecology.  
Levels of intra-host parasite multiclonality might be expected to increase proportionally to 
vector exposure. However, this assumes a constant force of infection, incomplete cross-
genotypic immunity, and lack of genotype interaction (e.g. genotype displacement, reciprocal 
inhibition, potentiation or recombination (Pinto et al., 1998; da Silveira Pinto et al., 2000; 
Gaunt et al., 2003; Martins et al., 2007; Araújo et al., 2014), transmission population 
bottlenecks (as observed in related trypanosomes (Oberle et al., 2009)) or any additional 
mechanisms that prevent the establishment of secondary infections. The complexity of 
natural multiclonal parasite populations is largely unknown and the ability to detect them 
restricted by genetic marker resolution (Llewellyn et al., 2011; Valadares et al., 2012). The 
study of this phenomenon conventionally necessitates deriving biological clones from live 
parasite populations, prior to genetic typing, which introduces a range of potential adaptation 
biases, discussed below.  
Genotyping of natural T. cruzi strains can be performed either directly from field samples 
(blood, tissue biopsies or vector faeces) or following parasite isolation by hemoculturing or 
xenodiagnoses. Due to the scarcity of parasites in peripheral blood, especially in chronically 
infected patients, the former method has limited sensitivity. The principal drawback 
associated with parasite isolation is selection bias for particular subpopulations, initially by 
preferential outgrowth due to faster dividing rates and/or culture media (Dvorak et al., 1980; 
Alves et al., 1994; Devera et al., 2003) and subsequently by loss of clonal diversity from 
serial maintenance in axenic culture or animals (Engel et al., 1982; Deane et al., 1984b; 
1984c; 1984d; Morel et al., 1986; Alves et al., 1993). Hemoculturing is laborious and 
recovery rates (usually less than 30% among chronic patients (Siriano et al., 2011)), entirely 
determined by size of parasite inoculum and distribution within the starting sample. 
Xenodiagnosis, which can facilitate greater parasite recovery, has also been shown to vary 
depending on vector permissibility to local strains (Miles et al., 1984; Luquetti et al., 1986). 
Furthermore, due to differential tropisms of strains, circulating clones which are isolated by 
hemoculture/xenodiagnosis are often genetically distinct from those sequestered in tissues 
(Vago et al., 2000; Burgos et al., 2008; 2010) and even between sequential blood samples 
(Sánchez et al., 2013). Together these observations strongly suggest that intra-host parasite 
diversity is routinely underestimated.  
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A plethora of molecular genotyping techniques have been developed to characterize T. cruzi 
genetic diversity, with varying degrees of resolution, experimental ease, reproducibility, 
subjectivity and transferability (Table 3.2). Typing of genetic polymorphisms in conserved 
housekeeping genes can define major genetic lineages (Souto et al., 1996; Fernandes et al., 
1998a; 1998b; Brisse et al., 2000; 2001), while analysis of hypervariable loci such as 
microsatellites (Oliveira et al., 1998; 1999; Llewellyn et al., 2009a; 2009b), or kDNA 
minicircles (Morel et al., 1980; Veas et al., 1990; Telleria et al., 2006; Velázquez et al., 
2008), potentially allows identification of profiles specific to individual strains. Choice of 
typing methodology is principally determined by sample source, research question and 
laboratory resources.  
Direct clinical genotyping is currently based on size polymorphisms in multi-copy genetic 
markers, including the nuclear spliced-leader intergenic region (SL-IR), 24α rDNA (Souto et 
al., 1996) and 18S rDNA (Brisse et al., 2001), and minicircle sequences (Lages-Silva et al., 
2006; Burgos et al., 2007; 2008; 2010) (for more detailed descriptions of historical 
genotyping techniques see Macedo et al., 2002; 2004; Devera et al., 2003). One major 
confounder associated with the use of any multi-copy gene is the level of intra-clone copy 
number and position homology to ensure comparability between strains; genome size 
(Dvorak et al., 1982; Lewis et al., 2009b), karyotype (Henriksson et al., 1990; 1993; Vargas 
et al., 2004; Souza et al., 2011; Lima et al., 2013) and chromosomal arrangements of tandem 
repeat regions (Wagner and So, 1990; O’Connor et al., 2007), are known to differ widely 
between natural T. cruzi strains and even biological clones derived from the same population. 
Similar caveats affect minicircle-based genotyping, which vary in copy number and 
complement between major DTUs (Morel et al., 1980; Moreira et al., 2013), are susceptible 
to contamination (Schijman et al., 2011) and whose profiles are highly sensitive to minor 
changes in reaction conditions, raising issues of reproducibility (Alves et al., 1993; Segatto et 
al., 2013). With all of these methods, strain DTU assignment is often dependent on absence 
of PCR products/restriction fragment bands which cannot be distinguished from variation in 
as yet untested strains.  
One recent method, developed to circumvent some of the limitations associated with clinical 
genotyping is to adopt an indirect approach, exploiting serological detection of antibodies 
produced in response to DTU-specific T. cruzi antigens (Di Noia et al., 2002; Mendes et al., 
2013; Bhattacharyya et al., 2014). However, serology cannot distinguish between 
contemporary infection or historical exposure to a particular lineage, given anti-T. cruzi 
antibodies can take years to decline.  
 
 
 
 
78
 
 T
ab
le
 3
.2
. O
ve
rv
ie
w
 o
f c
ur
re
nt
 a
nd
 h
is
to
ric
al
 T
. c
ru
zi
 g
en
ot
yp
in
g 
m
et
ho
ds
.  
G
en
ot
yp
in
g 
M
et
ho
d 
M
et
ho
d 
D
es
cr
ip
tio
n 
E
xa
m
pl
e 
of
 
G
en
et
ic
 M
ar
ke
rs
 
R
ep
ro
du
ci
bi
lit
y 
b/
w
 A
ss
ay
s  
L
ev
el
 o
f 
R
es
ol
ut
io
n 
R
ea
ge
nt
 
C
os
t 
A
dv
an
ta
ge
s 
D
is
ad
va
nt
ag
es
 
R
ef
er
en
ce
s 
M
L
E
E
 
M
ea
su
re
s 
di
ff
er
en
ce
s i
n 
el
ec
tro
ph
or
et
ic
 
m
ob
ili
tie
s o
f 
is
oe
nz
ym
es
 
A
SA
T,
 A
LA
T,
 
PG
M
, A
C
O
N
, 
M
PI
, A
D
H
, 
M
D
H
, M
E,
 IC
D
, 
6P
G
D
, G
6P
D
, 
G
D
, P
EP
, G
PI
 
H
ig
h 
D
TU
-le
ve
l 
In
tra
-li
ne
ag
e 
M
od
er
at
e 
- E
as
y 
vi
su
al
 
in
te
rp
re
ta
tio
n 
- D
at
a 
am
en
ab
le
 to
 
nu
m
er
ic
al
 ta
xo
no
m
ic
 
an
al
ys
is
, e
.g
. r
at
es
 o
f 
si
m
ila
rit
y 
or
 g
en
et
ic
 
di
st
an
ce
 
- R
eq
ui
re
s l
ar
ge
 
qu
an
tit
ie
s o
f p
ar
as
ite
 
ly
sa
te
 fr
om
 li
ve
 st
ra
in
s 
 
R
ea
dy
 a
nd
 
M
ile
s, 
19
80
; 
B
ar
ra
tt 
et
 a
l.,
 
19
80
; M
ile
s e
t 
al
., 
19
81
a;
 
19
84
; R
om
an
ha
, 
19
82
; C
ar
ne
iro
 
et
 a
l.,
 1
99
0 
R
A
PD
 
Sh
or
t r
an
do
m
 
se
qu
en
ce
 p
rim
er
s 
us
ed
 to
 a
m
pl
ify
 
un
kn
ow
n 
D
N
A
 
fr
ag
m
en
ts
 to
 c
re
at
e 
un
iq
ue
 b
an
d 
pa
tte
rn
s 
N
/A
 
Lo
w
 
D
TU
-le
ve
l 
Lo
w
 
- C
an
 b
e 
pe
rf
or
m
ed
 
di
re
ct
ly
 o
n 
fie
ld
 
sa
m
pl
es
 
- N
o 
pr
io
r s
eq
ue
nc
e 
kn
ow
le
dg
e 
ne
ed
ed
 
- U
nl
im
ite
d 
nu
m
be
r o
f 
pr
im
er
s 
- D
at
a 
am
en
ab
le
 to
 
nu
m
er
ic
al
 ta
xo
no
m
ic
 
an
al
ys
is
 
- R
ep
ro
du
ci
bi
lit
y 
is
su
es
 
- D
om
in
an
t m
ar
ke
rs
 
m
ay
 c
on
ce
al
 
he
te
ro
zy
go
si
ty
 
- S
tra
in
 p
ro
fil
es
 m
ay
 
va
ry
 w
ith
 D
N
A
 te
m
pl
at
e 
am
ou
nt
 a
nd
 q
ua
lit
y 
St
ei
nd
el
 e
t a
l.,
 
19
93
; S
ou
to
 e
t 
al
., 
19
96
; B
ris
se
 
et
 a
l.,
 2
00
0,
 
20
01
 
kD
N
A
-R
FL
P 
R
es
tri
ct
io
n 
fr
ag
m
en
t l
en
gt
h 
an
al
ys
is
 o
f 
ki
ne
to
pl
as
t 
m
in
ic
irc
le
 
hy
pe
rv
ar
ia
bl
e 
re
gi
on
 (m
H
V
R
)  
m
H
V
R
 
Lo
w
 
In
tra
-li
ne
ag
e 
Lo
w
 
- H
yp
er
va
ria
bl
e 
m
ar
ke
rs
 
- C
an
 p
ro
du
ce
 st
ra
in
-
sp
ec
ifi
c 
pr
of
ile
s 
 
- R
eq
ui
re
s i
so
la
tio
n 
of
 
kD
N
A
 fr
om
 li
ve
 
pa
ra
si
te
s 
- S
tra
in
 p
ro
fil
e 
in
he
rit
an
ce
 m
ay
 n
ot
 b
e 
st
ab
le
 o
r c
or
re
la
te
 w
ith
 
nu
cl
ea
r t
yp
in
g 
M
or
el
 e
t a
l.,
 
19
80
 
79
 
 
- P
ot
en
tia
l 
co
nt
am
in
at
io
n 
pr
ob
le
m
s 
du
e 
to
 v
er
y 
hi
gh
 c
op
y 
nu
m
be
r 
kD
N
A
 
hy
br
id
iz
at
io
n 
A
na
ly
si
s o
f m
H
V
R
 
by
 ra
di
oa
ct
iv
e 
pr
ob
e 
hy
br
id
iz
at
io
n 
m
H
V
R
 
Lo
w
 
D
TU
-le
ve
l 
In
tra
-li
ne
ag
e 
 
- H
yp
er
va
ria
bl
e 
m
ar
ke
rs
 
- C
an
 p
ro
du
ce
 st
ra
in
-
sp
ec
ifi
c 
pr
of
ile
s 
 
- D
N
A
 p
ro
be
s m
ay
 
cr
os
s-
re
ac
t b
/w
 D
TU
s 
- P
ot
en
tia
l 
co
nt
am
in
at
io
n 
pr
ob
le
m
s 
du
e 
to
 v
er
y 
hi
gh
 c
op
y 
nu
m
be
r  
St
ur
m
 e
t a
l.,
 
19
89
; B
rit
to
 e
t 
al
., 
19
95
 
K
ar
yo
ty
pi
ng
 
(a
C
SD
I)
 
C
om
pa
ris
on
 o
f 
ch
ro
m
os
om
e 
si
ze
 
va
ria
tio
n 
by
 P
FG
E 
se
pa
ra
tio
n 
an
d 
ra
di
oa
ct
iv
e 
pr
ob
e 
hy
br
id
iz
at
io
n 
1F
8,
 c
ru
zi
pa
n,
 
FF
A
g6
, T
c2
, 
C
A
7.
12
, C
A
7.
32
, 
P1
9 
M
od
er
at
e 
D
TU
-le
ve
l 
M
od
er
at
e 
- D
at
a 
am
en
ab
le
 to
 
nu
m
er
ic
al
 ta
xo
no
m
ic
 
an
al
ys
is
 
- R
eq
ui
re
s l
iv
e 
st
ra
in
s 
- S
tra
in
 p
ro
fil
es
 m
ay
 n
ot
 
be
 st
ab
le
 d
ue
 to
 
ex
pa
ns
io
n/
co
nt
ra
ct
io
n 
of
 
ta
nd
em
 re
pe
at
s 
- P
ro
ne
 to
 c
on
ve
rg
en
ce
 
b/
w
 u
nr
el
at
ed
 st
ra
in
s 
H
en
rik
ss
on
 e
t 
al
., 
19
93
; 1
99
5;
 
20
02
; P
ed
ro
so
 e
t 
al
., 
20
07
 
D
N
A
 
Fi
ng
er
pr
in
tin
g 
A
na
ly
si
s o
f 
va
ria
bi
lit
y 
in
 
nu
cl
ea
r 
m
in
is
at
el
lit
es
 b
y 
re
st
ric
tio
n 
di
ge
st
io
n 
an
d 
pr
ob
e 
hy
br
id
iz
at
io
n 
33
.1
5 
Lo
w
 
In
tra
-li
ne
ag
e 
Lo
w
 
- H
yp
er
va
ria
bl
e 
m
ar
ke
rs
 
- C
an
 p
ro
du
ce
 st
ra
in
-
sp
ec
ifi
c 
pr
of
ile
s 
 
-R
eq
ui
re
s l
iv
e 
st
ra
in
s 
- R
ep
ro
du
ci
bi
lit
y 
is
su
es
 
 
M
ac
ed
o 
et
 a
l.,
 
19
92
 
L
SS
P-
PC
R
 
A
na
ly
si
s o
f s
iz
e 
po
ly
m
or
ph
is
m
s i
n 
m
H
V
R
 a
m
pl
ifi
ed
 
by
 lo
w
 st
rin
ge
nc
y 
pr
im
er
s  
m
H
V
R
 
Lo
w
  
D
TU
-le
ve
l 
Lo
w
 
- H
ig
hl
y 
se
ns
iti
ve
 
- C
an
 b
e 
us
ed
 to
 d
et
ec
t 
T.
 c
ru
zi
 in
 in
fe
ct
ed
 
tis
su
es
 w
ith
ou
t 
- R
ep
ro
du
ci
bi
lit
y 
is
su
es
 
- P
ot
en
tia
l 
co
nt
am
in
at
io
n 
pr
ob
le
m
s 
du
e 
ve
ry
 h
ig
h 
co
py
 
Pe
na
 e
t a
l.,
 
19
94
; V
ag
o 
et
 
al
., 
19
96
a;
 
19
96
b 
80
 
 
pa
ra
si
te
 is
ol
at
io
n 
nu
m
be
r  
- k
D
N
A
 si
gn
at
ur
es
 m
ay
 
va
ry
 w
ith
 D
N
A
 te
m
pl
at
e 
am
ou
nt
 a
nd
 q
ua
lit
y 
PC
R
 P
ro
du
ct
 
Si
ze
 
Po
ly
m
or
ph
is
m
 
A
na
ly
si
s o
f s
iz
e 
po
ly
m
or
ph
is
m
s i
n 
m
ul
tic
op
y 
ge
ne
 
fr
ag
m
en
ts
  
SL
-I
R,
 2
4S
α 
rR
N
A,
 1
8S
 rR
N
A 
H
ig
h 
D
TU
-le
ve
l 
 
Lo
w
 
- C
an
 b
e 
pe
rf
or
m
ed
 
di
re
ct
ly
 o
n 
fie
ld
 
sa
m
pl
es
 
- R
eq
ui
re
s l
im
ite
d 
te
ch
ni
ca
l e
xp
er
tis
e 
- D
TU
 a
ss
ig
nm
en
t b
as
ed
 
on
 p
re
se
nc
e/
ab
se
nc
e 
of
 
am
pl
ic
on
s;
 in
se
ns
iti
ve
 to
 
m
ut
at
io
ns
 in
 u
nt
es
te
d 
st
ra
in
s 
- U
nk
no
w
n 
in
tra
-s
tra
in
 
co
py
 h
om
ol
og
y 
So
ut
o 
et
 a
l.,
 
19
96
; F
er
na
nd
es
 
et
 a
l.,
 1
99
8a
; 
Fe
rn
an
de
s e
t a
l.,
 
19
98
b 
PC
R
-R
FL
P 
R
es
tri
ct
io
n 
fr
ag
m
en
t l
en
gt
h 
an
al
ys
is
 o
f 
m
ul
tic
op
y 
ge
ne
 
fr
ag
m
en
ts
 
H
SP
60
, G
PI
, 
C
O
II
, G
P7
2,
 1
F8
, 
H
is
to
ne
 H
3,
 IT
S,
 
Tc
SC
5D
 
H
ig
h 
D
TU
-le
ve
l 
M
od
er
at
e 
- C
an
 b
e 
pe
rf
or
m
ed
 
di
re
ct
ly
 o
n 
fie
ld
 
sa
m
pl
es
 
- R
eq
ui
re
s l
im
ite
d 
te
ch
ni
ca
l e
xp
er
tis
e 
- D
TU
 a
ss
ig
nm
en
t b
as
ed
 
on
 p
re
se
nc
e/
ab
se
nc
e 
of
 
SN
Ps
; i
ns
en
si
tiv
e 
to
 
m
ut
at
io
ns
 in
 u
nt
es
te
d 
st
ra
in
s 
R
oz
as
 e
t a
l.,
 
20
07
; L
ew
is
 e
t 
al
., 
20
09
a;
 V
an
 
de
r A
uw
er
a 
et
 
al
., 
su
bm
itt
ed
; 
C
os
en
tin
o 
an
d 
A
gü
er
o,
 2
01
2 
N
uc
le
ot
id
e 
se
qu
en
ci
ng
: 
nu
cl
ea
r 
lo
ci
 
(n
M
L
ST
) 
SN
P 
an
al
ys
is
 in
 
nu
cl
ea
r 
ho
us
ek
ee
pi
ng
 g
en
es
 
Tc
M
SH
2,
 D
H
FR
-
TS
, T
R,
 L
YT
1,
 
M
et
-I
I, 
M
et
-I
II
, 
Tc
AP
X,
 T
cG
PX
, 
Tc
M
PX
, 
H
M
C
O
AR
, P
D
H
, 
G
TP
, S
TT
P2
, 
RH
O
1,
 G
PI
, 
SO
D
A,
 S
O
D
B,
 
LA
P 
H
ig
h 
D
TU
-le
ve
l  
(I
nt
ra
-li
ne
ag
e)
 
H
ig
h 
- D
at
a 
am
en
ab
le
 to
 
M
LS
T 
an
al
ys
is
 
- D
at
a 
hi
gh
ly
 
re
pr
od
uc
ib
le
, p
or
ta
bl
e 
an
d 
tra
ns
fe
ra
bl
e 
b/
w
 
la
bo
ra
to
rie
s 
-R
eq
ui
re
s l
iv
e 
st
ra
in
s 
- L
ev
el
 o
f i
nt
ra
-li
ne
ag
e 
re
so
lu
tio
n 
de
pe
nd
en
t 
up
on
 a
na
ly
si
s o
f 
m
ul
tip
le
 lo
ci
  
M
ac
ha
do
 a
nd
 
A
ya
la
, 2
00
1;
 
A
ug
us
to
-P
in
to
 
et
 a
l.,
 2
00
3;
 Y
eo
 
et
 a
l.,
 2
01
1;
 
La
ut
hi
er
 e
t a
l.,
 
20
12
 
N
uc
le
ot
id
e 
se
qu
en
ci
ng
: 
SN
P 
an
al
ys
is
 in
 
m
ito
ch
on
dr
ia
l g
en
e 
12
S 
rR
N
A,
 
9S
RN
A,
 C
yt
b,
 
H
ig
h 
(D
TU
-le
ve
l) 
H
ig
h 
- D
at
a 
am
en
ab
le
 to
 
-R
eq
ui
re
s l
iv
e 
st
ra
in
s 
de
 F
re
ita
s e
t a
l.,
 
20
06
; C
ar
ra
nz
a 
81
 
 
m
ax
ic
ir
cl
e 
lo
ci
 
(m
tM
L
ST
) 
fr
ag
m
en
ts
 
M
U
RF
1,
 N
D
1,
 
C
O
II
, N
D
4,
 N
D
5,
 
N
D
7 
In
tra
-li
ne
ag
e 
M
LS
T 
an
al
ys
is
 
- D
at
a 
hi
gh
ly
 
re
pr
od
uc
ib
le
, p
or
ta
bl
e 
an
d 
tra
ns
fe
ra
bl
e 
b/
w
 
la
bo
ra
to
rie
s 
- P
ot
en
tia
l p
hy
lo
ge
ne
tic
 
in
co
ng
ru
en
ce
 w
ith
 
nu
cl
ea
r l
oc
i  
 
- I
de
nt
ifi
es
 3
 m
ax
ic
irc
le
 
cl
as
se
s (
Tc
I, 
Tc
II
 a
nd
 
Tc
II
I-
V
I)
; n
ot
 sp
ec
ifi
c 
to
 
al
l 6
 D
TU
s 
et
 a
l.,
 2
00
7;
 
M
es
se
ng
er
 e
t 
al
., 
20
12
 
N
uc
le
ot
id
e 
se
qu
en
ci
ng
: 
m
in
ic
ir
cl
e 
re
gi
on
s 
SN
P 
an
al
ys
is
 in
 
m
H
V
R
  
m
H
V
R
 
H
ig
h 
D
TU
-le
ve
l 
In
tra
-li
ne
ag
e 
H
ig
h 
- H
yp
er
va
ria
bl
e 
m
ar
ke
rs
 
- C
an
 p
ro
du
ce
 st
ra
in
-
sp
ec
ifi
c 
pr
of
ile
s 
- S
tra
in
 p
ro
fil
e 
m
ay
 n
ot
 
be
 D
TU
-s
pe
ci
fic
; m
in
or
 
se
qu
en
ce
 c
la
ss
es
 sh
ar
ed
 
b/
w
 D
TU
s 
Te
lle
ria
 e
t a
l.,
 
20
06
; V
el
áz
qu
ez
 
et
 a
l.,
 2
00
8 
FF
L
B
 
A
na
ly
si
s o
f s
iz
e 
po
ly
m
or
ph
is
m
s i
n 
m
ul
tic
op
y 
ge
ne
 
fr
ag
m
en
ts
  
28
Sα
 rR
N
A,
 1
8S
 
rR
N
A 
H
ig
h 
D
TU
-le
ve
l 
H
ig
h 
- C
an
 b
e 
pe
rf
or
m
ed
 
di
re
ct
ly
 o
n 
fie
ld
 
sa
m
pl
es
 
 
- U
na
bl
e 
to
 d
iff
er
en
tia
te
 
hy
br
id
 li
ne
ag
es
 (T
cV
 
an
d 
Tc
V
I)
   
H
am
ilt
on
 e
t a
l.,
 
20
11
 
H
M
R
 
A
na
ly
si
s o
f 
am
pl
ic
on
 m
el
tin
g 
te
m
pe
ra
tu
re
s 
ge
ne
ra
te
d 
by
 re
al
-
tim
e 
PC
R
   
SL
-I
R,
 2
4S
α 
rR
N
A 
H
ig
h 
D
TU
-le
ve
l 
M
od
er
at
e 
- D
at
a 
ra
pi
dl
y 
ge
ne
ra
te
d 
in
 re
al
 ti
m
e 
 
-R
eq
ui
re
s l
iv
e 
st
ra
in
s 
 
- D
iff
ic
ul
t t
o 
st
an
da
rd
iz
e 
b/
w
 la
bo
ra
to
rie
s 
 
- R
eq
ui
re
s s
pe
ci
al
iz
ed
 
la
bo
ra
to
ry
 in
fr
as
tru
ct
ur
e 
H
ig
ue
ra
 e
t a
l.,
 
20
13
 
M
L
M
T
 
A
na
ly
si
s o
f a
lle
le
 
si
ze
 d
iff
er
en
ce
s i
n 
m
ic
ro
sa
te
lli
te
 
re
pe
at
 re
gi
on
s 
10
10
1(
C
A
) a,
 
11
28
3(
TA
) b
, 
70
93
(T
A
) b
, 
Tc
U
n4
, m
cl
f1
0,
 
10
18
7(
C
A
)(
TA
), 
68
55
(T
A
)(
G
A
), 
10
35
9(
C
A
), 
87
41
(T
A
), 
M
od
er
at
e 
D
TU
-le
ve
l 
In
tra
-li
ne
ag
e 
H
ig
h 
- N
eu
tra
lly
 e
vo
lv
in
g,
 
co
-d
om
in
an
t, 
hy
pe
rv
ar
ia
bl
e 
m
ar
ke
rs
 
- C
an
 p
ro
du
ce
 st
ra
in
-
sp
ec
ifi
c 
M
LG
s 
 
- R
eq
ui
re
s l
iv
e 
st
ra
in
s 
 
- P
ro
ne
 to
 h
om
op
la
sy
 
 
- D
at
a 
in
te
rp
re
ta
tio
n 
hi
gh
ly
 su
bj
ec
tiv
e 
O
liv
ei
ra
 e
t a
l.,
 
19
98
; 1
99
9;
 
M
ac
ed
o 
et
 a
l.,
 
20
01
; L
le
w
el
ly
n 
et
 a
l.,
 2
00
9a
; 
20
09
b;
 O
ca
ña
-
M
ay
or
ga
 e
t a
l.,
 
20
10
; R
am
íre
z 
82
 
 
10
18
7(
TT
A
), 
70
93
(T
A
) c 
et
 a
l.,
 2
01
2 
A
m
pl
ic
on
 
Se
qu
en
ci
ng
 
A
na
ly
si
s o
f 
m
ill
io
ns
 o
f 
se
qu
en
ci
ng
 re
ad
s 
ge
ne
ra
te
d 
by
 
Ill
um
in
a 
de
ep
 
se
qu
en
ci
ng
 
Tc
G
P6
3,
 N
D
5 
H
ig
h 
D
TU
-le
ve
l 
In
tra
-li
ne
ag
e 
Pa
ra
si
te
 
m
ul
tic
lo
na
lit
y 
V
er
y 
hi
gh
 
- C
an
 d
et
ec
t i
nt
ra
-h
os
t 
pa
ra
si
te
 m
ul
tic
lo
na
lit
y 
an
d 
ge
ne
tic
 d
iv
er
si
ty
 
- R
eq
ui
re
s l
iv
e 
st
ra
in
s 
- P
ro
ne
 to
 lo
ss
 o
f c
lo
na
l 
di
ve
rs
ity
 fr
om
 p
ar
as
ite
 
is
ol
at
io
n 
- R
eq
ui
re
s 
bi
oi
nf
or
m
at
ic
s e
xp
er
tis
e,
 
co
m
pu
ta
tio
na
l 
in
fr
as
tru
ct
ur
e 
an
d 
co
m
pa
ra
tiv
el
y 
hi
gh
 c
os
t 
re
ag
en
ts
 
Ll
ew
el
ly
n 
et
 a
l.,
 
ac
ce
pt
ed
 
 
       
83 
 
Additional genotyping options are available for axenic parasite cultures, including 
karyotyping (Henriksson et al., 2002; Pedroso et al., 2007), DNA fingerprinting (Macedo et 
al., 1992) and microsatellite analyses (Llewellyn et al., 2009a; 2009b; Ocaña-Mayorga et al., 
2010; Ramírez et al., 2012). However,  to date, no single, widely validated genetic marker 
affords complete, unequivocal DTU resolution (Cosentino and Agüero, 2012) and reliance on 
only one target is inadvisable given the potential confounding influence of genetic exchange 
(Westenberger et al., 2005). The availability of reference whole genome sequences (El-Sayed 
et al., 2005; Weatherly et al., 2009; Aslett et al., 2010; Franzen et al., 2011) has re-
invigorated interest in exploring T. cruzi genetic diversity and encouraged the development 
of nucleotide sequence-based genotyping techniques, particular MLST, and more recently 
Illumina amplicon deep sequencing. 
 
MLST was originally developed to characterize bacterial (Maiden et al., 1998; Spratt, 1999; 
Dingle et al., 2001; Enright et al., 2001; Nallapareddy et al., 2002) and fungal (Bougnoux et 
al., 2003; Tavanti et al., 2003; 2005) species and involves sequencing short fragments of 
usually seven or more chromosomally-independent, single-copy, housekeeping genes. 
Sequence polymorphisms within each locus are categorized as distinct STs, which can be 
concatenated to produce a unique allelic profile per strain. MLST data have the advantages of 
being highly reproducible, minimally subjective, electronically transferable between 
laboratories (especially if deposited in international databases such as http://pubmlst.org and 
http://www.mlst.net) and amenable to a range of different population genetics analyses.  
 
With the advent of next generation sequencing technologies and concomitant plummeting 
reagent costs, deep sequencing approaches are increasingly used to explore intra-host 
pathogen genetic diversity (McElroy et al., 2014). Illumina amplicon sequencing generates 
millions of ‘short’ sequencing reads from individual samples, potentially allowing correlation 
of read depth with genotype abundance within multiclonal populations. This strategy has 
been used to examine natural multiplicity of infection in Plasmodium falciparum (Juliano et 
al., 2010; Manske et al., 2012; Taylor et al., 2013), the dynamics of HIV anti-retroviral 
escape mutations, prior to the emergence of clinical drug resistance (Wang et al., 2007; 
Gibson et al., 2014), as well as expose serial population bottlenecks in Trypanosoma brucei 
brucei transmission (Oberle et al., 2009). 
 
 
 
!
!
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3.2 Objectives 
The aim of this chapter was to develop and evaluate nuclear and mitochondrial phylogenetic 
markers for T. cruzi DTU-level assignment, higher resolution population genetics studies and 
the investigation of intra-host parasite multiclonality. 
Specific objectives were to: 
a. Critically assess the suitability of candidate nuclear housekeeping genes for inclusion 
in an MLST scheme for T. cruzi DTU-level assignment and intra-lineage diversity 
studies.  
b. Contribute to the formalization of a standardized nuclear MLST scheme (nMLST), 
validated across a cohort of reference strains, representative of all six DTUs. 
c. Assemble mitochondrial Illumina sequencing reads from the TcI reference strain 
Sylvio X10/1 to resolve the existence of mitochondrial heteroplasmy, a potential 
genotyping confounder.  
d. Optimize a panel of mitochondrial multilocus sequence targets (mtMLST) to describe 
TcI intra-lineage genetic diversity. 
e. Compare phylogenetic incongruence between nuclear and mitochondrial topologies to 
uncover novel mitochondrial introgression events occurring within natural 
populations of TcI.  
f. Develop nuclear and mitochondrial markers to characterize intra-host parasite 
multiclonality by Illumina amplicon deep sequencing. 
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3.3 Results 
3.3.1 Development and evaluation of nuclear MLST targets 
To develop an MLST scheme for T. cruzi, nine nuclear housekeeping targets were selected 
from published literature and with reference to available genome sequences (Weatherly et al., 
2009; Aslett et al., 2010). Candidate genes were chosen on the basis of being single-copy, 
chromosomally-independent and under stabilising selection with a ratio of non-synonymous 
to synonymous amino acid changes (dN/dS) less than one (Maiden, 2006; Odds and 
Jacobson, 2008). 
The discriminatory power (number of genotypes identified per total number of isolates) and 
typing efficiency (number of genotypes identified per polymorphic site) of each target was 
assessed across a panel of 39 cloned reference strains, representing genetic and geographical 
diversity of all six T. cruzi DTUs. Sequence data were then concatenated to produce unique 
allelic profiles per strain (diploid sequence types; DST) and the minimum combination of 
genes was derived by subtractive analysis to: (i) assign isolates to DTU-level; and (ii) enable 
higher resolution intra-lineage analysis.  
This study is reported in full below by Yeo et al., 2011. 
In summary:  
- Robust amplification was confirmed for all targets and all genes satisfied the criteria for 
MLST candidates, with the exception of two loci (TcAPX and TR), found to be under 
positive selection (dN/dS >1). 
- A minimum panel of four MLST targets (DHFR-TS, Met-III, RB19 and TcGPXII) can be 
used to unequivocally assign isolates to DTU-level. No single gene was able to 
differentiate all 39 reference strains. 
- An expanded panel of six MLST targets (DHFR-TS, Met-II, Met-III, RB19, TcMPX and 
TR) afforded the greatest discriminatory power (DP=0.97), distinguishing 38 out of 39 
reference isolates. This DP was equivalent to that obtained using all nine concatenated 
loci. 
- Three genes (LYT1, DHFR-TS and RB19) separated genetically homogeneous DTUs TcV 
and TcVI with significant bootstrap support. For a subset of targets (Met-II, Met-III, 
RB19, TcMPX), loss of heterozygosity (LOH) affecting restricted portions of 
chromosomes, was observed in both TcV and TcVI, cautioning the solitary use of these 
loci for lineage assignment of hybrid strains.  
- Inter- and intra-lineage phylogenetic incongruence between individual genes trees was 
indicative of historical nuclear recombination. 
- MLST provided a reliable and reproducible method to characterize parasite strains, with 
the potential to contribute substantially to our understanding of T. cruzi genetic diversity, 
following the establishment of a standardized protocol. 
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Background: Multilocus sequence typing (MLST) is a powerful and highly discriminatory method for analysing pathogen
population structure and epidemiology. Trypanosoma cruzi, the protozoan agent of American trypanosomiasis (Chagas
disease), has remarkable genetic and ecological diversity. A standardised MLST protocol that is suitable for assignment of T.
cruzi isolates to genetic lineage and for higher resolution diversity studies has not been developed.
Methodology/Principal Findings: We have sequenced and diplotyped nine single copy housekeeping genes and assessed
their value as part of a systematic MLST scheme for T. cruzi. A minimum panel of four MLST targets (Met-III, RB19, TcGPXII,
and DHFR-TS) was shown to provide unambiguous assignment of isolates to the six known T. cruzi lineages (Discrete Typing
Units, DTUs TcI-TcVI). In addition, we recommend six MLST targets (Met-II, Met-III, RB19, TcMPX, DHFR-TS, and TR) for more in
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targets, putative corresponding homozygous and heterozygous loci within DTUs TcI and TcIII. Furthermore, individual gene
trees gave incongruent topologies at inter- and intra-DTU levels, inconsistent with a model of strict clonality.
Conclusions/Significance: We demonstrate the value of systematic MLST diplotyping for describing inter-DTU relationships
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Introduction
Trypanosoma cruzi is the causative agent of Chagas disease and
the most important parasitic infection in Latin America.
Approximately 8 million people are thought to be infected [1].
Chagas disease is a zoonosis: T. cruzi infects many mammal species
[2] and is transmitted to humans primarily by the infected faeces
of haematophagous triatomine bugs coming into contact with
mucosal membranes or broken skin. Transmission may also be by
blood transfusion, congenitally or, rarely, by ingestion of food
contaminated by infected triatomine faeces [3].
T. cruzi is monophyletic but genetically heterogeneous with at
least six phylogenetic lineages (discrete typing units, DTUs)
previously designated TcI, and TcIIa-e. A recent review meeting
on T. cruzi intraspecific nomenclature reached an international
consensus that these six DTUs should be renamed (former
nomenclature in parenthesis): TcI (TcI), TcII (TcIIb), TcIII
(TcIIc), TcIV (TcIIa), TcV (TcIId) and TcVI (TcIIe), to remove
the presumptive sublineage designations within TcII [4]. Here we
will adopt this new consensus nomenclature.
TcI and TcII are the most genetically distant groups. The
evolutionary ancestry of TcIII and TcIV is presently a debated
issue. Based on sequencing of individual nuclear genes Wester-
nberger et al. [5] suggested an ancient hybridisation event
occurred between TcI and TcII followed by a long period of
clonal propagation leading to the extant DTUs TcIII and TcIV.
Alternatively, de Freitas et al. [6] suggested that TcIII and TcIV
have a separate evolutionary ancestry with mitochondrial sequen-
ces that are similar to each other but distinct from both TcI and
TcII. Less controversially it is clear, using an array of molecular
markers [6,7,8] that TcV and TcVI are hybrid lineages sharing
haplotypes from both TcII and TcIII, with both DTUs retaining
www.plosntds.org 1 June 2011 | Volume 5 | Issue 6 | e1049
the mitochondrial genome of TcIII. Production of experimental
hybrids [9] proved that T. cruzi has an extant capacity for genetic
exchange (at least within TcI) but the mechanism of recombina-
tion is not fully understood, appearing to involve nuclear fusion
followed by genome erosion leading to relatively stable aneuploid
hybrids, a process distinct from classical meiosis [10].
There is currently no consensual discriminatory typing method
applicable to T. cruzi. Previous methods for characterisation have
included multilocus enzyme electrophoresis [11,12,13,14], PCR
amplification of single gene loci, [15] and various PCR based
assays [16,17]. Lewis et al. [18] recommended the use of a triple-
assay comprising SSU rDNA, HSP60 and GPI markers, allowing
reliable and low cost typing to DTU level. Microsatellite typing
(MLMT) provides a high resolution method for fine scale
population genetics analysis [19]. What is still lacking is an
unequivocally reproducible and standardised method that can
simultaneously distinguish the known genetic lineages, describe
inter-DTU relationships, and define high resolution intra-DTU
diversity for population genetics studies.
Multilocus sequence typing (MLST) has been applied to a
variety of bacterial [20,21] and yeast species [22,23] and typically
involves sequencing internal fragments of six single copy
housekeeping genes per strain [24]. The method is potentially
highly discriminatory, when sequence polymorphisms within
each housekeeping locus are categorised as distinct alleles.
Sequence data for all loci are usually concatenated to produce
a unique allelic profile (sequence type, ST). A major advantage of
MLST analysis is that sound sequence data are unambiguous and
suitable for population structure and epidemiological studies.
Results are particularly relevant if easily accessible international
databases are constructed such as MLST.net [25] which contains
MLST typing schemes and data for a growing number of
pathogens.
MLST was originally designed for haploid species, T. cruzi is
diploid organism and as such heterozygosity renders MLST analysis
more complicated. Heterozygosity from electropherograms can be
inferred by a double peak (with two bases) at the same variable bi-
allelic site [23]. One consequence of multiple bi-alleic sites is that of
ambiguous allelic phase within loci and also ambiguous combina-
tions of alleles across separate loci. However, it is possible for diploid
sequence data, (without phase resolution) to be modified, concat-
enated across multiple loci [26] and applied in distance based
phylogenetic methods for lineage assignment (see Materials and
Methods). From these data one can also infer evolutionary
relatedness, and detect gene mosaics, within or between homozy-
gous gene loci [27]. A MLST approach specific to T. cruzi was first
utilised by Machado and Ayala using two nuclear loci [8] in their
study of the genetic recombination in natural T. cruzi populations
and this is now being expanded by others to additional targets [28].
However the use of multicopy target genes is not recommended due
to the possibility of non-identical paralogous copies confusing
phylogenetic signals. The repetitive nature of the T. cruzi genome
has previously hampered the search for suitable single copy targets;
at least 50% of the T. cruzi genome consists of tandemly repeated
genes [29]. However, the recent publication of a draft chromosomal
level assembly by Weatherly et al. [30] has enabled both the
determination of copy number and chromosomal distribution of
markers to be established with reasonable confidence. A standard-
ised panel of suitable MLST gene loci has yet to be developed for T.
cruzi. Here we address this omission by sequencing and assessing 9
nuclear targets and evaluating them with a cohort of reference
strains representing the known lineages. We demonstrate the
potential of this formalised MLST for describing lineage assign-
ment, describing inter-DTU relationships and for high resolution
population genetic analysis of T. cruzi.
Materials and Methods
Isolates
A panel of 39 individual isolates (Table 1) was assembled,
consisting of cloned reference strains encompassing all of the
known DTUs (Table 1) spanning wide geographical and varied
ecological origins. Isolates were previously characterised to DTU
level by amplified fragment length polymorphisms (RFLP) in the
D7 divergent domain of the 24Sa rRNA, and restriction fragment
length polymorphism (RFLP) in the heat shock protein 60 (HSP60)
and GPI genes [18]. Parasites were cultivated in supplemented
RPMI liquid medium at 28uC, as described previously [31].
Genomic DNA was prepared from logarithmic phase cultures
using Dneasy kits (Qiagen, UK).
Choice of loci
Initially, 11 genes were investigated. This number was
subsequently reduced to 9 single copy targets after screening for
reliability of PCR amplification. The excluded genes were trypa-
nothione-dependent glyoxalase I (gene ID, Tc00.104705351
0659.240)and cyclophilin (gene ID, Tc00.1047053510947.50).
Targets were verified by PCR amplification and sequences
submitted for BLAST (blastn) analyses hosted at NCBI. Copy
number of targets was verified by submission of gene IDs to
TriTyrpDB 2.2 (http://TriTrypDB.org). The 9 single copy gene
fragments amplified for MLST analysis were ascorbate-dependent
haemoperoxidase (TcAPX), dihydrofolate reductase-thymidylate
synthase (DHFR-TS), glutathione-dependent peroxidase II
(TcGPXII), mitochondrial peroxidase (TcMPX), trypanothione
reductase (TR), RNA-binding protein-19 (RB19), metacyclin-II
(Met-II), metacyclin-III (Met-III) and LYT1. The ratio of non-
synonymous to synonymous amino acid changes (dN/dS) was
calculated according to the Nei-Gojobori method [32] using
SNAP software available at http://www.hiv.lanl.gov, [33] to infer
relative selection pressures. Genes possessing a dN/dS ratio ,1
meet the criteria for stabilising selection for the conservation of
Author Summary
The single-celled parasite Trypanosoma cruzi occurs in
animals and insect vectors in the Americas. When
transmitted to humans it causes a major public health
problem, Chagas disease (American trypanosomiasis). T.
cruzi is genetically diverse and currently split into six
groups, known as TcI to TcVI. Multilocus sequence typing
(MLST) is a method used for studying the population
structure and diversity of pathogens. MLST involves
sequencing the DNA of several different genes and
comparing the sequences between isolates. MLST has
not yet been developed and systematically applied to T.
cruzi. He, we sequence nine T. cruzi genes, selecting a
panel of four for lineage assignment and six for higher
resolution studies of genetic diversity. Our results showed
that one of the T. cruzi genetic groups is further
subdivided into North and South American subpopula-
tions. Furthermore, comparative analyses of the gene
sequences gave new evidence of genetic exchange in T.
cruzi. Application of MLST for assigning field isolates of T.
cruzi to genetic groups and for detailed investigation of
diversity provides a valuable approach to understanding
the taxonomy, population structure, genetics, ecology and
epidemiology of this important human pathogen.
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metabolic function. Taylor & Fisher [34] recommended the
incorporation of some loci with a dN/dS ratio of .1 in order to
obtain sufficient sequence diversity.
PCR amplification
Primers and annealing temperatures for PCR amplification are
given in Table 2. For DHFR-TS and TR, cyclic amplifications were
performed with an initial denaturation step for three minutes at
94uC, followed by 30 amplification cycles (94uC for 30 seconds,
58uC for 1 minute, 72uC for 2 minutes). Annealing temperatures
were 55uC for TcAPX, 50uC for TcMPX and 62uC TcGPXII.
Reaction conditions for Met-II, and RB19 were as follows: 3
minutes at 94uC, followed by 30 amplification cycles (94uC for 30
seconds, 53uC for 30 seconds, 72uC for 45 seconds; annealing
temperatures were 51uC for Met-III and 56uC for LYT1). All
reactions had a final ten minute elongation step at 72uC. Each
20 ml total reaction volume contained: 125 ng genomic DNA, 1 ml
of each primer (20 pmol/ml), 2 ml dNTPs (2 mM), 0.8 ml (50 mM)
MgCl2 and 5U Taq (BIO-21086, Bioline, UK).
PCR products were purified with QIAQuick PCR purification
kits (Qiagen) or SureClean (Bioline, UK). Bi-directional sequenc-
ing was performed with Big Dye Terminator Cycle Sequencing
V3.1 (Applied Biosystems) in ABI PRISM 377 DNA Sequencers
(Applied Biosystems) according to the manufacturer’s protocol.
Gene fragments were sequenced in both directions (59 and 39)
with the PCR primers described in Table 2. Additionally, in the
case of LYT1, Met-II, Met-III, DHFR-TS and TR internal primers
were used to obtain full sequence coverage. Sequence data were
assembled manually in BioEdit v7.0.9.0 sequence alignment
editor software (Ibis Biosciences, USA) and ambiguous peripheral
regions of aligned sequences discarded to produce unambiguous
partial gene sequences for each isolate. Chromatograms were
examined visually in both directions and in most instances the
results easily interpreted as heterozygous when two peaks in a
chromatogram overlap. Re-sequencing was undertaken if results
were ambiguous.
Strain differentiation by diploid sequence typing
The number of sequence types (STs) for each gene fragment
was identified from SNP data across the panel of isolates and the
discriminatory power (DP, genotypes recovered per unique isolate
tested) for each gene determined. STs were conjoined across gene
fragments in order to identify a diploid sequence type (DST) and
to assess overall discriminatory power (DP). DSTs were applied to
eBURST software to infer evolutionary relationships and
founders. The eBURST algorithm (http://eburst.mlst.net) identi-
fies related sequences and predicts a founding genotype (based on
the most overrepresented genotype) with variants identified
depending on the number of different loci.
Phylogenetic analysis was performed on modified sequences
using the methodology described by Tavanti et al. [26] which
renders diplotypic data suitable for use in MEGA analysis [35] to
produce distance based dendrograms. Briefly, variable loci
between isolates can be considered either homozygous or
heterozygous, assuming that T. cruzi is minimally diploid. For
example, a homozygous variable locus scored as A (adenine) was
modified by duplication to AA, and a heterozygous locus, for
example Y (C or T, in accordance with IUPAC nomenclature),
scored as CT, effectively creating a difference matrix across the
panel. Phylogenetically the data were examined in two different
ways. Firstly sequences were examined at the level of individual
genes by generating neighbor-joining trees (MEGA v4.0.2) in
order to assess the ‘‘usefulness’’ of gene fragments in the context
of lineage assignment, intralineage resolution and associated
bootstrap values. Secondly, sequence data were concatenated
across multiple gene fragments to produce MLST neighbor-
joining trees.
Table 1. Cohort of reference clonal isolates representing the
six known T. cruzi lineages (DTUs).
Strain DTU Origin Host
C8 cl1 TcI La Paz, Bolivia Triatoma infestans
X10/1 TcI Bele´m, Brazil Homo sapiens
JR cl4 TcI Anzoategui, Venezuela Homo sapiens
PI (CJ007) TcI Carajas, Brazil Didelphis marsupialis
PII (CJ005) TcI Carajas, Brazil Unidentified
triatomine
B187 cl10 TcI Para´ State, Brazil Didelphis marsupialis
SAXP18 cl1 TcI Majes, Peru Didelphis marsupialis
92101601P cl1 TcI Georgia, U.S.A. Didelphis marsupialis
Esm cl3 TcII Sa´o Felipe, Brazil Homo sapiens
Pot7a cl1 TcII San Martin, Paraguay Triatoma infestans
Pot7b cl2 TcII San Martin, Paraguay Triatoma infestans
Tu18 cl2 TcII Tupiza, Bolivia Triatoma infestans
Chaco23 col4 TcII Chaco, Paraguay Triatoma infestans
M5631 cl5 TcIII Marajo, Brazil Dasypus
novemcinctus
M6421 cl6 TcIII Bele´m, Brazil Homo sapiens
ARMA 18 cl3 TcIII Camp Lorro, Paraguay Dasypus
novemcinctus
ARMA 13 cl1 TcIII Campo Lorro, Paraguay Dasypus
novemcinctus
JA2 cl2 TcIII Amazonas, Brazil Unknown
CM25 cl2 TcIII Carimaga, Colombia Dasyprocta
fuliginosa
85/847 cl2 TcIII Alto Beni, Bolivia Dasypus
novemcinctus
SABP19 cl5 TcIII Peru Triatoma infestans
StC10R cl1 TcIV Georgia, U.S.A. Procyon lotor
92122102R TcIV Georgia, U.S.A. Procyon lotor
10R26 TcIV Santa Cruz, Bolivia Aotus Sp.
CanIII cl1 TcIV Bele´m, Brazil Homo sapiens
Saimiri3 cl1 TcIV Venezuela Saimiri sciureus
PARA4 cl3 TcV Paraguari, Paraguay Triatoma infestans
PARA6 cl4 TcV Paraguari, Paraguay Triatoma infestans
Sc43 cl1 TcV Santa Cruz, Bolivia Triatoma infestans
92–80 cl2 TcV Santa Cruz, Bolivia Homo sapiens
Chaco2 cl3 TcV Chaco, Paraguay Triatoma infestans
Vinch101 cl1 TcV Limari, Chile Triatoma infestans
PAH179 cl5 TcV Chaco, Argentina Homo sapiens
CL Brener TcVI Rio Grande do Sul,
Brazil
Triatoma infestans
Tula cl2 TcVI Tulahuen, Chile Homo sapiens
P251 cl7 TcVI Cochabamba, Bolivia Homo sapiens
EPV20-1 cl1 TcVI Chaco, Argentina Triatoma infestans
LHVA cl4 TcVI Chaco, Argentina Triatoma infestans
VFRA1 cl1 TcVI Francia, Chile Triatoma infestans
doi:10.1371/journal.pntd.0001049.t001
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Analysis of recombination at the level of individual genes was
applied to isolates with unambiguous phase applied through the
software package RDP3 [36] incorporating the following methods:
RDP [37], Bootscanning [38], GENECONV [39], Maximum Chi
Square method [40,41], the Chimaera method [40], the Sister
Scanning Method [42], the 3SEQ method [43], the Reticulate
compatibility matrix method [44] and the TOPAL DSS method
[45,46],
Results
Chromosomal localisation of markers
Gene IDs were confirmed by BLAST searches and submitted to
the TriTypDB 1.3 (http://TriTrypDB.org) to identify chromo-
somal location. Locations for each of the the genes under study are
shown in Table 2. Two pairs of genes were physically linked: genes
LYT1 (367579–369237) and TcMPX (P:120685–121365) on
chromosome 22, and MET-III (P:945156–945731) and TcAPX
(P:1142201–1143187) on chromosome 36. The remaining genes
were on independent chromosomes. The ratios of nonsynonymous
to synonymous amino acid substitutions, resulting from sequence
polymorphisms, were 1.0 or less for 7 genes, two genes possessed
dN/dS ratios of above 1 (Table 3).
Nucleotide polymorphisms and amino acid changes
The 304 nucleotide polymorphisms among the nine sequenced
fragments resulted in 121 nonsynonymous changes in amino acids
encoded by sequence-variable triplets. Up to three different amino
acids were present in different isolates at the same locus across the
panel. A deletion of 3 nucleotides (AAA = Lysine at position 179–
181) was present in C8, X10/1 and SAXP18 (TcI) within LYT1.
Within TcMPX, a single non-synonymous nucleotide polymor-
phism resulted in a conservative amino acid change between an
aspartic acid residue and a glutamic acid residue was evident
(position 21). All TcV representatives possessed glutamic acid but
all other panel isolates (including TcVI) possessed aspartic acid
residues at the corresponding position.
Discriminatory power of MLST targets by diploid
sequence typing
Diploid sequence typing using 9 genes was able to discriminate 38
of 39 isolates (DP 0.97, Table 4). Importantly, using only 6 genes
(Met-II, Met-III, RB19, TcMPX, DHFR-TS and TR) the same
number of DSTs could be identified. Only two isolates, Sc43 and
Vinch101, shared a DST (29). Both are positioned within the DTU
TcV which is known to possess a particularly homogenous
population structure by microsatellite analysis [10]. All other
isolates, notably even those those within the relatively homogenous
clade TcVI, produced a unique isolate specific DST. Discriminatory
power was determined for each of the 9 gene fragments (Table 4), in
decreasing power, as follows:Met-II,Met-III and RB19 (0.59), LYT1
(0.56), TR (0.54), DHFR-TS and TcGPXII (0.49), TcMPX (0.41), and
TcAPX (0.38). No single gene was able to distinguish all 39 reference
strains. Met-II, Met-III and RB19, taken individually, were the most
discriminatory genes, all three identifying 24 separate genotypes
from the panel of 39. TcAPX was the least resolutive marker
distinguishing 15 of 39 isolates (DP 0.38). Table 4 shows in detail the
number of STs (sequence types) that each individual gene fragment
resolved, and also the derived DSTs obtained from the concatena-
tion of all 9 STs for each isolate. Table 4 also indicates the reduced
panel of 6 genes required to obtain the same 38 DSTs. eBURST
analysis of the genotypes and DSTs for 39 T. cruzi isolates from the
panel revealed one cluster of 7 DSTs within TcV as the only related
set to emerge from this analysis. Vinch101 (Limari, Chile) and Sc43
(Santa Cruz, Bolivia), both DST 29 (Table 4) are the predicted
genetic founders of isolates of all other TcV isolates. The remaining
isolates across other DTUs appeared as unrelated singletons (isolates
that do not belong to any cluster). Overall the results reveal that
diploid sequence typing using just 6 genes is highly discriminatory.
Intra DTU diversity
Table 5 describes the levels of diversity seen in each gene
fragment represented as the number of variable sites per DTU
(VS), the number of genotypes differentiated per DTU (GT) and
the discriminatory power for each gene fragment for each DTU
(DP). The number of genotypes identified at the intra DTU level,
varied widely and is correlated to the SNP diversity within each
gene fragment. The most and least discriminatory genes for each
of the six DTUs are also shown in detail in Table 5. LYT1 and
RB19 genes revealed the most diversity for TcI discriminating 7 of
8 isolates (DP 0.88). Two genes DHFRS-TS and Met-III gave the
highest resolution for TcII (DP 0.80), generally considered to be a
relatively homogenous clade, and revealed surprising discrimina-
tory ability, distinguishing 4 of 5 isolates. A single gene (RB19) was
able to distinguish all 8 reference isolates within TcIII (DP 1.0). Six
of 9 genetic loci were able to discriminate individually the full
panel of 5 TcIV reference strains (DP 1.0). DTUs TcV and TcVI
have previously been shown to have homogenous population
Table 3. Properties of nine T. cruzi MLST targets.
Gene Fragment
No. Of
Polymorphic Sites
No. Of
Genotypes
No. Of
Genotypes/Polymorphism
(Typing Efficiency)
Ratio Of
Nonsynonymous To
Synonymous Changes
LYT1 47 22 0.47 0.833
Met-II 51 24 0.47 0.880
Met-III 50 24 0.48 0.440
RB19 27 24 0.89 0.129
TcAPX 27 14 0.52 2.04
TcMPX 15 16 1.06 0.061
DHFR-TS 32 19 0.59 0.088
TcGPXII 27 18 0.66 0.502
TR 28 21 0.75 1.964
doi:10.1371/journal.pntd.0001049.t003
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structures with low intralineage diversity. Nevertheless TcAPX
resolved three of 5 isolates within TcV (DP 0.43) and TcMPX 5 of
6 (DP 0.83) isolates within DTU VI.
Phylogenies and incongruence
In addition to the derivation of DSTs, neighbor-joining trees for
individual and concatenated gene fragments were constructed,
representatives of which are shown in Figures 1 and 2.
Concatenation using all of the original 9 gene fragments generated
phylogenies with the expected DTU assignments for all 39 isolates
with much higher bootstrap values than for individual genes
(supporting information, Figure S1); there were no unexpected
outliers. However, bootstrap support distinguishing TcV and VI
was low (21%), but to distinguish between these DTUs concatena-
tion of just two genes (DHFR-TS and LYT1 sequences) generated
robust lineage assignment, and also two separate clusters within
Table 4. Sequence types (STs) and diploid sequence types (DSTs) for nine gene fragments.
Strain DTU DST LYT1 (ST) Met-II* Met-III* RB19* TcAPX TcMPX* DHFR-TS* TcGPXII TR*
C8 cl1 TcI 1 1 1 1 1 1 1 1 1 1
X10/1 TcI 2 2 2 1 2 2 1 1 2 1
JR cl4 TcI 3 3 3 2 3 3 1 1 3 1
PI (CJ007) TcI 4 4 1 1 4 2 1 1 1 2
PII (CJ005) TcI 5 5 4 3 1 2 1 1 1 3
B187 cl10 TcI 6 6 4 1 5 2 1 1 4 4
SAXP18 cl1 TcI 7 1 1 1 6 2 1 1 1 5
92101601P cl1 TcI 8 7 1 4 7 2 1 2 3 6
Esm cl3 TcII 9 8 5 5 8 4 2 3 5 7
Pot7a cl1 TcII 10 8 5 6 8 4 3 4 5 7
Pot7b cl2 TcII 11 8 5 5 8 4 3 4 5 8
Tu18 cl2 TcII 12 9 6 7 9 5 2 5 5 8
Chaco23 col4 TcII 13 10 7 8 9 4 2 6 6 8
M5631 cl5 TcIII 14 11 8 9 10 6 4 7 7 9
M6421 cl6 TcIII 15 11 9 10 11 7 4 7 8 10
ARMA18 cl3 TcIII 16 12 10 10 12 6 5 7 8 11
ARMA13 cl1 TcIII 17 12 9 11 13 6 5 7 9 11
JA2 cl2 TcIII 18 13 11 12 14 6 4 8 10 10
CM25 cl2 TcIII 19 14 12 13 15 7 4 7 11 12
85/847 cl2 TcIII 20 15 11 14 16 6 4 9 12 13
SABP19 cl5 TcIII 21 16 13 15 17 6 6 7 7 11
StC10R cl1 TcIV 22 17 14 16 18 8 7 10 13 14
92122102R TcIV 23 17 15 17 18 8 8 11 14 15
10R26 TcIV 24 18 16 18 19 9 9 12 15 16
Can III cl1 TcIV 25 19 17 19 20 10 10 13 16 17
Saimiri3 cl1 TcIV 26 20 18 20 20 11 11 14 17 18
PARA4 cl3 TcV 27 21 19 21 21 12 11 15 18 19
PARA6 cl4 TcV 28 21 20 22 21 12 11 15 18 19
Sc43 cl1 TcV 29 21 19 22 21 13 11 16 18 19
92–80 cl2 TcV 30 21 19 22 21 13 11 15 18 19
Chaco2 cl3 TcV 31 21 19 22 21 13 11 16 18 20
Vinch101 cl1 TcV 29 21 19 22 21 13 11 16 18 19
PAH179 cl5 TcV 32 21 19 22 21 14 12 16 18 19
CL Brener TcVI 33 22 21 23 22 13 13 17 18 19
Tula cl2 TcVI 34 22 21 24 23 13 14 18 18 19
P251 cl7 TcVI 35 22 21 24 22 13 8 18 18 19
EPV20–1 cl1 TcVI 36 22 22 23 22 13 15 18 18 19
LHVA cl4 TcVI 37 22 23 23 22 14 8 18 18 19
VFRA1 cl1 TcVI 38 22 24 23 24 15 16 19 18 21
Discriminatory Power 0.97 0.56 0.62 0.62 0.62 0.38 0.41 0.49 0.49 0.54
*Indicate six genes required to identify the same number of DSTs as the full panel of 9 genes.
doi:10.1371/journal.pntd.0001049.t004
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TcV and TcVI (supporting information, Figure S1). Generally,
individual trees assigned each of the reference DTUs to the
predicted clade (TcI-TcIV). As expected, bootstrap support for
individual gene loci was variable depending on locus. For example
TcAPX, generated dendrograms with high bootstraps for lineage
assignment (with the exception of TcV and TcIV) but low
intralineage diversity. Other genes (for example Met-II and Met-
III) generated trees with high bootstrap values for both lineage
assignment and comparatively high bootstraps for intralineage
diversity. Conversely, TcMPX produced the least phylogenetically
informative dendrograms with low associated bootstrap values.
Three genes (LYT1, DHFRS-TS, RB19) individually separated the
difficult to distinguish homogenous clades TcV and TcVI with
relatively high bootstraps. Loss of heterozygosity (LOH, the loss of
one allele at a specific locus) was observed in DTUs TcV and TcVI,
in some isolates, in 4 gene fragments (see below) and confused the
phylogenetic assignment of those individual isolates affected. In
these instances the remaining allelic profiles clustered with either the
respective TcII or TcIII clades. One surprising output was the level
of incongruent DTU topologies between individual genetic loci
(Figure 1). For example TcAPX, TcMPX, Met-II, and Met-III
generated TcI clades that were most closely associated to TcIV. In
contrast, DHFR-TS, TR, and LYT1 dendrograms inferred a closer
association of TcI to TcIII. TcGPXII inferred that TcI was more
similar to TcIII. Similarly, at the intra DTU level there was also
incongruence between dendrograms. For example, TcGPXII and
Met-II each separated TcIII into two clusters but with incongruent
isolates (for example M5631 and CM25, Figure 1).
Choice of loci for lineage assignment
The minimum number of genes required for phylogenetic
assignment to DTU level was investigated according to the
following criteria. Firstly, the minimum number of genes required
to produce phylogenetically robust bootstrap support. Secondly, to
choose those genes that produced the most consistent unambig-
uous sequences. Thirdly, to choose genes requiring the minimum
number of internal primers. Using these criteria a minimum
combination of 4 genes (Met-III, RB19, TcGPXII and DHFR-TS)
enabled all reference isolates to be assigned to DTU level.
Specifically, concatenated sequences of Met-III, RB19 and
TcGPXII assigned isolates to DTUs TcI-TcIV (Figure 2A).
Separately, DHFR-TS (the only gene requiring internal primers)
distinguished the DTUs TcV and TcVI (Figure 2B, insert).
Internal primers for Met-III, RB19 and TcGPXII were not required
after initial optimisation (Table 2).
Intralineage phylogenies
Generally, bootstrap support within DTUs using concatenated
sequences was lower than between DTUs (Figure 1) which is
expected in data originating from gene fragments with non-
contiguous topologies at the intralineage level. In most instances
intralineage topology of individual gene dendrograms was
generally low and/or not contiguous across loci (Figure 1).
However, certain observations deserve closer scrutiny. Important-
ly, two distinct clusters within TcIV separated isolates from North
America and South America. This genetic partitioning was
detected in 8 out of 9 gene individual targets in the present study,
indicating a robust cladistic subdivision within TcIV. Interestingly,
two TcI isolates SAXP18 (Peru, Didelphis marsupialis) and C8
(Bolivia, Triatoma infestans) were isolated from silvatic and domestic
sources respectively, and are genetically similar suggesting present
or past overlapping transmission cycles. Relatively high bootstrap
support for isolates of the TcII clade did not reveal evidence of
geographical clustering and genetically similar isolates originated
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from distant localities. Within TcIII at least two clusters were seen
(in concatenated data); silvatic isolates (from Dasypus novemcinctus) in
the Paraguayan Chaco clustered with a domestic strain (SABP19)
isolated from a domestic T. infestans in Peru. The 8 TcIII isolates
included in our panel showed considerable diversity. However,
numbers are insufficient to examine population substructuring.
Intralineage recombination
Analysis for the presence of mosaic alleles, at the level of
individual genetic loci was performed using RDP [37], applied to a
total of 240 representative sequences of known allelic phase (single
SNP heterozygous and homozygous sequence profiles) encom-
passing DTUs TcI, TcII, TcIII and TcIV across the 9 genetic loci.
We found no evidence of allelic mosaics within individual genes.
However, diplotypic SNP data revealed for three genes (LYT1,
TcGPXII and TcMPX) that putative donor homozygous SNP
profiles and the corresponding heterozygous profiles were present
as shown in Figure 3. Specifically, within LYT1 the heterozygous
isolate (PII) and putative donors (B187 and PI) were identified
within TcI. For TcGPXII, 2 heterozygous isolates (ARMA18 and
M6421) possess SNP profiles of the putative donor isolates CM25
and 85/847 (TcIII). Lastly, for TcMPX, SABP19 was heterozygous
at a single locus with potential donors in the same DTU (TcIII). In
each instance individual isolates containing heterozygous and
donor SNPs were present only in a single gene and were not
contiguous across loci.
SNP data and loss of heterozygosity
Our panel of isolates included 13 representatives of DTUs V and
VI, which are known to be genetic hybrids of TcII and TcIII [8]
Figure 1. Phylogenetic DTU incongruence between two individual gene trees (TcI, TcIII and TcIV). *loss of heterozygosity in isolates at
the Met-II locus (EPV20-1, TcVI: Para 6, TcV).
doi:10.1371/journal.pntd.0001049.g001
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Across all 9 loci the expected allelic heterozygous profile was
observed in most individual isolates. However, at four gene loci
complete LOH was detected for individual isolates within the
hybrid lineages. The observations are as follows: withinMet-III, two
TcVI isolates (Tula cl2 and P251 cl7) possessed a TcII-like allele but
not a TcIII-like allele as did an individual TcV isolate for Met-II
(PARA6 cl4). In contrast a single TcVI isolate at the locus RB19
(VFRA cl1) possessed only the TcIII-like allele. At the TcMPX locus,
all TcV isolates (with the exception of PAH179) appeared to have
lost the TcIII-like allele and 2 representatives of TcVI (P251 and
LHVA) lost the TcII-like allele; the remaining 4 TcVI isolates
retained heterozygosity. LOH among individual isolates in genetic
loci could be clearly visualised when dendrograms were constructed,
for example, hybrid isolates PARA6 (TcV) and EPV20-1(TcVI) for
Met-II clustered within TcII (Figure 1). There was no continuity of
allelic loss across different genes for individual isolates. For example,
the two aforementioned isolates exhibiting homozygosity in Met-III
were heterozygous in TcAPX, which are linked on chromosome 36.
It is therefore evident that heterozygosity has been maintained
elsewhere on the same chromosome. Taken together the results
indicate a return to homozygosity in 6.24% of TcV and TcIV
(combined) isolates when considering the four affected gene
fragments.
Discussion
Discriminatory power and diploid sequence typing
Diploid sequence typing of 39 reference isolates indicates that
together the nine genes under study were highly discriminatory, 38
of 39 reference isolates generated a unique DST. It was apparent
that the number of STs identified for each gene fragment varied
considerably (Table 5) despite the fact that all but two of the genes
(TcAPX and TR) were under stabilising selection. However, by
using just 6 of the original panel of nine genes the same 38 DSTs
could be identified. The reduced panel consisted of those genes
with the highest overall DPs (Met-II, Met-III and Rb19) with
additional genes (TcMPX, DHFR-TS and TR) resolving further
STs for the genetically homogenous DTUs TcV and TcVI. The
reduction in the number of genes would represent a considerable
saving in sequencing effort if applied to new samples. Further-
more, the reduced panel consists primarily of genes that are easily
amplified and sequenced. The derived STs and DSTs applied to
eBURST software, designed specifically for MLST data to infer
evolutionary relationships and genetic founders, identified one
cluster encompassing all of the TcV reference isolates. The
inferred founder of this group (DST29) was found in 2 isolates
(Vinch101 and Sc43). Both of these isolates were originally isolated
Figure 2. Concatenation and lineage assignment. A combination of 4 genes allows for DTU assignment. 2A, Unrooted neighbor-joining
diplotypic tree showing p-distance for 3 concatenated gene fragments (Met-III, RB19, and TcGPXII) which discriminate all lineages except TcV and VI.
2B, DHFR-TS differentiates between TcV and TcVI.
doi:10.1371/journal.pntd.0001049.g002
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from domestic T. infestans from Chile and Bolivia respectively. The
ability to differentiate isolates within TcV is an important
development, as this DTU is found throughout the Southern
Cone countries in domestic cycles. Currently other methods to
demonstrate diversity within TcV have been lacking. The high
number of singletons observed in remaining DTUs was surprising,
although this is probably a consequence of reference isolates
spanning diverse spatial and ecological origins and diversity found
within our panel. It is likely that high intensity localised sampling
would reveal more easily genetic relationships between isolates.
High numbers of singletons are often observed in other MLST
typing schemes (for example Candida species) when applied to small
datasets. Furthermore distance based dendrograms have been
shown to correlate well with clonal clusters generated by eBURST
when applied to large numbers [27]. It is also worth noting that
high rates of singletons are typical of populations with a high rate
of recombination relative to mutation [27]. Although eBURST is
an established software for diplotyping and haplotyping pathogens
[47,48] until analysis has been applied to a larger number of
sympatric T. cruzi isolates it is difficult to evaluate the usefulness of
the analysis as a tool for predicting founders and clusters in DTUs
other than TcV, and other approaches should be considered in
parallel.
Phylogenies and incongruence
A separate approach for the analysis of diplotypic MLST data is
to generate phylogenetic trees utilising distance based methods and
modified sequences, adapted for diplotyping. At the level of
individual gene fragments, isolates were generally assigned to the
predicted clades, although bootstap support varied widely and no
single gene was able to assign all isolates robustly. A noticeable
observation was that of incongruent topologies in individual gene
trees and in particular between DTUs TcI, TcIII, and TcIV. At
the intra DTU level there was incongruence between dendro-
grams (Figure 1). The bootstraps supporting incongruence varied
widely between genes and DTUs and similar patterns of
incongruence have been previously observed in nuclear genes
[5,49]. Specifically, our data revealed that DTUs TcIII and TcIV
possessed split affinities to DTUs TcI and TcII. For 4 genes,
DTUs TcIII and TcIV showed greater affinity to TcI. These split
affinities of TcIII and TcIV to TcI and TcII are in broad
agreement with the spectrum of polymorphism observed by
Westenberger et al. [5]. Such incongruence is not immediately
compatible with a model of strict clonality; genealogical relation-
ships where sequences vary in topological position is a classical
marker in populations that have undergone recombination.
Choice of loci for lineage assignment
Sequence data concatenated across all 9 genes produced robust
phylogenetic assignment for all DTUs except for TcV and TcVI,
which could be resolved using two concatenated genes (DHFR-TS
and LYT1 sequences). Importantly, this number could subse-
quently be reduced to a combination of just 4 genes (Met-III,
RB19, TcGPXII and DHFR-TS) while maintaining high bootstrap
support. The first three aforementioned gene sequences were
concatenated to differentiate DTUs TcI-TcIV, with DHFR-TS
dendrograms separately able to distinguish DTUs TcV and VI.
Notably concatenated data implies a cladistic subdivision within
TcIV, separating North American from South American isolates.
Bootstrap support is a requirement for any MLST scheme, but of
equal importance are reliable PCR amplifications which generate
unambiguous sequences in both forward and reverse directions.
All four targets meet this criterion. Met-III, RB19 and TcGPXII do
not require internal primers, although some were used initially in
Figure 3. Raw SNP data showing putative donor and recipient isolates. Sequences containing heterozygous SNP’s (R) and putative
homozygous donors (D) within a single DTU. Genetic loci are LYT1 (top), TcGPXII (bottom left) and TcMPX (bottom right).
doi:10.1371/journal.pntd.0001049.g003
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the optimisation process, and generate small amplicons (824 bp,
408 bp and 487 bp respectively). DHFR-TS alone requires the use
of internal sequencing primers. LYT1 was considered to be an
alternative candidate, also able to distinguish TcV and TcVI, but
it was technically more difficult to obtain sequences in the forward
direction despite multiple attempts at optimisation.
Intralineage recombination
SNP data revealed that for three genes (LYT1, TcGPXII and
TcMPX) putative donor homozygous SNP profiles and the
corresponding heterozygous profiles, were present within TcI (a
single heterozygous isolate) and TcIII (1 heterozygous isolate) one
tentative explanation of the presence of heterozygous SNPs is that
of a recombination signature within these DTUs. In the present
paper examination 240 sequences (of known allelic phase) using an
array of recombination detection algorithms did not detect evi-
dence of allelic mosaics. This result is not unexpected as
diplotyping is not as sensitive as haplotyping for detecting mosaic’s
or investigating the sexual reproduction in evolutionary history
[50]. Future recombination analysis will include more refined
phase resolution of sequences heterozygous at two or more loci,
typically not required for diplotypic MLST typing schemes.
However, haplotypes can be derived from current targets
reconstructed by the program PHASE [51], or more recently
fastPHASE (http://depts.washington.edu/uwc4c/express-licenses/
assets/ fastphase/ ), by cloning, or by allelic specific PCR [52]. In
a sexually reproducing population the frequencies of genotypes
(defined by haplotypes) should be in Hardy-Weinberg equilibrium.
New software to analyse haplotypic data include those incorporat-
ing Bayesian methodologies; Structure [53] and Beast [54]
reconstruct phylogenies with epidemiologically and evolutionary
informative results.
Loss of heterozygosity
LOH observed in 4 gene fragments affecting the hybrid lineages
TcV and TcIV has potentially significant consequences for MLST
and lineage assignment. For example, TcMPX hybrid isolates
(TcV) would be incorrectly assigned if judgment was based on a
single locus due to LOH (Figure 1). There was no continuity of
allelic loss across different genes for individual isolates, linked
genes (chromosome 36) were homozygous in Met-III but
heterozygous in TcAPX indicating local rather than large scale
events indicative of LOH seen in C. albicans [55]. Such apparent
random loss is consistent with gene conversion. However, within
TcMPX all TcV isolates (with the exception of PAH179) possessed
only a TcII like allele suggesting clonal expansion subsequent to
this LOH event. Discriminating between recombination, gene
conversion, duplication or mitotic recombination requires analysis
at the haplotypic level and should be possible by MLST,
particularly in light of the considerable heterozgosity found in a
T. cruzi (in particular DTUs TcI, TcIII, and TcIV). Use of a larger
number of sympatric isolates and gene targets evenly distributed
along those chromosomes where LOH has been previously
identified (chromosomes 6, 36, 29, 22) would be a suitable
approach, and one that has been exploited in C. albicans [55].
LOH in C. albicans [56,57,58] is one mechanism generating minor
genetic changes which over time enable adaptation to new
microenvironments [59,60,61,62]. Such microvariation has been
demonstrated by passage of C. albicans in vitro. Prolonged passage of
MLST characterised T.cruzi isolates under a range of different
environmental stresses could be applied to detect genetic basis for
fitness. In the current panel 40% of the SNPs were non
synonymous and resulted in amino acid changes. Some of these
were nontrivial (e.g., acidic to basic side chains, aliphatic to
aromatic side chains) which would be expected to result in
significant changes in higher and secondary peptide structures and
inter and intralineage catalytic/phenotypic differences.
Taken together we demonstrate that diploid sequence typing is
a powerful and practical method to describe the extent of diversity
in T. cruzi that can be integrated into population and evolutionary
studies, particularly if the current protocol can be applied to an
MLST database for T. cruzi. We propose that four genes (Met-III,
RB19, TcGPXII and DHFR-TS) be used for the characterisation of
isolates to DTU level. Additionally we propose that six gene
fragments (Met-II, Met-III, RB19, TcMPX, DHFR-TS and TR) form
the basis for a formalised MLST diplotyping scheme for further
high resolution studies on the basis that DST diversity differen-
tiated 38 out of 39 isolates. The proposed panel does not exclude
the addition or replacement of new gene targets to further optimise
diversity studies. eBURST analysis predicts that DST 29 isolated
from T. infestans in Boliva and Chile is the genetic founder of all
other TcV isolates in the reference panel (although isolate
numbers were small), phylogenies also support a cladistic
subdivision between North and South American TcIV isolates.
SNP data revealed that for three genes (LYT1, TcGPXII and
TcMPX) putative donor homozygous SNP profiles and the
corresponding heterozygous profiles, were present within DTUs
TcI and TcIII for single isolates. Incongruent topologies and the
intra and inter DTU level is not consistent with a model of strict
clonality. The high levels of heterozygosity detected in the gene
targets offers the potential for a future deeper level of analysis of
population genetics based on haplotypes.
Supporting Information
Figure S1 Concatenation and lineage assignment. Unrooted
neighbor-joining diplotypic tree showing p-distance for 9 concat-
enated gene fragments (A). Concatenation of LYT1 and DHFR-TS
discriminate between DTUs V and VI (inset). Concatenated
diplotypic tree using a reduced panel of 4 gene fragments (B).
Concatenation of Met-III, RB19, and TcGPXII assign isolates to
DTUs TcI-TcIV. DHFR-TS differentiates DTUs V and VI (B
inset).
Found at: doi:10.1371/journal.pntd.0001049.s001 (0.41 MB
DOC)
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3.3.2 Formalization of a standardized MLST scheme for T. cruzi 
To formalize a standardized MLST scheme for T. cruzi, a subset of the most discriminatory 
genetic markers from two published schemes (Yeo et al., 2011 and Lauthier et al., 2012) 
were evaluated across a modified panel of 25 T. cruzi reference strains, shared by both 
research groups. A total of thirteen nuclear housekeeping genes were assessed, including 
three fragments previously examined by Yeo et al. (Met-II, RB19 and TcMPX), to determine 
the optimum combination of loci for: (i) robust bootstrap-supported DTU-level assignment; 
(ii) DTU monophyly; and (iii) detection of intra-DTU genetic diversity. 
This study is reported in full below by Diosque et al., 2014. 
In summary:  
- The optimum combination of MLST genes consisted of seven loci (GPI, HMCOAR, 
LAP1, RB19, RHO1, SODB and TcMPX), which discriminated between all reference 
strains and separated all DTUs as monophyletic clades (DP=1.0). 
- A reduced panel of four MLST targets (GPI, HMCOAR, RHO1 and TcMPX,) can be used 
to assign the majority of isolates to DTU-level (19/25 DSTs; DP=0.76).  
- PCR reproducibility, examined across an expanded panel of 91 isolates, demonstrated 
>98% PCR positivity rate with minimal non-specific amplification. 
- LOH was observed in TcV and TcVI for two targets (Met-II and TcMPX), resulting in 
phylogenetic incongruence. However, the latter target was included in both final panels to 
distinguish between the two hybrid lineages.  
- This formalized MLST scheme represents a highly discriminatory strain typing technique 
and new ‘gold standard’ for routine T. cruzi lineage assignment (four loci) and higher 
resolution diversity studies (seven loci). 
- Future work will include application of this MLST scheme to larger field cohorts for 
more comprehensive population genetics studies. 
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Abstract
Trypanosoma cruzi, the aetiological agent of Chagas disease possess extensive genetic diversity. This has led to the
development of a plethora of molecular typing methods for the identification of both the known major genetic lineages
and for more fine scale characterization of different multilocus genotypes within these major lineages. Whole genome
sequencing applied to large sample sizes is not currently viable and multilocus enzyme electrophoresis, the previous gold
standard for T. cruzi typing, is laborious and time consuming. In the present work, we present an optimized Multilocus
Sequence Typing (MLST) scheme, based on the combined analysis of two recently proposed MLST approaches. Here,
thirteen concatenated gene fragments were applied to a panel of T. cruzi reference strains encompassing all known genetic
lineages. Concatenation of 13 fragments allowed assignment of all strains to the predicted Discrete Typing Units (DTUs), or
near-clades, with the exception of one strain that was an outlier for TcV, due to apparent loss of heterozygosity in one
fragment. Monophyly for all DTUs, along with robust bootstrap support, was restored when this fragment was subsequently
excluded from the analysis. All possible combinations of loci were assessed against predefined criteria with the objective of
selecting the most appropriate combination of between two and twelve fragments, for an optimized MLST scheme. The
optimum combination consisted of 7 loci and discriminated between all reference strains in the panel, with the majority
supported by robust bootstrap values. Additionally, a reduced panel of just 4 gene fragments displayed high bootstrap
values for DTU assignment and discriminated 21 out of 25 genotypes. We propose that the seven-fragment MLST scheme
could be used as a gold standard for T. cruzi typing, against which other typing approaches, particularly single locus
approaches or systematic PCR assays based on amplicon size, could be compared.
Citation: Diosque P, Tomasini N, Lauthier JJ, Messenger LA, Monje Rumi MM, et al. (2014) Optimized Multilocus Sequence Typing (MLST) Scheme for
Trypanosoma cruzi. PLoS Negl Trop Dis 8(8): e3117. doi:10.1371/journal.pntd.0003117
Editor: Philippe Bu¨scher, Institute of Tropical Medicine, Belgium
Received January 7, 2014; Accepted July 15, 2014; Published August 28, 2014
Copyright: ! 2014 Diosque et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research is funded by The European Union Seventh Framework Programme Grant 223034. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: patricio.diosque@unsa.edu.ar
Introduction
Trypanosoma cruzi, the protozoan causative agent of Chagas
disease, is a monophyletic and genetically heterogeneous taxon,
with at least six phylogenetic lineages formally recognised as
Discrete Typing Units (DTUs), TcI–TcVI [1], or near-clades
(clades that are blurred by infrequent inter-lineage genetic
recombination, [2]). T. cruzi is considered to have a predomi-
nantly clonal population structure but with at least some intra-
lineage recombination [3,4,5,6]. TcI and TcII are the most
genetically distant groups, and the evolutionary origins of TcIII
and TcIV remain controversial. Based on sequencing of individual
nuclear genes Westenberger et al. [7] suggested that an ancient
hybridisation event occurred between TcI and TcII followed by a
long period of clonal propagation leading to the extant TcIII and
TcIV. Alternatively, de Freitas et al. [8] suggested that TcIII and
TcIV have a separate evolutionary ancestry with mitochondrial
sequences that are similar to each other but distinct from both TcI
and TcII. Recently, Flores-Lopez and Machado [9] proposed that
TcIII and TcIV have no hybrid origin. Based on the sequence of
32 genes, they strongly suggested that TcI, TcIII and TcIV are
clustered into a major clade that diverged from TcII around 1–2
millions of years ago. Less controversially, it is clear that TcV and
TcVI, both overwhelmingly represented in the domestic trans-
mission cycles in the Southern Cone region of South America, are
hybrid lineages sharing haplotypes from both TcII and TcIII, with
both DTUs retaining the mitochondrial genome of TcIII [8,10].
Recent phylogenetic studies suggest that the emergence of the
hybrid lineages TcV and TcVI may have occurred within the last
60,000 years [11]. Reliable DTU identification and the potential
for high resolution investigation of genotypes at the intra DTU
level are of great interest for epidemiological, host association,
clinical and phylogenetic studies. Historically, a plethora of typing
techniques have been applied to T. cruzi. Initial pioneering work
applied multilocus enzyme electrophoresis (MLEE) techniques
[12,13,14,15,16,17,18,19,20] revealing the remarkable genetic
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heterogeneity of this parasite. Subsequently, several PCR-based
typing assays have been designed to differentiate the main DTUs
[21,22,23,24] and more recently, combinations of PCR-RFLP
schemes have been published [25,26,27]. Some approaches based
on DTU characterisation by direct sequential PCR amplifications
from blood and tissue samples are also promising, although
various sensitivity and reliability issues need to be resolved
[28,29,30]. Microsatellite typing (MLMT) has also been applied
to population data for fine-scale intra DTU genetic analysis
[31,32,33].
Multilocus sequence typing (MLST), originally developed for
bacterial species typing, has now been applied to a wide range of
prokaryotic [34,35,36,37] and increasingly eukaryotic microor-
ganisms [38,39,40,41,42,43,44,45,46,47,48]. The technique typi-
cally involves the sequencing and concatenation of six to ten
internal fragments of single copy housekeeping genes per strain
[49]. Data are often hosted on interactive open access databases
such as MLST.net for use in the wider research community. A
major advantage of MLST analysis is that sequence data are
unambiguous, minimizing interpretative errors. In this context, the
MLST approach represents an excellent candidate to become the
gold standard for T. cruzi genetic typing with outputs suitable for
phylogenetic and epidemiological studies, particularly where large
numbers of isolates from varied sources are under study.
Recently, two multilocus sequence typing (MLST) schemes have
been developed in parallel for T. cruzi, each of them based on
different gene targets [50,51]. Both schemes display a high
discriminatory power and are able to clearly differentiate the main
T. cruzi DTUs. The current work proposes to resolve the
optimum combination of loci across the two schemes to produce
a reproducible and robust formalised MLST scheme validated
across a shared reference panel of isolates for practical use by the
wider T. cruzi research community.
Methods
Parasite strains and DNA isolation
Twenty five cloned reference strains belonging to the six known
DTUs were examined (Table 1). These strains have been widely
used as reference strains in many previous studies, and are
regularly examined in our laboratory by Multilocus Enzyme
Electrophoresis (MLEE). Parasite stocks were cultivated at 28uC in
liver infusion tryptose (LIT) supplemented with 1% hemin, 10%
fetal bovine serum, 100 units/ml of penicillin, and 100 mg/mL of
streptomycin or in supplemented RPMI liquid medium.
MLST loci
Initially a total of 19 gene fragments were considered, 10
housekeeping genes previously described by Lauthier et al. [50]
[Glutathione peroxidase (GPX), 3-Hidroxi-3-metilglutaril-CoA
reductase (HMCOAR), Piruvate dehydrogenase component E1
subunit alfa (PDH), Small GTP-binding protein Rab7 (GTP),
Serine/treonine-protein phosphatase PP1 (STPP2), Rho-like GTP
binding protein (RHO1), Glucose-6-phosphate isomerase (GPI),
Superoxide dismutase A (SODA), Superoxide dismutase B (SODB)
and Leucine aminopeptidase (LAP)]; and 9 gene fragments from
Yeo et al. [51] [ascorbate-dependent haemoperoxidase (TcAPX),
dihydrofolate reductase-thymidylate synthase (DHFR-TS), gluta-
thione-dependent peroxidase II (TcGPXII), mitochondrial perox-
idase (TcMPX), trypanothione reductase (TR), RNA-binding
protein-19 (RB19), metacyclin-II (Met-II), metacyclin-III (Met-
III) and LYT1]. However, 6 of them were discarded based on
initial findings [50,51]. Although some of the excluded targets
were informative, they were not amenable for routine use. More
specifically, LYT1 was discarded due to unreliable PCR amplifi-
cation and sequencing despite multiple attempts at optimization;
TR, DHFR-TS and TcAPX were also deemed unsuitable as
internal sequencing primers were required; finally, Met-III and
TcGPXII were also excluded because generated non-specific PCR
products with some isolates.
The final 13 gene fragments assessed included 3 fragments
described by Yeo et al. [51] and the 10 housekeeping genes
previously described by Lauthier et al. [50]. These were: TcMPX,
RB19, Met-II, SODA, SODB, LAP, GPI, GPX, PDH,
HMCOAR, RHO1, GTP and STPP2. For the 13 loci under
study, searches in the CL-Brener and Sylvio X10 genomes (http://
tritrypdb.org/tritrypdb/), using the primer sequences as well as
the fragment sequences as query, displayed single matches in all
cases. Chromosome location, primer sequences and amplicon size
for each target are shown in Table 2. Nucleotide sequences for all
the analysed MLST targets are available from GenBank under the
following accession numbers: JN129501-JN129502, JN129511-
JN129518, JN129523-JN129524, JN129534-JN129535, JN12954
4-JN129551, JN129556-JN129557, JN129567-JN129568, JN129
577-JN129584, JN129589-JN129590, JN129600-JN129601, JN12
9610-JN129617, JN129622-JN129623, JN129633-JN129634, JN1
29643- JN129650, JN129655-JN129656, JN129666-JN129667,
JN129676-JN129683, JN129688-JN129689, JN129699-JN1297
00, JN129709-JN129716, JN129721-JN129722, JN129732-JN12
9733, JN129742-JN129749, JN129754-JN129755, JN129765-JN1
29766, JN129775-JN129782, JN129787-JN129788, JN129798-JN
129799, JN129808-JN129815, JN129820-JN129821, KF889442-
KF889646. Additionaly, we used T. cruzi marinkellei as outgroup.
Sequence data of the selected targets for T. cruzi marinkellei were
obtained from TriTrypDB (http://tritrypdb.org), under the
following accession Ids: TcMARK_CONTIG_2686, TcMARK_-
CONTIG_670, TcMARK_CONTIG_1404, Tc_MARK_2068,
Tc_MARK_3409, Tc_MARK_5695, Tc_MARK_9874, Tc_MA
RK_515, Tc_MARK_4984, Tc_MARK_5926, Tc_MARK_
8923, TcMARK_CONTIG_1818 and Tc_MARK_2666.
Molecular methods
PCRs were performed in 50 ml reaction volumes containing
100 ng of DNA, 0.2 mM of each primer, 1 U of goTaq DNA
polymerase (Promega), 10 ml of buffer (supplied with the GoTaq
Author Summary
The single-celled parasite Trypanosoma cruzi occurs in
mammals and insect vectors in the Americas. When
transmitted to humans it causes Chagas disease (American
trypanosomiasis) a major public health problem. T. cruzi is
genetically diverse and currently split into six groups,
known as TcI to TcVI. Multilocus sequence typing (MLST) is
a method used for studying the population structure and
diversity of pathogens and involves sequencing DNA of
several different genes and comparing the sequences
between isolates. Here, we assess 13 T. cruzi genes and
select the best combination for diversity studies. Outputs
reveal that a combination of 7 genes can be used for both
lineage assignment and high resolution studies of genetic
diversity, and a reduced combination of four loci for
lineage assignment. Application of MLST for assigning field
isolates of T. cruzi to genetic groups and for detailed
investigation of diversity provides a valuable approach to
understanding the taxonomy, population structure, ge-
netics, ecology and epidemiology of this important human
pathogen.
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polymerase) and a 50 mM concentration of each deoxynucleoside
triphosphate (Promega). Amplification conditions for all targets
were: 5 min at 94uC followed by 35 cycles of 94uC for 1 min;
55uC 1 min, and 72uC for 1 min, with a final extension at 72uC
for 5 min. Amplified fragments were purified (QIAquick, Qiagen)
and sequenced in both directions (ABI PRISM 310 Genetic
Analyzer or ABI PRISM 377 DNA Sequencers, Applied
Biosystems) using standard protocols. Primers used for sequencing
were identical to those used in PCR amplifications. In order to
assess reproducibility, each PCR amplification was performed
multiple times and associated sequencing was repeated at least
twice.
Data analysis
MLST data were analysed with MLSTest software (http://ipe.
unsa.edu.ar/software) [52] with the objective of identifying the
most resolutive and minimum number of targets for unequivocal
DTU assignment and potential fine scale characterisation.
MLSTest contains a suite of MLST data specific analytical tools.
Briefly, single nucleotide polymorphisms (SNPs) were identified in
all loci in MLSTest alignment viewer. Typing efficiency (TE) was
calculated using the same software. TE for a determined locus is
calculated as the number of identified genotypes divided by the
number of polymorphic sites in this locus. Additionally, discrim-
inatory power, defined as the probability that two strains are
distinguished when chosen at random from a population of
unrelated strains [53], was determined for each target (Table 3).
Sequence data were concatenated and Neighbour Joining
phylogenetic trees were generated by using uncorrected p-
distances. Heterozygous sites were handled in the analyses using
two different methods. First, a SNP duplication method described
by Yeo et al. and Tavanti et al. [51,54] was implemented. Briefly,
the SNP duplication method involves the elimination of mono-
morphic sites and duplication of polymorphisms in order to
‘‘resolve’’ the heterozygous sites. As an example, a homozygous
variable locus scored as C (cytosine) will be modified by CC; while
a heterozygous locus, for example Y (C or T, in accordance with
IUPAC nomenclature), will be scored as CT. Alternatively,
heterozygous SNPs were considered as average states. In more
detail, the genetic distance between T and Y (heterozygosity
composed of T and C) is considered as the mean distance between
the T and the possible resolutions of Y (distance T-T= 0 and
distance T-C= 1, average distance = 0.5, see [53] and MLSTest
1.0 manual at http://www.ipe.unsa.edu.ar/software for further
details). Statistical support was evaluated by 1000 bootstrap
replications. Overall phylogenetic incongruence among loci (by
comparison with the concatenated topology) was assessed by the
Incongruence Length Difference Test using the BIO-Neighbour
Joining method (BIONJ-ILD, [55]) and evaluated by a permuta-
tion test with 1,000 replications. Briefly, the ILD evaluates
whether the observed incongruence among fragments is higher
than that expected by random unstructured homoplasy across the
different fragments. A statistical significant ILD p value indicates
that many sites, in at least one fragment, support a phylogeny that
Table 1. Cohort of clonal reference isolates representing the six known T. cruzi lineages (DTUs).
Strain DTU Origin Host
1. X10cl1 TcI Bele´m, Brazil Homo sapiens
2. Cutia c1 Tcl Espiritu Santo, Brazil Dasyprocta aguti
3. Sp104 cl1 Tcl Region IV, Chile Triatoma spinolai
4. P209 cl93 Tcl Sucre, Bolivia Homo sapiens
5. OPS21 cl11 Tcl Cojedes, Venezuela Homo sapiens
6. 92101601P cl1 TcI Georgia, USA Didelphis marsupialis
7. TU18 cl93 TcII Potosı´, Bolivia Triatoma infestans
8. CBB cl3 TcII Region IV, Chile Homo sapiens
9. Mas cl1 TcII Federal District, Brazil Homo sapiens
10. IVV cl4 TcII Region IV, Chile Homo sapiens
11. Esm cl3 TcII Sa`o Felipe, Brazil Homo sapiens
12. M5631 cl5 TcIII Selva Terra, Brazil Dasypus novemcinctus
13. M6241 cl6 TcIII Belem, Brazil Homo sapiens
14. CM17 TcIII Meta, Colombia Dasypus sp.
15. X109/2 TcIII Makthlawaiya, Paraguay Canis familiaris
16. 92122102R TcIV Georgia, USA Procyon lotor
17. CanIII cl1 TcIV Bele´m, Brazil Homo sapiens
18. Dog Theis TcIV USA Canis familiaris
19. Mn cl2 TcV Region IV, Chile Homo Sapiens
20. Bug 2148 cl1 TcV Rio Grande do sul, Brazil Triatoma infestans
21. SO3 cl5 TcV Potosi, Bolivia Triatoma infestans
22. SC43 cl1 TcV Santa-Cruz, Bolivia Triatoma infestans
23. CL Brener TcVI Rio Grande do Sul, Brazil Triatoma infestans
24. P63 cl1 TcVI Makthlawaiya, Paraguay Triatoma infestans
25. Tula cl2 TcVI Talahuen, Chile Homo sapiens
doi:10.1371/journal.pntd.0003117.t001
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is contradicted by other fragments. In order to localize significant
incongruent branches in concatenated data we used the Neigh-
bour Joining based Localized Incongruence Length Difference
(NJ-LILD) test available in MLSTest. NJ-LILD is a variant of the
ILD test that allows localizing incongruence at branch level.
All combinations from 2 to 12 fragments were analysed using
the scheme optimisation algorithm in MLSTest which identifies
the combination of loci producing the maximum number of
diploid sequence types (DSTs). Three main sequential criteria
were applied to select the optimum combination of loci: firstly,
monophyly of DTUs and lineage assignment; secondly, robust
bootstrap values for the six major DTUs (1000 replications); and
thirdly detection of genetic diversity at the intra-DTU level.
Results
PCR amplification and sequencing
All 13 gene fragments were successfully amplified using identical
PCR reaction conditions (see methods) which generated discrete
PCR fragments. PCR amplifications of the 13 targets were applied
to an extended panel of 90 isolates obtaining more than 98% of
positive PCR and amplifications produced strong amplicons and
an absence of non-specific products (data not shown). We obtained
amplicons of the expected length for all the assayed targets and for
all the examined strains. Amplification for various DNA template
concentrations was assayed via serial dilution. No difference in
PCR amplifications were obtained when DNA concentrations
from 20 to 100 ng were used. A total of 5,121 bp of sequence data
were analysed for each strain (Table 2). There were no gaps in
sequences. The number of polymorphic sites (Table 3) for each of
the different fragments varied from 8 (STPP2) to 40 (Met-II).
STTP2 showed the lowest discriminatory power (describing just 5
different genotypes in the dataset). Rb19 was the fragment with the
highest discriminatory power identifying 21 distinct genotypes in
the dataset.
Optimized scheme for MLST
Initially, Neighbor Joining trees were generated from concat-
enated sequences across the 13 prescreened loci which identified
four monophyletic DTUs with robust bootstrap support (TcI,
Table 2. Details of gene targets.
Gene Gene IDa
Chromosome
Number Primer Sequence (59-39)
Amplicon
size (bp)b
Sequence
start 59c
Fragment
Length (bp)d
GPI*{ Tc00.1047053506529.508 6 CGCCATGTTGTGAATATTGG (20) 405 21 365
GGCGGACCACAATGAGTATC (20)
HMCOAR*{ TC00.1047053506831.40 32 AGGAGGCTTTTGAGTCCACA (20) 554 21 514
TCCAACAACACCAACCTCAA (20)
RHO1*{ Tc00.1047053506649.40 8 AGTTGCTGCTTCCCATCAAT (20) 455 21 415
CTGCACAGTGTATGCCTGCT (20)
Tc MPX*{ Tc00.1047053509499.14 22 ATGTTTCGTCGTATGGCC (18) 678 109 505
TGCGTTTTTCTCAAAATATTC (21)
LAP* Tc00.1047053508799.240 27 TGTACATGTTGCTTGGCTGAG (21) 444 22 402
GCTGAGGTGATTAGCGACAAA (21)
SODB* Tc00.1047053507039.10 35 GCCCCATCTTCAACCTT (17) 313 18 266
TAGTACGCATGCTCCCATA (19)
RB19* Tc00.1047053507515.60 29 GCCTACACCGAGGAGTACCA (20) 408 49 340
TTCTCCAATCCCCAGACTTG (20)
GPX Tc00.1047053511543.60 35 CGTGGCACTCTCCAATTACA (20) 360 21 321
AATTTAACCAGCGGGATGC (19)
PDH Tc00.1047053507831.70 40 GGGGCAAGTGTTTGAAGCTA (20) 491 21 451
AGAGCTCGCTTCGAGGTGTA (20)
GTP Tc00.1047053503689.10 12 TGTGACGGGACATTTTACGA (20) 561 21 521
CCCCTCGATCTCACGATTTA (20)
SODA Tc00.1047053509775.40 21 CCACAAGGCGTATGTGGAC (19) 300 20 263
ACGCACAGCCACGTCCAA (18)
STPP2 Tc00.1047053507673.10 34 CCGTGAAGCTTTTCAAGGAG (20) 409 21 369
GCCCCACTGTTCGTAAACTC (20)
Met-II TC00.1047053510889.280 6 TCATCTGCACCGATGAGTTC (20) 700 51 389
CTCCATAGCGTTGACGAACA (20)
*Gene fragments included in the 7 loci MLST scheme;
{Gene fragments included in the reduced 4 loci MLST scheme;
aGene ID: GenBank access number for the complete gene in the CL-Brener strain;
bAmplicon size refers to the sequence size of the gene fragment including the primers regions;
c59 starting position: indicates the position where the analyzed sequence starts, counting from the first base of the amplicon;
dFragment Length refers to the sequence length used for the analyses (the analyzed fragments do not include the primer regions).
doi:10.1371/journal.pntd.0003117.t002
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TcII, TcIII, TcIV, bootstrap.98%). TcVI was also monophyletic
but with a relatively low support (Figure 1). Additionally, TcV was
paraphyletic with Mncl2 as an outlier. The concatenated 13
fragments differentiated all 25 reference strains in terms of DSTs.
We observed that bootstrap values were slightly different between
the two methods (SNP duplication and average states) as they
manage heterozygous sites differently. Values were higher for the
SNP duplication method in most branches (Figure 1, branch
values highlighted in blue) as a consequence of base duplication,
which modifies the alignment and increases the informative sites
used for bootstrapping. To avoid the potential for methodologi-
cally elevated bootstraps, the average states method was imple-
mented for further analyses. From the selected 13 loci, all possible
combinations of 2 to 12 loci were analysed (8,177 combinations)
by implementing the MLSTest scheme optimisation algorithm.
One combination of 7 loci was the best according to the proposed
criteria. This combination consisted of Rb19, TcMPX,
HMCOAR, RHO1, GPI, SODB and LAP discriminating all 25
strains as DSTs, and importantly categorising all separate DTUs
as a monophyletic group. DTUs were also well-supported by
associated bootstraps values (TcI,100; TcII, 100; TcIII, 99.8;
TcIV, 88.2; TcV, 88.7; TcVI, 99.6) as illustrated in Figure 2.
Combinations with higher number of loci (from 8 to 12) did not
significantly increased bootstrap values of TcIV and TcV.
We assessed whether the outlier for TcV (Mn cl2) and the low
bootstrap observed for TcVI (applied to all 13 fragments) was due
to incongruence among fragments. The thirteen fragment dataset
was significantly incongruent (BIONJ-ILD p-value,0.001) for at
least one partition which was corroborated using NJ-LILD with a
permutation test and 500 replications. Significant incongruence (p-
value,0.05 after Bonferroni correction) was detected in the TcV
and TcVI nodes. Incongruence was likely due to strains within
DTUs TcV and TcVI demonstrating apparent loss of heterozy-
gosis (LOH) in theMet-II fragment. ExcludingMet-II, the p-value
for ILD was not significant (BIONJ-ILD p-value = 0.33), and the
bootstrap values for TcV and TcVI exceeded 85%, furthermore
tree topology was congruent with expected DTU assignment.
Reduced scheme for DTU assignment
Attempts were made to reduce the number of fragments
required for DTU assignment while maintaining DST identifica-
tion. All combinations of 3 and 4 fragments (1,001 combinations)
from the panel of 13 fragments were analysed as described above.
A reduced MLST panel incorporating TcMPX, HMCOAR,
RHO1 and GPI (four loci) produced the highest bootstrap values
for DTU assignment across the DTUs, TcI (99.9), TcII (100),
TcIII (99.5), TcIV (86.7), TcV (100) and TcVI (96.8) (Figure 3),
and discriminated 19 of 25 DSTs. Other combinations showed
higher discriminatory power but presented with lower bootstrap
values (data not shown). The TcMPX locus exhibits an apparent
loss of heterozygosity (LOH) in the hybrid DTU TcV, retaining
the TcII like allele but not the TcIII allele. Therefore DTU
assignment using TcMPX alone would not assign a TcV isolate
correctly. However concatenation of TcMPX with HMCOAR,
RHO1 and GPI allow distinguishing TcV from TcII.
Inter and intra DTU phylogenies
Topologies obtained for the 7 and 4 loci combinations
(Figures 2 and 3, respectively) were similar to the 13 loci scheme,
showing consistently the two major groups (TcI-TcIII-TcIV and
TcII-TcV-TcVI) supported by high bootstrap values, even when
trees were rooted using TcMB7 (Figure 1). The primary difference
between the 13 target concatenated phylogenies and the trees
obtained for the 7 and 4 targets was that for the 13 concatenated
targets TcV was paraphyletic, showing the Mncl2 strain as an
outlier. Regarding inter-DTU relationships, the analysis of the
concatenated 13 fragments divided DTUs into two major clusters:
one composed by TcI, TcIII and TcIV, with a bootstrap value of
100%; while the remaining group containing TcII, TcV and TcVI
was supported by lower bootstrap values (,70%), possibly due to
presence of the two hybrid DTUs (TcV and TcVI) (Figure 1).
Within clusters, internal topologies were supported with relatively
high but variable bootstrap values with 4, 7 and 13 loci
combinations and generally consistent intralineage topologies
(Figures 1, Figure 2, Figure 3), although the panel of 25 reference
Table 3. T. cruzi MLST targets.
Gene fragment No. of genotypes No. of polymorphic sites Typing efficiency1 DP
GPI*{ 9 18 0.500 0.889
HMCOAR*{ 15 20 0.750 0.954
RHO1*{ 13 23 0.565 0.914
Tc MPX*{ 11 12 0.917 0.905
LAP* 13 16 0.812 0.942
SODB* 12 9 1.333 0.914
RB19* 21 26 0.808 0.985
GPX 12 16 0.750 0.908
PDH 11 15 0.733 0.920
GTP 10 18 0.556 0.905
SODA 10 10 1.000 0.880
STPP2 5 8 0.625 0.585
Met-II 19 40 0.475 0.978
DP: Discriminatory Power according to [53],
1Number of genotypes per polymorphic site,
*Included in the seven loci scheme,
{Included in the four loci scheme.
doi:10.1371/journal.pntd.0003117.t003
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strains would need to be expanded further for assessment of fine
scale intralineage associations.
Discussion
Thirteen gene fragments were assessed in an optimised MLST
scheme which is a combination of targets from two recently
separately proposed schemes [50,51]. Here we evaluated the
optimal combination of loci based on three main sequential
criteria: first, assignment to the expected DTU; second, to attain
robust bootstrap values for the six major DTUs, and third to
detect intra-DTU diversity. For the first time we propose an
optimised MLST scheme, validated against a panel representing
all known lineages, for characterisation of T. cruzi isolates.
However, it should be emphasized that this MLST scheme is
proposed as a typing method for T. cruzi isolates but not as a
typing method to be used directly on biological samples as blood,
tissues or Triatomine feces, for which more sensitive and simpler
methods are needed. Moreover, we have performed assays with
the purpose of determining the limit of detection of each gene
fragment on blood and triatomines feces (data not shown) and we
found that none of these targets are suitable for detecting T. cruzi
in the normal concentration found in natural biological samples.
As a result of our data analyses, we obtained one combination of
7 loci and one combination of only 4 targets which most closely
adhered to the selection criteria described above. It is worth noting
that the three used criteria for selecting optimum combination of
targets are sequential; it means that there is a hierarchical order of
these criteria. In first place, we look for obtaining monophyly for
the six DTUs and accurate lineage assignment of each examined
strain. In a second place, we look for obtaining robust bootstrap
values for each of the six major DTUs. Finally, we expect detecting
genetic diversity at the intra-DTU level. In this context, due to the
hierarchical order of the criteria of selection of loci, the selected
combinations will optimise the number of DSTs but subordinated
to the two previous criteria. Theoretically, using these criteria, we
could obtain a combination of loci that does not give the
maximum number of DST for a determined DTU, because our
algorithm previously prioritized obtaining monophyly and strong
bootstrap values for the six DTUs. This was the case for the
selected 4-loci scheme (which differentiated 19 from 25 strains). In
spite of this, the selected 7-loci combination that we propose, allow
us to differentiate the 25 examined strains, i.e. the maximum
possible number of DSTs. The results illustrate that MLST is a
highly discriminatory strain-typing technique. From these data we
suggest that the 7 locus scheme provides scope for both lineage
assignment and diversity studies, generating robust bootstrap
values for distance based phylogenies and that a reduced panel of
only four targets is sufficient for assignment to DTU level. For
population genetics scale analyses and detailed epidemiological
Figure 1. Neighbor Joining tree based on the concatenation of 13 MLST fragments. Different DTUs are represented by vertical bars. Branch
values represent bootstrap values (1000 replications), different bootstrap values indicate the method of handling heterozygous sites: SNP duplication
method (first value) and average states (second values). Branch supports highlighted in blue shows branches where support for SNP duplication
method was higher than the average states method. The outlier TcV is highlighted in red. Scale bar at the bottom left represents uncorrected p-
distances.
doi:10.1371/journal.pntd.0003117.g001
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studies a comprehensive larger panel of T. cruzi isolates should be
assessed by sequencing the proposed targets.
The phylogenetic associations among DTUs TcI, TcII, TcIII
and Tc IV are debatable. Split affinities and incongruence have
been observed in nuclear phylogenies [7,8,51,56]. One interpre-
tation of phylogenetic incongruence is genetic recombination,
although due to the highly plastic nature of the T. cruzi genome
other causes are also possible. Mutation rates and gene conversion
may create distinct levels of sequence diversity [57]. Here,
concatenated phylogenies showed a partition into two main
clusters for all gene combinations tested, the first consisting of TcI,
TcIII and TcIV (bootstrap value = 100%); and the second
composed of TcII, TcV and TcVI (bootstrap value ,70%). The
presence of the two known hybrid lineages (TcV and TcVI)
generated artifactual phylogenetic structuring and excluding these
representatives revealed clustering of DTUs TcI, TcIII and TcIV,
indicating that TcI has a closer affinity to TcIII than to TcIV. TcII
is the most genetically distant group which is in agreement with
previous findings [9,10,51]. In addition, it would be interesting to
analyze in the future the new lineage described as TcBat [58]
using the MLST scheme proposed here, since it could shed light
on the phylogenetical position of this interesting lineage.
LOH observed in Met-II and TcMPX gene fragments affecting
the hybrid lineages TcV and TcVI has potentially significant
consequences for MLST and lineage assignment [51]. Isolates
affected retain the TcII like allele and would be misassigned in
single locus characterisation. For example, hybrid isolates TcV
would be assigned to TcII based on TcMPX sequencing due to
apparent LOH. Despite this LOH the TcMPX locus was included
in the 4 target scheme to increase bootstrap support in
differentiating between TcV from TcVI.
Although MLST has been successfully applied to other diploid
organisms including Candida albicans, the potential for heterozygous
alleles complicates typing schemes. In the present work, two methods
to handle heterozygous sites, SNPs duplication and average states
algorithms, produced broadly similar results with SNP duplication
producing marginally higher bootstraps due to the physical
duplication of informative sites. Here we decided to implement the
average states methodology to derive genetic distances and phylog-
enies. Both approaches can be found in the software MLSTest [52]
producing results that enable resolution at the DTU level and an
associated DP of 1 for the panel tested. A significant advantage of
MLST based analysis over sequential PCR based gels is that once
generated, sequences can be applied to a range of complementary
downstream analyses. For example, the resolution of haplotypes for
recombination analysis and investigation of more detailed evolution-
ary associations can be applied to population sized studies. At present,
whole genome sequencing applied to large numbers of isolates is not
feasible and microsatellite analysis is often difficult to reproduce
precisely across laboratories, unlike MLST which has proven
reproducibility both within and between laboratories [59]. However,
microsatellites could be more convenient for population genetics
studies at a microevolutionary level, due to their high resolution
power. A further consideration in the analysis of diploid sequences is
differentiating heterozygosity from copy number diversity. Ideally, we
should prefer single copy genes for MLST schemes in order to avoid
comparisons among paralogous. We performed in silico analyses in
order to estimate the copy number of the selected targets on the
genomic data of CL-Brener (TcVI) and Sylvio X10 (TcI) (http://
tritrypdb.org/tritrypdb/). For these analyses, we used as query the
primer sequences as well as the complete fragment sequences. These
searches displayed just single matches in all cases. Consequently, we
propose that all the examinedMLST fragments may be considered as
single copy genes, at least for typing and clustering.
One of the most important aspects in any MLST scheme is to
provide targets that consistently produce PCR amplicons requiring
Figure 2. Neighbor Joining tree based on the concatenation of
7 selected MLST fragments: Rb19, TcMPX, HMCOAR, RHO1, GPI,
SODB and LAP. Different DTUs are represented by vertical bars. Branch
values represent bootstrap values (1000 replications). Heterozygous
sites were considered as average states (see methods). Scale bar at the
bottom left represents uncorrected p-distances.
doi:10.1371/journal.pntd.0003117.g002
Figure 3. Neighbor Joining tree based on the concatenation of
4 selected MLST fragments (TcMPX, HMCOAR, RHO1, GPI) for
DTU assignment. Different DTUs are represented by vertical bars.
Branch values represent bootstrap values (1000 replications). Hetero-
zygous sites were handled using the average states method. Scale bar
at the bottom left represents uncorrected p-distances.
doi:10.1371/journal.pntd.0003117.g003
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minimal cleanup and are suitable for sequencing. Although in the
current protocol, we recommend purifying PCR products with a
suitable commercial kit (Quiagen), in most cases, this was not
necessary and sequencing was performed directly from the PCR
product. The exception was TcGPXII, and very occasionally
SODA produced nonspecific products, neither of which are
included in final recommended panels. Although the two
previously published MLST [50,51] schemes showed promise in
identifying diversity, some of the gene targets were not amenable
for routine use. For example, LYT1 was discarded due to
unreliable amplification and DHFR-TS due to the need for
internal primers. Therefore further optimisation performed here
was necessary for practical use. An important criterion for
choosing targets was identifying those that used the same primers
for both PCR amplification and sequencing to maintain simplicity
and reduce costs.
Taken together, we propose a MLST scheme validated against
a panel representing all of the known lineages of T. cruzi. We
propose that a 7 loci MLST scheme could provide the basis for
robust DTU assignment and strain diversity studies of new isolates
and a reduced 4 loci scheme for lineage assignment. Importantly,
the sequence data generated can be utilised for a wide range of
downstream analyses, including the resolution of haplotypes for
recombination analysis, population genetics analyses, and other
statistical approaches to the phyloepidemiological study of T.
cruzi.
Finally, we propose that the seven-fragment MLST scheme
could be used as a gold standard for T. cruzi typing, against which
other typing approaches, particularly single locus approaches or
systematic PCR assays based on amplicon size, could be
compared.
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3.3.3 Development and evaluation of mitochondrial MLST targets 
To evaluate the suitability of multi-copy maxicircle genes as phylogenetic markers, the level 
of intra-clone maxicircle genetic diversity was examined in silico using Illumina sequencing 
reads, generated as part of the Sylvio X10/1 genome project (Franzén et al., 2011). 
Sequencing reads were assembled and mapped onto the Sylvio X10/1 maxicircle genome to 
identify the presence of any minor maxicircle haplotypes (evidence of mitochondrial 
heteroplasmy), which could represent a potential source of genotyping error.  
Subsequently, to describe intra-DTU diversity, a high resolution mtMLST scheme was 
developed based on ten mitochondrial gene fragments. This mtMLST scheme was evaluated 
using a panel of 32 TcI isolates, which was representative of the endemic geographical range 
of this DTU. In parallel, isolates were also characterized using nuclear loci and the extent of 
nuclear-mitochondrial phylogenetic incongruence was examined to detect incidences of 
genetic exchange.  
This study is reported in full below by Messenger et al., 2012.  
In summary:  
- Illumina sequencing data from the TcI genome strain revealed multiple minor 
heteroplasmic maxicircles (~10 fold lower abundance compared to the consensus 
genome) within an individual parasite that were, however, not sufficiently divergent to 
represent a major source of genotyping error. 
- Robust amplification of the ten maxicircle gene fragments was confirmed across all six T. 
cruzi DTUs.  
- The resolutive power of the mtMLST scheme was equivalent or superior to nuclear 
markers routinely used to describe intra-TcI diversity (GPI, SL-IR and MLMT). 
- Comparison of nuclear and mitochondrial topologies revealed multiple mitochondrial 
introgression events between major lineages in Venezuela and North America (TcI and 
TcIII/TcIV) and within TcI populations in Argentina, Bolivia and Brazil. 
- Absence of reciprocal nuclear hybridization suggests that mitochondrial introgression 
may occur independently of nuclear recombination. These observations also highlight the 
importance of using mitochondrial markers to identify cryptic diversity and 
recombination events which were undetectable using conventional nuclear loci.  
- Gross phylogenetic incongruence indicates that genetic exchange is contemporary and 
geographically widespread among natural TcI populations, a conclusion which challenges 
the traditional paradigm of clonality in T. cruzi. 
- The mtMLST scheme provided a powerful approach to genotyping at the sub-lineage 
level. The combined nuclear-mitochondrial strategy will facilitate attempts to address 
epidemiologically important hypotheses in conjunction with intensive spatio-temporal 
parasite sampling. 
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Abstract
Background: Mitochondrial DNA is a valuable taxonomic marker due to its relatively fast rate of evolution. In Trypanosoma
cruzi, the causative agent of Chagas disease, the mitochondrial genome has a unique structural organization consisting of
20–50 maxicircles (,20 kb) and thousands of minicircles (0.5–10 kb). T. cruzi is an early diverging protist displaying
remarkable genetic heterogeneity and is recognized as a complex of six discrete typing units (DTUs). The majority of
infected humans are asymptomatic for life while 30–35% develop potentially fatal cardiac and/or digestive syndromes.
However, the relationship between specific clinical outcomes and T. cruzi genotype remains elusive. The availability of
whole genome sequences has driven advances in high resolution genotyping techniques and re-invigorated interest in
exploring the diversity present within the various DTUs.
Methodology/Principal Findings: To describe intra-DTU diversity, we developed a highly resolutive maxicircle multilocus
sequence typing (mtMLST) scheme based on ten gene fragments. A panel of 32 TcI isolates was genotyped using the
mtMLST scheme, GPI, mini-exon and 25 microsatellite loci. Comparison of nuclear and mitochondrial data revealed clearly
incongruent phylogenetic histories among different geographical populations as well as major DTUs. In parallel, we
exploited read depth data, generated by Illumina sequencing of the maxicircle genome from the TcI reference strain Sylvio
X10/1, to provide the first evidence of mitochondrial heteroplasmy (heterogeneous mitochondrial genomes in an individual
cell) in T. cruzi.
Conclusions/Significance: mtMLST provides a powerful approach to genotyping at the sub-DTU level. This strategy will
facilitate attempts to resolve phenotypic variation in T. cruzi and to address epidemiologically important hypotheses in
conjunction with intensive spatio-temporal sampling. The observations of both general and specific incidences of nuclear-
mitochondrial phylogenetic incongruence indicate that genetic recombination is geographically widespread and continues
to influence the natural population structure of TcI, a conclusion which challenges the traditional paradigm of clonality in T.
cruzi.
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Introduction
Mitochondrial genes are among the most popular markers for
the reconstruction of evolutionary ancestries and resolution of
phylogeographic relationships [1]. Their pervasive use in popula-
tion genetics can be attributed to several intrinsic characteristics,
notably, their high copy number, small size (,15–20 kb) and
faster mutation rate (compared with nuclear DNA). In addition,
their widespread application is founded on the assumptions that
mitochondrial genomes are homoplasmic, uniparentally inherited
and lack homologous recombination [2]. However, with techno-
logical advances affording increased sensitivity and greater sample
throughput, a growing number of reports of heteroplasmy
(heterogeneous mitochondrial genomes in an individual cell),
introgression and inter-molecular recombination are challenging
what was previously regarded as a strict set of rules for eukaryotic
mitochondrial inheritance.
Chagas disease remains the most important parasitic infection in
Latin America, where an estimated 10–12 million individuals are
infected, with a further 80 million at risk [3]. The aetiological agent,
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Trypanosoma cruzi, displays remarkable genetic diversity and is
currently recognized as a complex of six lineages or discrete typing
units (DTUs), each broadly associated with disparate ecologies and
geographical distributions [4]. T. cruzi infection is life-long and can
lead to debilitation and death by irreversible cardiac and/or
gastrointestinal complications [5]. It has been suggested that the
geographical heterogeneity in Chagas disease pathology is related to
the genetic variation among T. cruzi DTUs [6,7]. However, the
relationship between parasite genotype and clinical outcome
remains enigmatic. DTU nomenclature has recently been revised
by international consensus to reflect the current understanding of T.
cruzi genetic diversity [8]. Several evolutionary scenarios have been
proposed to account for the emergence of two hybrid lineages (TcV
and TcVI) and their parental progenitors (TcII and TcIII).
However, the number of ancestral nuclear clades (two or three)
remains controversial [9,10].
TcI is the most abundant and widely dispersed of all T. cruzi
lineages, with an ancient parental origin estimated at ,0.5–0.9
MYA [11]. The distribution of domestic TcI, propagated by
domiciliated triatomine vector species, principally extends from
the Amazon Basin northwards, where it is implicated as the main
cause of Chagas disease in endemic areas such as Venezuela and
Colombia [12,13]. TcI is also ubiquitous in sylvatic transmission
cycles throughout South America and extends into North and
Central America [14,15]. Recent advances in new high resolution
genotyping techniques have seen a resurgence of interest in
unravelling TcI intra-lineage diversity. In Colombia, sequencing of
the mini-exon spliced leader intergenic region (SL-IR) has
subdivided TcI isolates from domestic and sylvatic transmission
cycles, irrespective of geographical origin [16–18]. Other studies
have demonstrated geographical clustering of TcI strains and an
ecological association between specific genotypes and Didelphis
hosts [19]. Higher resolution studies exploiting multiple microsat-
ellite markers (MLMT) also report limited gene flow between
sylvatic and domestic transmission cycles manifesting as genetic
diversity between TcI isolates from sympatric sites [20,21]. In
addition, unexpectedly high levels of homozygosity in multiple
clones from single hosts may be indicative of recombination
between similar genotypes (inbreeding) or recurrent, genome wide,
and dispersed gene conversion [20,22]. The frequency and
mechanism of natural intra-TcI genetic exchange are thus
unknown, largely due to inappropriate or inadequate sampling.
Evidence for such recombination is increasing and has already
been documented among strains isolated from sylvatic Didelphis
and Rhodnius in the Amazon Basin [23] and within a domestic/
peridomestic TcI population in Ecuador [21]. Furthermore, the
generation of intra-lineage TcI hybrids in vitro indicates that this
ancestral lineage has an extant capacity for genetic exchange [24].
In kinetoplastids, the mitochondrial genome is represented
by 20–50 maxicircles (20–40 kb) which, together with thousands
of minicircles (0.5–10 kb), form a catenated network or kineto-
plast (kDNA), comprising 20–25% of total cellular DNA [25].
Maxicircles are the functional equivalent of eukaryotic mitochon-
drial DNA, encoding genes for mitochondrial rRNAs and
hydrophobic proteins involved in energy transduction by oxidative
phosphorylation [26]. Previously, phylogenetic analyses of T. cruzi
maxicircle fragments classified isolates into three mitochondrial
clades A (TcI), B (TcIII, TcIV, TcV and TcVI) and C (TcII)
[10,27]. To date, maxicircle typing has been principally used to
examine T. cruzi inter-lineage diversity, with sequencing efforts
reliant on a limited number of genes [28] and often in the absence
of any comparative nuclear targets [29,30]. However, the inherent
features of mitochondrial markers argue for their inclusion as
principal but not solitary components of phylogenetic studies.
Indeed, the caveats highlighted by other eukaryotes are especially
pertinent with respect to T. cruzi. Mitochondrial introgression has
been reported in North America where identical maxicircles
circulate in sympatric TcI and TcIV from sylvatic reservoirs [27]
and in South America where maxicircle haplotypes are shared
between TcIII and TcIV strains with highly divergent nuclear
genomes [11]. However, this phenomenon has not been described
among South American TcI isolates. In addition, mitochondrial
heteroplasmy, a possible confounder of phylogenetic studies, has
not been examined in the coding region of the T. cruzi maxicircle
but is not unexpected considering the presence of up to fifty
maxicircle copies within an individual parasite.
The potential for mitochondrial DNA to reveal diversity hidden
at the sub-DTU level in T. cruzi has been largely overlooked. To
address this deficit, we first employed a whole genome approach to
investigate the existence of maxicircle heteroplasmy and to resolve
its role as a source of genotyping error. Secondly, we exploited the
online availability of three complete T. cruzi maxicircle genomes
[31,32] to develop a high resolution mitochondrial multilocus
typing scheme (mtMLST) in order to describe TcI intra-lineage
diversity. Lastly, we investigated the extent of incongruence
between mitochondrial and nuclear loci (SL-IR, GPI and 25 short
tandem repeat (STR) loci) to detect incidences of genetic
exchange.
Materials and Methods
Illumina Sequencing of the Sylvio X10/1 Maxicircle
Genome
The maxicircle genome from Sylvio X10/1 (TcI) was sequenced
at 183X coverage using Illumina HiSeq 2000 technology as part of
the Sylvio X10/1 Whole Genome Shotgun project [33]. A total of
66,882 reads were generated which covered the maxicircle coding
region (15,185 bp). The consensus maxicircle genome sequence
Author Summary
Chagas disease, caused by the protozoan parasite
Trypanosoma cruzi, is an important public health problem
in Latin America. While molecular techniques can differ-
entiate the major T. cruzi genetic lineages, few have
sufficient resolution to describe diversity among closely
related strains. The online availability of three mitochon-
drial genomes allowed us to design a multilocus sequence
typing (mtMLST) scheme to exploit these rapidly evolving
markers. We compared mtMLST with current nuclear
typing tools using isolates belonging to the oldest and
most widely occurring lineage TcI. T. cruzi is generally
believed to reproduce clonally. However, in this study,
distinct branching patterns between mitochondrial and
nuclear phylogenetic trees revealed multiple incidences of
genetic exchange within different geographical popula-
tions and major lineages. We also examined Illumina
sequencing data from the TcI genome strain which
revealed multiple different mitochondrial genomes within
an individual parasite (heteroplasmy) that were, however,
not sufficiently divergent to represent a major source of
typing error. We strongly recommend this combined
nuclear and mitochondrial genotyping methodology to
reveal cryptic diversity and genetic exchange in T. cruzi.
The level of resolution that this mtMLST provides should
greatly assist attempts to elucidate the complex interac-
tions between parasite genotype, clinical outcome and
disease distribution.
Mitochondrial Introgression in T. cruzi
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was derived from the predominant nucleotide present across
multiple read alignments at each position. However, this criterion
masks minor maxicircle haplotypes (evidence of heteroplasmy) by
disregarding low abundance single nucleotide polymorphisms
(SNPs). To assess the presence/absence of true minor SNPs, all
66,882 reads were re-aligned to the Sylvio X10/1 maxicircle
genome using the alignment software SAMtools [34] and SNPs
were called using the SAMtools mpileup commands. A SNP was
defined as a nucleotide variant present in at least 5 independent
reads (with parameters: 20X coverage; and mapping quality, 30).
The final alignment was manually inspected using Tablet [35]. In
parallel, ten maxicircle gene fragments, described below, were
amplified by PCR and Sanger sequenced from Sylvio X10/1.
Strains
A panel of 32 TcI isolates was assembled for analysis (Table 1).
Parasites (epimastigotes) were cultured at 28uC in RPMI-1640
liquid medium supplemented with 0.5% (w/v) tryptone, 20 mM
HEPES buffer pH 7.2, 30 mM haemin, 10% (v/v) heat-
inactivated fetal calf serum, 2 mM sodium glutamate, 2 mM
sodium pyruvate and 25 mg/ml gentamycin (Sigma, UK) [23].
Genomic DNA was extracted using the Gentra PureGene Tissue
Kit (Qiagen, UK), according to the manufacturer’s protocol.
Isolates were previously characterized to DTU level using a triple-
marker assay [36] and classified into seven genetic populations by
microsatellite profiling [20]: North and Central America
(AMNorth/Cen), Venezuelan sylvatic (VENsilv), North-Eastern Brazil
(BRAZNorth-East), Northern Bolivia (BOLNorth), Northern Argen-
tina (ARGNorth), Bolivian and Chilean Andes (ANDESBol/Chile)
and Venezuelan domestic (VENdom). Genotypes for additional
TcI–TcVI strains were included for comparison in selected
analyses as indicated (Tables S1 and S2).
Maxicircle Genes (mtMLST)
Ten maxicircle gene fragments were amplified: ND4 (NADH
dehydrogenase subunit 4), ND1 (NADH dehydrogenase subunit 1),
Table 1. Panel of T. cruzi isolates assembled for analysis.
Strain Code* Strain Date of isolation Host/Vector Locality Latitude Longitude Population
9209 92090802P cl1 1992 Didelphis marsupialis Georgia, USA 32.43 283.31 AMNorth/Cen
9307 93070103P cl1 1993 Didelphis marsupialis Georgia, USA 32.43 283.31 AMNorth/Cen
DAVIS DAVIS 9.90 cl1 1983 Triatoma dimidiata Tegucigalpa, Honduras 14.08 287.2 AMNorth/Cen
OPOS USAOPOSSUM cl2 Unknown Didelphis marsupialis Louisiana, USA 30.5 291 AMNorth/Cen
ARMA USAARMA cl3 Unknown Dasypus novemcinctus Louisiana, USA 30.5 291 AMNorth/Cen
COT38 COTMA38 13.10.04 Akodon boliviensis Cotopachi, Bolivia 217.43 266.27 ANDESBol/Chile
P234 P234 1985 Homo sapiens Cochabamba, Bolivia 217.38 266.16 ANDESBol/Chile
P238 P238 1985 Homo sapiens Cochabamba, Bolivia 217.38 266.16 ANDESBol/Chile
P268 P268 1987 Homo sapiens Cochabamba, Bolivia 217.38 266.16 ANDESBol/Chile
PAL23 PALDAV2‘3 23.03.01 Triatoma infestans Chaco, Argentina 227.133 261.46 ARGNorth
PAL4 PALDA4 23.03.01 Didelphis albiventris Chaco, Argentina 227.133 261.46 ARGNorth
PAL5 PALDA5 23.03.01 Didelphis albiventris Chaco, Argentina 227.133 261.46 ARGNorth
PAL20 PALDA20 23.03.01 Didelphis albiventris Chaco, Argentina 227.133 261.46 ARGNorth
PAL21 PALDA21 23.03.01 Didelphis albiventris Chaco, Argentina 227.133 261.46 ARGNorth
SJ34 SJM34 07.09.04 Didelphis marsupialis Beni, Bolivia 214.81 264.6 BOLNorth
SJ41 SJM41 09.09.04 Philander opossum Beni, Bolivia 214.81 264.6 BOLNorth
SJ37 SJM37 09.09.04 Didelphis marsupialis Beni, Bolivia 214.81 264.6 BOLNorth
SJ12 SJMC12 13.09.04 Philander opossum Beni, Bolivia 214.81 264.6 BOLNorth
SJ22 SJM22 cl1 06.09.04 Didelphis marsupialis Beni, Bolivia 214.81 264.6 BOLNorth
SJ39 SJM39 cl3 09.9.04 Didelphis marsupialis Beni, Bolivia 214.81 264.6 BOLNorth
M13 M13 12.06.04 Didelphis marsupialis Barinas, Venezuela 7.5 271.23 VENsilv
M16 M16 cl4 13.06.04 Didelphis marsupialis Barinas, Venezuela 7.5 271.23 VENsilv
M18 M18 13.06.04 Didelphis marsupialis Barinas, Venezuela 7.5 271.23 VENsilv
M7 M7 14.05.04 Didelphis marsupialis Barinas, Venezuela 7.5 271.23 VENsilv
XE51 XE5167 cl1 14.09.99 Didelphis marsupialis Para, Brazil 21.71 248.88 BRAZNorth-East
IM48 IM4810 23.04.02 Didelphis marsupialis Manaus, Brazil 23.07 260.16 BRAZNorth-East
XE29 XE2929 10.08.88 Didelphis marsupialis Para´, Brazil 25.83 248.03 BRAZNorth-East
B2085 B2085 03.01.91 Didelphis marsupialis Belem, Brazil 21.36 248.36 BRAZNorth-East
1180 11804 2003 Homo sapiens Portuguesa, Venezuela 9.01 269.29 VENdom
1171 11713 2003 Homo sapiens Lara, Venezuela 10.04 269.32 VENdom
9354 9354 1999 Homo sapiens Sucre, Venezuela 10.46 263.61 VENdom
1154 11541 2003 Homo sapiens Merida, Venezuela 8.59 271.23 VENdom
*Strain code corresponds to labels on Figure 3 and descriptions in text.
doi:10.1371/journal.pntd.0001584.t001
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COII (cytochrome c oxidase subunit II), MURF1 (Maxicircle
unidentified reading frame 1, two fragments), CYT b (cytochrome
b), 12S rRNA, 9S rRNA, and ND5 (NADH dehydrogenase subunit
5, two fragments) coding regions. Degenerate primers were
designed in primaclade [37] using complete maxicircle reference
sequences from CL Brener (TcVI), Sylvio X10/1 (TcI), and Esm
cl3 (TcII) available online at www.tritrypdb.org [38]. Primer
sequences and annealing temperatures for PCR amplifications are
given in Table 2. Robust amplification was first confirmed across a
reference panel of all six T. cruziDTUs (see Table S1 and Figure 1).
Amplifications for all targets were achieved in a final volume of
20 ml containing: 16 NH4 reaction buffer, 1.5 mM MgCl2
(Bioline, UK), 0.2 mM dNTPs (New England Biolabs, UK),
10 pmol of each primer, 1 U Taq polymerase (Bioline, UK) and
10–100 ng of genomic DNA. PCR reactions were performed with
an initial denaturation step of 3 minutes at 94uC, followed by 30
amplification cycles (94uC for 30 seconds, 50uC for 30 seconds,
72uC for 30 seconds) and a final elongation step at 72uC for ten
minutes. PCR products were purified using QIAquick PCR
extraction kits (Qiagen, UK) according to the manufacturer’s
protocol.
Nuclear Genes
The mini-exon spliced leader intergenic region (SL-IR) and
glucose-6-phosphate isomerase (GPI) were amplified as previously
described by Souto et al. (1996) [39] and Lewis et al. (2009) [36],
respectively. PCR products were visualized in 1.5% agarose gels
and if necessary purified using QIAquick PCR and gel extraction
kits (Qiagen, UK) to remove non-specific products. Bi-directional
sequencing was performed for both nuclear and maxicircle targets
using the BigDyeH Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems, UK) according to the manufacturer’s
protocol. Maxicircle PCR products were sequenced using the
relevant PCR primers described in Table 2. Nuclear amplicons
were sequenced using their respective PCR primers. When
ambiguous sequences were obtained, PCR products were cloned
into the pGEMH - T Easy Vector System I (Promega, UK),
according to the manufacturer’s instructions, and transformed into
XL1-Blue E. coli (Agilent Technologies, UK), prior to colony PCR
and re-sequencing. For strains that produced incongruent nuclear
and maxicircle phylogenetic signals, PCR and sequencing
reactions were replicated twice using DNA derived from two
independent genomic DNA extractions.
Microsatellite Loci
Data from 25 previously described microsatellite loci [20],
distributed among ten chromosomes [40], were included for
analysis. Loci were selected from a wider panel of 48 microsatellite
loci based on their level of TcI intra-lineage resolution. In
addition, these 25 microsatellite loci were amplified across eight
new unpublished biological clones (M16 cl4, SJM22 cl1, SJM39
cl3, USAARMA cl3, USAOPOSSUM cl2, 92090802P cl1,
93070103P cl1 and DAVIS 9.90 cl1). Primers and binding sites
are listed in Table S3. The following reaction conditions were
implemented across all loci: a denaturation step of 4 minutes at
95uC, then 30 amplification cycles (95uC for 20 seconds, 57uC for
20 seconds, 72uC for 20 seconds) and a final elongation step at
72uC for 20 minutes. Amplifications were achieved in a final
volume of 10 ml containing: 16ThermoPol Reaction Buffer (New
England Biolabs, UK), 4 mM MgCl2, 34 mM dNTPs, 0.75 pmol
of each primer, 1 U Taq polymerase (New England Biolabs, UK)
and 1 ng of genomic DNA. Five fluorescent dyes were used to
label the forward primers: 6-FAM and TET (Proligo, Germany)
and NED, PET and VIC (Applied Biosystems, UK). Allele sizes
were determined using an automated capillary sequencer
(AB3730, Applied Biosystems, UK), in conjunction with a
fluorescently tagged size standard, and were manually checked
for errors. All isolates were typed ‘‘blind’’ to control for user bias.
Phylogenetic Analysis of Nuclear Loci
Pair-wise distances (DAS) between microsatellite genotypes for
individual samples were calculated in MICROSAT v1.5d [41]
under the infinite-alleles model (IAM). To accommodate multi-
allelic genotypes ($3 alleles per locus), a script was written in
Microsoft Visual Basic to generate random multiple diploid re-
samplings of each multilocus profile (software available on
request). A final pair-wise distance matrix was derived from the
mean of each re-sampled dataset and used to construct a
Neighbour-Joining phylogenetic tree in PHYLIP v3.67 [42].
Majority rule consensus analysis of 10,000 bootstrap trees was
performed in PHYLIP v3.67 by combining 100 bootstraps created
in MICROSAT v1.5d, each drawn from 100 respective randomly
re-sampled datasets.
Nucleotide sequences were assembled manually in BioEdit
v7.0.9.0 sequence alignment editor software (Ibis Biosciences,
USA) [43] and unambiguous consensus sequences were produced
for each isolate. Heterozygous SNPs were identified by the
presence of two coincident peaks at the same locus (‘split peaks’),
verified in forward and reverse sequences and scored according to
the one-letter nomenclature for nucleotides from the International
Union of Pure and Applied Chemistry (IUPAC). For both nuclear
genes (SL-IR and GPI), edited sequences were used to generate
Neighbour-Joining trees based on the Kimura-2 parameter model
in MEGA v5 [44]. Bootstrap support for clade topologies was
estimated following the generation of 1000 pseudo-replicate
datasets. Once both trees were visualized independently to confirm
congruent topologies, nuclear SNPs were re-coded numerically
and concatenated with microsatellite data (see Dataset S1). DAS
values were calculated for the concatenated dataset as described
above and used to generate a single Neighbour-Joining phyloge-
netic tree encompassing all nuclear genetic diversity. Nucleotide
sequences for GPI and the SL-IR are available from GenBank
under the accession numbers JQ581371–JQ581402 and
JQ581481–JQ581512, respectively.
Phylogenetic Analysis of Maxicircle Genes
Sequence data were assembled manually as described for
nuclear loci. For each isolate, maxicircle sequences were con-
catenated according to their structural arrangement (12S rRNA,
9S rRNA, CYT b, MURF1, ND1, COII, ND4 and ND5) and in
the correct coding direction (alignment available on request).
Nucleotide sequences for all ten gene fragments are available from
GenBank under the accession numbers listed in Table 2.
Phylogenies were inferred using Maximum-Likelihood (ML)
implemented in PhyML (4 substitution rate categories) [45]. The
best-fit model of nucleotide substitution was selected from 88
models and its significance evaluated according to the Akaike
Information Criterion (AIC) in jMODELTEST 1.0. [46]. The
best model selected for this dataset was GTR+I+G. Bootstrap
support for clade topologies was estimated following the
generation of 1000 pseudo-replicate datasets. Bayesian phyloge-
netic analysis was performed using MrBAYES v3.1 [47] (settings
according to jMODELTEST 1.0). Five independent analyses were
run using a random starting tree with three heated chains and one
cold chain over 10 million generations with sampling every 10
simulations (25% burn-in). Shimodaira-Hasegawa likelihood tests
(SH tests) [48] were implemented in PAML v.4 [49] to statistically
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evaluate incongruencies between alternative tree topologies
derived from the mitochondrial and nuclear data.
Results
Maxicircle Heteroplasmy
Across the 15,185 bp of the Sylvio X10/1 maxicircle coding
region a total of 74 SNPs were identified among eight genes (12S
rRNA, 9S rRNA,MURF5, CYT b,MURF1,MURF2, CR4 and ND4)
and three intergenic regions (between 12S rRNA and 9S rRNA,
between 9S rRNA and ND8 and between CR4 and ND4,
respectively) (Figure 2 and Table S4). Average read depth for
each SNP site was 163. At heterozygous sites, the minor nucleotide
was present among an average of 12.2% (69.1%) of sequence
reads. In each gene, SNPs were clustered often ,5 bp apart in
pairs and triplets. The most common mutations were transversions
from ART (14/74), TRA (10/74), TRG (7/74) and GRT (6/
74) and transitions from ARG (13/74). SNPs were bi-variable at
all sites. The presence of different contiguous SNPs distributed
across separate sequencing reads at overlapping positions suggests
the occurrence of at least two minor maxicircle templates within
the same sample. However, the short average length of Illumina
reads (,100 bp) prohibits the full reconstruction of minor
maxicircle sequence types. No evidence of heterozygosity was
observed in any of the ten maxicircle Sanger sequences (from the
mtMLST scheme) that covered the corresponding areas of
heteroplasmy identified in Sylvio X10/1, which is consistent with
the low sensitivity of this method.
Figure 1. PCR products from ten maxicircle gene fragments amplified across the six T. cruzi DTUs. Amplification products were visualized
on 1.5% agarose gels stained with ethidium bromide. Molecular weight marker is Hyperladder IV (Bioline, UK). For all gels: lane 1 - Sylvio X10/1 (TcI),
lane 2 - Esm cl3 (TcII), lane 3 - M5631 cl5 (TcIII), lane 4 - CanIII cl1 (TcIV), lane 5 - Sc43 cl1 (TcV), and lane 6 - CL Brener (TcVI). Robust amplification was
observed for the ten maxicircle gene fragments across reference isolates belonging to the six DTUs.
doi:10.1371/journal.pntd.0001584.g001
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Maxicircle Genes (mtMLST)
Degenerate primers were designed by reference to complete
TcI, TcII and TcVI maxicircle genomes. Ten gene fragments
from eight maxicircle coding regions were selected in order to
sample genetic diversity present across the whole T. cruzi
maxicircle. For two genes (MURF1 and ND5) two fragments were
selected from each coding region to examine intra-gene variation.
Reliable PCR amplification of all ten maxicircle fragments was
first confirmed using a panel of T. cruzi reference strains from each
DTU (see Figure 1).
The maxicircle gene targets were then sequenced across the TcI
panel (Table 1) and seven additional TcIII/TcIV strains (Table
S2). Relatively uniform substitution rates were observed among all
genes (gamma shape parameter a=0.8121, based on the
GTR+I+G model). For each TcI isolate, gene fragments were
concatenated according to their structural position and assembled
into a 3686 bp alignment. Twenty-two unique haplotypes were
identified from a total of 355 variable sites (,9.6% sequence
diversity). No evidence of heterozygosity (‘split peaks’) was
observed.
Maximum-Likelihood (Figure 3, right) and Bayesian phyloge-
nies were both constructed from the concatenated maxicircle data.
No statistically-supported incongruence was observed between the
two topologies (Bayesian tree L=26770.21, ML tree
L=26768.85, P=0.428). The presence of at least three
incongruent haplotypes (see below) precludes the accurate
clustering of their respective populations (AMNorth/Cen, VENdom
and BRAZNorth-East). However, phylogenetic analysis does resolve
two well-supported clades corresponding to VENsilv and
ANDESBol/Chile (90.8%/1.0 and 100%/1.0, respectively). Once
the two TcIV-type maxicircles were excluded from analysis, the
mtMLST was re-evaluated with respect to intra-TcI discrimina-
tory power. One hundred SNPs were identified among 3681 bp
(,2.7% sequence diversity), corresponding to twenty maxicircle
haplotypes. Both Bayesian and Maximum-Likelihood topologies
were congruent with those constructed previously for the entire
TcI isolate panel.
Nuclear Loci
The resolutive power of the mtMLST scheme was evaluated by
comparison to current markers used to investigate TcI intra-DTU
nuclear diversity, specifically, a housekeeping gene (GPI), a non-
coding multi-copy intergenic region (SL-IR) and a MLMT panel of
25 loci. Sequences for GPI were obtained for 32 T. cruzi isolates
(Table 1) and assembled into a gap-free alignment of 921
nucleotides. Of the 921 bp, a total of 911 invariable sites and 10
polymorphic sites were identified (,1.1% sequence diversity). A
350 bp alignment corresponding to the SL-IR was generated for the
same panel of samples. Strains from two populations (5/6 BOLNorth
and 4/4 ANDESBol/Chile) presented sequences with multiple
ambiguous base calls due to the presence of a GTn microsatellite
at positions 14–24. For these nine isolates, haplotypes were
determined by sequencing four cloned PCR products to derive a
consensus sequence. In the 350 bp alignment, 323 conserved sites
and 36 polymorphic sites were observed (,10.3% sequence
diversity). All samples were also typed at 25 polymorphic
microsatellite loci yielding a total of 1612 alleles. The majority of
strains presented one or two alleles at each locus. Multiple alleles
($3) were observed at a small proportion of loci (1.5%).
Individual Neighbour-Joining trees were re-constructed for GPI,
SL-IR and the MLMT data. No well-supported sub-DTU level
clades were recovered using GPI sequences. The SL-IR phylogeny
resolved two populations (VENsilv and ARGNorth) with strong
statistical support (85% and 99%, respectively; data not shown).
Three major clades were identified by MLMT (VENdom, ARGNorth
and ANDESBol/Chile) with good bootstrap support (72.6%, 99.3%
and 98.4%, respectively; data not shown). There was no bootstrap-
supported incongruence between the three nuclear tree topologies.
This justified their concatenation and these data were re-coded and
analyzed in a single distance-based phylogeny (independent of
mutation rate heterogeneity) (Figure 3, left and Dataset S1). The
concatenated nuclear tree recovered three well supported clades
corresponding to TcI populations (VENsilv, ARGNorth and AN-
DESBol/Chile) (96%, 100% and 77.9%, respectively, Figure 3).
Isolates belonging to the VENdom population remained grouped
together but with a minor reduction in bootstrap values (64.8%),
compared to the MLMT tree. In addition, the concatenated tree
also subdivided BOLNorth into two well defined sympatric clades
each containing three isolates (99.8% and 82.2%). No nuclear
targets (either individually or concatenated) were able to reliably
identify AMNorth/Cen, or BRAZNorth-East as discrete clusters.
However, AMNorth/Cen was more closely related to VENdom than
any other population by MLMT (90.2%), the SL-IR (99%) and the
concatenated nuclear tree (100%).
Figure 2. Distribution of seventy-four heteroplasmic sites across the 15, 185 bp Sylvio X10/1 maxicircle genome (schematic shows
linearized maxicircle). 66,882 sequencing reads covering the Sylvio X10/1 maxicircle were generated using Illumina HiSeq 2000 technology as part
of the Sylvio X10/1 Whole Genome Shotgun project. Multiple reads were re-aligned to the maxicircle genome and SNPs were identified if a
nucleotide variant was present in at least five independent reads. Bars represent the abundance of major (reference nucleotide) and minor bases
among multiple reads at each position. All SNPs are bi-variable. At some overlapping positions, different contiguous SNPs are distributed among
separate sequencing reads. These observations suggest the occurrence of at least two additional maxicircle genomes at a,10-fold lower abundance
compared to the consensus genome. Red stars denote gene fragments used in the mtMLST scheme.
doi:10.1371/journal.pntd.0001584.g002
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Nuclear-Mitochondrial Incongruence
Comparison of the mitochondrial and nuclear phylogenies
revealed clear incongruence at multiple scales. The nuclear topol-
ogy was a significantly worse model to fit the maxicircle data
(nuclear tree L=27008.72, mtMLST ML tree L=26554.50,
P,0.001). Three individual isolates had unambiguously different
phylogenetic positions between the nuclear and mitochondrial
datasets: 9307, 9354 and IM48 (Figure 3). The maxicircle
sequences from 9307, a sylvatic TcI AMNorth/Cen strain, and
9354, a human TcI strain from VENdom, were divergent from all
other TcI strains. Comparison with sequences from other DTUs
indicates that the maxicircle from 9307 was most closely related to
those found in TcIV samples from North America (92122) (100%/
1.0) while 9354 shared its mitochondrial haplotype with TcIV and
TcIII strains from neighbouring areas of Venezuela, Bolivia and
Colombia (ERA, 10R26, X106, Sairi3 and CM17) (97.8%/0.9).
IM48 from BRAZNorth-East also had a distinct maxicircle haplotype
that formed a long branch separated from the other members of
this population whereas for nuclear data all BRAZNorth-East
isolates, including IM48, clearly grouped together.
To test whether inclusion of these isolates could explain the
overall incongruence, the SH analysis was repeated for alternative
nuclear vs. mitochondrial topologies with each of these strains
excluded individually and then collectively. In all cases, statistically
significant incongruence persisted (no 9307 P=0.004, no 9354
P=0.002, no IM48 P,0.001 and without all three P=0.008). This
indicated that mitochondrial introgression was generally pervasive
in the TcI panel beyond these three isolates. For example, ARGNorth
samples, which formed a homogeneous monophyletic clade that
was most closely related to ANDESBol/Chile by nuclear data,
grouped paraphyletically amongst subsets of BOLNorth strains in the
maxicircle tree. In addition, BRAZNorth-East is grouped with one of
the BOLNorth clades in the nuclear tree, but receives a basally
diverging position in the maxicircle phylogeny. In agreement with
Figure 3. Unrooted Neighbour-Joining tree based on DAS values from nuclear loci (left) and Maximum-Likelihood tree from
concatenated maxicircle sequences (right) showing TcI population structure across the Americas. A panel of 32 TcI isolates from seven
nuclear populations was assembled for analysis. Origin of individual strains is shown on the map by small red circles. Large red circles correspond to
multiple samples, isolated from the same geographical area. Branch colours indicate strain population. The nuclear tree was constructed from
concatenated polymorphisms present within the SL-IR, GPI and 25 microsatellite loci. DAS values were calculated as the mean across 1000 random
diploid re-samplings of the dataset and those greater than 70% are shown on major clades. A Maximum-Likelihood topology was assembled from
concatenated maxicircle sequences. Branches show equivalent bootstraps and posterior probabilities from consensus Maximum-Likelihood (1000
replicates) and Bayesian topologies, respectively. The maxicircle topology is rooted against additional outgroup strains from TcIII and TcIV. The blue
and red circles on branches represent inter-lineage introgression events. The blue circle indicates that the maxicircle in a sylvatic TcI isolate from
AMNorth/Cen is most closely related to the maxicircle found in TcIV samples from the same area. The red circle shows that the maxicircle haplotype in a
human VENdom strain is the same as those in TcIII and TcIV isolates from neighbouring areas of Venezuela, Bolivia and Colombia. Divergent maxicircle
haplotypes at the intra-DTU level are also observed in BRAZNorth-East (IM48) and AMNorth/Cen (ARMA and OPOS). Another incidence of nuclear-
mitochondrial incongruence is demonstrated by the paraphyletic grouping of ARGNorth among a subset of BOLNorth isolates in the maxicircle tree,
compared to its monophyletic placement in the nuclear phylogeny.
doi:10.1371/journal.pntd.0001584.g003
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the nuclear data, AMNorth/Cen was most closely related to VENdom.
However, two isolates from AMNorth/Cen (ARMA and OPOS)
displayed an unexpected level of maxicircle diversity and are
grouped separately with strong bootstrap support (96.6%/1.0).
Discussion
Elucidating the complex epidemiology, phylogeography and
taxonomy of T. cruzi requires a clear understanding of the
parasite’s genetic diversity [4]. One objective of this study was to
develop the first mitochondrial (maxicircle) multilocus sequence
typing scheme (mtMLST) to investigate T. cruzi intra-lineage
diversity and to critically assess its resolutive power compared to
the current repertoire of phylogenetic markers.
The presence of intra-strain maxicircle diversity within Sylvio
X10/1 is the first demonstration of heteroplasmy in the coding
region of a T. cruzi maxicircle genome. Seventy-four variable sites
were identified by read depth analysis of Illumina sequence data
but undetected by conventional Sanger sequencing. These SNPs
indicate the occurrence of at least two additional maxicircle
genomes, present at a ,10-fold lower abundance compared to the
consensus published Sylvio X10 maxicircle genome [32]. Most
heteroplasmic SNPs were linked. This may indicate an older most
recent common ancestor (MRCA) between the major and minor
maxicircles than that expected to have emerged in culture post-
cloning. Thus these minor maxicircle classes more likely represent
heteroplasmy within a single parasite than within a subpopulation
of cells. Furthermore, the presence of SNPs ,3 bp apart on
contiguous sequence reads may have non-synonymous coding
implications, although their relative rarity, and a lack of indels
suggest that minority and majority maxicircle variants would not
differ phenotypically. Finally, the presence of heteroplasmy at less
than 0.5% of sites indicates it is unlikely to represent a major
source of typing error when using maxicircle Sanger sequencing to
characterize isolates.
Several factors are likely to contribute to mitochondrial het-
eroplasmy. Mutation in length or nucleotide composition and/or
bi-parental inheritance in genetic exchange events are both ex-
acerbated by differential replication rates and inequitable
cytoplasmic segregation of mitochondrial genomes during mitosis
[50,51]. In kinetoplastids, maxicircle intra-clone diversity in the
non-coding region was previously reported in both T. cruzi [31]
and Leishmania major [52,53]. In addition, an earlier study
attributed a change in T. cruzi maxicircle gene repertoire (elimina-
tion of one of two heteroplasmic ND7 amplicons) to sub-culture
[54]. However, biologically cloned samples were not used and the
possibility of a mixed infection was excluded on the basis of only
four microsatellite loci. Sylvio X10/1 (a biological clone produced
by micromanipulation) was first isolated from a Brazilian patient in
1979 [55] and has been in intermittent sub-culture ever since. The
retention of minor maxicircle classes in Sylvio X10/1 for over
thirty years suggests that a heteroplasmic state in T. cruzi is
naturally sustained.
The observations that T. cruzi mitochondrial heteroplasmy is
not present at sufficient levels to adversely disrupt phylogenetic
reconstructions stimulated the development of the mtMLST
scheme and its assessment against traditional nuclear targets.
Initially, three types of nuclear marker were evaluated, each
characterized by different rates of evolution. Unsurprisingly GPI
was highly conserved across TcI and lacked sufficient resolution
to discriminate between isolates. The slow accumulation of point
mutations at housekeeping loci, which are generally under
purifying selection, renders these targets more appropriate to
describe inter-DTU variation. Thus they are valuable candidates
for inclusion in traditional nuclear MLST schemes [56]. The
mini-exon SL-IR is widely used as a TcI taxonomic marker in
view of its heterogeneity and ease of amplification [57]. In this
study, SL-IR variability manifested as a ten-fold increase in
sequence diversity as compared to that of GPI, and supported the
robust delineation of two nuclear populations (VENsilv and
ARGNorth). However, there are several caveats associated with
the SL-IR, notably the presence of multiple tandemly-repeated
copies with undefined chromosomal orthology between strains
[58]. Previous attempts to estimate the level of intra-isolate SL-IR
diversity have reported .96% homology between copies [19].
However, only ten clones were sequenced from each sample,
representing less than 10% of the ,200 copies present per
genome. Recent observations of substantial variation in gene
copy number and chromosomal arrangement between T. cruzi
strains further discourage the use of such targets for taxonomy
[59]. In addition, numerous indels in the SL-IR prevent the
sequencing of a suitable outgroup [39] and multiple ambiguous
alignments, introduced by the microsatellite region, can disrupt
phylogenetic signals [60]. Ultimately both GPI and the SL-IR
suffer from the same fundamental criticism that single genes are
inadequate to infer the overall phylogeny of an entire species
[61]. Recombination, gene conversion and concerted evolution
have all contributed to the genealogical history of T. cruzi [62] but
remain undetectable using single loci.
The 25 microsatellite loci afforded the highest level of resolution
from an individual set of markers, defining three statistically-
supported groupings (VENdom, ARGNorth and ANDESBol/Chile).
Their superior performance compared to GPI and the SL-IR is
expected considering microsatellites are neutrally-evolving, co-
dominant and hypervariable with mutation rates several orders of
magnitude higher than protein-coding genes [63]. However, the
use of these markers is not devoid of limitations. Most importantly,
microsatellites are particularly sensitive to homoplasy, a situation
where two alleles are identical in sequence but not descent, and
thus fail to discriminate between closely related but evolutionarily
distinct strains [64]. The three nuclear markers (GPI, SL-IR and
microsatellites) were concatenated based on the assumption that
no robust incongruence was observed between individual
phylogenetic trees. However, concatenating these data did not
have a significant additive effect on the level of resolution, with
just three populations (VENsilv, ARGNorth and ANDESBol/Chile)
emerging as well-supported groups. Importantly this dataset
did reveal a subdivision in the BOLNorth group, which went
undetected by all individual nuclear markers.
Gross incongruence between the mtMLST and nuclear
phylogenies revealed two incidences of inter-DTU mitochondrial
introgression, indicative of multiple genetic exchange events in
T. cruzi. Introgression was detected in North America, where
identical maxicircles were observed in sylvatic TcI and TcIV
isolates. A 1.25 kb fragment (COII-ND1) of this TcIV maxicircle
haplotype has been previously described in other TcI samples
from the US states of Georgia and Florida [11,27]. On the basis of
the limited nuclear loci examined, and in line with previous work
[27], only TcI derived nuclear genetic material appears to have
been retained in these hybrids. The genetic disparity between
North and South American TcIV isolates, coupled with their
geographical and ecological isolation [65], implies that this event
most likely occurred in North/Central America. A second,
independent novel mitochondrial introgression event was identi-
fied in a Venezuelan clinical isolate. This TcI strain (9354) shares
its maxicircle haplotype with a subset of human and sylvatic TcIV
and TcIII isolates from Bolivia, Venezuela and Colombia,
consistent with a local and possibly recent origin. Presumably
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TcIV, a known secondary agent of human Chagas disease in
Venezuela, is a more likely donor candidate than TcIII, which is
largely absent from domestic transmission cycles [4].
Nonetheless, evidence of homogeneous maxicircle sequences in
multiple, geographically dispersed isolates from different transmis-
sion cycles implies the occurrence of several genetic exchange
events. It is conceivable that the TcIV/TcIII-type maxicircle
sampled in this study is a relic from a TcI antecedent, supporting a
common ancestry between TcI, TcIII and TcIV [9]. Alternatively,
this haplotype may have originated from a TcIV or TcIII strain
and its distribution reflects a recent unidirectional backcrossing
event into TcI. Introgression is a more parsimonious explanation
than the retention of ancestral polymorphisms through incomplete
lineage sorting, particularly in areas of sympatry or parapatry
among DTUs [66]. However, the historical diversification of TcI
[67] and TcIII [68–70], driven by disparate ecological niches [71],
and the current separation between most arboreal and terrestrial
transmission cycles of TcIV and TcIII, respectively, challenge the
likelihood of secondary contact between these lineages, a
prerequisite of introgressive hybridization. Resolving the donor
DTU of this event is complicated by the presence of indistin-
guishable mitochondrial sequences and paradoxically divergent
nuclear genes in TcIII and TcIV isolates. It is unclear whether this
results from a mechanism acting to homogenize maxicircles while
allowing nuclear genes to slowly deviate [11] (unlikely), repeated
and recurrent backcrossing (more likely), or merely reflects the
relative paucity of available TcIV and TcIII genotypes for
comparison (a certainty).
Regardless of the underlying mechanisms, it is clear that genetic
exchange continues to influence the natural population structure
of T. cruzi TcI. In this study, the failure to detect reciprocal transfer
of nuclear DNA using an array of loci readily demonstrates the
importance of adopting an integrative approach, complementing
traditional nuclear markers with multiple mitochondrial targets. In
the absence of comparative genomics, it is impossible to establish
whether mitochondrial introgression is entirely independent of
nuclear recombination.
Another advantage of the mtMLST scheme is its ability to
reveal cryptic sub-DTU diversity. The significantly different
evolutionary histories of the nuclear and maxicircle genes from
members of BOLNorth and ARGNorth are consistent with intra-
lineage recombination. The low levels of diversity observed within
this incongruent maxicircle clade are indicative of recent and
possibly multiple exchange events. In addition, two divergent
maxicircles from AMNorth/Cen have also exposed a level of diver-
sity that conflicts with earlier reports of reduced genetic differentia-
tion in this group resulting from their recent biogeographical
expansion [18,72]. Furthermore, the incongruent basal phyloge-
netic position of most of BRAZNorth-East in the maxicircle tree as
well as the presence of another divergent maxicircle in one isolate
(IM48) from this population highlights the extent to which intra-
lineage diversity can be neglected by other genotyping methods.
The phylogenetic placement of IM48 suggests it may be the
product of an intra-TcI introgression event. However, IM48 is also
a geographical outlier within the BRAZNorth-East population and it
is difficult to determine the origin of this maxicircle haplotype in
the absence of additional isolates from West-Central Amazonia.
The mechanisms governing maxicircle genetic exchange and
the origins of heteroplasmy observed in Sylvio X10/1 are
debatable. Currently, all reported maxicircle inheritance in
natural [11] and experimental T. cruzi hybrids [24] is uniparental.
However, the demonstration of heteroplasmy in this study suggests
that, following genetic exchange, any minor maxicircle genotypes
may be undetectable using conventional sequencing techniques. In
addition, evidence of bi-parental transmission of both maxicircles
[73,74] and minicircles [75] in experimentally-derived T. brucei
hybrids indicates that this phenomenon can occur in kinetoplastids
as a result of recombination. The mechanism of genetic exchange
in T. cruzi [24] differs from meiosis, which is observed in T. brucei
[73,76]. Current data suggest in vitro recombination in T. cruzi may
be analogous to the parasexual cycle of Candida albicans where
nuclear fusion creates a tetraploid intermediate, followed by
genome erosion and reversion to aneuploidy [24,77,78]. It is not
implausible to suggest that the process of cell fusion and nuclear
re-assortment may be accompanied by asymmetrical kinetoplast
distribution to progeny cells. Furthermore, the sequence redun-
dancy observed among minicircle guide RNAs has been postulated
to allow biparental inheritance to occur with no detrimental
consequences to mitochondrial RNA editing and hybrid viability
[79].
Most importantly, the phenotypic implications of mitochon-
drial heteroplasmy and introgression in T. cruzi are unknown.
Maxicircles play a fundamental role in parasite metabolism and
development in the triatomine bug vector. Therefore the relation-
ship between genetic recombination and phenotypic heterogene-
ity may have important implications for disease epidemiology.
mtMLST presents a valuable new strategy to detect directional
gene flow and examine the dispersal history of T. cruzi at the
transmission cycle level. Furthermore, mtMLST is an excellent
tool to identify genetic exchange between closely related isolates in
conjunction with nuclear MLMT data. By adopting a combined
nuclear and mitochondrial approach, one can simultaneously
address local, epidemiologically important hypotheses as well as
robustly identify parasite mating systems. Thus in combination
with adequate spatio-temporal sampling, we strongly recommend
this methodology as an alternative to exclusively nuclear or
mitochondrial population genetic studies in future work with
medically important trypanosomes. Finally, the level of resolution
that the mtMLST method provides should greatly facilitate
attempts to elucidate the relationship between specific parasite
genotypes and phenotypic traits relating to Chagas disease
pathology.
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3.3.4 Development and evaluation of amplicon deep sequencing markers to characterize 
intra-host parasite multiclonality 
To investigate the extent of natural intra-host parasite multiclonality and its association with 
congenital infection and clinical status of chronic Chagas disease, two 450 bp multi-copy 
polymorphic sequence markers (TcGP63 and ND5) were designed, amplified and deep 
sequenced from 93 clinical primary hemocultures. T. cruzi strains were isolated from 
chronically-infected patients across the clinical spectrum (asymptomatic to severe 
cardiomyopathy, megaoesophagus or megacolon) and included 46 chronic patients from 
Goiás, Brazil and 27 chronic patients and 10 mother-infant pairs from Cochabamba, Bolivia. 
This study is reported in full below by Llewellyn et al., accepted.  
In summary:  
- A total of 6,736,749 and 871,855 sequencing reads were generated for ND5 (a 
mitochondrial gene) and TcGP63 (which encodes a constitutively expressed antigenic 
surface protease), respectively, and normalized by patient cohort (Goiás – ND5 and 
TcGP63: 10,000; Cochabamba – ND5: 30,000 and TcGP63: 10,000). 
- A series of artificial control mixes of equimolar genomic DNA from DTUs I-IV were 
also evaluated. Resulting sequence data demonstrated that PCR amplification bias 
dramatically skewed ST recovery towards the most abundant ST in the mix. A fourfold 
over representation of a ST in the original mix, resulted in a 100-1000 fold over 
representation after PCR, which was controlled for in subsequent analyses. 
- Three principal ND5 STs were identified among patients, corresponding to TcI, TcII and 
TcIII-VI. In most clinical samples, STs were monomorphic at the 97% identity level, thus 
ND5 was used principally to assign populations to DTU-level. 
- On the basis of ND5, most Cochabamba chronic cases contained a single ST, likely TcV 
(25/27), the remaining were TcI (2/27).  
- By comparison, sequence diversity was considerably higher in Goiás; TcII was the 
predominant ND5 DTU identified, and multiple patients were co-infected with minor 
genotypes at frequencies two orders of magnitude lower (usually TcII/TcIII-TcVI or 
TcII/TcI).  
- Paired congenital cases from Cochabamba resembled chronic cases from the same area in 
terms of ND5 DTU composition; a subset showed a similar phenomenon to Goiás, with 
mixed infection profiles (TcI/TcIII-VI) at similar relative abundances (c.1:1000). 
- Based on measurements of TcGP63 alpha diversity (Shannon Index), in both 
Cochabamba and Goiás, there was no clear correlation between intra-host genetic 
diversity in chronic patients and age, sex or symptoms at the 97% (age p= 0.734 and 
0.382; sex p=0.298 and 0.535; symptoms p=0.136 and 0.486, respectively) and 99% (age 
p=0.854 and 0.319; sex p=0.169 and 0.696; symptoms p=0.00988 and 0.697, 
respectively) ST divergence level. This might be explained by micro-geographic variation 
in T. cruzi genetic diversity and/or infection intensity and possible cross-genotype 
immunity which accumulated with exposure and therefore age.  
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- Between congenital pairs multiple STs were transmitted from mother to infant; in most 
cases (6/10), similar or greater numbers of TcGP63 STs were observed in mothers; in 
four infants novel genotypes were detected. Multiclonal repertoires sampled in mothers 
and infants will be influenced by parasite tissue sequestration in the mother, stochastic 
transplacental transfer to the neonate and availability of circulating clones for isolation by 
hemoculturing.  
- At the 97% sequence divergence level, when considering well represented TcGP63 STs, 
dN/dS ratios among chronic patients were indicative of strong diversifying selection 
(Goiás, ST1 = 2.6436, ST4 = 6.3415; Cochabamba, ST3=2.8059). 
- This is the first study to examine parasite multiclonality in individual patients to an 
unprecedented depth. While this approach demonstrated the resolutive power of amplicon 
deep sequencing to reveal genetic diversity in chronic and congenital cases, it also 
highlighted potential biases that can be introduced by the addition of a PCR step and 
encourages the exploration of novel genome sequencing techniques, including whole 
genome deep sequencing or single cell genome sequencing, as reference genome 
assemblies improve and reagent costs decline.  
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Deep sequencing of the Trypanosoma cruzi GP63 surface proteases reveals diversity and 1 
diversifying selection among chronic and congenital Chagas disease patients.  2 
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Abstract 17  18 
Background 19 
 20 
Chagas disease results from infection with the diploid protozoan parasite Trypanosoma cruzi. T. 21 
cruzi is highly genetically diverse, and multiclonal infections in individual hosts are common but 22 
little studied. In this study we explore T. cruzi infection multiclonality in the context of age, sex 23 
and clinical profile among a cohort of chronic patients, as well as paired congenital cases from 24 
Cochabamba, Bolivia and Goias, Brazil using amplicon deep sequencing technology. 25 
 26 
Methodology/ Principal Findings 27 
 28 
A 450bp fragment of the trypomastigote TcGP63I surface protease gene was amplified and 29 
sequenced across 70 chronic and 22 congenital cases on the Illumina MiSeq platform. In addition 30 
a second, mitochondrial target - ND5 - was sequenced across the same cohort of cases. Several 31 
million reads were generated and sequencing read depths were normalized within patient cohorts 32 
(Goias chronic, n = 43, Goias congenital n = 2, Bolivia chronic, n=27; Bolivia congenital, n=20), 33 
Among chronic cases, analyses of variance indicated no clear correlation between intra-host 34 
sequence diversity and age, sex or symptoms, while principal coordinate analyses showed no 35 
clustering by symptoms between patients. Between congenital pairs, we found evidence for the 36 
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 2 
transmission of multiple sequence types from mother to infant, as well as widespread instances of 37 
novel genotypes in infants. Finally, non-synonymous to synonymous (dn:ds) nucleotide 38 
substitution ratios among sequences of TcGP63Ia and TcGP63Ib subfamilies within each cohort 39 
provided powerful evidence of strong diversifying selection at this locus.  40 
 41 
Conclusions/Significance 42 
 43 
Our results shed light on the diversity of parasite DTUs within each patient, as well as the extent 44 
to which parasite strains pass between mother and foetus in congenital cases.  Although we were 45 
unable to find any evidence that parasite diversity accumulates with age in our study cohorts, 46 
putative diversifying selection within members of the TcGP63I gene family suggests a link 47 
between genetic diversity within this gene family and survival in the mammalian host. 48 
 49 
Author Summary 50 
 51 
Trypanosoma cruzi, the causal agent of Chagas disease in Latin America, infects several million 52 
people in some of the most economically deprived regions of Latin America. T. cruzi infection is 53 
lifelong and has a variable prognosis: some patients never exhibit symptoms while others 54 
experience debilitating and fatal complications. Available data suggest that parasite genetic 55 
diversity within and among disease foci can be exceedingly high. However, little is know about 56 
the frequency of multiple genotype infections in humans, as well as their distribution among 57 
different age classes and possible impact on disease outcome. In this study we develop a next 58 
generation amplicon deep sequencing approach to profile parasite diversity within chronic Chagas 59 
Disease patients from Bolivia and Brazil. We were also able to compare parasite genetic diversity 60 
present in eleven congenitally infants with parasite genetic diversity present in their mothers. We 61 
did not detect any specific association between the number and diversity of parasite genotypes in 62 
each patient with their age, sex or disease status. We were, however, able to detect the 63 
transmission of multiple parasite genotypes between mother and foetus.  Furthermore, we also 64 
detected powerful evidence for natural selection at the antigenic locus we targeted, suggesting a 65 
possible interaction with the host immune system.   66 
 67 
Introduction 68 
 69 
Trypanosoma cruzi is a kinetoplastid parasite and the causative agent of Chagas disease (CD) in 70 
Latin America. T. cruzi infects approximately 8 million people throughout its distribution and 71 
causes some 13,000 deaths annually [1].  Chagas disease follows a complex course. Infection, 72 
often acquired in childhood, is generally lifelong but progression from the indetermined 73 
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(asymptomatic) to symptomatic stage occurs in only 30% of cases [2]. A broad pathological 74 
spectrum is associated with clinical CD including potentially fatal cardiological and 75 
gastrointestinal abnormalities [3]. The relative contributions of parasite and host immunity in 76 
driving disease pathology are a matter of continuing debate [4]. Recently, for example, 77 
bioluminescent parasite infections in BALB/c mouse models have suggested that heart disease can 78 
progress in the absence of detectable local parasite load [5].  79 
It is widely recognized that natural parasitic infections are often comprised of several parasite 80 
clones [6]. Malariologists use the term ‘multiplicity of infection’ (MOI) to describe when multiple 81 
Plasmodium sp. genotypes occur within the same host [7,8]. A similar phenomenon has been 82 
observed in T. cruzi in vectors (e.g. [9]), as well as mammalian reservoir hosts (e.g [10]) and 83 
humans hosts (e.g. [11]) using solid phase plating and cell sorting techniques. The occurrence of 84 
multi-genotype infections has fundamental implications for host immunity [12], as well as for 85 
accurate evaluation of pathogen drug resistance [13], transmission rate, epidemiology and 86 
population structure (e.g. [7,11]). The efficiency with which it is possible to sample pathogen 87 
clonal diversity from biological samples has soared in recent years with the advent of next 88 
generation sequencing. Deep sequencing approaches have long been applied to study the 89 
dynamics of HIV anti-viral therapy escape mutations. As a result amplicon sequencing 90 
increasingly features in a clinical diagnostic context [14]. Plasmodium falciparum MOI can be 91 
resolved at merozoite surface protein loci at far greater depths than possible by standard PCR 92 
approaches [15]. Furthermore, targeting low copy number antigens in parasite populations via 93 
amplicon sequencing can provide important clues to frequency-dependent selection pressures 94 
within hosts, between hosts and between host populations [16].  95 
T. cruzi can persist for several decades within an individual host. Unsurprisingly perhaps, 96 
therefore, T. cruzi shows significant antigenic complexity. T. cruzi surface proteins are encoded 97 
by several large, repetitive gene families that are distributed throughout the parasite genome [17]. 98 
Among these gene families the mucins, transialidases, ‘dispersed gene families’ (DGFs), mucin-99 
associated surface proteins (MASPs) and GP63 surface proteases comprise the vast majority of 100 
sequences - 10-15% of the total genome size [17,18]. Whilst the role of some of the proteins 101 
encoded by surface gene families in host cell recognition and invasion is relatively well 102 
understood (e.g. the transialidases [19]), the role of others (e.g. the MASPs, DGFs) is not. 103 
Furthermore, the role each plays in evading an effective host response remains largely unknown. 104 
The GP63 surface proteases are found in a wide variety of organisms, including parasitic 105 
trypanosomatids [20]. In Leishmania spp. GP63 proteases are the most common component of the 106 
parasite cell surface with crucial roles in pathogenicity, innate immune evasion, interaction with 107 
the host extracellular matrix and ensuring effective phagocytosis by macrophages [21]. In T. 108 
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brucei subspp. the role of GP63 proteins is less well defined, although some protein classes are 109 
thought to be involved with variant surface glycoprotein processing between different life cycle 110 
stages [22]. In T. cruzi at least four classes of GP63 gene are recognized [20]. Like many GP63 111 
proteases in Leishmania spp., surface expressed T. cruzi GP63 (TcGP63) genes are anchored to 112 
the cell membrane via glycosyl phosphatidylinositol moieties [23,24]. Among these are the 113 
TcGP63 Ia & Ib genes (collectively TcGP63I). TcGP63 Ia & Ib encode 78kDa 543 amino acid 114 
proteins, are expressed in all life cycle stages and are implicated in the successful invasion of 115 
mammalian cells in vitro [23,24]. 116 
In the current study we target TcGP63I genes as markers of antigenic diversity among three 117 
cohorts of Chagas disease patients: two in Cochabamba, Bolivia and one in Goias, Brazil. We also 118 
targeted a maxicircle gene for the NADH dehydrogenase subunit 5 to provide basic T. cruzi 119 
genotypic information for each case. Diversity at each of the two T. cruzi loci within each patient 120 
was characterized using a deep amplicon sequencing approach, generating several million 121 
sequence reads. Our results shed light on the diversity of parasite DTUs within each patient, as 122 
well as the extent to which parasite strains pass between mother and foetus in congenital cases. 123 
We were unable to find any evidence that parasite diversity accumulates with age in our study 124 
cohorts, or to detect a link between parasite diversity and clinical profile. However, we were able 125 
to detect evidence of putative diversifying selection within members of the TcGP63 gene family, 126 
suggesting a link between genetic diversity within this gene family and survival in the mammalian 127 
host. 128 
Materials and Methods 129 
Ethical Statement Ethical permissions were in place at the two centres where human sample 130 
collections were made, as well as at the London School of Hygiene and Tropical Medicine 131 
(LSHTM). Local ethical approval for the project was given at the Plataforma de Chagas, Facultad 132 
de Medicina, UMSS, Cochabamba, Bolivia by the Comite de Bioetica, Facultad de Medcina, 133 
UMSS. Local ethical permission for the project was given at the Hospital das Clínicas da 134 
Universidade Federal de Goias (UFG), Goias, Brazil by the Comite de Etica em Pesquisa Médica 135 
Humana e Animal, protocol number 5659. Ethical approval for sample collection at the LSHTM 136 
was given for the overall study, “Comparative epidemiology of genetic lineages of Trypanosoma 137 
cruzi” protocol number 5483. Samples were collected with written informed consent from the 138 
patient and/or their legal guardian.    139 
 140 
Biological sample collection: Parasite isolation protocols were different between centres. At the 141 
UMSS, 0.5 mL of whole venous blood was taken from chronic patients and inoculated directly 142 
into biphasic blood agar culture. T. cruzi positive samples were minimally repassaged and 143 
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cryopreserved at log phase (precise repassage history unavailable). For infants, 0.5 mL of chord 144 
blood was taken at birth and inoculated into culture. Again, positive samples were cryopreserved 145 
at log phase after minimal repassage (precise repassage history unavailable). DNA extractions, 146 
using a Roche High-Pure Template Kit, were made directly from the cryopreserved stabilate. At 147 
the UFG, 17 mL of whole blood was collected into EDTA, centrifuged for 10 minutes at 1200g at 148 
4 °C and the plasma replaced with 8mL Liver Infusion Tryptone (LIT) medium. After a further 10 149 
minutes at 1200g (4°C), the supernatant was again removed. Two mL of packed red blood cells 150 
were subsequently transferred to 3 mL of LIT medium and checked periodically for signs of 151 
epimastigote growth by light microscopy. Positive cultures were not repassaged. Instead primary 152 
cultures were stabilized by the addition of guanidine 6 M-EDTA 0.2 M (Sigma-Aldrich, UK). 153 DNA extractions were made from the full volume using the QIAamp® DNA Blood Maxi Kit 154 (Qiagen, UK) according to the manufacturer’s instructions.  Among Bolivian strains, DNA 155 concentrations submitted to PCR were standardized after quantitation using a PicoGreen® 156 assay. In view of presence of human genetic material in Goias samples, parasite DNA 157 concentrations were standardized to within the same order of magnitude via qPCR as 158 previously described [25].  All samples collected for in this study are listed in Table 1. 159 
 160 
Epidemiological and clinical observations: The two areas studied have dissimilar 161 histories in terms of Chagas disease transmission intensity. Vector-borne T. cruzi 162 transmission in Goias and its surrounding states (where samples were collected – Table 1) 163 was interrupted approximately 20 years before the sampling detailed in this study [26,27]. 164 In the sub-Andean semi-arid valleys of Cochabamba and its environs, however, vector-borne 165 domestic transmission is still a likely source of new infections, albeit at a reduced rate since 166 intensive spraying campaigns in the mid 2000s [28]. Clinical data collected in this study 167 were categorised simply into symptomatic and asymptomatic classes for statistical tests in 168 view of samples sizes. Sub-categories within symptoms were defined as 1) Cardiopathy 169 (including any electrocardiographic and/ or echocardiographic abnormalities, X-ray with 170 cardiac enlargement. Patients with atypical cardiac abnormalities i.e. those not exclusively 171 associated with Chagas disease, were included in the symptomatic class in the context of this 172 study.) 2) Megaesophagous (including achalasia and barium swallow abnormalities) 3) 173 Megacolon (constipation associated with dilation as by barium enema) and 4) Normal (no 174 symptoms or signs on examination and a normal electrocardiogram) (Table 1)  175 
 176 
Primer design, PCR conditions, amplicon sequencing and controls: Degenerate primers for a 177 
450bp fragment of the maxi-circle NADH dehydrogenase 5 were designed as described in 178 
Messenger et al. 2012 [29]. Degenerate primer design for the TcGP63I family surface proteases 179 
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(including Ia and Ib sublaclasses) [24] was achieved by reference to sequences retrieved from 180 
EuPathDB for Esmeraldo (TcII), CL Brener (TcVI), Silvio (TcI) and JR (TcI) 181 
(http://eupathdb.org/). Primer biding site positions in relation to TcGP63I putative functional 182 
domains are displayed in Figure S1. Homologs were identified by BLAST similarity to a complete 183 
TcGP63I sequence (bit score (S) ≥ 1000). Alignments of resulting sequences were made in 184 
MUSCLE [30] and primers were designed manually to target a variable region within and 185 
between individual strains with a final size of 450bp. ND5b primer sequences were ND5b_F 186 
ARAGTACACAGTTTGGRYTRCAYA; ND5b_R CTTGCYAARATACAACCACAA. The final 187 
TcGP63 primers were TcGP63_F RGAACCGATGTCATGGGGCAA and TcGP63_R 188 
CCAGYTGGTGTAATRCTGCYGCC. Amplification was undertaken using the Fluidigm® 189 
platform and a reduction of the manufacturer’s recommended number of cycles to total of 26 was 190 
made in an attempt to minimise PCR amplification bias. Thus, the manufacturer’s recommended 191 
conditions were adapted to the following protocol: one cycle of 50°C for 2 minutes, 70°C for 20 192 
minutes, and 95°C for 10 minutes; six cycles of 95°C for 15 seconds, 60°C for 30 seconds, 72°C 193 
for 60 seconds; two cycles of  95°C for 15 seconds, 80°C for 30 seconds, 60°C for 30 seconds and 194 
72°C for 60s; five cycles of  95°C for 15 seconds, 60°C for 30 seconds, 72°C for 60 seconds; two 195 
cycles of  95°C for 15 seconds, 80°C for 30 seconds, 60°C for 30 seconds and 72°C for 60 196 
seconds; five cycles of  95°C for 15 seconds, 60°C for 30 seconds, 72°C for 60 seconds, and 197 
finally five cycles of 95°C for 15 seconds, 80°C for 30 seconds, 60°C for 30 seconds and 72°C for 198 
60 seconds. Amplifications were performed using the FastStart High Fidelity PCR System 199 
(Roche).  Three PCR reactions were pooled per sample prior to sequencing in an attempt to 200 
further reduce amplification biases [31]. Equimolar concentrations of ND5 and TcGP63I 201 
amplicons from 96 DNA samples were multiplexed on Illumina runs using dual index sequence 202 
tags (Illumina Inc). Sequencing was undertaken using a MiSeq platform using a 2 x 250 bp 203 
(Reagent Kit version 2) according to the manufacturer’s protocol. In addition to the clinical 204 
samples, we included a dilution series of control samples. The controls comprised artificially 205 
mixes of DTUs I-VI genomic DNA at equimolar concentrations. At the ND5 locus, comparison 206 
between the expected DTU abundance ratios and diversity of artificial control mixes and that 207 
defined via amplicon sequencing was made (Figure S2).  208 
 209 
Amplicon sequence data analysis – De-multiplexed paired-end sequences were submitted to 210 
quality control and trimming in Sickle [32] and mate pairs trimmed in FASTX Toolkit 211 
(http://hannonlab.cshl.edu/fastx_toolkit/). ND5, TcGP63 and contaminating sequences were then 212 
sorted against a reference using BOWTIE2 [33]. Individual paired reads were found to be 213 
overlapping in only a minority of cases. Thus we chose to proceed with analysis of a sequence 214 
fragment with a truncated central section for both targets. Further sequence manipulations were 215 
undertaken using FASTX Toolkit and custom awk scripts to parse files and concatenate each mate 216 
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pair into a single sequence for downstream analysis. MUSCLE [30] was used for alignment of 217 
amplicon sequences in each patient sample. Next, analysis was undertaken in the Mothur software 218 
package [34] for the elimination of putative PCR chimeras and individual sequence clustering. 219 
The Shannon index of diversity was calculated at the intra-patient level based on sequence types 220 
(STs) defined at 97% and 99% identity in Mothur [34]. Comparisons of Shannon diversity were 221 
made between patients in each cohort (Bolivia chronic, Bolivia congenital, Goias chronic) via 222 
analyses of covariance and linear regression in the R package (http://CRAN.R-project.org). 223 
TcGP63I sequence datasets for patients from each cohort were then merged and analyses 224 
conducted using 97% and 99% STs defined with UPARSE [35] across patients. Weighted UniFrac 225 
distances between TcGP63I STs among samples were generated and subsequently clustered via a 226 
principal coordinates analysis in QIIME [36]. Estimates of diversifying selection among TcGP63I 227 
STs were made in KaKs Calculator [37] using Yang and Neilson’s 2000 approximate method [38] 228 
and tested for significance using a Fisher’s exact test. Prior to selection calculations, sequences 229 
were clustered into 99% identity STs and singletons excluded in an attempt to exclude SNPs 230 
introduced as PCR artefacts. To test for diversifying selection across putative TcGP63I gene 231 
families (TcGP63Ia & Ib - 97% cut-off as defined by Cuevas and colleagues [24]), 99% identity 232 
STs from each patient cohort were pooled (Table 2). To test for selection within TcGP63I gene 233 
families, STs within each 97% category (corresponding to TcGP63Ia & b respectively) were 234 
examined separately per cohort (Table 2). 235 
All amplicon sequences generated in this study are freely available from the authors on request. 236 
Results 237 
Sequence yields and discrete typing unit (DTU) designations. After quality filtering, trimming, 238 
decontamination and removal of unpaired reads, 6,736,749 reads were assigned to the ND5 239 
mitochondrial marker and 871,855 to TcGP63I marker across the 92 clinical samples, perhaps 240 
reflecting higher copy number in the former than the latter. After trimming, the overlap between 241 
individual mate pairs was marginally too short to be assembled into a single read. Thus paired 242 
reads were first aligned against a full-length reference fragment and the central portion excised to 243 
remove any gaps and ensure correct alignment. Sequence depth thresholds per sample for 244 
inclusion were set for each dataset (Goias - ND5 & TcGP63 – 10,000; Cochabamba – ND5: 245 
30,000; TcGP63 10,000; see Figure 1).  Reads from samples in excess of this threshold were 246 
discarded and samples with read counts below this threshold excluded. Our aim in setting the 247 
threshold was: 1) To include as many samples as possible while maintaining a good depth of 248 
coverage; 2) To standardise sampling intensity across individuals and thus facilitate comparisons 249 
between them.  250 
 251 
The ND5 mitochondrial target was sequenced to provide DTU I-VI identification of parasites 252 
circulating within and among patients by comparison to existing data [29]. However, with 253 
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reference to the results from the control samples - and due the necessary truncation of the 254 
sequence fragment - only three groups could be reliably distinguished, corresponding to the three 255 
major T. cruzi maxicircle sequence classes [39]. The three groups corresponded to TcI, TcII and 256 
TcIII-VI respectively. Furthermore, in reference to the control mixes, we found evidence that 257 
amplification bias dramatically skewed the recovery of sequence sypes (STs) towards the TcIII-VI 258 
group. Some skew is expected, as these four DTUs (TcIII-VI) share the same maxicircle sequence 259 
class, and this class is thus more abundant in the control mix. However, TcI and TcII - which 260 
should have in theory been present as 16% (1/6) of all sequences in the controls respectively - 261 
were in fact present (on average) at only 2.9% and 0.03% among the four samples where all three 262 
STs were recovered (Figure S2). Amplicon sequencing from the two most concentrated controls 263 
(57 ng/uL and 125 ng/uL genomic DNA respectively) resulted in poor sequence yields and a 264 
failure to recover all three STs.  265 
 266 
Unsurprisingly perhaps in the light of the control data, most clinical samples were dominated by 267 
sequences from a single group, with minor contributions from others (Figure 2). Indeed sequences 268 
recovered from many strains were monomorphic at the 97% identity level - especially in 269 
Cochabamba. As such, comparisons based on ND5 are necessarily descriptive and meaningful 270 
alpha (within sample) and beta (between sample) diversity statistics were not calculated. Figure 2 271 
shows the distribution of DTUs among samples as defined by the ND5 locus. Most Cochabamba 272 
chronic cases samples were assigned to a single sequence within the TcIII-VI group (likely to be 273 
TcV, as we defined with standard genotyping assays [40] with the exception to two TcI cases – 274 
PCC 240 and PCC 289 (Figure 2, Panel B). Sequence-type diversity in Goias was considerably 275 
higher (Figure 2, Panel A). In this case the TcII group, rather than the TcIII-VI group, 276 
predominated. Unlike in Bolivia, sequences from other groups were present alongside TcII in 277 
multiple patients but at frequencies two orders of magnitude lower. Congenital pairs that 278 
originated from Cochabamba resembled chronic cases from the same region in their DTU 279 
composition (TcIII-VI group predominant, Figure 2, Panel C). Strikingly, mother/child pair 280 
CIUF65 (B5) and CIUF75 (M5) share similar mixed infection profiles (TcI/ TcIII-VI) at similar 281 
relative abundances (c.1:1000), consistent with the minor to major genotype abundance ratios 282 
observed in Goias. The same is also true for the Goias congenital pair (Figure 1) which both 283 
showed TcII/TcI mixes. Finally, sequential isolates taken from the same Goias chronic patient at 284 
different time points suggest that minor abundance genotypes are not always consistently 285 
detectable in the blood (Figure 2): TcI is absent at first sampling of patient y, but present at the 286 
second sampling. For patient z, the TcIII-VI genotype is only present in the first of the two sample 287 
points. For both Cochabamba and Goias, reference to the control data suggests that ‘minor 288 
genotypes’ could be substantially more abundant in the patients than the amplicon sequence data 289 
suggest.  290 
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 291 
TcGP63I surface protease alpha diversity among clinical and congenital cases Alpha 292 
diversity measurements aim to summarise the diversity of species (in this case STs), within an 293 
ecological unit (in this case a host). We summarized the number of STs and their relative 294 
abundance in each of our samples, using the Shannon Index (SI) [41]. Among non-congenital 295 
cases, our aim was to evaluate possible associations between TcGP63I antigenic diversity and 296 
several epidemiological and clincal parameters - age, sex and disease status. We used analyses of 297 
covariance (ANCOVA) to test for the effect of these parameters on intra-host antigenic diversity 298 
(STs defined both at 97% and 99% for comparison), combining continuous (age) and categorical 299 
(sex, clinical forms) data. In Cochabamba, regardless of the order in which parameters were 300 
included as factors in the model, there was no evidence for a main effect of age, sex or symptoms 301 
on alpha diversity (SI) at either ST divergence level (97% ST Age: p = 0.734; Sex: p = 0.298; 302 
clinical form: p = 0.136. 99% ST - Age: p = 0.854; Sex: p = 0.169; clinical form = 0.0988). 303 
Similarly, ANCOVAs were non-significant for an association between the SI and age, sex or 304 
symptoms in Goias (97% ST - Age: p = 0.382; Sex: p = 0.535; clinical form: p = 0.486. 99% ST - 305 
Age:  p = 0.319; Sex: p = 0.696; clinical form: p = 0.697). Finally, we undertook linear 306 
regressions of SI with age in each population. As one might expect from previous ANCOVAs, no 307 
significant correlation was detected (Goias R2= 0.0233, p=0.340 (97% ST); R2 = 0.0256, p=0.3049 308 
(99% ST) Cochabamba R2=0.0287, p=0.429 (97% ST); R2 = 0.0230 p = 0.479(99% ST)). 309 
 310 
Congenital comparisons were made pairwise between mother and infant at 99% ST similarity. In 311 
addition to the ten matched isolate pairs from Cochabamba, a single pair from Goias was also 312 
included (6718 & 6720) in the comparisons. The results of the alpha diversity comparisons are 313 
shown in Figure 3, and read depths were balanced between samples. In terms of the absolute 314 
number of STs identified, infants exceeded mothers in most instances (pairs 2, 3, 4, 5, 6, 8 & 9). 315 
In the remaining cases however (4/11), the number of antigenic sequence types was greater in the 316 
mother. Shannon diversity index comparisons between mothers and infants, which also takes ST 317 
abundance into account, suggested that some differences (e.g. pairs 4, 5 &6) might be marginal 318 
(Figure 3). 319 
 320 
TcGP63I ST distributions among clinical and congenital CD patients. Individual sample 321 
sequence datasets within each of the different study cohorts (Cochabamba congenital, 322 
Cochabamba non-congenital and Goias) were merged to facilitate analysis of the distribution of 323 
antigen 99% STs among individuals (i.e. beta-diversity comparisons). Pairwise weighted Unifrac 324 
distances were calculated within cohorts of chronic cases from Cochabamba and Goias to examine 325 
whether the sequence diversity of the TcGP63I antigenic repertoire present in each patient could 326 
be associated with disease outcome. Principal coordinate analyses of the resulting matrices are 327 
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displayed in Figure 4. Among cases from Goias, repertoires varied considerably among cases, 328 
with several outliers. However, repertoires from symptomatic and asymptomatic cases were 329 
broadly overlapping in terms of sequence identity, and no clustering was noted among different 330 
symptom classes either (Figure 4, Plot B). TcGP63I read yields permitted comparisons for only 331 
two pairs of sequential isolates from the sample patients – x and y (see Table 1) – both of which 332 
showed closely clustering, although non-identical, profiles.  TcGP63I diversity between 333 
Cochabamba chronic cases was arguably lower, with the exception of two outliers unambiguously 334 
identified as TcI with reference to the ND5 locus (all others were classified as TcIII-VI - likely 335 
TcV). Again, however, symptomatic and asymptomatic cases were broadly overlapping.  336 
 337 
Sequence type profile comparisons among Cochabamba congenital cases were made for 99% STs 338 
and are displayed in heatmap format in Figure 5. There are two key features of interest. The first is 339 
that profiles in mother an infant can match very closely (e.g. pairs 2&6). The second is that novel 340 
STs were present in the infant sample with respect to the mother in half of the cases. Indeed, in 341 
pair 9, the infant profile was radically different to that of the mother.  342 
 343 
Population-level Ka/Ks ratios within and between TcGP63I gene family members.  Trimmed 344 
TcGP63 reads, pre-filtered for quality and PCR errors, were pooled within each study site (Bolivia, 345 
Goias). To further reduce minority SNPs and PCR errors, STs were defined at 99% with each site 346 
in UPARSE [35]. Ka/Ks ratio estimates within each study area indicated a significant excess of 347 
synonymous mutations among STs (Goias = 0.8354, Bolivia = 0.7515) averaged across sites 348 
(Table 2). However, when calculations were based on diversity present among well represented 349 
STs of each gene family member (TcGP63Ia and TcGP63Ib, 97% cut-off [24]) a powerful and 350 
significant excess of non-synonymous substitutions was noted within each study area (Ka/Ks, 351 
Goias, ST1 = 2.6436, ST4 = 6.3415; Bolivia ST3 = 2.8059; Table 2). Again, calculations were 352 
based not on individual sequences, but rather 99% STs within predefined 97% clusters. The 353 
position of the 97% STs in question is shown in the tree in Figure S3, with clear similarity 354 
between those clusters under apparent diversifying selection (Goias ST1 & 2, and Bolivia ST3) 355 
with TcGP63Ia and TcGP63Ib references respectively [24]. 356 
 357 
 358 
Discussion 359 
In this study our aim was to collect a cohort of T. cruzi samples from clinical CD cases, 360 
representative of different endemic regions and of different ages and disease presentations, to 361 
explore links between CD epidemiology and multiplicity of infection. To provide a robust, 362 
sensitive and quantifiable means of assessing intra-host parasite diversity we first implemented 363 
standardized parasite isolation (and enrichment) strategies within each study cohort. Latterly, we 364 
 11 
developed an amplicon sequencing approach to profile parasite diversity within each patient. 365 
Given the relatively short (400-500bp) read lengths generated by next generation sequencing 366 
platforms (at the time of experimentation), we chose a rapidly evolving maxicircle gene (ND5) in 367 
an attempt to resolve DTU level diversity ([29]). Current multilocus nuclear targets are generally 368 
too long (500bp+) to meet our selection criteria [42]). To explore antigenic diversity, we chose 369 
a putatively low (5-10) copy number gene family member TcGP63I, expressed on the parasite 370 
surface during the amastigote and trypomastigote lifecycle stage and thus exposed to the human 371 
immune system [24]. Given that both ND5 and TcGP63I are present as several copies per parasite 372 
genome (and potentially show inter-strain copy number variation e.g. [43]), one cannot presume a 373 
1:1 relationship between ST and parasite individual, even if we were able to account for the PCR 374 
amplification bias we detected. The identification of a genetically, variable, single copy, surface 375 
expressed antigen locus is a major challenge in T. cruzi – antigen genes are by their nature highly 376 
repetitive [17,18]. TcGP63I, with its relatively low copy number represents the closest currently 377 
available fit, and, as we have shown, provides a useful target for revealing intra-host antigenic 378 
diversity. Merozoite surface proteins (MSP) 1 and 2 have traditionally provided useful targets for 379 
detecting MOI in P. falciparum (e.g. [44,45]. Furthermore, amplicon sequencing of the MSP locus 380 
has been successfully proven to reveal as many as six-fold more variants than traditional PCR-381 
based approaches [15]. 382 
 383 
The substantial historical interest in defining MOI among P. falciparum owes itself to the strong 384 
correlation between MOI and rate of parasite transmission [46]. As such, fluctuations in 385 
transmission intensity can be tracked to evaluate the efficiency of vector eradication campaigns, 386 
drug treatments, the introduction of insecticide-treated nets etc – without the need to directly 387 
estimate the entomological inoculation rate. Evaluation of CD transmission intensity has its own 388 
challenges. The presence of infected individuals, triatomine vectors in domestic buildings, 389 
incrimination of vectors via human blood meal identification (e.g. [47]) can all help to build the 390 
overall picture. However, parasite transmission is likely to occur in only a tiny proportion of blood 391 
meals [48,49], and vector efficiency is thought to vary considerably between triatomine species 392 
[50] - thus the presence of vectors is no guarantee of transmission. Infection with T. cruzi is 393 
lifelong, thus positive patient serology is not a reliable indicator of active parasite transmission 394 
either. Traditionally, active T. cruzi transmission has been implied from positive serology among 395 
younger age classes. Especially in hyperendemic areas of Bolivia, Paraguay and Argentina the 396 
proportion of seroprevalent individuals increases with age [51,52]. MOI in T. cruzi patients should 397 
follow a similar trend given a stable force of infection. Furthermore MOI comparisons between 398 
disease foci could, controlling for age, facilitate an appreciation of relative transmission intensities 399 
– a useful tool for those who wish to track the efficacy of interventions. In the current study, 400 
however, we were unable to identify a correlation between MOI and age, even once patient sex 401 
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and clinical form had been corrected for. Our inability to validate this fundamental prediction has 402 
many possible causes. First, patients in each cohort originate from different communities within 403 
each study area (Table 1). Micro-geographic variation in T. cruzi genetic diversity is commonly 404 
observed (e.g. [11,53,54], and the same is likely to be true for infection intensity. Thus, if patients 405 
from different sites share dissimilar histories in the intensity and diversity of exposure to T. cruzi 406 
clones, comparisons between them are difficult to make. Secondly, the relationship between MOI 407 
and age is not necessarily linear. If a degree of cross-genotype immunity accumulates with 408 
exposure, one might expect a slower increase in intra-host antigenic diversity in older age groups. 409 
However, this was not the case in our dataset and neither a linear, nor a unimodal relationship 410 
could be established. 411 
 412 
Amplicon sequencing approaches to the study of transmission patterns in human parasites have so 413 
far been restricted to those species that replicate and reach high parasitemias in peripheral blood 414 
(i.e. T. brucei [55] and P. falciparum [13,15]). T. cruzi trypomastigote circulating parasitemias, as 415 
measured by qPCR, are thought to vary considerably between acute (400 parasites/ml), newborn 416 
(150-12000 parasites/ml) and chronic (3-16 parasites/ml) cases [25,56]. Nonetheless, they remain 417 
several orders of magnitude lower than those that occur during T. brucei or P. falciparum 418 
infections. Low circulating T. cruzi parasitemia presents major problems to studies that aim to 419 
achieve molecular diagnosis of CD in chronic cases and ours is no exception. One problem is that 420 
much of the parasite diversity present in the host is likely to be sequestered in the tissues at any 421 
give time [57], as our sequential samples from Goias also suggest. Thus blood stage parasite 422 
genetic diversity may be a poor representation of that actually present in the host. Another 423 
confounder is culture bias, by which differential growth of clones in culture, as well as loss of 424 
clonal diversity during repassage can both influence diversity estimates. Attempts to generate 425 
amplicon sequence data directly from clinical blood samples would likely to be thwarted by low 426 
circulating parasitemia [25, 56]. Instead we elected to enrich for parasite DNA via culture – in 427 
Goias without further repassage, but in Bolivia with at least one repassage before cryopreservation. 428 
Low circulating parasitemia in Chagas patients also means it is possible that amplicon-sequencing 429 
strategies might rapidly ‘bottom out,’ if few parasites are present within a sample. In our dataset, 430 
for example, at the ND5 locus, minority DTUs at 97% divergence can be present as a proportion 431 
of < 1 in 1000 (Figure 1), with the implication that several thousand parasites must be present in 432 
the sample. In both Goias and Bolivia matched instances occurred in congenital cases where TcI 433 
exists in mother and infant as the minor DTU at similar relative abundance (i.e. 1 in 1000, Figure 434 
1). It is highly unlikely that these data directly reflect chronic CD parasitemia levels. Instead, with 435 
reference to the data we obtained from the controls, PCR amplification bias is a more likely 436 
source of unrealistic major to minor genotype ratios. As such, the fourfold over-representation of a 437 
ST in the original sample, for example, can result in 100-1000 fold over-representation after PCR. 438 
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However, while the relative abundance of sequence types recovered using the amplicon approach 439 
may be an inaccurate reflection of those present for both ND5 and TcGP63, similar profiles 440 
between mother and infant suggests that this bias is likely to be consistent across samples. Thus 441 
comparisons between samples are still valid. Furthermore for ND5 at least it seems that T. cruzi 442 
frequently exchanges mitochondrial (maxicircle) genomes with little apparent evidence of nuclear 443 
exchange [11,29]. Fusion of maxicircle genomes occurs transiently during T. brucei genetic 444 
exchange events [58], and may also do so in T. cruzi. Even though standard maxicircle genotyping 445 
of progeny only ever reveals a single parent in both species, it is possible that heterologous 446 
maxicircle sequences may persist at low abundance in parasite clones. Such a phenomenon could 447 
explain the DTU sequence type ratios observed, and this study is the first to sequence a maxicircle 448 
gene to this depth.    449 
 450 
There is general consensus in the literature is that the likelihood of congenital CD transmission is 451 
not strongly influenced by the genotype of the parasite infecting the mother [59-61]. Nonetheless, 452 
the majority of cases are reported in the Southern Cone region of South America, providing a 453 
circumstantial link with major human-associated T. cruzi genotypes TcV TcII, and TcVI.  In this 454 
study, in the one mixed infection we found, major and minor DTUs (TcVI / TcI) detected in the 455 
mother at the ND5 locus were recovered from the infant in similar proportions. TcGP63I beta 456 
diversity comparisons of STs defined at 99% showed substantial sharing of between mother and 457 
infant (Figure 5). However, both beta diversity comparisons (Figure 5) and total ST diversity 458 
(alpha) comparisons (Figure 3) at 99% indicate that while maternal diversity sometimes exceeds 459 
that of the infant (explicable perhaps by sequestration in the mother and selective or stochastic 460 
trans-placental transfer), the reverse is frequently true. The occurrence of STs in the infant, not 461 
present in the mother, has several possible explanations. The infants sampled in this study were 462 
neonates, thus superinfection can be ruled out as a source of further parasite clonal diversity. A 463 
recent study of infected neonates in Argentina estimated mean infant parasitemia at 1,789 464 
parasites/ml via qPCR - far in excess of that one might expect in the mother [56]. Thus the 465 
parasite sample size discrepancy between mother and infant perhaps explains the unexpected 466 
levels of diversity in the infant.  Even though the TcGP63I gene family is apparently under intense 467 
diversifying selection, it seems unlikely that point mutation could generate novel variants over 468 
such a short time scale to explain genetic diversity in the infant. Structural variants and 469 
homologous recombination are a potential source of diversity, although most, if not all of 470 
recombinants should have been excluded in the quality filtering stages, and would be hard to 471 
distinguish from PCR chimeras in any case.   472 
Many important T. cruzi surface genes belong to large, recently expanded paralogous multigene 473 
families [17]. The abundance of these gene copies highlights their likely adaptive significance in 474 
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terms of infectivity and host immune evasion, especially because trypansomatids exert so little 475 
control of gene expression at the level of transcription [62]. In Leishmania major, for example, it 476 
has been recently shown that gene amplification may rapidly duplicate segments of the genome in 477 
response to environmental stress [63]. As well as expansion, adaptive change is also likely to 478 
occur at the amino acid level among members of paralogous gene families, as has been suggested 479 
for T. brucei [64]. Despite the relatively small size of the TcGP63I gene family, the amplicon 480 
sequencing approach we employed allowed us to explore selection at the level of the gene within 481 
the population, i.e. within and between parasite genomes within and between hosts at the 482 
population level. Highly elevated non-synonymous substitutions suggest intense diversifying 483 
selection within TcGP63Ia and TcGP63Ia STs respectively for those assigned to TcII or TcI. STs 484 
from patients infected with TcIII-TcVI (putative TcV) showed few apparent substitutions (Table 485 
2), perhaps consistent with the recent origin of this DTU [65]. The sequence fragment we studied 486 
was outside the zinc binding domain of this metalloprotease, indicating selective forces can act on 487 
this protein independent of its core proteolyic function, perhaps through repeated exposure to host 488 
immunity. 489 
 490 
It is important not to overlook the potential importance of multliclonal infections for parasitic 491 
disease, both as markers of population level factors such as parasite transmission, but also at the 492 
host level, including immunity and disease progression. In this study we have developed an 493 
amplicon sequencing approach to probe parasite genetic diversity within and among clinical CD 494 
cases to unprecedented depth. While our approach shows the power of this amplicon-seq to 495 
resolve diversity in clinical and congenital CD cases, it also highlights the potential biases that 496 
might be introduced with the addition of a PCR step. A tool that allows the accurate evaluation 497 
MOI would be valuable for tracking transmission rates at restricted disease foci (i.e. villages, 498 
outbreaks) in the context of measuring the success of intervention strategies.  A similar tool could 499 
provide a powerful means of longitudinal tracking of T. cruzi infections in terms of disease 500 
progression, treatment failure and immunosuppression. Here we demonstrate that amplicon 501 
sequencing could have a role to play in this context. However, as sequencing costs decline and 502 
reference genome assemblies improve, whole genome deep sequencing, perhaps even of 503 
individual parasite cells, becomes and increasingly viable option as it already has for Plasmodium 504 
sp. [7,66]. 505 
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Figures and Tables 689 
 690 
Figure 1 – Read depths by sample and locus for Goias and Cochabamba chronic patient 691 
cohorts after quality filtering. Read depths generated on the Illumina MiSeq platform were 692 
standardized across samples prior to analysis. Inclusion thresholds for TcGP63 (Goias – 10,000; 693 
 20 
Cochabamba – 3000; wide dash line; red bars) and ND5 (Goais - 10,000; Cochabamba - 30,000; 694 
thin dash line; blue bars) are shown for each population. 695 
 696 
Figure 2 – Bar plot showing sequence type identity and abundance defined at 97% similarity 697 
for the ND5 locus across all samples. A – Goias cohort chronic/intermediate cases; B - 698 
Cochabamba chronic/intermediate cases; C – Cochabamba congenital cases. Y axes show log 699 
transformed abundance (read counts). X axes show clustered bars for individual samples. 700 
Sequence type identities are given in the legend. Stars denote congenital pair from Goias. Labels x 701 
(6416 / 6452), y (6401 / 6536) and z (6379 / 6445) sample pairs from the same patient at different 702 
time points (see Table 1) 703 
 704 
Figure 3 – Alpha diversity indices for TcGP63I amplicon diversity derived from pairs of 705 
congenital Chagas disease cases. Diversity indices were derived from STs defined at 99% 706 
sequence similarity. Bar plot and associated x-axis on the right hand side shows the Shannon 707 
diversity index calculated in Mothur [34], with error bars defining upper and lower 95% 708 
confidence intervals. 709 
 710 
Figure 4 – Principal coordinates analysis of sequence diversity between chronic Chagas 711 
Disease patient TcGP63I antigenic repertoires. Genetic distances are based on a weighted 712 
unifrac metric. Plot A shows diversity comparisons among Goias asymptomatic (asympt) and 713 
symptomatic (sympt) clinical cases, as well as one acute case. Plot B shows Goias cases with 714 
symptoms categorised as acute, card (cardiopathy), card + mega (cardiopathy as well as 715 
megacolon and / or megaesophagous), mega (megacolon and / or megaesophagous) or asympt 716 
(asymptomatic). Plot C shows comparisons among Cochabamba clinical cases (not including 717 
congenital cases) classified as either asymptomatic (asympt) and symptomatic (sympt). The 718 
dashed circle on plot C indicates samples unambiguously defined as TcI at the ND5 locus. Pairs of 719 
sequential isolates from the same patient are labelled x and y respectively. 720 
 721 
Figure 5 – Heatmap comparing the TcGP63I antigenic repertoires of mother and infant 722 
congenital pairs. Pairs are indicated down the left hand side of the image (y axis). The mid-point 723 
rooted maximum likelihood tree on the x axis describes relationships among the 99% similarity 724 
sequence types (STs) identified in UPRASE [35] and was generated in Topali under equal-725 
frequency transversion model, allowing gamma distributed weights across sites [67]. Values on 726 
dendrogram notes indicate % bootstrap support.  Starred congenital pairs are those where STs are 727 
present in the infant but not in the mother. 728 
Figure S1 – TcGP63Ia and Ib amino acid alignments showing amplicon seq primer binding 729 
sites in relation to putative functional domains.  Amino acid sequences are derived for those 730 
 21 
define by Cuevas and colleagues [24]. The colour key on the left hand side indicates primer 731 
binding sites and functional domains. The green shaded regions indicate the area covered by the 732 
Illumina paired end reads along each amplicon. The purple shaded central region indicates the 733 
area not covered. 734 
Figure S2  - Bar plot of amplicon sequence data generated from control DTU mixes. 735 
Expected ratios of ND5 sequence types (far right) are compared to those recovered via amplicon 736 
sequencing. All three sequence types (I, II, III-VI) were recovered from all but the two most 737 
concentrated control mixes.  However, the relative proportions of each sequence type derived 738 
from amplicon sequence data were radically different to that expected. 739 
Figure S3 – Maximum likelihood phylogeny of 97% TcGP63I STs derived in this study and 740 
available T. cruzi and T. cruzi marinkellei TcGP63 paralogues. Homologous sequences were 741 
recovered from www.TriTrypDB.org via BLAST. The appropriate substitution model was defined 742 
as the transversion model with invariable sites plus gamma in Topali [67]. Abundant ST labels 743 
correspond with those indicated in Table 2. Branches are coloured by source DTU or red, for 744 
sequences generated in this study. Reference sequences TcGP3Ia and TcGP63Ib from the 745 
literature are also shown along side 97% sequence types generated in this study [24]. 746 
 747 
 748 
 749 
 750 
 751 
 752 
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Table 1 – Sam
ples provenance and sym
ptom
s 
 
 
 
 
 
 
 
TcGp63I Shannon Index 
Code 
Sex 
Age 
Province 
Country 
Symptoms 
ND5 Sequence 
Type 
97%
 ST 
99 %
 ST 
PCC 313 
F 
33 
Pam
pa San M
iguel, C
ochabam
ba 
B
olivia 
C
ardiopathy 
TcIII-V
I 
0.863833 
2.104583 
PCC 221 
F 
52 
C
ercado, C
ochabam
ba 
B
olivia 
C
ardiopathy 
TcIII-V
I 
0.911279 
2.757206 
PCC 310 
F 
58 
C
ollaj chullpa 
B
olivia 
C
ardiopathy 
TcIII-V
I 
0.80038 
2.267772 
PCC 302 
F 
55 
O
ropeza, C
huquisaca 
B
olivia 
C
ardiopathy 
TcIII-V
I 
N
D
 
N
D
 
PCC 277 
F 
50 
Pucara G
rande, C
ochabam
ba 
B
olivia 
C
ardiopathy 
TcIII-V
I 
0.680276 
1.896947 
PCC 460 
M
 
43 
Q
uillacollo, C
ochabam
ba 
B
olivia 
C
ardiopathy 
TcIII-V
I 
0.64493 
1.609727 
PCC 240 
F 
36 
Pucara grande, C
ochabam
ba 
B
olivia 
C
ardiopathy 
TcI 
0.19757 
0.970659 
PCC 243 
F 
19 
C
hilim
arca, C
ochabam
ba 
B
olivia 
C
ardiopathy 
TcIII-V
I 
0.863657 
2.235602 
PCC 262 
F 
36 
Ticti N
orte, C
ochabam
ba 
B
olivia 
C
ardiopathy 
TcIII-V
I 
0.602361 
2.407113 
PCC 096 
F 
58 
C
ercado-C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
N
D
 
N
D
 
PCC 295 
F 
45 
Sacaba, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.82236 
2.641406 
PCC 151 
F 
24 
C
erro verde, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.809111 
2.424673 
PCC 253 
M
 
46 
C
am
pero, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.765955 
2.147924 
PCC 210 
F 
40 
C
ercado, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.79258 
2.335818 
PCC 263 
M
 
50 
C
alicanto, Santa C
ruz 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.654315 
1.948427 
PCC 451 
F 
32 
U
spa U
spa, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.715735 
2.016351 
PCC 480 
F 
46 
C
ercado, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.735419 
1.883752 
PCC 481 
F 
26 
H
uayra kasa 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
1.12695 
3.229099 
PCC 149 
F 
20 
C
ercado, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.849494 
2.875091 
PCC 502 
F 
44 
A
lto Q
uer-Q
ueru, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.813833 
2.570795 
PCC 456 
M
 
27 
Scaba, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.529413 
1.677289 
PCC 489 
M
 
46 
Q
uillacollo, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.935067 
2.67856 
PCC 499 
F 
41 
Sacaba, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.878578 
2.402874 
PCC 289 
F 
24 
Sacaba, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcI 
1.0811 
N
D
 
PCC 226 
F 
22 
Santivañez, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
N
D
 
2.364685 
 
23 
PCC 255 
F 
49 
Q
uillacollo, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.703573 
1.966296 
PCC 251 
F 
37 
Sacaba, C
ochabam
ba 
B
olivia 
A
sym
ptom
atic 
TcIII-V
I 
0.774534 
2.312599 
6339 
F 
58 
Sao Luiz M
B
elos, G
oias 
B
razil 
C
ardiopathy 
TcII 
0.373205 
1.409882 
6340 
F 
76 
Serra do Salitre, M
inas G
erais 
B
razil 
M
egaesophagus 
TcII 
0.19035 
1.879923 
6345 
F 
67 
Form
osa, G
oias 
B
razil 
M
egacolon, 
M
egaesophagus 
TcII/TcI 
0.303881 
1.574604 
6349 
F 
37 
W
anderlei, B
ahia 
B
razil 
M
egaesophagus 
TcII/TcIII-V
I 
0.841102 
1.801845 
6356 
M
 
65 
Itapaci, G
oias 
B
razil 
C
ardiopathy, 
M
egacolon, 
M
egaesophagus 
TcII 
1.168083 
2.787444 
6360 
F 
40 
M
araR
osa, G
oias 
B
razil 
C
ardiopathy 
TcII/TcIII-V
I 
0.28487 
2.332717 
6372 
M
 
38 
C
orrentina, B
ahia 
B
razil 
M
egaesophagus 
TcII 
0.198327 
1.72982 
6373 
F 
54 
R
ubiataba, G
oias 
B
razil 
M
egaesophagus 
TcII 
0.457692 
1.929769 
6378 
F 
39 
Itapaci, G
oias 
B
razil 
M
egacolon, 
m
egaesophagus 
TcII 
0.357508 
1.259254 
6379 z 
M
 
39 
Sao Luiz M
B
elos, G
oias 
B
razil 
A
sym
ptom
atic 
TcII/TcIII-V
I 
N
D
 
N
D
 
6380 
F 
59 
B
razabrantes, G
oias 
B
razil 
A
sym
ptom
atic 
TcII 
0.742025 
1.786299 
6382 
M
 
56 
Jussara, G
oias 
B
razil 
M
egaesophagus 
TcII 
0.332897 
2.104033 
6383 
M
 
30 
A
ngical, B
ahia 
B
razil 
A
sym
ptom
atic 
TcII 
0.561749 
1.653877 
6385 
F 
31 
SantaM
ariaV
itoria, B
ahia 
B
razil 
A
sym
ptom
atic 
TcII 
0.304854 
1.87694 
6386 
M
 
33 
C
orrentina, B
ahia 
B
razil 
C
ardiopathy 
TcII/TcIII-V
I 
0.222146 
1.393783 
6387 
F 
57 
Lagolandia, G
oias 
B
razil 
C
ardiopathy 
(nontypical), 
M
egaoesophagos 
TcII 
0.07458 
1.601748 
6389 
F 
24 
C
ocos, B
ahia 
B
razil 
A
sym
ptom
atic 
N
D
 
0.025177 
1.835489 
6390 
M
 
32 
C
ocos, B
ahia 
B
razil 
C
ardiopathy 
N
D
 
0.037499 
1.722559 
6400 
F 
47 
C
orrentina, B
ahia 
B
razil 
A
sym
ptom
atic 
TcII/TcI 
0.625396 
1.664578 
6401 y 
M
 
30 
SantaM
ariaV
itoria, B
ahia 
B
razil 
M
egaesophagus 
TcII 
0.73448 
1.570591 
6403 
F 
47 
C
orrentina, B
ahia 
B
razil 
C
ardiopathy 
(nontypical) 
M
egaesophagus 
TcII/TcI 
0.309724 
1.136665 
 
24 
6407 
F 
52 
Jussara, G
oias 
B
razil 
C
ardiopathy 
(nontypical) 
TcII 
0.164841 
1.86004 
6416 x 
M
 
45 
C
eres, G
oias 
B
razil 
Severe cardiopathy 
TcII/TcI 
0.320845 
2.110287 
6423 
M
 
63 
V
arzeas, B
ahia 
B
razil 
M
egaesophagus 
TcII/TcI 
0.308932 
2.268015 
6425 
M
 
71 
JoaoPinheiro,M
inas G
erais 
B
razil 
C
ardiopathy, 
m
egaesophagus 
N
D
 
0.623522 
1.895166 
6445 z 
M
 
40 
Sao Luiz M
B
elos, G
oias 
B
razil 
C
ardiopathy 
(nontypical) 
TcII 
0.733916 
1.707039 
6452 x 
M
 
46 
C
eres, G
oias 
B
razil 
Severe cardiopathy 
TcII/TcI 
0.225277 
1.316351 
6453 
M
 
72 
JoaoPinheiro,M
inas G
erais 
B
razil 
M
egaesophagus 
TcII 
0.841132 
1.880447 
6536 y 
M
 
30 
SantaM
ariaV
itoria, B
ahia 
B
razil 
M
egaesophagus 
TcII/TcI 
0.515696 
2.510533 
6548 
F 
57 
G
uiratinga, M
ato G
rosso 
B
razil 
A
sym
ptom
atic 
TcII 
N
D
 
N
D
 
6561 
F 
46 
C
orrentina, B
ahia 
B
razil 
A
sym
ptom
atic 
N
D
 
0.868331 
1.82152 
6563 
F 
58 
Sao D
om
ingos, G
oias 
B
razil 
C
ardiopathy 
(non-typical) 
TcII 
1.049223 
2.262427 
6569 
M
 
65 
A
napolis, G
oias 
B
razil 
M
egaesophagus 
TcII/TcIII-V
I 
0.615555 
1.578375 
6571 
F 
69 
U
ruana, G
oias 
B
razil 
C
ardiopathy, 
m
egaesophagus 
N
D
 
0.366073 
2.659534 
6574 
F 
39 
SantaM
aria da V
itoria, B
ahia 
B
razil 
M
egaesophagus 
N
D
 
0.846975 
1.682228 
6577 
F 
63 
D
am
olandia, G
oias 
B
razil 
C
ardiopathy, 
M
egacolon, 
M
egaesophagus 
N
D
 
0.258461 
1.892257 
6581 
M
 
55 
R
ubiataba, G
oias 
B
razil 
C
ardiopathy 
TcII 
0.820042 
2.019464 
6582 
M
 
45 
M
orroC
hapeu, B
ahia 
B
razil 
C
ardiopathy, 
m
egacolon, 
m
egaesophagus 
TcII/TcIII-V
I 
1.079722 
1.940343 
6588 
M
 
51 
Luziania, G
oias 
B
razil 
C
ardiopathy 
TcII 
0.197856 
0.719487 
6590 
M
 
49 
Itaberai, G
oias 
B
razil 
Severe cardiopathy 
TcII/TcIII-V
I 
0.32446 
2.4802 
6597 
F 
56 
A
lm
as, TO
 
B
razil 
M
egaesophagus, 
m
egacolon 
TcII/TcI 
0.640673 
1.910199 
6603 
F 
36 
SantaM
ariaV
itoria, B
ahia 
B
razil 
C
ardiopathy 
TcII 
0.403289 
1.987725 
6687 
F 
49 
A
rapua, M
inas G
erais 
B
razil 
C
ardiopathy, 
TcII/TcI 
0.390482 
1.752364 
 
25 
m
egaesophagus 
6718 a 
F 
28 
Sao Luiz M
B
elos, G
oias 
B
razil 
C
ardiopathy 
TcII/TcI 
0.281918 
1.826416 
6720 a 
F 
1 
Sao Luiz M
B
elos, G
oias 
B
razil 
A
cute phase 
TcII/TcI 
0.224137 
1.67497 
CIUF 45 
(B1) 
N
D
 
<1 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.679934 
CIUF 63 
(M
1) 
F 
18 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.582106 
CIUF 91 
(B10) 
N
D
 
<1 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.948954 
CIUF 84 
(M
10) 
F 
35 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
2.247228 
CIUF24 
(B2) 
N
D
 
<1 
A
lto C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.390874 
CIUF31 
(M
2) 
F 
20 
A
lto C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.662247 
CIUF40 
(B3) 
N
D
 
<1 
Sucre 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.621565 
CIUF25 
(M
3) 
F 
19 
Sucre 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.231294 
CIUF 42 
(B4) 
N
D
 
<1 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.886761 
CIUF26 
(M
4) 
F 
21 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.914621 
CIUF65 
(B5) 
N
D
 
<1 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I/TcI 
N
D
 
1.578691 
CIUF75 
(M
5) 
F 
17 
C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I/TcI 
N
D
 
1.576942 
CIUF 105 
(B6) 
N
D
 
<1 
Q
uillacollo, C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
2.330751 
CIUF 104 
(M
6) 
F 
17 
Q
uillacollo, C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
2.082838 
CIUF 53 
(B7) 
N
D
 
<1 
Sucre 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.6921 
CIUF 76 
(M
7) 
F 
27 
Sucre 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
2.683029 
CIUF 35 
N
D
 
<1 
C
him
ba, C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.992589 
 
26 
(B8) 
CIUF 93 
(M
8) 
F 
N
D
 
C
him
ba, C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.653714 
CIUF 98 
(B9) 
N
D
 
<1 
V
into, C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.983814 
CIUF 109 
(M
9) 
F 
18 
V
into, C
ochabam
ba 
B
olivia 
C
ongenital 
TcIII-V
I 
N
D
 
1.716494 
 a Sam
ples from
 G
oias congenital case 
x Sam
ples from
 the sam
e patient taken >12 m
onths apart 
y Sam
ples from
 the sam
e patient taken < 6 m
onths apart 
z Sam
ples taken from
 the sam
e patient >12 m
onths apart  
             
 
27 
Table 2  - Y
ang and N
eilson estim
ates for positive selection w
ithin and am
ong abundant 97%
 STs identified in this study.  
Population / 
ST 
Infecting 
strain 
Sequences 
in cluster a 
M
ethod 
Ka 
Ks 
Ka/Ks 
P-
Value b 
S- 
Sites 
N- 
Sites 
Substitutions 
S-Substitutions 
N-Substitutions 
Goias 
TcII 
357227 (271) 
Y
N
 
0.06 
0.07 
0.8354 
0.0000 
14910 
37539.0 
3061 
974.0 
2087.0 
Goias ST1 
TcII 
236805 (149) 
Y
N
 
7.45 
2.82 
2.6436 
0.0000 
6628.46 
20575.5 
20094 
4528.3 
15565.7 
Goias ST2 
TcII 
96274 (82) 
Y
N
 
7.04 
1.11 
6.3415 
0.0000 
4112.28 
12000.7 
11713 
2328.3 
9384.7 
Goias ST4 
TcII 
9981 (19) 
Y
N
 
0.02 
0.05 
0.4151 
0.0000 
978.551 
2543.5 
102 
48.4 
53.6 
Bolivia 
TcV
/TcI 
59431 (86) 
Y
N
 
0.06 
0.08 
0.7515 
0.0002 
4333.81 
10471.2 
904 
314.8 
589.2 
Bolivia ST1 
TcV
 
38455 (36) 
Y
N
 
0.02 
0.03 
0.7876 
0.1600 
2092.15 
5077.9 
182 
62.0 
120.0 
Bolivia ST2 
TcV
 
12676 (24) 
Y
N
 
0.03 
0.03 
0.7868 
0.2290 
1208.92 
3471.1 
134 
41.0 
93.0 
Bolivia ST3 
TcI 
3448 (13) 
Y
N
 
5.57 
1.98 
2.8059 
0.0000 
582.981 
1679.0 
1739 
402.5 
1336.5 
Bolivia ST4 
TcI 
242 (3) 
Y
N
 
4.48 
3.61 
1.2422 
0.3484 
138.391 
392.6 
410 
102.9 
307.1 
 a N
um
bers in brackets represent the num
ber of 99%
 STs define w
ithin each cluster from
 w
hich estim
ates w
ere generated. 
b P values are give for Fisher’s exact tests for deviation from
 the neutral expectation of K
a/K
s = 0. 
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3.4 Discussion 
In lieu of comparative genomics of representative T. cruzi field isolates, not yet a reality, as is 
the case with other more experimentally-tractable trypanosomatids (Downing et al., 2011; 
Goodhead et al., 2013; Rogers et al., 2014), the four papers included in this chapter describe 
recent advances in T. cruzi genotyping technology.  
Multiple, single-copy, chromosomally-independent, nuclear housekeeping genes were 
evaluated initially for reliable amplification, their ability to assign isolates to DTU-level, to 
facilitate higher resolution intra-lineage analyses (Yeo et al., 2011) and finally their inclusion 
alongside additional targets in a standardized T. cruzi MLST scheme (Diosque et al., 2014). 
Overall nuclear MLST (nMLST) was a robust, reproducible, and in many cases, highly 
discriminatory method to characterize T. cruzi isolates to DTU-level. Modified data were 
amenable to statistical algorithms available for bacterial MLST (e.g. eBURST (Feil et al., 
2004)) and now new software has been developed specifically to handle diploid eukaryotic 
sequence data (Tomasini et al., 2013).  
Potential limitations of this technique, highlighted by these studies, include unpredictable 
LOH observed among different strains and loci, which resulted in spurious phylogenetic 
incongruence and isolate misclassification (especially when loci were examined 
individually). However, this phenomenon is interesting to examine in the context of gene 
conversion and homologous recombination, which have both been implicated in inflating 
homozygosity estimates in T. cruzi previously (Llewellyn et al., 2009a; 2011). Additionally, 
candidate genes were assessed against a limited number of reference isolates (39 and 25, 
respectively), which encompass current known T. cruzi genetic diversity, but were under-
representative of some particular disease foci, e.g. Colombia and Central America.  
For the immediate future, these promising results argue for nMLST to become the new gold 
standard for DTU assignment of isolated parasite strains. A minimum panel of four targets 
can allocate samples to DTU-level, while up to seven loci afforded potential intra-lineage 
resolution. For future applications, it is likely that the combination and number of markers 
used will depend on the particular strain origin and DTU(s) under investigation. For example, 
recent nMLST studies of TcI isolates from geographically-restricted areas of the Argentinian 
Chaco and North-East Colombia relied on eight and thirteen loci, respectively, to obtain 
sufficient intra-lineage resolution (Tomasini et al., 2014a; Ramírez et al., 2013d).  
An alternate approach for intra-DTU studies in T. cruzi is analysis of more variable markers 
such as maxicircle genes or microsatellites which both have mutation rates several orders of  
magnitude higher than protein coding genes (Ellegren, 2000; Ballard and Whitlock. 2004; 
Lewis et al., 2011). Firstly, to address undefined intra-strain homology associated with multi-
copy mitochondrial markers, Illumina sequencing reads, generated as part of the Sylvio 
X10/1 genome project (Franzen et al., 2011), were reassembled and mapped against the 
maxicircle genome, to demonstrate that heteroplasmy within the coding region was present at 
<0.5% of sites. Based on these observations, an MLST scheme comprising ten maxicircle 
gene fragments was developed and evaluated for reproducible amplification across the six T. 
cruzi DTUs and subsequently for its levels of intra-TcI resolution, compared to conventional 
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single (GPI and SL-IR) and multiple (MLMT) nuclear genotyping markers (Messenger et al., 
2012).  
One advantage of this combined nuclear-mitochondrial methodology over nMLST alone, is 
its ability to detect cryptic hybridization and identify potential underlying mechanisms (in 
this study, seemingly asymmetric mitochondrial introgression with minimal reciprocal 
nuclear recombination) (Messenger et al., 2012). However, these observations also caution 
the interpretation of mtMLST without any comparative nuclear data, which could lend itself 
to incorrect strain assignment. Similarly, phylogenetic incongruence between nMLST 
topologies may also be indicative of historical recombination but, at least in T. cruzi, appears 
to occur less frequently (Yeo et al., 2011; Diosque et al., 2014; Tomasini et al., 2014a). The 
genotyping approach described by Messenger et al., 2012, is currently recommended for 
intra-lineage population genetics studies (Ramírez et al., 2012; Zumaya-Estrada et al., 2012; 
Lima et al., 2014) and can also be expanded to include nMLST (see chapter 5), enabling 
analysis of three different types of molecular marker at several overlapping levels of 
resolution.  
The application of MLST (both nuclear and mitochondria) in endemic areas, is restricted 
primarily by reagent cost, technical expertise and access to a sequencer. The same limitations 
apply to other genotyping methods, such as microsatellites, which are notoriously difficult to 
reproduce precisely between laboratories. Without concomitant improvements in 
infrastructure, it is evident that in some of the more underdeveloped regions, routine 
genotyping of T. cruzi will still need to rely on lower technological approaches e.g. PCR-
RFLPs (Rozas et al., 2007; Lewis et al., 2009a; Cosentino and Agüero, 2012). 
Finally, Illumina amplicon deep sequencing markers were developed to examine parasite 
multiclonality within individual chronic and congenital chagasic patients; putative evidence 
of diversifying selection affecting antigenic genes was observed, suggesting a link between 
genetic diversity in this gene family and survival in the mammalian host (Llewellyn et al., 
accepted). The failure of this study to identify any correlation between parasite genetic 
diversity and patient sex, age or clinical symptoms, may simply reflect limitations of this 
particular sample cohort. The ‘ideal’ population to examine such associations is an endemic 
community where active vector transmission and high force of infection persists, such as 
those described in the Bolivian Gran Chaco, where Chagas seroprevalence is directly 
proportional to age, reaching up to 97% in adults older than 30 years (Samuels et al., 2013). 
While it is generally accepted that geographical variation in chronic Chagas disease 
pathology is partially attributable to differences in parasite genetic diversity, no clear 
relationship between T. cruzi genotype and clinical disease status has yet been established 
(Miles et al., 2009).  
With targeted cross-sectional sampling of such a population, deep sequencing has the 
potential to investigate phenomena such as super-infection, which may be more relevant in 
the context of Chagas disease pathogenesis. Super-infection due to ongoing vector exposure 
has been proposed to increase parasite load, sustain antigen exposure and consequent 
inflammatory immune response at a higher levels, thereby driving progression of cardiac 
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morbidity and risk of congenital transmission (Bustamante et al., 2002; 2003; 2004; 2007; 
Andrade et al., 2006; Torrico et al., 2006; Marin-Neto et al., 2007; Dutra and Gollob, 2008).  
Future studies could adopt a multidisciplinary approach, incorporating parallel 
immunological assays and quantification of parasitaemia by qPCR to investigate the impact 
of T. cruzi multiclonality on chronic immune dysregulation. Additionally, improvements can 
also be made with regards to sequencing technology, particularly elimination of any PCR 
steps which likely biased ST recovery, and exploration of deep sequencing directly from 
clinical samples, e.g. via whole genome amplification (WGA), to circumvent potential loss of 
clonal diversity during parasite enrichment stages (Morrison et al., 2007). 
All of the genotyping methods described herein supported the six current T. cruzi DTUs. By 
comparison the level of nuclear sequence divergence between major lineages was equivalent 
to inter-species diversity among New World Leishmania species (Yeo et al., 2011; Boité et 
al., 2012), raising the question, is current nomenclature sufficient to describe known T. cruzi 
genetic diversity? There appears to be mounting evidence for the inclusion of a seventh DTU: 
TcBat (Marcili et al., 2009; Pinto et al., 2012; Ramírez et al., 2014). No TcBat isolates were 
examined as part of these studies. It would be interesting to apply these markers to the 
genetic characterization of this novel lineage, to confirm its affiliations with TcI, and 
investigate its proposed role as the antecedent of the other T. cruzi DTUs (Guhl et al., 2014). 
Recently, there has been significant interest in subdividing TcI by transmission cycle (TcIa-e) 
(Herrera et al., 2007b; 2009; Falla et al., 2009; Cura et al., 2010; Guhl and Ramírez, 2011) 
on the basis of variability in the SL-IR. However, when multiple MLMT and mtMLST 
markers have been applied to equivalent strains, these subdivisions, particularly among 
peridomestic and sylvatic cycles, collapse. Instead TcI isolates group either alongside low 
diversity isolates from humans and domestic vectors (TcIDOM) or with sylvatic samples that 
display continental-wide spatial structuring (Llewellyn et al., 2009a; Zumaya-Estrada et al., 
2012). The latter designation of a subset of human-associated genotypes is arguably more 
biologically relevant, but may still be characterizing diversity for its own sake.  
It is probable that as more T. cruzi whole genome sequences become available additional 
distinct genotypes relating to pathogenesis, including structural and copy number variants 
(Urban et al., 2011; Minning et al., 2011; Sterkers et al., 2011; Pavia et al., 2012), may be 
uncovered and call for nomenclature reclassification. Until that time, presented herein are 
some of the highest resolution genotyping techniques developed in T. cruzi to date which 
support and will potentially expand our current understanding of parasite genetic diversity. 
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4. Investigating the association between T. cruzi genetic diversity and 
ecophylogeography of Chagas disease  
 
4.1 Background 
An improved understanding of the interactions between natural parasite populations and their 
environment is crucial to establish the epidemiological risk associated with emergent 
pathogenic genotypes. T. cruzi is an ancient, pervasive multi-host zoonotic disease which was 
likely introduced to South America via North American bats approximately 7-10 MYA 
(Stadelmann et al., 2007). The diversification of T. cruzi from its MRCA into its current 
DTUs occurred within the last 3-4 MYA (Flores-López and Machado, 2011; Lewis et al., 
2011).  
Paleoparasitology data indicate that soon after colonizing South America ~15,000 years ago 
(Goebel et al., 2008), humans became infected with T. cruzi; the earliest recorded human 
infection is from a 9000 year old Chinchorro mummy, which inhabited the coastal region of 
the Atacama Desert (Aufderheide et al., 2004). Similar incidences of T. cruzi infection 
among mummies from subsequent cultures that succeeded the Chinchorros (including the 
Alto Ramirez, Cabuza, Maitas, Chiribaya, San Miguel, Inca and Colonial people), at an 
average prevalence of 40.6%, suggests that by pre-Colombian times, Chagas disease was 
already widespread in human societies (Aufderheide et al., 2004). Subsequent studies in the 
same area have identified different T. cruzi genotypes predominating throughout this time 
period; TcI and TcII among the Chinchorros were replaced by TcV and TcVI among Cabuza 
and Chiribaya mummies (Guhl et al., 2014). TcI and TcII infections have also been detected 
in more recent human remains from other archeological sites in Minas Gerais, Brazil 
(Fernandes et al., 2008; Lima et al., 2008) and the Chihuahuan Desert, Texas (Dittmar et al., 
2003; Araújo et al., 2009), respectively. 
Based on these observations it has been hypothesized that Chagas disease originated in the 
Andean region amongst the nomadic Chinchorro people (Ferreira et al., 2011) whose 
descendants were the first to domesticate wild guinea pigs (likely Cavia tschudii) for 
consumption and religious rituals (Gade, 1967; Wing, 1986), initiated maize storage as part 
of early arable farming (Rothhammer et al., 1985) and undertook ritual pilgrimages (Cortez 
et al., 2010), thereby providing ample habitats, bloodmeal sources and dispersal mechanisms 
for T. infestans, also believed to have emerged and become domiciliated in the Bolivian 
highlands (Dujardin, 1998; Panzera et al., 2004; Bargues et al., 2006; Cortez et al., 2010). 
In parallel, T. cruzi had already dispersed throughout the sylvatic environment, adapting to 
infect a wide range of mammalian reservoirs including members of the orders Marsupialia, 
Xenarthra, Rodentia, Primates, Carnivora, Chiroptera and Artiodactyla (Noireau et al., 
2009a; Jansen and Roque, 2010). As yet, relatively few in depth host association studies 
between T. cruzi and its triatomine vectors and vertebrate hosts have been conducted. TcI is 
frequently isolated from the triatomine tribe Rhodniini, and arboreal marsupials, particularly 
D. marsupialis and TcIII from Dasypus species (Gaunt and Miles, 2000; Yeo et al., 2005; 
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Llewellyn et al., 2009a; 2009b). However, in both cases these relationships are not absolute 
and genotypes appear to cluster according to geography rather than host species (Acosta et 
al., 2001; Llewellyn et al., 2009a; 2009b; Marcili et al., 2009b).   
Interestingly, animal models suggest that not all mammalian host species are equally 
susceptible to infection by different T. cruzi DTUs. Attempts to artificially infect two species 
of opossum (Monodelphis domestica and Didelphis virginiana) demonstrated that both were 
resistant to TcIV but fully susceptible to TcI (Roellig et al., 2009; 2010). Similar 
observations have been reported with Rhodnius vectors which tend to be less permissible to 
experimental TcII infection (Mello et al., 1996; Araújo et al., 2014). By comparison, recent 
field evidence from Brazil have proposed that some Carnivora can act as indiscriminant 
bioaccumulators of T. cruzi genetic diversity with the potential to connect independent 
transmission cycles (Rocha et al., 2013). The key determinants of contemporary sylvatic host 
associations and parasite diversification are largely unknown. 
Also of particular interest in the context of sylvatic T. cruzi transmission, is the impact of 
anthropogenic activity on the ecoepidemiology of Chagas disease and the evolution of T. 
cruzi. Habitat destruction has the capacity to drive triatomine species to invade the domestic 
environment; successful control of one species in houses can expose a niche for others to 
invade, especially in areas such as Venezuela, where domestic and sylvatic transmission 
cycles potentially overlap (Fitzpatrick et al., 2008). Likewise, in areas unaffected by 
deforestation, including some of the indigenous inhabitations of the Amazon, domestic T. 
cruzi transmission has thus far failed to establish (Miles et al., 1978; Walsh et al., 1993).  
Human encroachment into sylvatic areas has undoubtedly influenced parasite genetic 
diversity and has been hypothesized to explain the emergence of TcV and TcVI and their 
seemingly epidemic propagation across the Southern Cone (Lewis et al., 2011). Similarly, 
multiple molecular markers suggest that TcI human infections in Venezuela and Colombia 
are associated with genetically homogenous strains (TcIDOM/TcIa/VENDOM) which are distinct 
and absent from local sylvatic populations (Herrera et al., 2007b; 2009; O’Connor et al., 
2007; Falla et al., 2009; Llewellyn et al., 2009a; Ocaña-Mayorga et al., 2010; Cura et al., 
2010; Ramírez et al., 2012). The pathological implications of these low diversity genotypes 
and their evolutionary origins remain unresolved.!
 
!
!
!
!
!
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4.2 Objectives 
The aim of this chapter was to exploit the phylogenetic markers developed in chapter 3 to 
investigate the interaction between parasite genetic diversity and ecophylogeography of 
Chagas disease. 
Specific objectives were to: 
a. Identify ecological determinants of sylvatic TcI genetic diversification in arboreal and 
terrestrial transmission cycles in Bolivia. 
b. Examine putative hybrid contact zones to detect incidences of nuclear-mitochondrial 
phylogenetic incongruence, which are indicative of natural genetic exchange. 
c. Explore the interaction between intra-TcI genetic heterogeneity and ecological 
biodiversity among different biomes in Brazil.  
d. Investigate the evolutionary origin of TcIDOM, a subset of homogeneous strains 
associated with human infections in northern South and Central America. 
!
!
! !
!
!
!
!
!
!
!
!
!
!
!
!
!
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4.3 Results 
4.3.1 Ecological host fitting of sylvatic T. cruzi 
Two hypotheses exist to explain contemporary T. cruzi host associations. Some have 
proposed that T. cruzi co-evolved in close synergy with discrete vertebrate hosts and insect 
vectors (Miles et al., 1981b; Gaunt and Miles, 2000; Yeo et al., 2005), while others favour 
ecological host fitting (Hamilton et al., 2007; Llewellyn et al., 2009a; 2009b), i.e. co-option 
of existing genetic traits to colonize an unfamiliar resource, environmental niche or facilitate 
host switching. To identify key determinants of sylvatic T. cruzi genetic diversification and 
explore potential hybridization and spatial genetic structure of natural parasite populations, 
high resolution nuclear (Llewellyn et al., 2009a) and mitochondrial (Messenger et al., 2012) 
genotyping was used to characterize 199 contemporaneous TcI clones isolated from sylvatic 
transmission cycles in Bolivia. 
This study is reported in full below in Messenger et al. accepted.  
In summary: 
- Based on multiple clustering algorithms (a non-parametric discriminant analysis of 
principal components (DAPC) and a NJ-DAS tree), TcI clones were grouped into three 
distinct sylvatic transmission cycles, corresponding to one terrestrial highland population 
(Cochabamba, Tupiza and Toro Toro), composed of genetically homogenous strains (Ar 
= 1.92-2.22; PA/L = 0.19-0.42; DAS = 0.151; Hd=0.54) and two adjacent, highly diverse, 
arboreal lowland groups (East and North Beni) (Ar = 3.40 and 3.93; PA/L = 1.12 and 0.60 
DAS = 0.425 and 0.311; Hd=0.84 and 0.81, respectively).  
- Estimates of subdivision (FST) demonstrated limited gene flow between neighbouring 
terrestrial and arboreal areas (Cochabamba-Beni distance ~220 km; FST = 0.42 and 0.35) 
and low levels of subdivision among similar but geographically-disparate terrestrial 
ecotopes (Cochabamba-Tupiza distance >465 km; FST = 0.016-0.084) and adjacent 
arboreal study sites (North – East Beni distance = ~155km; FST = 0.087).  A hierarchical 
AMOVA, indicated 23% of genetic diversity was attributed to differences between 
highland and lowlands, while only 4.5% and 7% were present at the population and the 
individuals between populations levels, respectively. Together these observations 
strongly support ecological host fitting as the predominant mechanism structuring 
parasite populations. 
- Potential differences in mating strategies between highland and lowland populations was 
evidenced by dissimilar heterozygosity estimates (excess: FIS = -0.241-0.026, 5-13% 
polymorphic loci with significant deficit in heterozygosity, and deficit: FIS = 0.176 and 
0.203, 63.2% and 52.3% polymorphic loci with significant deficit in heterozygosity, 
respectively) and mitochondrial introgression among lowland strains. Significant nuclear-
mitochondrial phylogenetic incongruence (SH test: ML tree L = -4845.86, Bayesian tree 
L = -4849.55 vs. DAS tree L = -5006.48, p = 0.001) was indicative of multiple independent 
genetic exchange events occurring in a potential hybridization zone in East Beni. A 
second contact area was putatively identified in Chapare, North Cochabamba, where a 
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single terrestrial isolate was more closely related to lowland populations by both nuclear 
and mitochondrial loci. Additionally, human isolates from Cochabamba, while 
genetically distinct from sylvatic strains circulating in the same area, were clustered 
together in the mitochondrial topology.  
- Significant nuclear isolation by distance (IBD) was detected among lowland isolates (RXY 
= 0.209, p<0.001, slope = 0.0003 ± 0.0000179), while limited evidence for spatial 
structuring was apparent among highland strains from the same spatial scale (RXY = 
0.109, p = 0.085, slope = 0.0002 ± 0.00000873). Concordant with FST estimates between 
populations, these results support accelerated parasite dissemination between densely 
populated highland areas, compared to uninhabited lowland foci, which might be 
explained by passive, long-range anthroponotic dispersal, supported by evidence of 
mitochondrial gene flow between domestic and sylvatic populations in Cochabamba.!
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Abstract  13 
An improved understanding of how a parasite species exploits its genetic repertoire to 14 
colonize novel hosts and environmental niches is crucial to establish the 15 
epidemiological risk associated with emergent pathogenic genotypes. Trypanosoma 16 
cruzi, a genetically heterogeneous, multi-host zoonosis, provides an ideal system to 17 
examine the sylvatic diversification of parasitic protozoa. In Bolivia T. cruzi I, the 18 
oldest and most widespread genetic lineage, is pervasive across a range of ecological 19 
clines. High resolution nuclear (26 loci) and mitochondrial (10 loci) genotyping of 20 
199 contemporaneous sylvatic TcI clones was undertaken to provide insights into the 21 
biogeographical basis of T. cruzi evolution. Three distinct sylvatic transmission cycles 22 
were identified, corresponding to one terrestrial highland population, composed of 23 
genetically homogenous strains (Ar = 2.95; PA/L = 0.61; DAS = 0.151) and two 24 
adjacent, highly diverse, arboreal lowland groups (Ar = 3.40 and 3.93; PA/L = 1.12 25 
and 0.60 DAS = 0.425 and 0.311, respectively). Limited gene flow between 26 
neighbouring terrestrial and arboreal areas (Distance ~220 km; FST = 0.42 and 0.35) 27 
and low levels of subdivision among similar but geographically-disparate terrestrial 28 
ecotopes (Distance >465 km; FST = 0.016-0.084) strongly support ecological host 29 
fitting as the predominant mechanism of parasite diversification. Dissimilar 30 
heterozygosity estimates (excess in highlands, deficit in lowlands) and mitochondrial 31 
introgression among lowland strains, may indicate fundamental differences in mating 32 
strategies between populations. Finally, accelerated parasite dissemination between 33 
densely populated, highland areas, compared to uninhabited lowland foci, likely 34 
reflect passive, long-range anthroponotic dispersal. The impact of humans on the risk 35 
of epizootic Chagas disease transmission in Bolivia is discussed. 36 
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Introduction 43 
Host-parasite relationships are assumed to be ecologically-specialised, tightly co-44 
evolved systems driven by either mutual modification (‘synchronous co-speciation’) 45 
or exaptation into novel environmental niches, often accompanied by host switching 46 
(‘ecological fitting’) (Janzen 1985; Brooks et al. 2006). Ecological fitting occurs 47 
when an organism co-opts their existing suite of genetic traits to exploit an unfamiliar 48 
resource or colonize and persist in a new or modified environment (Agosta & 49 
Klemens 2008). Distinguishing between host-parasite relationships that result from 50 
ecological fitting or long-term co-evolution remains challenging. However, 51 
understanding how a species exploits their existing genetic repertoire to form novel 52 
host associations, is of primary interest to the study of emerging infectious diseases, 53 
with considerable implications for the design of disease control programmes (Brooks 54 
& Ferrao 2005; Agosta et al. 2010). In this regard, Trypanosoma cruzi 55 
(Kinetoplastida: Trypanosomatidae), the aetiological agent of Chagas disease, a 56 
pervasive zoonosis that is eclectic with respect to ecotope and host, provides a model 57 
system to examine the genetic diversification of parasitic protozoa.  58 
Chagas disease is the most important vector-borne infection in Latin America, 59 
affecting an estimated 8-10 million individuals, with a further 90 million at risk 60 
(Hotez et al. 2008). Following acute disease, which is often undiagnosed, the majority 61 
of patients are clinically asymptomatic for life. Without treatment, approximately 20-62 
30% will develop irreversible, potentially fatal cardiomyopathy, or more rarely, 63 
dilatation of the gastrointestinal tract (megaesophagus or megacolon) (Rassi Jr et al. 64 
2010). The geographical distribution of T. cruzi extends from the southern United 65 
States to Argentinean Patagonia, where it is transmitted by more than 100 species of 66 
hematophagus triatomine bugs (Hemiptera: Reduviidae: Triatominae) (Lent & 67 
Wygodzinsky 1979; Galvão et al. 2003).  Human disease is primarily confined to 68 
areas of Central and South America where individuals are exposed to infected faeces 69 
of domiciliated or invasive triatomines through contact with intact mucosae or 70 
abraded skin (Coura & Dias 2009). In addition, enzootic T. cruzi infection is naturally 71 
sustained by an extensive range of domestic, synanthropic and sylvatic mammalian 72 
hosts (Noireau et al. 2009).   73 
T. cruzi is an ancient parasite, estimated to have diverged from its most recent 74 
common ancestor 3-4 million years ago (Lewis et al. 2011), and as such, is 75 
characterized by considerable genetic diversity (Stevens et al. 1999). Current 76 
international consensus recognises a minimum of six stable genetic lineages or 77 
discrete typing units (DTUs) (TcI-TcVI) (Zingales et al. 2009), which have 78 
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distributions loosely defined by geography, ecology and transmission cycle (Miles et 79 
al. 2009). The level of nuclear sequence divergence between major T. cruzi DTUs is 80 
equivalent to inter-species diversity among New World Leishmania species (Boité et 81 
al. 2012; Yeo et al. 2011). TcI is the most widely distributed DTU; it is the principal 82 
cause of human chagasic cardiomyopathy in Colombia and Venezuela (Ramirez et al. 83 
2010; Carrasco et al. 2012) and is ubiquitous among sylvatic transmission cycles 84 
across its endemic range (Llewellyn et al. 2009a). Multiple molecular markers 85 
consistently identify high levels of genetic diversity within sylvatic TcI populations, 86 
(Herrera et al. 2007; Herrera et al. 2009; O’Connor et al. 2007; Falla et al. 2009; 87 
Llewellyn et al. 2009a; Ocaña-Mayorga et al. 2010; Lima et al. 2014), and divergent, 88 
but genetically homogeneous, strains isolated from human infections (Llewellyn et al. 89 
2009a; Cura et al. 2010; Ramírez et al. 2012; Zumaya-Estrada et al. 2012). However, 90 
the genetic determinants that drive natural T. cruzi diversification are largely 91 
unknown. Some have proposed that T. cruzi lineages co-evolved in close concert with 92 
discrete vertebrate hosts and insect vectors (Miles et al. 1981a; Gaunt & Miles 2000; 93 
Yeo et al. 2005), while others favour ecological fitting as a more parsimonious 94 
explanation for contemporary host associations (Hamilton et al. 2007; Agosta & 95 
Klemens 2008; Llewellyn et al. 2009a).  Evidence to support the latter is increasing; 96 
TcI has now been isolated from the Orders Didelphimorphia, Rodentia,, Carnivora 97 
and Primates, spanning multiple ecological niches (Lima et al. 2014; Rocha et al. 98 
2013; Llewellyn et al. 2009a; Herrera et al. 2008a; Herrera et al. 2008b; Herrera et al. 99 
2005; Lisboa et al. 2004), and genetic diversity of terrestrial TcIII appears similarly 100 
independent of host species (Llewellyn et al. 2009b; Marcilli et al. 2009). 101 
Bolivia offers a range of diverse sylvatic ecotopes where T. cruzi transmission persists 102 
unabated. Colonies of Triatoma infestans, infected with TcI (Breniere et al. 2012), 103 
have been reported in highland Andean valleys (Buitrago et al. 2010; Cortez et al. 104 
2006; Cortez et al. 2007) and to the South in the arid, lowland Chaco region (Waleckx 105 
et al. 2012; Ceballos et al. 2011), where their potential for domestic re-invasion 106 
threatens the success of the National Control Programme (Noireau et al. 2005; 107 
Noireau 2009). Sylvatic transmission also extends northwards to sparsely populated 108 
Amazonian Beni, where disease ecology is poorly described (Matias et al. 2003; Justi 109 
et al. 2010).  Human Chagas disease remains a prominent public health problem in 110 
Bolivia, affecting roughly 6.75% of the population (Jannin & Salvatella 2006). It is 111 
endemic across two-thirds of the country and concentrated disproportionally among 112 
lower socioeconomic rural populations with seroprevalence reaching 72.7-97.1% 113 
among adults of some communities (Medrano-Mercado et al. 2008; Samuels et al. 114 
2013). Continuing domestic transmission, principally of TcI and TcV (Flores-Chavez 115 
et al. 2006; Barnabé et al. 2011; Bosseno et al. 1996), can be attributed to a decrease 116 
in intensity of residual insecticide spraying (Samuels et al. 2013; Espinoza et al. 117 
2014), the emergence of insecticide resistance (Lardeux et al. 2010; Germano et al. 118 
2010) and decentralized vector control initiatives in areas of recurrent political, social 119 
and economic instability (Gürtler 2009).  120 
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To date few studies have adopted rigorous sampling strategies and genetic markers 121 
with sufficient resolution to elucidate fully the biogeographical basis of T. cruzi 122 
evolution.  Ideally, parasite samples should be minimally subdivided biologically, 123 
spatially and temporally, with multiple clones examined from each host (Prugnolle & 124 
De Meeus 2010).  In practice, low circulating parasitaemia often prohibits parasite 125 
isolation and thus many studies are heavily reliant on historical collections of 126 
reference isolates. T. cruzi genetic analysis is further complicated by the presence of 127 
mixed DTU infections (Burgos et al. 2008; Yeo et al. 2005; Bosseno et al. 1996) and 128 
multiclonal parasite populations within individual hosts and vectors (Llewellyn et al. 129 
2011), requiring strains to be biologically cloned prior to genotyping, a laborious 130 
caveat often overlooked by researchers. 131 
In this study we applied high resolution nuclear and mitochondrial genotyping to 132 
contemporaneous biologically-cloned TcI strains, isolated from triatomines and 133 
mammalian hosts in Bolivia, to identify key determinants of sylvatic T. cruzi genetic 134 
diversification. We also explore genetic diversity and potential hybridization along 135 
two ecological clines, firstly between highland and lowland Bolivia and secondly 136 
within lowland Bolivia itself. Finally, we examine the spatial genetic structure of 137 
natural TcI populations and consider the implications of our data for human Chagas 138 
disease transmission in Bolivia. 139 
 140 
 141 
 142 
 143 
 144 
 145 
 146 
 147 
 148 
 149 
 150 
 151 
 152 
 153 
 154 
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Materials & Methods 155 
Study area and parasite sampling 156 
Parasite strains were isolated from sylvatic terrestrial and arboreal transmission cycles 157 
in five localities across three departments in Bolivia (Cochabamba, Potosí and Beni) 158 
(Figure 1).  Study sites were situated at altitudes that ranged from ~143 to 3200 m and 159 
selected to span five major ecoregions: savannah grassland and Madeira-Tapajós 160 
moist forests (Beni), dry Andean puna and Yungas (Cochabamba) and wet Andean 161 
puna (Potosí). Parasite sampling was undertaken from 2003 - 2010 and is described 162 
for each study site individually.   163 
Cotopachi, Cochabamba department is a densely populated area of open dry Andean 164 
puna (thorny scrub vegetation interspersed with rocky outcrops and large, spiny 165 
cacti), located ~20 km south-west of Cochabamba city at an elevation of ~2600 m.  166 
Here, parasites were sampled from wild T. infestans by manual microhabitat 167 
dissection and live-baited Noireau traps (Noireau et al. 2002) and from mammals 168 
(Akodon boliviensis and Phyllotis ocilae) following capture using a combination of 169 
baited Sherman and Tomohawk traps and spool-and-line tracking (Miles et al. 1981).  170 
Triatomine sampling (T. infestans and T. guasayana) was also undertaken in 171 
neighbouring Toro Toro, an area of similar ecology to Cotopachi, situated at ~2700 172 
m.  North of Cotopachi, sylvatic Rhodnius robustus were collected from Chapare, a 173 
dense temperate montane forest (‘Yungas’) in the westernmost foothills of the Andes.   174 
South of Cochabamba, parasites were isolated from wild T. infestans in Tupiza, a 175 
region of high altitude (~3200 m) wet Andean puna (montane grasslands) in South 176 
East Potosí department. 177 
Sampling was undertaken in two regions of Beni department, a sparsely populated 178 
province in eastern lowland Bolivia.  Ecologically Beni is a patchwork of two 179 
principal vegetation types. The majority of the department is covered by lush 180 
savannah grassland (‘Llanos de Moxos’). Along riverine alluvial plains and to the 181 
northern and western borders of the area, this ecotope is supplanted by dense 182 
Amazonian moist forests.  To the east, Beni borders another moist forest (‘Madeira-183 
Tapajós’ forest), which extends into Brazil and Santa Cruz department. In East Beni 184 
(Nueva Alianza, San Juan de Aguas Dulces, and San Juan de Mocovi), parasites were 185 
isolated from triatomines (Rhodnius pictipes) and mammals (Didelphis marsupialis, 186 
Philander opossum and Sciureus species) in areas of savannah grassland, interspersed 187 
with large evergreen palm trees, on the boundary between Llanos de Moxos and the 188 
moist forests of north-western Santa Cruz.  The study sites in North Beni (Mercedes, 189 
San Cristobal and Santa Maria de Apere) were remote, largely uninhabited, open 190 
savannah grasslands with occasional lone standing trees, bordered by riverine forests. 191 
Here parasites were isolated from R. robustus, P. opossum and D. marsupialis. Both 192 
study sites in North and East Beni were situated at low-lying altitudes (~143 m and 193 
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~160 m, respectively) and parasite sampling was undertaken using similar methods 194 
described for other departments.   195 
All parasite strains were isolated by direct inoculation of triatomine faeces or 196 
heparinized venous animal blood into biphasic hemoculture media (Miles 1993). 197 
Parasite strains and DTU-genotyping 198 
A panel of 199 biological clones derived from 68 T. cruzi TcI isolates was assembled 199 
for analysis (Table S1).  Biological clones were obtained from primary cultures by 200 
plate cloning according to Yeo et al. 2007 to minimize any loss of genetic diversity 201 
incurred by long-term maintenance in culture. Parasites (epimastigotes) were 202 
expanded to logarithmic phase at 28oC in RPMI-1640 liquid media supplemented 203 
with 0.5% (w/v) tryptone, 20 mM HEPES buffer (pH 7.2), 30 mM haemin, 10% (v/v) 204 
heat-inactivated fetal calf serum, 2 mM sodium glutamate, 2 mM sodium pyruvate 205 
and 25µg/ml gentamycin (all Sigma-Aldrich, UK).  Genomic DNA was extracted 206 
using the Gentra PureGene Tissue Kit (Qiagen, UK), according to the manufacturer’s 207 
protocol.  Clones were initially genotyped to DTU level using a triple-marker assay 208 
(Lewis et al. 2009) and classified a priori into five populations according to 209 
geographical origin: Cochabamba (n=28), Tupiza (n=15), Toro Toro (n=43), North 210 
Beni (n=26) and East Beni (n=87).  211 
 212 
High Resolution Genotyping: Multilocus Microsatellite Typing (MLMT) 213 
Twenty-six microsatellite loci were amplified for all 199 clones, as previously 214 
described by Llewellyn et al. 2009a.  These markers are distributed across ten 215 
putative chromosomes, including six groups of physically linked loci (Weatherly et 216 
al. 2009).  A full list of microsatellite targets and primers are given in Table S2.  217 
Allele sizes were determined using an automated capillary sequencer (AB3730, 218 
Applied Biosystems, UK), in conjunction with a fluorescently tagged size standard, 219 
and were manually checked for errors.  All isolates were typed ‘blind’ to control for 220 
user bias. 221 
 222 
High Resolution Genotyping: Mitochondrial Multilocus Sequence Typing (mtMLST) 223 
Ten maxicircle gene fragments were sequenced for a subset of 78 clones, chosen to be 224 
representative of total nuclear genetic diversity (Messenger et al. 2012).  For ND4 an 225 
alternate set of primers was designed to improve amplification efficiency: ND4 Fwd 226 
(5’-TTYTTCCCAATATGTATBGTMAG-3’) and ND4 Rvs (5’-227 
TGTATTAYCGAYCAATTYGC-3’), and reactions were performed using the same 228 
conditions as previously (Messenger et al. 2012).  229 
 230 
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Microsatellite Analysis  231 
Individual-level sample clustering was initially defined using a Neighbour-Joining 232 
(NJ) tree based on pair-wise distances (DAS: 1 – proportion of shared alleles at all 233 
loci/n) between microsatellite genotypes calculated in MICROSAT v1.5d (Minch et 234 
al. 1997) under the infinite-alleles model (IAM).  To accommodate multi-allelic 235 
genotypes (≥3 alleles per locus), a script was written in Microsoft Visual Basic to 236 
generate random multiple diploid re-samplings of each multilocus profile (software 237 
available upon request).  A final pair-wise distance matrix was derived from the mean 238 
across multiple re-sampled datasets and used to construct a NJ phylogenetic tree in 239 
PHYLIP v3.67 (Felsenstein 1989).  Majority rule consensus analysis of 10,000 240 
bootstrap trees was performed in PHYLIP v3.67 by combining 100 bootstraps 241 
generated in MICROSAT v1.5d, each drawn from 100 respective randomly re-242 
sampled datasets. 243 
A second analysis to define the number of putative populations in the dataset was 244 
performed using a nonparametric approach (free from Hardy-Weinberg assumptions).  245 
A K-means clustering algorithm, implemented in adegenet (Jombart et al. 2008), was 246 
used to determine the optimal number of ‘true’ populations, by reference to the 247 
Bayesian Information Criterion (BIC), which reaches a minimum when approaching 248 
the best supported assignment of individuals to the appropriate number of clusters.  249 
The relationship between these clusters and the individuals within them was then 250 
evaluated via a discriminant analysis of principal components (DAPC) according to 251 
Jombart et al. 2010.   252 
A single randomly sampled diploid dataset was used for all subsequent analyses.  253 
Population-level genetic diversity was evaluated using sample size corrected allelic 254 
richness (Ar) in FSTAT 2.9.3.2 (Goudet 1995).  In addition, mean FIS, which 255 
measures the distribution of heterozygosity within and between individuals, was 256 
calculated per population in FSTAT 2.9.3.2. FIS can vary between -1 (all loci 257 
heterozygous for the same alleles) and +1 (all loci are homozygous for different 258 
alleles).  FIS = 0 indicates Hardy-Weinberg allele frequencies.  Sample size corrected 259 
private (population-specific) allele frequency per locus (PA/L) was calculated in HP-260 
Rare (Kalinowski 2005).   261 
Population subdivision was estimated using pair-wise FST, linearised with Slatkin’s 262 
correction, in ARLEQUIN v3.11 (Excoffier et al. 2005).  Statistical significance was 263 
assessed via 10,000 random permutations of alleles between populations.  Within 264 
population subdivision was evaluated in ARLEQUIN v3.11 using a hierarchal 265 
Analysis of Molecular Variance (AMOVA).  Population-level heterozygosity indices 266 
were also calculated in ARLEQUIN v3.11 and associated significance levels for p-267 
values derived after performing a sequential Bonferroni correction to minimise the 268 
likelihood of Type 1 errors (Rice 1989).  Multilocus linkage disequilibrium, estimated 269 
by the Index of Association (IA) was calculated in MULTILOCUS 1.3b (Agapow & 270 
Burt 2001) and statistical significance was evaluated by comparison to a null 271 
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distribution of 1000 randomisations.  Mantel’s tests for the effect of isolation by 272 
distance within populations (pair-wise genetic vs. geographic distance) were 273 
implemented in GenAIEx 6.5 using 10,000 random permutations (Peakall & Smouse 274 
2012). 275 
 276 
Mitochondrial Analysis  277 
Sequence data from ten maxicircle gene fragments were concatenated for each isolate 278 
according to Messenger et al. 2012 and are available from GenBank under the 279 
accession numbers listed in Table S1. Additional mtMLST data from 24 previously 280 
published TcI strains were included in selected analyses, as indicated (Messenger et 281 
al. 2012). The most appropriate nucleotide substitution model was selected from 282 
1,624 candidates, based on the Akaike Information Criterion (AIC), in 283 
jMODELTEST 2.1.4 (Darriba et al. 2012). Alternate Maximum-Likelihood (ML) 284 
phylogenies were constructed using the TrN+G model (six substitution rate 285 
categories) in MEGA 5.10 (Tamura et al. 2011).  Bootstrap support for clade 286 
topologies was estimated following the generation of 1000 pseudo-replicate datasets.  287 
Bayesian phylogenetic analysis was performed with MrBAYES, implemented 288 
through TOPALi v2.5, using the best-fit model based on the BIC (GTR+G) (Milne et 289 
al. 2009).  Five independent analyses were run for one million generations, with 290 
sampling every 100 simulations (30% burn-in).  Statistically-supported topological 291 
incongruence between alternate mitochondrial and nuclear phylogenies was evaluated 292 
using Kishino-Hasegawa (KH) (Kishino & Hasegawa 1989) and Shimodaira-293 
Hasegawa (SH) (Shimodaira & Hasegawa 1999) likelihood tests in PAML v.4 (Yang 294 
2007).  Haplotype diversity (Hd) was calculated using DnaSP v5.10.1 (Librado & 295 
Rozas 2009). 296 
 297 
 298 
 299 
 300 
 301 
 302 
 303 
 304 
 305 
 306 
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Results 312 
Strain Characteristics  313 
One hundred and ninety-nine biological clones were genotyped across 26 314 
polymorphic microsatellite loci (Supporting file S1).  In total, 10122 alleles were 315 
identified, corresponding to 178 unique multilocus genotypes (MLGs). Multiple (≥3) 316 
alleles were observed at 0.83% of loci.  Levels of intra-strain genetic diversity were 317 
high; multiclonality was observed in 65 (out of 68) uncloned strains. Identical intra-318 
clonal genotypes were sampled in five isolates (1/18 Toro Toro, 1/11 Cochabamba 319 
and 3/26 East Beni). Clones were initially categorized into five populations based on 320 
geographical origin, consisting of three high (Cochabamba, Tupiza and Toro Toro) 321 
and two low altitude groups (North and East Beni). All populations demonstrated 322 
uniformly high numbers of unique MLGs and low frequencies of repeated MLGs 323 
(Table 1).  324 
 325 
Nuclear genetic clustering among isolates 326 
Patterns of isolate clustering were evaluated using two different methodologies: 327 
nonparametric population assignment (DAPC) and a NJ analysis based on pair-wise 328 
genetic distances (DAS). Ten genetic clusters were defined among the 199 clones 329 
submitted to DAPC, once three principal components (PCs) were retained and 330 
analysed (representing 80% of the total variation).  A full list of isolate assignments to 331 
DAPC populations is included in Table S1 and a multidimensional scaling plot of the 332 
DAPC results is shown in Figure 2.  We observed a slight ‘elbow’ in the distribution 333 
of the BIC values across optimal cluster numbers at K=10 (Figure 2). DAPC-derived 334 
clusters were largely congruent with a priori allocations of strains to geographical 335 
populations.  The ten DAPC clusters separated into three genetically distinct groups: 336 
highlands (clusters 1, 8 and 10), lowlands 1 (clusters 2, 3 and 6) and lowlands 2 337 
(clusters 4, 5, 7 and 9).  The highlands group corresponded exclusively to samples 338 
from Cochabamba, Tupiza and Toro Toro, with the exception of a single clone from 339 
R. robustus in Chapare (CV-05 cl1), which was instead assigned to cluster 2 in the 340 
lowlands 1 group.  Within the highlands group, isolates from different sampling areas 341 
and sources (hosts and vectors) were distributed across clusters 8 and 10, while cluster 342 
1 comprised only a subset of clones from T. infestans found in Tupiza and Toro Toro. 343 
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The lowlands 1 group encompassed all strains from North Beni (only cluster 2) and 344 
roughly half of the isolates from Rhodnius spp. and D. marsupialis in East Beni 345 
(interspersed among clusters 2, 3 and 6).  Lastly, the lowlands 2 group contained all 346 
remaining East Beni clones, including those isolated from Rhodnius spp., D. 347 
marsupialis, P. opossum and Scuireus spp. 348 
A NJ tree based on the same microsatellite data was constructed and further 349 
corroborated the DAPC strain assignments. A clear division between highland and 350 
lowland populations was observed, with isolates segregating into two well-supported 351 
clades (64% BS) (Figure 3). Similar to the DAPC results, the DAS topology supported 352 
the delineation of isolates from Beni into two groups (71% BS), one composed of all 353 
North Beni clones and the same portion of East Beni clones (DAS lowlands 1), the 354 
other containing the remaining East Beni strains (DAS lowlands 2). As previously, 355 
CV-05 cl1 from Chapare clustered as an outlier amongst North and East Beni isolates. 356 
Comparison of branch lengths in Figure 3 between the two lowland populations 357 
indicated high and consistent levels of genetic variation across strains.  By contrast, 358 
highland isolates were less diverse overall (mean pair-wise DAS = 0.151 and 0.425 for 359 
highlands and lowlands, respectively). Within this clade, there was strong evidence 360 
for the existence of local geographic clusters in Tupiza (100% BS) and Toro Toro 361 
(73% BS), which clustered basally to the remaining highland strains. 362 
Population Characteristics 363 
Population genetic indices were calculated using both a priori geographical and 364 
DAPC/DAS-supported strain assignments (Table 1). Overall a clear division in genetic 365 
diversity and heterozygosity was apparent between highland and lowland areas.  The 366 
three highland populations were characterized by lower levels of genetic diversity, as 367 
evidenced by smaller estimates of allelic richness (Ar = 1.92 – 2.22) and numbers of 368 
private alleles per locus (PA/L = 0.19 – 0.42), compared to the lowlands (Ar = 3.40 369 
and 3.93 and PA/L = 1.12 and 0.60, respectively) (Table 1 and Figure 4A).  All 370 
highland groups had moderately excess heterozygosity (FIS = -0.241 – 0.026, 5-13.3% 371 
polymorphic loci with significant deficit in heterozygosity), whereas both lowland 372 
populations demonstrated more pronounced deviations from H-W allele frequencies 373 
(FIS = 0.176 and 0.203, 63.2 and 52.3% polymorphic loci with significant deficit in 374 
heterozygosity, respectively) (Table 1).  Strongly significant multilocus linkage 375 
disequilibrium was observed among all study areas (IA = p<0.0001 for all 376 
populations). 377 
Inter-Population Gene Flow & Intra-Population Subdivision   378 
Estimates of subdivision (FST) between a priori populations support a genetic 379 
demarcation between highland and lowland areas (Table 2). Little evidence for 380 
subdivision existed among the three highland study sites (FST = 0.084, 0.016 and 381 
0.079 and p = 0.00089, 0.0032 and 0.0001 for Cochabamba - Tupiza, Cochabamba -382 
Toro Toro and Tupiza - Toro Toro, respectively) or between the two lowland 383 
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populations (FST = 0.087 and p<0.0001 for North - East Beni).  However, elevated FST 384 
values between closest highland and lowland study sites (Cochbamba – Beni distance 385 
= ~220 km; FST = 0.42 and 0.35 and p<0.0001 for Cochabamba – North and East 386 
Beni, respectively) indicate very limited gene flow, suggesting a powerful role for 387 
altitude and/or ecotope in structuring parasite populations. Interestingly, the extent of 388 
genetic subdivision between the most geographically distant highland populations 389 
(Cochabamba – Tupiza; distance = ~465 km) and adjacent areas of Beni (distance = 390 
~155 km) was equivalent (FST = 0.084 and 0.087, respectively). 391 
Finally, a hierarchical AMOVA was conducted, to evaluate the distribution of genetic 392 
diversity between groups of populations (highlands vs. lowlands), among populations 393 
within groups (Cochabamba, Tupiza, Toro Toro, North Beni and East Beni), and 394 
among individuals within populations. Strikingly, 23% of total genetic variation was 395 
attributed to difference between highlands and lowlands, while 4.5% and 7% were 396 
present at the population and the individuals within populations levels, respectively. 397 
 398 
Mitochondrial introgression across ecological clines 399 
For a subset of 78 clones, ten mitochondrial gene fragments (mtMLST) were 400 
sequenced and concatenated into a 3684 bp alignment. Twenty-four unique 401 
haplotypes were identified from a total of 48 variable sites (~1.3% sequence 402 
diversity).  Maximum-Likelihood and Bayesian phylogenies constructed from 403 
concatenated data were not significantly different (KH test: ML tree L = -4845.23, 404 
Bayesian tree L = -4848.13 p = 0.12).  A second ML tree was assembled using 24 405 
additional outgroup sequences representing known TcI mitochondrial diversity, 406 
including a small population of domestic Bolivian isolates (ANDESBol/Chile, previously 407 
described in Llewellyn et al. 2009a and Messenger et al. 2012) (Figure 5).  408 
The mitochondrial topology demonstrated the presence of considerable genetic 409 
variation among Bolivian TcI clones. The deepest and most robust internal branch 410 
(87/1.0) separated highland and lowland populations into two major clades, each with 411 
strongly supported internal structuring.  The highland group was largely 412 
homogeneous, with a number of geographically dispersed strains sharing identical 413 
mitochondrial haplotypes. The mitochondrial topology also confirmed the existence 414 
of Tupiza and Toro Toro-specific populations (98/1.0), in agreement with the nuclear 415 
tree.  416 
Human isolates from Cochabamba (ANDESBol/Chile), while genetically distinct from 417 
sylvatic strains circulating in the same area (63/1.0), were grouped within the main 418 
highlands clade. As previously, lowland strains were subdivided into two well-419 
supported clades (74/1.0) with higher overall levels of genetic diversity, compared to 420 
highland isolates (Hd = 0.81 and 0.84 vs. 0.54, respectively; Table 1). 421 
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While the gross topology of the mitochondrial tree was broadly concordant with that 422 
of the nuclear phylogeny, internal branch patterns were significantly incongruent (SH 423 
test: ML tree L = -4845.86, Bayesian tree L = -4849.55 and DAS tree L = -5006.48, p = 424 
0.001). No evidence of recombination between highland and lowland strains was 425 
observed, even in Chapare, a zone of ecological transition. Across the more ‘gentle’ 426 
ecological cline of East-North Beni, several instances of genetic hybridization were 427 
apparent. Three clones from the mixed East-North Beni group (DAS lowlands 1) and 428 
three isolates from the East Beni-specific population (DAS lowlands 2) received 429 
unambiguously different phylogenetic positions in the maxicircle topology, and are 430 
likely the progeny of multiple, independent mitochondrial introgression events 431 
(Figure 5). 432 
Geographical dispersal within populations  433 
To determine the extent of spatial genetic structure (or isolation by distance (IBD)) 434 
among highland and lowland isolates, Mantel’s tests were conducted using alternate 435 
nuclear and mitochondrial datasets. Nuclear IBD was detected within both highland 436 
and lowland populations (highland RXY = 0.307, p<0.001 and lowland RXY = 0.209, 437 
p<0.001). However, the strength of the effect was significantly larger among lowland 438 
isolates (highland slope = 0.0002 ± 0.00000873; lowland slope = 0.0003 ± 439 
0.0000179). Furthermore, when focusing on highland clones from approximately the 440 
same spatial scale as their lowlands counterparts (i.e. omitting the local subpopulation 441 
of Tupiza isolates identified in the DAS tree (n=6)), little evidence for spatial 442 
structuring remained (RXY = 0.109, p = 0.085). Concordant with estimates of FST 443 
between populations, the differing extent of spatial genetic structuring suggests 444 
accelerated parasite dispersal among geographically disparate highland areas by 445 
comparison to adjacent lowland foci (Figure 4B). 446 
Interestingly, no IBD was detected in either highland (RXY = 0.068, p = 0.161; slope = 447 
0.000001 ±0.000000345) or lowland (RXY = 0.119, p= 0.0654; slope = 0.000001 448 
±0.000000349) populations using mitochondrial sequence data, potentially the result 449 
of lower population genetic resolution at these loci, but also consistent with the 450 
occurrence of mitochondrial introgression among lowland isolates.  451 
 452 
 453 
 454 
 455 
 456 
 457 
 458 
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 465 
Discussion 466 
This study exploited rigorous population genetic analyses of contemporaneous 467 
parasite clones. Herein we provide several insights into the biogeographical basis of 468 
T. cruzi genetic diversification in Bolivia. Additionally our study undertook an in-469 
depth dissection of TcI spatial genetic diversity and hybridization across two 470 
ecological clines.   471 
 472 
Lowland arboreal and highland terrestrial sylvatic populations show different genetic 473 
structures  474 
A clear dichotomy in population structure emerged between highland and lowland 475 
areas. Lowland parasites from two adjacent arboreal transmission cycles were 476 
strongly subdivided within a restricted contact zone in East Beni (~15 km2). Deep 477 
internal nuclear branching patterns in both lowland groups were indicative of stable, 478 
undisturbed, long-term genetic diversification, with correspondingly high levels of 479 
diversity. Mitochondrial introgression occurring among genetically distinct strains in 480 
Beni support prolonged historical interactions between these two populations. 481 
Consistent with high intra-host and vector clonal diversity, these data support intense, 482 
local transmission and/or low rate of genotypic extinction (Criscione & Blouin 2006). 483 
MLGs were rarely repeated, indicating only a fraction of total population genetic 484 
diversity was sampled.   485 
In contrast, highland populations were considerably less diverse compared to their 486 
lowland counterparts. Substantial admixture and widespread dispersal of genetically 487 
homogeneous strains was observed across more geographically disparate terrestrial 488 
highland populations, supported by little evidence of genetic sub-structuring (low 489 
FST). Dissimilar heterozygosity estimates between highland (excess) and lowlands 490 
(deficit) suggest a recent hybrid origin for some highland strains or fundamental 491 
differences in mating systems between these two populations (Ramirez & Llewellyn 492 
2014). Importantly, human isolates from Cochabamba were closely related to adjacent 493 
sylvatic highland strains. 494 
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Gross differences between highland and lowland population structures may be 495 
partially explained in the context of their respective ecological niches. Most lowland 496 
parasites were isolated from Didelphimorphia mammals, prominent disease reservoirs 497 
which are susceptible to high circulating parasitaemia (Legey et al. 2003) and have a 498 
propensity for non-vectoral routes of infection, including oral transmission via 499 
predation of infected vectors or mammals (Jansen & Roque 2010; Rocha et al. 2013) 500 
and exposure to contaminated anal scent gland secretions (Carreira et al. 2001). These 501 
biological features may predispose these hosts to multiplicity of infection which will 502 
be directly related to intensity and efficiency of parasite transmission and duration and 503 
course of disease (Roellig et al. 2010; Nouvellet et al. 2013). The high levels of 504 
genetic diversity among Bolivian lowland strains are consistent with this hypothesis. 505 
While minimal parasite interaction was observed between neighbouring terrestrial and 506 
arboreal transmission cycles (high FST values between Cochabamba and Beni), a 507 
single clone (CV-05 cl1) isolated from R. robustus in the Andean foothills, was more 508 
closely related to lowland Beni strains on the basis of both nuclear and mitochondrial 509 
markers, suggesting the existence of an additional, under-sampled transmission cycle 510 
and potential hybridization zone in Chapare, northern Cochabamba. 511 
The remaining lowland strains were isolated from Rhodnius vectors (R. robustus and 512 
R. pictipes). In general, sylvatic Rhodnius species are promiscuous feeders, which can 513 
actively migrate at night to colonize domestic environments (Fitzpatrick et al. 2008; 514 
Feliciangeli et al. 2007), thus promoting the accumulation of mixed DTU infections 515 
(Bosseno et al. 1996; Yeo et al. 2005), as well as infra-host multiclonality and co-516 
infections with other trypanosome species, such as Trypanosoma rangeli (Dias et al. 517 
2014). The lower genetic diversity observed among highlands strains may reflect 518 
more restricted feeding preferences and limited independent dispersal of their host 519 
vector species T. infestans (<500 m) (Rabinovich & Himschoot 1990; Richer et al. 520 
2007). As a more recent host of TcI, vector competency and carrying capacity of 521 
sylvatic T. infestans may also vary (Araújo et al. 2014), particularly in terms of 522 
bottlenecks during transmission, which can further reduce genetic diversity, as 523 
demonstrated in tsetse fly vectors of other digenetic trypanosome species (Ruepp et 524 
al. 1997; Oberle et al. 2010).  525 
 526 
Ecological fitting is a driver of contemporary T. cruzi genetic diversification 527 
No clear association of genotype by host or vector was observed among any sylvatic 528 
Bolivian TcI populations, with the exception of a small subset of co-clustering T. 529 
infestans clones sampled in Tupiza and Toro Toro (DAPC cluster 1 and DAS 530 
highlands; n=15). Previous T. cruzi studies that favoured constrained, extant co-531 
evolutionary scenarios were likely limited by sampling bias (O’Connor et al. 2007); 532 
Didelphimorphia mammals continue to be over represented as sources of sylvatic TcI 533 
due to their aforementioned high circulating parasitaemia, which can facilitate greater 534 
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hemoculture positivity rates and thus parasite isolation, as well as their ease of 535 
capture.  536 
With improved and more exhaustive sampling strategies, TcI has now been detected 537 
among a range of Mammalia (Lisboa et al. 2004; Herrera et al. 2005; Yeo et al. 2005; 538 
Herrera et al. 2008a; Herrera et al. 2008b; Rocha et al. 2013; Lima et al. 2014), 539 
cautioning the interpretation of putative host associations.  Here we demonstrate that 540 
parasite genetic diversity was principally partitioned by ecotope: arboreal lowland or 541 
terrestrial highland. Limited gene flow between neighbouring arboreal and terrestrial 542 
transmission cycles and low levels of subdivision among similar ecotopes, spanning 543 
much larger geographical distances (FST), strongly suggest ecological host fitting is 544 
the predominant mechanism of sylvatic T. cruzi diversification (Llewellyn et al. 545 
2009a; Llewellyn et al. 2009b).  Our observations support a current model for wider 546 
trypanosome evolution where ecological host fitting has been proposed to define 547 
major parasite clades (Hamilton et al. 2007; Lukes et al. 2014).  548  549 
Mitochondrial introgression is a common phenomenon among natural T. cruzi 550 
populations  551 
The majority of field evidence indicates T. cruzi does not conform to strict clonality 552 
or panmixia and that recombination is common, non-obligatory and idiosyncratic, 553 
potentially involving independent exchange of kinetoplastid and nuclear genetic 554 
material and both canonical meiotic and parasexual mechanisms (Carrasco et al. 555 
1996; Machado & Ayala 2001; Ramirez et al. 2012; Ocaña-Mayorga et al. 2010; 556 
Messenger et al. 2012; Lewis et al. 2011; Roellig et al. 2013; Baptista et al. 2014). 557 
The relative contributions of alternate mating strategies to T. cruzi population 558 
structures are as yet unclear and strongly debated (Ramirez & Llewellyn 2014; 559 
Tibayrenc & Ayala 2012; Tibayrenc & Ayala 2013).  560 
One aim of our study was to evaluate the extent of genetic recombination within two 561 
putative hybrid zones. Due to limited sample size (only a single isolate could be 562 
recovered from the politically unstable Chapare region), we were unable to detect 563 
hybridization across the highland – lowland cline. However, mitochondrial 564 
introgression was observed among a subset of lowland strains between East and North 565 
Beni. Evidence of intra-TcI genetic exchange in a primary Amazonian forest 566 
(Carrasco et al. 1996), between domestic/peri-domestic populations in Ecuador 567 
(Ocaña-Mayorga et al. 2010) and within an endemic focus in Colombia (Ramirez et 568 
al. 2012) suggests that intensive local sampling of transmission cycles is most likely 569 
to reveal recombination.  570 
Arboreal lowland populations in Beni provide an example of an undisturbed 571 
epidemiological situation where genetic exchange might be expected (Carrasco et al. 572 
1996). Two divergent TcI populations overlap in this region, one sharing affinities to 573 
TcI populations from the Chaco region to the South (East Beni), the other with 574 
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affiliations to Amazonian TcI to the North (North Beni) (Llewellyn et al. 2009, Lima 575 
et al. 2014). Experimental recombination in T. cruzi was shown to arise in 576 
mammalian cell cultures (Gaunt et al. 2003). The aforementioned Didelphimorphia 577 
maintain high levels of multiclonal parasite populations, providing ample 578 
opportunities for hybridization to occur. Multiple mitochondrial introgression events 579 
were detected in East Beni, which appeared independent of parasite nuclear genotype, 580 
mammalian host species and study site. Consistent with previous studies, no evidence 581 
of reciprocal nuclear hybridization was detected among recombinant strains 582 
(Messenger et al. 2012; Ramirez et al. 2012; Baptista et al. 2014). While the 583 
biological cues that initiate genetic exchange remain unresolved (Gaunt et al. 2003; 584 
Lewis et al. 2010), in these populations we speculate that asymmetric introgression 585 
may act as a mechanism to facilitate ecological fitting (e.g. host range extension or 586 
resource tracking), considering the crucial role that mitochondria play in parasite 587 
metabolism, growth and development and their elevated need to escape Muller’s 588 
ratchet compared to the nuclear genome (Neiman & Taylor 2009; Ramírez & 589 
Llewellyn 2014). 590 
Dispersal of Chagas disease in highland Bolivia 591 
Multiple lines of evidence suggest that there is no ‘bona fide’ sylvatic transmission 592 
cycle in the Bolivian highlands. Little spatial differentiation was detected among 593 
geographically-disparate highland populations (~465 km) and this level was 594 
comparable to that observed between neighbouring lowland areas (~155 km). 595 
Terrestrial clones also displayed limited genetic IBD, a lack of private alleles and 596 
excess heterozygosity, all potentially attributable to a recent population bottleneck 597 
and/or founder event followed by clonal propagation.  598 
This putative accelerated parasite dispersal between highland sites in comparison with 599 
lowland areas does not accord with the ecology expected for local established sylvatic 600 
transmission. Indeed, Didelphid marsupials and Rhodnius vectors have a far greater 601 
capacity for auto-dissemination than T. infestans and smaller rodents (Richer et al. 602 
2007). One adaptive explanation for this lack of genetic population sub-structuring 603 
and geographical isolation between highland areas, is that sustained, conserved 604 
heterozygosity provides stable versatility to facilitate survival in high altitude, 605 
fluctuating climatic conditions (Widmer et al. 1987).  606 
Alternatively, dispersal across the highlands may be recent and anthroponotic. 607 
Substantial population genetic evidence indicates that T. infestans has a precedent for 608 
passive dissemination by human populations throughout history, initially during Pre-609 
Incan times throughout the Western Andes (Schofield 1988; Bargues et al. 2006; 610 
Cortez et al. 2010) and subsequently, Post-Colombian, eastwards into Argentina, 611 
Paraguay, Uruguay and Brazil (Panzera et al. 2004; Piccinali et al. 2009).  Trafficking 612 
of genetically homogeneous, human-infective (at least in Cochabamba), highland TcI 613 
clones is reminiscent of the epidemic propagation of hybrid T. cruzi lineages TcV and 614 
TcVI by domestic T. infestans across the Southern Cone (Lewis et al. 2011).  All 615 
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highland study sites coincided with major, densely-populated, transport routes 616 
transecting the department of Cochabamba and Potosí and the distribution of highland 617 
strains closely reflected human migratory movements.  618 
Genetic continuity between human and sylvatic strains in the highlands adjacent to 619 
Cochabamba by mitochondrial MLST, confirms the existence of gene flow from local 620 
sylvatic to domestic transmission cycles. More widespread highland domestic 621 
infestation with T. infestans might be expected if sylvatic distribution is 622 
anthropogenically propagated. Thus the extent to which humans are responsible for 623 
long-range parasite distribution throughout highland Bolivia remains to be resolved. 624 
Importantly, the widespread dispersal of limited diversity genotypes in Bolivia has 625 
significant biological and medical implications with respect to virulence, 626 
transmissibility and drug susceptibility, and the potential risk for emergent epizootic 627 
Chagas disease. 628 
 629 
Figures 630 
Figure 1. Map of Bolivia showing distribution of sylvatic TcI isolates among 631 
different ecotopes.   632 
Parasite strains were isolated from terrestrial and arboreal transmission cycles in five 633 
localities across three departments: Cochabamba, Potosí and Beni.  Study sites were 634 
situated at altitudes that ranged from ~143 to 3200 m and spanned five different 635 
ecoregions: savannah grassland and Madeira-Tapajós moist forests (Beni), dry 636 
Andean puna and Yungas (Cochabamba) and wet Andean puna (Potosí).  Origins of 637 
individual strains are shown by closed red circles. Circle areas are proportionate to 638 
sampling density.  Open white circles designate five a priori populations: 639 
Cochabamba, Tupiza, Toro Toro, North Beni and East Beni used for population 640 
genetic analyses. Population and department names are indicated in uppercase and 641 
lowercase, respectively. 642 
 643 
Figure 2. Nuclear genetic clustering among 199 sylvatic Bolivian TcI clones. 644 
Multidimensional scaling plot based on DAPC analysis for 10 clusters defined via K-645 
means clustering algorithm (109 iterations, 3 PCs representing 80% of total variation 646 
in the dataset).  BIC curve is inserted with error bars representing the standard 647 
deviation about the mean of five independent runs. Inertia ellipses correspond to the 648 
optimal (as defined by the BIC minimum) number of population clusters among the 649 
genotypes analysed.  Individual clones are indicated by dots. The ten DAPC clusters 650 
are separated into three genetically distinct groups: highlands (clusters 1, 8 and 10), 651 
lowlands 1 (clusters 2, 3 and 6) and lowlands 2 (clusters 4, 5, 7 and 9). 652 
 653 
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Figure 3. Unrooted Neighbour-Joining tree based on DAS values between MLGs 654 
generated from 199 sylvatic Bolivian TcI clones.  655 
DAS values were calculated as the mean across 1000 random diploid re-samplings of 656 
the dataset.  Branch colours indicate isolate a priori population (Cochabamba, Tupiza, 657 
Toro Toro, East Beni and North Beni; see legend). Closed grey triangles are adjacent 658 
to nodes that receive >60% bootstrap support. Isolates are grouped into three 659 
statistically-supported clades (highlands, lowlands 1 and lowlands 2).  Orange stars 660 
denote clones which have phylogenetically incongruent positions between nuclear and 661 
mitochondrial topologies. 662 
 663 
Figure 4A: Allelic richness (Ar) per microsatellite locus for grouped a priori 664 
geographical highland (diamonds) and lowland (squares) populations. 665 
Highland populations were characterized by smaller estimates of allelic richness (Ar), 666 
compared to the lowlands (average of Ar = 1.92 – 2.22 and 3.40 and 3.93, 667 
respectively). Error bars represent ± standard error about the mean. Values without 668 
error bars correspond to markers containing only a single variable locus. 669 
B: Nuclear spatial genetic analysis among T. cruzi isolates from highland (open 670 
circles) and lowland (closed circles) populations.  671 
Nuclear genetic isolation by distance (IBD) was observed among lowland populations 672 
(RXY = 0.209, p<0.001; slope = 0.0003 ± 0.0000179), while no spatial structure was 673 
evident among highland populations spanning a much greater geographical area (RXY 674 
= 0.109, p=0.085; slope = 0.0002 ±0.0000307). 675 
 676 
Figure 5. Maximum-Likelihood tree constructed from concatenated maxicircle 677 
sequences for 78 sylvatic Bolivian TcI clones and 24 additional TcI isolates from 678 
across the Americas.  679 
A Maximum-Likelihood topology was constructed from concatenated maxicircle 680 
sequences for 78 sylvatic Bolivian TcI clones and rooted using 24 additional TcI 681 
strains belonging to six previously characterised populations (AMNorth/Cen, 682 
ANDESBol/Chile, ARGNorth, BRAZNorth-East, VENdom, and VENsilv from Messenger et al. 683 
2012). The most appropriate nucleotide substitution model was TrN+G (six 684 
substitution rate categories) based on the AIC.  Branch colours indicate sample a 685 
priori population (Cochabamba, Tupiza, Toro Toro, East Beni and North Beni; see 686 
legend).  Statistical support for major clades are given as equivalent bootstraps and 687 
posterior probabilities from consensus Maximum-Likelihood (1000 pseudo-replicates) 688 
and Bayesian trees (based on the GTR+G model), respectively. Orange stars denote 689 
clones which have statistically-supported phylogenetically incongruent positions 690 
between nuclear and mitochondrial topologies.  691 
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4.3.2 Impact of ecological disturbance on T. cruzi population structure 
T. cruzi TcI is ubiquitous in sylvatic transmission cycles throughout its endemic range, where 
it is eclectic with respect to ecotope, vertebrate hosts and insect vectors. Diversity of sylvatic 
TcI hosts across Brazil, an ecological mosaic, is highly variable, ranging from caviomorph 
rodents in the Caatinga scrubland (Herrera et al., 2005), to lion tamarins in the tropical 
Atlantic forest (Lisboa et al., 2004), feral pigs and other carnivores in the Pantanal wetland 
(Herrera et al., 2008a; 2008b; Rocha et al., 2013) and primates, marsupials and rodents in 
Amazonia (Yeo et al., 2005). To explore the interaction between intra-TcI genetic 
heterogeneity and ecological biodiversity, high resolution nuclear (Llewellyn et al., 2009a) 
and mitochondrial (Messenger et al., 2012) genotyping was used to characterize 107 sylvatic 
TcI strains, isolated from five distinct Brazilian biomes: Amazonia, Cerrado, Caatinga, 
Pantanal and the Atlantic Forest. 
This study is reported in full below in Lima et al. 2014. 
In summary: 
- Isolates were grouped into nine populations which all displayed considerable intra-TcI 
genetic diversity, as evidenced by measurements of allelic richness (Ar). Comparisons of 
Ar and the standard deviations (SD) around DAS (mean pair-wise nuclear genetic 
distances), grouped populations into those which were uniformly diverse across all 
samples (high Ar and low SD: e.g. Goiás, Cerrado and Para, Amazonia) and others that 
demonstrated intra-population substructuring (high Ar and high SD: e.g. Pantanal, 
Atlantic forest, Tocantins, Cerrado and Piaui, Caatinga). 
- A highly divergent, geographically-dispersed, homogeneous group of strains isolated 
from rodents (Pantanal), Didelphimorphia, R. prolixus, lion tamarins (all Atlantic Forest) 
and bats (Cerrado) was identified, which clustered outside the known genetic diversity of 
TcI in the Americas, but was also distinct from the novel DTU TcBat. 
- Comparison of nuclear and mitochondrial topologies revealed a single incidence of 
mitochondrial introgression in an isolate from D. albiventris in Caatinga which possessed 
a mitochondrial haplotype of Amazonian origin. 
- Nuclear clustering indicated genetic admixture was common among strains from the 
Atlantic Forest which can be explained by both ongoing habitat fragmentation and long-
range sylvatic introductions of TcI from distant populations, likely facilitated by volant 
mammals. The direct correlation between human disruption and parasite population 
structuring, highlighted the potential to exploit measurements of T. cruzi genetic diversity 
as a proxy for overall ecosystem health. 
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Wild Trypanosoma cruzi I genetic diversity in Brazil
suggests admixture and disturbance in parasite
populations from the Atlantic Forest region
Valdirene S Lima1, Ana M Jansen1, Louisa A Messenger2, Michael A Miles2 and Martin S Llewellyn2,3*
Abstract
Background: Trypanosoma cruzi (Kinetoplastida, Trypanosomatidae) infection is an ancient and widespread
zoonosis distributed throughout the Americas. Ecologically, Brazil comprises several distinct biomes: Amazonia,
Cerrado, Caatinga, Pantanal and the Atlantic Forest. Sylvatic T. cruzi transmission is known to occur throughout
these biomes, with multiple hosts and vectors involved. Parasite species-level genetic diversity can be a useful
marker for ecosystem health. Our aims were to: investigate sylvatic T. cruzi genetic diversity across different biomes,
detect instances of genetic exchange, and explore the possible impact of ecological disturbance on parasite
diversity at an intra-species level.
Methods: We characterised 107 isolates of T. cruzi I (TcI; discrete typing unit, DTU I) from different major Brazilian
biomes with twenty-seven nuclear microsatellite loci. A representative subset of biologically cloned isolates was
further characterised using ten mitochondrial gene loci. We compared these data generated from Brazilian TcI
isolates from around America.
Results: Genetic diversity was remarkably high, including one divergent cluster that branched outside the known
genetic diversity of TcI in the Americas. We detected evidence for mitochondrial introgression and genetic
exchange between the eastern Amazon and Caatinga. Finally, we found strong signatures of admixture among
isolates from the Atlantic Forest region by comparison to parasites from other study sites.
Conclusions: Atlantic Forest sylvatic TcI populations are highly fragmented and admixed by comparison to others
around Brazil. We speculate on: the possible causes of Atlantic Forest admixture; the role of T. cruzi as a sentinel for
ecosystem health, and the impact disrupted sylvatic transmission cycles might have on accurate source attribution
in oral outbreaks.
Background
Trypanosoma cruzi (Kinetoplastida, Trypanosomatidae)
infection is an ancient and widespread zoonosis distrib-
uted throughout the Americas south of 33′ latitude,
where it infects approximately 8 million people [1,2]. T.
cruzi is eclectic in terms of its mammalian hosts and
haematophagous triatomine vectors. Several hundred
species of mammal and many of the 140 extant triato-
mine species maintain transmission of T. cruzi in wild
(sylvatic) transmission cycles [2-4]. Transmission to the
host occurs usually via contamination of the mucosae or
abraded skin with infected vector faeces. Oral transmis-
sion to humans via contaminated foods, especially fruit
juices and sugar cane, is increasingly reported, and sus-
pected to occur widely among sylvatic mammals through
opportunistic insectivory of triatomines [5].
T. cruzi population genetic diversity is well described
at a species level. Six discrete typing units (DTUs) are
now accepted by international consensus [6]. Dates for
the origin of T. cruzi in the Americas range between 5
and 1 MYA (calibrated biogeographically at 100 MYA)
[7-9]. Estimates for the MRCA of TcI strains, arguably
the most widely dispersed and abundant of all the
DTUs, are younger: 1.3-0.2 MYA [7]. Nonetheless, the
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age of TcI in the Americas has been sufficient to see
this genotype expand throughout multiple ecological
settings, from Amazonian forests [10] to highland An-
dean puna [11]. Furthermore, the last 1.3-0.2 MYA in
Latin America have seen intense climatic fluctuations,
including at least two glaciations [12]. The impact of
Pleistocene cycles of warming and cooling on the bio-
mic, ecological and species diversity of Latin America, in
particular in Brazil and the Brazilian Amazon, are a matter
of long debate [13]. Nonetheless, there is evidence that
historical cycles of forest expansion, contraction and
fragmentation have impacted on the current ecology
of Brazil, including small mammal distribution and
diversity [14].
Today the terrestrial ecology of Brazil is summarized
by several distinct biomes or ‘ecoregions’ [15]. The lar-
gest of these is the Amazon basin to the north, bordered
by the dryer Cerrado and seasonally flooded Pantanal to
the south. North-eastern Brazil is dominated by the xeric
scrubland of the Caatinga. Along the Atlantic coast of
Brazil south of Recife, a tropical forest ecosystem, the
Atlantic Forest, predominates. The diversity of wild TcI
hosts across this ecological mosaic is striking: cavio-
morph rodents in the Caatinga [16]; lion tamarins in the
Atlantic forest [17]; coatis, peccaries and felid carnivores
in the Pantanal [18-20]; and multiple species of pri-
mates, marsupials and rodents in Amazonia [2]. Some
important genera are widespread – especially Didelphid
opossums. Human Chagas disease was once widespread
in Brazil, especially in central and southern parts of the
country [21]. Indeed, Chagas disease has probably been
endemic in human populations in Brazil since the earli-
est human settlements more than 10,000 years ago. It is
important not to overlook the impact that humans, an
abundant and mobile T. cruzi host species, present
throughout all Brazilian ecoregions, may have had on
contemporary parasite diversity.
Parasite alpha diversity at a species level is recognised
as a marker for ecosystem persistence, productivity,
organization and resilience [22]. Put simply, those eco-
systems in which host organisms are parasitized by an
array of different parasite species, fairly evenly distrib-
uted among hosts and host species, are considered to be
healthy. Furthermore, parasites, with their short life-
cycles and rapid mutational turnover with respect to
their hosts, can facilitate fine-scale analyses of host
population dispersal and differentiation [23]. However,
close association between host and parasite species is a
prerequisite for the use of parasite genetic diversity to
track host populations. Multi-host parasite lineages like
TcI are therefore unsuitable for such applications. None-
theless, there is some evidence that habitat fragmenta-
tion impacts on both T. cruzi diversity and prevalence of
infection [24-26]. Thus, alpha diversity in a multi-host
parasite like T. cruzi might be a useful proxy for parasite
diversity as a whole, and thus for ecosystem health.
Multilocus microsatellite typing (MLMT) is now a
widely established means of defining genetic diversity
among TcI isolates and clones [27]. Simultaneous ana-
lysis of multilocus sequence data from the mitochondrial
(maxicircle) genome (mMLST) provides a proven means
of detecting genetic exchange among clones [25,28].
Here we undertook a comparison of representative TcI
isolates from across the ecological diversity of Brazil,
examining the relationship between biomes and diversity
within biomes. We found considerable genetic diversity
among several populations, and multiple instances of
genetic admixture, especially in the Atlantic Forest re-
gion. We consider these data, and the potential affect of
human-mediated habitat fragmentation on the diversity
of wild TcI in Brazil.
Methods
Parasite strains and biological cloning
One hundred and seven strains, the great majority sam-
pled from mammalian reservoir hosts captured at syl-
vatic foci throughout Brazil, were assembled for analysis
and their genotype confirmed as TcI via sequencing of a
short fragment of the glucose-6-phosphate isomerase
(GPI) gene [29]. Details of strain origin are given in
Additional file 1: Table S1 and geographic distribution in
Figure 1. A total of fourteen strains were selected from
across all biomes and biologically cloned using the plate
cloning technique described by Yeo et al. [30].
Microsatellite analysis
Twenty-seven microsatellite loci, distributed across eight
putative chromosomes, were amplified following previ-
ously described protocols across 107 strains [27]. A re-
duced subset of 19 microsatellites was employed to
evaluate diversity among a larger panel of 161 samples
including the original strains, derived clones and thirty-
three previously published multilocus microsatellite pro-
files [28]. Population genetic diversity parameters were
first calculated from sample groupings based on geog-
raphy and biome for the full 27 locus dataset (Table 1).
There were nine such groupings, as identified in Figure 1
and listed in Additional file 1: Table S1. Population-level
genetic diversity was assessed first using sample size cor-
rected allelic richness (Ar) in FSTAT 2.9.3.2 [31]. Sec-
ondly, to provide a better measure on intra-population
sub-clustering, mean pairwise DAS and associated stand-
ard deviation was also evaluated per population. FIS, a
measure of the distribution of heterozygosity within and
between individuals, was estimated per locus per popula-
tion in FSTAT 2.9.3.2 [31]. Tests for population specific
departures from Hardy Weinberg Equilibrium at specific
loci were calculated in ARLEQUIN v3.1 and associated
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Figure 1 Composite map and multidimensional scaling plot depicting sample clustering by biome and geography among 107
Trypanosoma cruzi I isolates.
Table 1 Population genetic parameters across nine Trypanosoma cruzi I populations sampled from five biomes in Brazil
Population N Ar ± SE DAS ± SD % PL HE
a % PL Hdb FIS ± SE
c
Ceara 14 1.746 ± 0.121 0.290 ± 0.131 0 0 0.020 ± 0.012
Goais 4 1.734 ± 0.101 0.136 ± 0.067 0 0 -0.526 ± 0.032
PARANORTH 28 2.134 ± 0.143 0.445 ± 0.082 0 19.2 0.147 ± 0.008
PARASOUTH 5 2.027 ± 0.152 0.416 ± 0.053 0 0 0.250 ± 0.019
Pantanal 13 1.698 ± 0.121 0.219 ± 0.197 26.3 5.2 0.068 ± 0.029
Piaui 6 1.930 ± 0.140 0.357 ± 0.188 0 0 0.080 ± 0.023
Atlantic Forest 27 2.010 ± 0.133 0.369 ± 0.199 33.3 33.3 0.077 ± 0.015
Santa Catarina 3 1.412 ± 0.098 0.057 ± 0.020 0 0 -0.740 ± 0.033
Tocantins 7 1.959 ± 0.133 0.362 ± 0.221 14.2 0 0.180 ± 0.025
N number of isolates in population.
Ar allelic richness as a mean over loci ± standard error, calculated in FSTAT.
DAS mean pair-wise inverse allele sharing between samples ± standard deviation calculated in MICROSAT.
aProportion of loci showing significant excess heterozygosity after a sequential Bonferroni correction. Calculated in ARLEQUIN v3.1.
bProportion of loci showing a significant deficit in heterozygosity after a sequential Bonferroni correction. Calculated in ARLEQUIN v3.1.
cMean FIS over loci ± standard error, calculated in FSTAT.
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significance levels for p values derived after sequential
Bonferroni correction to minimise the likelihood of Type 1
errors [32].
For the 19 locus dataset, individual level sample clus-
tering was defined via a neighbour-joining tree based on
pairwise distances between multilocus genotypes MLGs
[evaluated using DAS (1 − proportion of shared alleles at
all loci/n)] calculated in MICROSAT [33] (Figure 2). For
the 27 locus dataset we defined genetic composition via
a K-means clustering algorithm, implemented in ade-
genet [34], with which the optimal number of popula-
tions is defined by reference to the Bayesian Information
Criterion. These groupings were subsequently submitted
to a discriminant analysis of principal components (DAPC)
[35], and the resulting plot is found in Figure 1.
Maxicircle analysis
Ten maxicircle sequence fragments were amplified and
sequenced from fourteen T. cruzi clones (see Additional
file 1: Table S1 for clone identity) following previously
described protocols [28]. Sequence fragments were then
concatenated in each sample and aligned against previ-
ously published sequences prior to analysis [28]. Phylog-
enies were inferred using Maximum-Likelihood (ML)
Figure 2 Comparison of phylogenetic clustering between nuclear and mitochondrial phylogenies among Trypanasoma cruzi I isolates
from Brazil and beyond reveals genetic exchange.
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implemented in PhyML (4 substitution rate categories)
[36]. The best-fit model of nucleotide substitution was se-
lected from 88 models and its significance evaluated ac-
cording to the Akaike Information Criterion (AIC) in
jMODELTEST 1.0 [37]. The best model selected for this
dataset was GTR + I +G. Bootstrap support for clade top-
ologies was estimated following the generation of 1000
pseudo-replicate datasets. Bayesian phylogenetic analysis
was performed using Mr BAYES v3.1 [38] (settings ac-
cording to jMODELTEST 1.0). Five independent analyses
were run using a random starting tree with three heated
chains and one cold chain over 10 million generations
with sampling every 10 simulations (25% burn-in).
Results
Nuclear microsatellite loci demonstrated considerable
genetic diversity among the 107 strains studied. For com-
parative purposes isolates were grouped a priori according
to both geography and biome of origin (Figure 1). As such
nine populations were defined. Sample assignment to
these populations is presented in Additional file 1: Table S1
and population genetic parameters associated with them
in Table 1. Of primary interest are sample size corrected
values for allelic richness (Ar). Ar is highest among
PARANORTH and PARASOUTH samples in the Eastern
Amazon (Ar = 2.027 & 2.134), as well as in the Atlantic
Forest (Ar = 2.010) and Tocantins, in the Cerrado (Ar
1.959). While Ar is a useful measure of overall sample size
corrected genetic diversity, structured diversity within a
population may be overlooked. We thus also calculated
mean pairwise allele sharing (DAS) between multilocus ge-
notypes (MLGs) in each population – Table 1. The stand-
ard deviations associated with mean DAS values are
particularly informative. Diverse populations with elevated
standard deviations (e.g. Atlantic Forest – 0.369 ± 0.199,
Tocantins - 0.362 ± 0.221) are likely to possess intra-
population sub-clusters. By contrast genetic diversity is
uniformly distributed among samples within popula-
tions with low standard deviations about the mean
DAS (PARANORTH - 0.445 ± 0.082, PARASOUTH - 0.416 ±
0.053). Observed heterozygosity varied considerably across
populations. However, where population sizes (N > 10) are
likely to facilitate meaningful interpretation, positive
values for FIS prevailed, and by inference heterozygous
deficit compared to Hardy-Weinberg expectations (Table 1).
Sample clustering based on pair-wise nuclear genetic
distances provides insight into the idiosyncratic patterns
of genetic diversity noted across populations. As such,
considerable admixture is present between multiple pop-
ulations. This phenomenon is best represented by the
composite bars adjacent to the clusters in the multidi-
mensional scaling plot displayed in Figure 1. Samples re-
covered from the Atlantic Forest and Tocantins cluster
among multiple, divergent groups. Meanwhile TcI from
PARANORTH, PARASOUTH and Ceara occur among the
same or closely related clusters. Remaining clusters rep-
resent intermediates between these two extremes. In
summary, genetic diversity among some populations
looks considerably more fragmented than among others.
Mean pair-wise values for DAS and their associated SD
seem to reflect this (Table 1).
Given the intense degree of admixture and substruc-
ture in several populations we decided not to calculate
population specific linkage disequilibrium indices. Sub-
structure is known to inflate such measures and increase
the likelihood of a type 1 error [39]. Instead we chose to
evaluate congruence between nuclear and mitochondrial
genome clustering as evidence for rare genetic exchange
events. To make such a comparison we incorporated
previously published nuclear and mtDNA data into our
dataset [28]. Figure 2 shows the resulting trees and the
single recombinant we were able to detect mong the 14
clones assayed – 6824, isolated from Didelphis albiven-
tris in the Caatinga, possesses a mitochondrial genome
of Amazonian origin. The hypothetical direction of the
introgression event (recipient and donor) is detailed in
the map inset.
The inclusion of nuclear reference microsatellite pro-
files from throughout the Americas in Figure 2 provides
insight into the wider affinities of the Brazilian isolates.
Most notably, isolates belonging to cluster 11 in Figure 1
form a homogenous group that cluster basally, well out-
side global TcI diversity. GPI sequences for this group
nonetheless confirmed this group as TcI and no affinities
with Tcbat were apparent based on the same target (data
not shown).
Discussion
TcI diversity in Brazil is clearly considerable by compari-
son to that in the rest of South, Central and North
America. Figure 2 shows a comparison of isolates evalu-
ated in this study with those analysed previously [27].
Nuclear genetic data (left hand tree) indicate a clade
(corresponding to population 11 in Figure 1) that lies
outside the known diversity of TcI in the Americas. The
presence of a bat trypanosome among this group led us
to suspect that this cluster may be Tcbat, a novel DTU
with affiliations to TcI originally isolated from chiroptera
in Sao Paolo state, but now recognised as more wide-
spread [40,41]. However, sequence comparison of this
clade and Tcbat at the GPI gene rejected this hypothesis
(data not shown). In contrast, all remaining TcI isolates
from Brazil fall alongside their congeners, including iso-
lates from Bolivia and Argentina, but distinct from iso-
lates north of the Amazon basin (Venezuela, North and
Central America).
The available data suggest that genetic exchange is a
fairly common phenomenon among TcI isolates [25,42],
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which is also capable of genetic recombination in the la-
boratory [43]. A consistent feature of genetic exchange
events is the uniparental inheritance of mtDNA. At a
population level, as well as between DTUs, these events
lead to clear instances of mitochondrial introgression
[25]. Thus a pair of isolates maybe highly genetically
similar on a nuclear level, but lack any affinity between
mitochondrial genomes. We identified one such hybrid
among those clones we assayed - 6824. In a recent re-
view, it was proposed that ‘different evolutionary pres-
sures and molecular clocks’ between non-coding nuclear
microsatellite and coding mtDNA, rather than genetic
exchange, might account for such signals of introgres-
sion [44]. However, such a theory requires a situation in
which two (or more) near identical nuclear genotypes (e.g.
6824 and 9667) experience radically different evolutionary
pressures on their mitochondrial genomes, which end up
closely resembling the mitochondrial genotype of nearby
or sympatric clones, in this case from the same host
(Didelphis albiventris). Given that this pattern of intro-
gression fits precisely with that observed in hybrids in the
laboratory [43], and between DTUs in the field (TcI/TcIV)
[45], recombination is the only reasonable explanation.
Of particular interest in our study was the distribution
and structure of genetic diversity within and between
ecoregions. Admixture was most common in the Atlantic
forest region, and largely absent from the Amazon re-
gion in Pará state (Figure 1). As such, samples from the
Atlantic Forest region have strong affinity with those
from around Brazil and are thus distributed across mul-
tiple genetic clusters in Figure 1. The inset in Figure 1
provides fine details of parasite genetic diversity in the
Atlantic Forest region. Isolates at the northern extreme
of this region have predictable affinity with samples from
the Caatinga (cluster 5). However, admixture into Atlantic
forest from other populations is far less predictable, espe-
cially from Amazonia, and the Pantanal, which lie thou-
sands of kilometres from the Atlantic forest. The impact
of Atlantic forest fragmentation on species abundance and
diversity is well documented (e.g. [46-48]). Most studies
report loss of alpha diversity correlating inversely with for-
est fragment size, within as well as between species
[46,49]. In contrast, allelic richness indices in our study
suggested substantial T. cruzi genetic diversity within the
Atlantic Forest (Table 1). However, invasive species intro-
ductions are common in the Atlantic Forest region (e.g.
[50]), and it seems that several long range introductions
from distant populations may also explain the high genetic
diversity of TcI in the region. Thus, unlike TcI populations
from Amazonia and Caatinga, which generally exhibit
high genetic diversity but little admixture, high genetic di-
versity in the Atlantic Forest region is explained by these
introductions and associated admixture. Long-range syl-
vatic dispersal of T. cruzi can be achieved by bats. Indeed,
the presence of T. cruzi clade trypanosomes in Africa can
be explained by rapid aerial dispersal [51]. Cluster 11 con-
tains several isolates from bats, which could explain the
geographic diversity of isolates in this clade (Atlantic
Forest, Pantanal, Cerrado), as well as its genetic homogen-
eity. However, other geographically diverse isolate group-
ings containing Atlantic Forest isolates have no link to
volant mammals.
There is a circumstantial link between Atlantic Forest
loss (88% of its former extent [52]), human population
density, and TcI genetic admixture in the region. T. cruzi
infection is commonly termed a ‘zoonosis’, which implies
unidirectional dispersion from sylvatic transmission cy-
cles to man. Until the successful triatomine eradication
campaigns of the 1970s and 1980s, domestic T. cruzi in-
fection was endemic throughout much (although not all)
of the Atlantic Forest region [21]. It is thus possible that
many of these long-range introductions into the Atlantic
are ‘enzooses’, i.e. TcI strains imported via immigrant hu-
man populations, which subsequently escaped in the
local sylvatic environment.
Conclusions
Rather like primary rainforest, ‘pristine’ sylvatic T. cruzi
diversity may be now relatively rare in South America,
especially where human population densities and infec-
tions rates have been historically high. The presence of
disturbed and admixed sylvatic T. cruzi populations in
populous areas has major implications for the effective
source attribution and thus future prevention of oral
outbreaks [5]. Many such outbreaks have occurred in
Brazil in recent years [53]. As such, the discrimination
of the source of oral outbreak strains as being from ei-
ther the local wild population or from another region via
the importation of foodstuffs becomes complex. This is
because the local wild strains themselves may represent
long-range introductions. Nonetheless, admixture among
sylvatic parasite populations has a possible role as a proxy
for environmental disturbance. Future approaches could
involve high-resolution genotyping and focused sampling
of Atlantic forest fragments, including co-variates like
mammalian and insect biodiversity, to further explore the
use of T. cruzi as a sentinel species for ecosystem health.
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4.3.3 Emergence of human-associated genotypes (TcIDOM) in Central America 
TcI, the most abundant and widely distributed lineage, is the principal cause of human 
chagasic cardiomyopathy in northern South America (Ramirez et al., 2010; Carrasco et al., 
2012). Multiple molecular markers consistently identify high levels of genetic diversity 
within sylvatic TcI populations (Herrera et al., 2007b; 2009; O’Connor et al., 2007; Falla et 
al., 2009; Llewellyn et al., 2009a; Ocaña-Mayorga et al., 2010; Messenger et al., 2012; Lima 
et al., 2014; Messenger et al., accepted), and divergent, but genetically homogeneous, strains 
isolated from human infections and largely absent from mammals or vectors, henceforth 
TcIDOM  (previously TcIa/VENDOM) (Llewellyn et al., 2009a; Cura et al., 2010; Ramírez et al., 
2012).  
To investigate the evolutionary origin of TcIDOM, high resolution nuclear (Llewellyn et al., 
2009a) and mitochondrial (Messenger et al., 2012) genotyping was used to characterize 72 
TcI isolates, including 22 strains from Central America (Guatemala, Mexico and Honduras) 
and 50 additional reference isolates, chosen to be representative of T. cruzi intra-TcI genetic 
diversity. The aim of this study was to determine whether TcIDOM emerged in northern South 
America as a sister group of North American strains and propagated among domestic 
transmission cycles or whether it originated in North America, prior to dispersal into South 
American domestic populations.  
This study is reported in full below in Zumaya-Estrada et al. 2012.  
In summary: 
- Nuclear and mitochondrial topologies grouped isolates into three statistically-supported 
populations: TcISOUTH, TcINORTH-CENT and TcIDOM. Nuclear allelic richness (Ar) and 
mitochondrial nucleotide diversity (π) demonstrated a hierarchical cline in genetic 
diversity TcISOUTH > TcINORTH-CENT > TcIDOM, consistent with phylogenetic branching 
patterns.  
- The microsatellite phylogeny robustly grouped TcINORTH-CENT as a monophyletic clade 
with TcIDOM clustered firmly within it. 
- Reduced genetic diversity among TcINORTH-CENT by comparison to TcISOUTH supports the 
hypothesis that TcI originated in South America before dispersal across the Isthmus of 
Panama during the Great American Interchange.  
- The phylogenetic placement of TcIDOM within TcINORTH-CENT, suggests this group most 
likely originated in North/Central America before disseminating southwards, a finding 
which is consistent with the migration patterns of early colonizing Amerindians. 
- The historical and current mechanisms of TcIDOM dispersal remain largely unexplained. 
However, its widespread geographical distribution suggests that distinct human-restricted 
genotypes can be sustained, despite the presence of sympatric infective sylvatic strains, 
due to inefficient stercorarian vector transmission.  
- This study reinforces the need for additional sampling efforts from Central and South 
America to characterize TcIDOM further and from the Southern Cone to define the 
geographical distribution of this putative human-associated genotype. 
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North American import? Charting the origins of
an enigmatic Trypanosoma cruzi domestic
genotype
Federico A Zumaya-Estrada1, Louisa A Messenger2, Teresa Lopez-Ordonez1, Michael D Lewis2,
Carlos A Flores-Lopez3, Alejandro J Martínez-Ibarra4, Pamela M Pennington5, Celia Cordon-Rosales5,
Hernan V Carrasco6, Maikel Segovia6, Michael A Miles2 and Martin S Llewellyn2*
Abstract
Background: Trypanosoma cruzi, the agent of Chagas disease, is currently recognized as a complex of six lineages
or Discrete Typing Units (DTU): TcI-TcVI. Recent studies have identified a divergent group within TcI - TcIDOM.
TcIDOM. is associated with a significant proportion of human TcI infections in South America, largely absent from
local wild mammals and vectors, yet closely related to sylvatic strains in North/Central America. Our aim was to
examine hypotheses describing the origin of the TcIDOM genotype. We propose two possible scenarios: an
emergence of TcIDOM in northern South America as a sister group of North American strain progenitors and
dispersal among domestic transmission cycles, or an origin in North America, prior to dispersal back into South
American domestic cycles. To provide further insight we undertook high resolution nuclear and mitochondrial
genotyping of multiple Central American strains (from areas of México and Guatemala) and included them in an
analysis with other published data.
Findings: Mitochondrial sequence and nuclear microsatellite data revealed a cline in genetic diversity across
isolates grouped into three populations: South America, North/Central America and TcIDOM. As such, greatest
diversity was observed in South America (Ar = 4.851, π = 0.00712) and lowest in TcIDOM (Ar = 1.813, π = 0.00071).
Nuclear genetic clustering (genetic distance based) analyses suggest that TcIDOM is nested within the North/Central
American clade.
Conclusions: Declining genetic diversity across the populations, and corresponding hierarchical clustering suggest
that emergence of this important human genotype most likely occurred in North/Central America before moving
southwards. These data are consistent with early patterns of human dispersal into South America.
Keywords: Trypanosoma cruzi, Maxicircle, Microsatellite, Chagas Disease, Phylogeography, Population genetics, TcI
Findings
Trypanosoma cruzi, the aetiological agent of Chagas dis-
ease, infects 6-8 million people in Latin America, while
some 25 million more are at risk of acquiring the disease
[1]. Parasite transmission to mammal hosts, including
humans, can occur through contact with the faeces of
hematophagous triatomine bugs. However, non-vectorial
routes are also recognized, including blood transfusion,
organ transplantation, congenital transmission, and oral
transmission via ingestion of meals contaminated with
infected triatomine feces [2,3].
T. cruzi (family Trypanosomatidae; Euglenozoa:
Kinetoplastida) is most closely related to several widely
dispersed species of bat trypanosomes [4]. Salivarian try-
panosomes including medically important Trypanosoma
brucei subspecies, represent a more divergent group [5].
The age of the split between the T. cruzi-containing and
T. brucei-containing trypanosome lineages is thought to
have been concurrent with the separation of Africa
and South America/Antarctica/Australasia 100MYA [6],
implying that T. cruzi and the other Schizotrypanum
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Table 1 Trypanosoma cruzi I samples included in this study
Strain
code
Strain Host/vector Country State Latitude Longitude Date Population Reference
PALDA4 PALDA4 Didelphis
albiventris
Argentina Chaco -27.133 -61.460 2001 SOUTH Messenger et al., [12]
PALDA21 PALDA21 Didelphis
albiventris
Argentina Chaco -27.133 -61.460 2001 SOUTH Messenger et al., [12]
PALDA5 PALDA5 Didelphis
albiventris
Argentina Chaco -27.133 -61.460 2001 SOUTH Messenger et al., [12]
PALDAV2 PALDAV2^3 Triatoma
infestans
Argentina Chaco -27.133 -61.460 2001 SOUTH Messenger et al., [12]
PALDA20 PALDA20 Didelphis
albiventris
Argentina Chaco -27.133 -61.460 2001 SOUTH Messenger et al., [12]
COTMA38 COTMA38 Akodon
boliviensis
Bolivia Cotopachi -17.430 -66.270 2004 SOUTH Messenger et al., [12]
P234 P234 Homo sapiens Bolivia Cochabamba -17.380 -66.160 1985 SOUTH Messenger et al., [12]
P238 P238 Homo sapiens Bolivia Cochabamba -17.380 -66.160 1985 SOUTH Messenger et al., [12]
P268 P268 Homo sapiens Bolivia Cochabamba -17.380 -66.160 1987 SOUTH Messenger et al., [12]
SJM22 SJM22 cl1 Didelphis
marsupialis
Bolivia Beni -14.810 -64.600 2004 SOUTH Messenger et al., [12]
SJM34 SJM34 Didelphis
marsupialis
Bolivia Beni -14.810 -64.600 2004 SOUTH Messenger et al., [12]
SJM37 SJM37 Didelphis
marsupialis
Bolivia Beni -14.810 -64.600 2004 SOUTH Messenger et al., [12]
SJM39 SJM39 cl3 Didelphis
marsupialis
Bolivia Beni -14.810 -64.600 2004 SOUTH Messenger et al., [12]
SJM41 SJM41 Philander
opossum
Bolivia Beni -14.810 -64.600 2004 SOUTH Messenger et al., [12]
SJMC12 SJMC12 Philander
opossum
Bolivia Beni -14.810 -64.600 2004 SOUTH Messenger et al., [12]
XE5167 XE5167 cl1 Didelphis
marsupialis
Brasil Para -1.710 -48.880 1999 SOUTH Messenger et al., [12]
IM4810 IM4810 Didelphis
marsupialis
Brasil Manaus -3.070 -60.160 2002 SOUTH Messenger et al., [12]
B2085 B2085 Didelphis
marsupialis
Brasil Belem -1.360 -48.360 1991 SOUTH Messenger et al., [12]
XE2929 XE2929 Didelphis
marsupialis
Brasil Pará -5.830 -48.030 1988 SOUTH Messenger et al., [12]
AAA1cl5 AAA1cl5 Rhodnius
prolixus
Colombia Casanare 4.150 -71.200 2010 SOUTH Ramirez et al., Molecular
Ecology In press
AAA7cl2 AAA7cl2 Rhodnius
prolixus
Colombia Casanare 5.100 -71.600 2010 SOUTH Ramirez et al., Molecular
Ecology In press
AAB3cl3 AAB3cl3 Rhodnius
prolixus
Colombia Casanare 4.150 -71.200 2010 SOUTH Ramirez et al., Molecular
Ecology In press
AAC1cl3 AAC1cl3 Rhodnius
prolixus
Colombia Casanare 5.100 -71.600 2010 SOUTH Ramirez et al., Molecular
Ecology In press
AACf1cl4 AACf1cl4 Canis familiaris Colombia Casanare 5.100 -71.600 2010 SOUTH Ramirez et al., Molecular
Ecology In press
AAD6cl6 AAD6cl6 Rhodnius
prolixus
Colombia Casanare 5.100 -71.600 2010 SOUTH Ramirez et al., Molecular
Ecology In press
CACQcl7 CACQcl7 Homo sapiens Colombia Santander 6.963 -73.420 2009 TcIDOM Ramirez et al., Molecular
Ecology In press
CACQcl8 CACQcl8 Homo sapiens Colombia Santander 6.644 -73.654 2009 TcIDOM Ramirez et al., Molecular
Ecology In press
DYRcl16 DYRcl16 Homo sapiens Colombia Boyacá 5.640 -72.899 2007 TcIDOM Ramirez et al., Molecular
Ecology In press
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Table 1 Trypanosoma cruzi I samples included in this study (Continued)
EBcl11 EBcl11 Homo sapiens Colombia Boyacá 5.130 -73.119 2007 TcIDOM Ramirez et al., Molecular
Ecology In press
FECcl10 FECcl10 Homo sapiens Colombia Boyacá 5.920 -73.500 2001 TcIDOM Ramirez et al., Molecular
Ecology In press
Td3cl11 Td3cl11 Triatoma
dimidiata
Colombia Boyacá 6.270 -71.200 2000 TcIDOM Ramirez et al., Molecular
Ecology In press
X-1084cl10 X-1084cl10 Rhodnius
prolixus
Colombia Boyacá 4.960 -73.630 2010 SOUTH Ramirez et al., Molecular
Ecology In press
X-236cl9 X-236cl9 Rhodnius
prolixus
Colombia Boyacá 4.960 -73.630 2010 SOUTH Ramirez et al., Molecular
Ecology In press
YAS1cl3 YAS1cl3 Alouatta spp Colombia Casanare 5.300 -72.400 2010 SOUTH Ramirez et al., Molecular
Ecology In press
38 38 Triatoma
dimidiata
Guatemala Jutiapa 14.287 -89.844 2000 NORTH-
CENT
This study
46 46 Triatoma
dimidiata
Guatemala Santa Rosa 14.177 -90.303 2001 NORTH-
CENT
This study
66 66 Triatoma
dimidiata
Guatemala Jalapa 14.633 -89.989 2001 NORTH-
CENT
This study
67 67 Triatoma
dimidiata
Guatemala Jutiapa 14.287 -89.844 2001 NORTH-
CENT
This study
70 70 Triatoma
dimidiata
Guatemala Jutiapa 14.287 -89.844 2001 NORTH-
CENT
This study
71 71 Triatoma
dimidiata
Guatemala Jalapa 14.633 -89.989 2001 NORTH-
CENT
This study
83 83 Triatoma
dimidiata
Guatemala Chiquimula 14.768 -89.458 2002 NORTH-
CENT
This study
95 95 Triatoma
dimidiata
Guatemala Chiquimula 14.768 -89.458 2002 NORTH-
CENT
This study
100 100 Triatoma
dimidiata
Guatemala Santa Rosa 14.177 -90.303 2002 NORTH-
CENT
This study
113 113 Triatoma
dimidiata
Guatemala Chiquimula 14.768 -89.458 2002 NORTH-
CENT
This study
116 116 Triatoma
dimidiata
Guatemala Baja Verapaz 15.079 -90.413 2002 NORTH-
CENT
This study
154 154 Triatoma
dimidiata
Guatemala Alta Verapaz 15.594 -90.149 2002 NORTH-
CENT
This study
DAVIScl1 DAVIS 9.90 cl1 Triatoma
dimidiata
Honduras Tegucigalpa 14.080 -87.200 1983 NORTH-
CENT
Messenger et al., 2012
ANITA II ANITA Triatoma
dimidiata
Mexico Campeche 19.188 -90.300 2011 NORTH-
CENT
This study
CAM6 CAM6 Triatoma
dimidiata
Mexico Campeche 19.188 -90.300 2011 NORTH-
CENT
This study
CRISTY CRISTY Homo sapiens Mexico San Luis
Potosí
22.159 -100.990 2007 NORTH-
CENT
This study
MICH1 MICH Triatoma
dimidiata
Mexico Michoacan 19.567 -101.707 2011 NORTH-
CENT
This study
NINOA NINOA Homo sapiens Mexico Oaxaca 17.054 -96.714 1994 NORTH-
CENT
This study
PLI PL Dipetalogaster
maxima
Mexico Baja
California Sur
26.044 -111.666 2001 NORTH-
CENT
This study
QROI QRO Triatoma
barberi
Mexico Queretaro 20.594 -100.393 1986 NORTH-
CENT
This study
TQI TQ Triatoma
pallidipennis
Mexico Morelos 18.953 -99.223 1991 NORTH-
CENT
This study
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species evolved exclusively in South America. Others
propose an alternative origin of T. cruzi from an an-
cestral bat trypanosome potentially capable of long
range dispersal [7]. Whilst the precise scenario for the
arrival of ancestral Schizotrypanum lineages in South
America is a matter for debate, the current continental
distribution and genetic diversity of T. cruzi supports
an origin within South America. Parasite transmission
is maintained via hundreds of mammal and triatomine
species in different biomes throughout South and
Central America, as well as the southern states of the
USA [8].
Biochemical and molecular markers support the exist-
ence of six lineages or Discrete Typing Units (DTU): TcI, -
TcVI agreed by international consensus ([9]. Each DTU
can be loosely associated with a particular ecological and/
or geographical framework [10]. TcI is ubiquitous among
arboreal sylvatic foci throughout the geographic distribu-
tion of T. cruzi and is the major agent of human Chagas
disease in northern South America. Several molecular
tools now identify substantial genetic diversity within TcI
[11-14]. Importantly these new approaches consistently
reveal the presence of a genetically divergent and homoge-
neous TcI group (henceforth TcIDOM – previously TcIa/
VENDOM) associated with human infections from Vene-
zuela to Northern Argentina, and largely absent from wild
mammals and vectors sampled to date [14]. The origin of
this clade is unclear, although recent work supports a
Table 1 Trypanosoma cruzi I samples included in this study (Continued)
XAL1 XAL Triatoma
dimidiata
Mexico Veracruz 19.173 -96.133 2003 NORTH-
CENT
This study
9209802P 9209802P cl1 Didelphis
marsupialis
USA Georgia 32.430 -83.310 1992 NORTH-
CENT
Messenger et al., [12]
9307 93070103P cl1 Didelphis
marsupialis
USA Georgia 32.430 -83.310 1993 NORTH-
CENT
Messenger et al., [12]
ARMA USAARMA cl3 Dasypus
novemcinctus
USA Lousiana 30.500 -91.000 Unknown NORTH-
CENT
Messenger et al., [12]
USA USAOPOSSUM
cl2
Didelphis
marsupialis
USA Lousiana 30.500 -91.000 Unknown NORTH-
CENT
Messenger et al., [12]
9354 9354 Homo sapiens Venezuela Sucre 10.460 -63.610 1999 TcIDOM Messenger et al., [12]
11541 11541 Homo sapiens Venezuela Merida 8.590 -71.230 2003 TcIDOM Messenger et al., [12]
11713 11713 Homo sapiens Venezuela Lara 10.233 -69.866 2003 TcIDOM Messenger et al., [12]
11804 11804 Homo sapiens Venezuela Portuguesa 9.084 -69.103 2003 TcIDOM Messenger et al., [12]
10462P2C3 10462P2C3 Homo sapiens Venezuela Miranda 10.266 -66.485 Unknown TcIDOM This study
10462P2C7 10462P2C7 Homo sapiens Venezuela Miranda 10.080 -66.449 Unknown TcIDOM This study
10968P1C1 10968P1C1 Homo sapiens Venezuela Sucre 10.406 -63.298 Unknown TcIDOM This study
ANT3P1C6 ANT3P1C6 Homo sapiens
(oral)
Venezuela DC 10.500 -66.951 Unknown SOUTH This study
M13 M13 Didelphis
marsupialis
Venezuela Barinas 7.500 -71.230 2004 SOUTH Messenger et al., [12]
M16 M16 cl4 Didelphis
marsupialis
Venezuela Barinas 7.500 -71.230 2004 SOUTH Messenger et al., [12]
M18 M18 Didelphis
marsupialis
Venezuela Barinas 7.500 -71.230 2004 SOUTH Messenger et al., [12]
M7 M7 Didelphis
marsupialis
Venezuela Barinas 7.500 -71.230 2004 SOUTH Messenger et al., [12]
92122 92122102R Procyon lotor TcIV USA Georgia OUTGROUPS Messenger et al., [12]
CANIII CANII cl1 Homo sapiens TcIV Brazil Belem OUTGROUPS Messenger et al., [12]
CM17 CM17 Dasypus spp. TcIII Colombia Carimaga OUTGROUPS Messenger et al., [12]
X1060 X10610 cl5 Homo sapiens TcIV Venezuela Guárico OUTGROUPS Messenger et al., [12]
ERA ERA cl2 Homo sapiens TcIV Venezuela Anzoátegui OUTGROUPS Messenger et al., [12]
10R26 10R26 Aotus spp. TcIV Bolivia Santa Cruz OUTGROUPS Messenger et al., [12]
SAIRI3 Saimiri3 cl1 Saimiri
sciureus
TcIV Venezuela Venezuela OUTGROUPS Messenger et al., [12]
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sister group relationship with TcI circulating in North
America (e.g. [12,13]).
In this manuscript we have set out to evaluate the genetic
diversity of TcI in North/Central America, undertaking a
comparison with TcI diversity in South America, including
TcIDOM. Our aim was to examine hypotheses describing
the origin of the TcIDOM clade. We propose two possible
scenarios: an emergence of TcIDOM in northern South
America as a sister group of North American strains and
dispersal among domestic transmission cycles, or an origin
in North America, prior to dispersal back into South
American domestic cycles, possibly anthropically. To pro-
vide further insight into this question we undertook high
resolution nuclear and mitochondrial genotyping of mul-
tiple Central American strains (from areas of México and
Guatemala) and included them in an analysis with other
published data [11-13].
A panel of 72 TcI isolates and clones was assembled for
analysis (Table 1) [11-16]. Of these, existing sequences
and microsatellite data were available for 46 isolates
[11,12]. Isolates were classified into three populations: TcI-
NORTH-CENT, TcISOUTH and TcIDOM. TcINORTH-CENT
includes samples from the USA, México, Guatemala and
Honduras; TcISOUTH corresponds to South America
(Argentina, Bolivia, Colombia, Venezuela and Brazil) and
TcIDOM with exclusively domestic isolates from Colombia
and Venezuela, already known to correspond to a geno-
type with restricted genetic diversity: TcIa, as previously
described by Herrera et al., (2007) [17] and VENDom, as
described by Llewellyn et al., (2009) [13]. Additional DTU
isolates (TcIII-TcIV) were included as out-groups in the
mitochondrial analysis.
Isolates from México and Guatemala were character-
ized to DTU level via the amplification and sequencing
of glucose-6-phosphate isomerase (GPI) as previously
described by Lauthier et al., (2012) [18]. Subsequently,
nine maxicircle gene fragments were amplified,
sequenced and concatenated from the Méxican and
Guatemalan strains according to Messenger et al., 2012
(excluding ND4) [12]. Phylogenetic analysis was also
conducted as in Messenger et al., 2012 [12]. Nineteen
nuclear microsatellite loci previously described by
Llewellyn et al., 2009 [13], were selected based on their
level of TcI intra-lineage resolution. Microsatellite loci
were amplified across 21 unpublished biological stocks
from México and Guatemala. Reaction conditions were
as described previously [13]. Dendrograms based on
multilocus allele profiles were constructed also accord-
ing to Llewellyn et al., 2009 [13].
Maxicircle nucleotide diversity (π) was calculated for
TcINORTH-CENT, TcISOUTH and TcIDOM respectively in
DNAsp v5 [19]. Nuclear allelic diversity was calculated
for the same populations using allelic richness (Ar) in
FSTAT [20]. The resulting values are shown in Figure 1.
Nucleotide sequences per gene fragment are available
from GenBank under the accession numbers MURF1
(fragment a): JX431060 - JX431084; MURF1 (fragment
b): JX431085 - JX431109; ND1: JX431110 - JX431134;
ND5 (fragment a): JX431135 - JX431159; ND5 (fragment
b): JX431160 - JX431184; 9S rRNA: JX431185 -
JX431209; 12S rRNA: JX431210 - JX431234; COII:
JX431235 - JX431259 and CYT b: JX431260 - JX431284.
Across the 3,449 bp final concatenated alignment (in-
cluding outgroups), a total of 374 variable sites were
found. The mitochondrial phylogeny supported the pres-
ence of significant diversity among the isolates examined
(Figure 2). TcIDOM strains formed a monophyletic clade
[60% ML BS/0.98 BPP]. The principal division in the
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Figure 1 Nucleotide diversity and allelic richness comparisons across North and South American. Trypanosoma cruzi I populations. Left
hand data points (diamond) indicate allelic richness ± standard error over loci. Right hand data points (square) indicate nucleotide diversity (π) ±
standard error over pair-wise comparisons.
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phylogeny was between TcISOUTH and TcIDOM/TcI-
NORTH-CENT (98% ML BS/0.98 BPP). However, this div-
ision is incomplete, such that a subset of South
American strains is also grouped with TcIDOM and TcI-
NORTH-CENT. Thus, it is not possible to conclude that
TcIDOM maxicircle sequences nest uniquely among those
from TcINORTH-CENT strains. Conversely, a basal rela-
tionship of the TcINORTH-CENT to TcIDOM is suggested at
the level of nucleotide diversity by population (Figure 1),
whereby TcIDOM<TcINORTH-CENT<TcISOUTH. Low stand-
ard errors about the mean in all three populations, but
especially in TcIDOM and TcINORTH-CENT, suggest that
sample size had little impact on the accuracy of estima-
tion between populations.
Distance-based clustering using the microsatellite data-
set indicated the presence of several well defined clades
(Figure 3). Importantly in this case the monophyly of
North-Central American isolates was corroborated, and
TcIDOM clustered firmly within them (bootstrap 65%). By
contrast, South American isolates fall into a divergent but
diverse clade. Thus the nuclear data provide stronger sup-
port for divergence of TcIDOM from within TcINORTH-CENT
than the maxicircle phylogeny. Sample size-corrected al-
lelic richness estimates are consistent with hierarchical
patterns of clustering based on pair-wise genetic distances.
As with the maxicircle dataset, there is a pronounced cline
in diversity across the populations studied - Ar TcIDOM<
Ar TcINORTH-CENT< Ar TcISouth (Figure 1).
Figure 2 Isolate grouping of 72 Trypanosoma cruzi I strains, as well as outgroups, based on nine concatenated maxicircle sequences.
Bayesian consensus topology is displayed. Bayesian posterior probability analysis (BPP) was performed using MrBAYES v3.1. Five independent
analyses were run using a random starting tree with three heated chains and one cold chain over 10 million generations with sampling every 10
simulations (25% burn-in). Decimal values (second number) on nodes indicate Bayesian probabilities for clusters. First number indicates the
Maximum-Likelihood (ML) % bootstrap support for clade topologies, which was estimated following the generation of 1000 pseudo-replicate
datasets. Branch colours indicate isolate origin. Isolates that show clear incongruity between nuclear genotype and maxicircle genotype are
marked. Outgroup branches were cropped for ease of visualization, full branch lengths are show inset top right.
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TcI dispersion into Central and North America
Using a 100 MYA biogeographic calibration point [6],
molecular clock analyses point to the origin of T. cruzi
(sensu stricto) 5 – 1 MYA [21-23] and a most recent
common ancestor for TcI at 1.3-0.2 MYA [22]. Reduced
genetic diversity among North-Central American isolates
by comparison to their southern counterparts is power-
ful evidence in support of others who suggest that TcI
originated in South America [13,24]. The emergence of
TcI in the South occurred prior to either migration
across the Isthmus of Panama alongside didelphid mar-
supials during the Great American Interchange [25], or
perhaps prior to northerly dispersal via volant mammals
(e.g. bats).
Origin of TcIDOM
Recent findings indicate a close resemblance between
TcIDOM isolates from the northern region of South
America and parasite populations from Central and
North America by the use of nuclear and mitochondrial
markers [11-13]. Indeed SL-IR genotyping suggests a
distribution for TcIDOM that now extends as far south as
the Argentine Chaco, where multiple sequences have
been identified from human and domestic vector
sources [14]. Llewellyn et al., (2009) originally hypothe-
sised that a distinct human/domestic clade could be
maintained despite the presence of nearby infective syl-
vatic strains due to the low parasite transmission effi-
ciency by the vector [13]. In this case multiple feeds by
domestic vector nymphs are required to infect indivi-
duals, as such human – human transmission is far more
common than reservoir host - human transmission. Ori-
ginally this hypothesis was developed to explain the epi-
demiology of Chagas disease in Venezuela. However,
TcIDOM is clearly widespread and recent data propose a
date for its emergence 23,000 ± 12,000 years ago [11].
Figure 3 Isolate grouping of 72 Trypanosoma cruzi I strains based on nineteen nuclear micrsoatellite markers. Neighour-joining
clustering algorithm implemented. Bootstrap values are included on important nodes. The first figure indicates % bootstrap support over 10,000
trees, the second the % stability over 1000 trees accounting for multi-allelic loci in the dataset. For further details see Llewellyn et al., 2009 [13].
Branch colours indicate isolate origin. The three principal populations TcIDOM TcISOUTH and TcINORTH-CENT are shown on both map and tree. Red
circles correspond to isolates from TcIDOM. Isolates that show clear incongruity between nuclear genotype and maxicircle genotype are marked
with reference to Figure 2.
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This corresponds to the earliest human colonisation of
the Americas [26]. Thus it seems that TcIDOM may be as
ancient as humans in South America. Crucially, our
data, which show that TcIDOM is nested among North
and Central American strains, suggest that this wide-
spread domestic T. cruzi genotype may actually have
made first contact with man in North–Central America.
The expansion of limited diversity genotypes into do-
mestic transmission cycles is a familiar story in T. cruzi.
This phenomenon seems to have occurred almost simul-
taneously with TcIDOM (<60,000 YA) in the Southern
Cone region but involving DTUs TcV and TcVI [22].
Nonetheless, static human population densities sufficient
to support a sustained domestic cycle are presumably
vital. For TcIDOM, patterns of genetic diversity suggest
early colonizing Amerindians may have been responsible
for its southerly migration and dispersal from North/
Central America. However, such early settler populations
were probably small, dynamic, and inherently unsuitable
to sustain transmission of such a genotype. Many ques-
tions, therefore, remain unanswered regarding its emer-
gence. Insight could perhaps be drawn from a better
understanding of the current distribution and diversity
of TcIDOM (including samples from the Southern Cone),
patterns of vector population migrations, and even from
analysis of ancient DNA (e.g. [27]). We hope this report
serves to galvanize efforts towards this understanding,
especially among researchers in Central and North
America, where many of the answers lie.
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4.4 Discussion  
The three papers presented in this chapter describe the natural population structures of T. 
cruzi TcI in three different epidemiological situations.  
In both Bolivia and Brazil, where sylvatic transmission cycles were sampled, considerable 
genetic diversity was observed among TcI populations, which was consistent with intense, 
local parasite transmission and/or minimal extinction of distinct genotypes. In many of the 
study areas, multilocus genotypes (MLGs) were rarely repeated indicating only a fraction of 
total genetic variation was sampled. Indeed, all three of these studies would have benefited 
from additional strains. In Brazil, a novel, highly divergent, homogenous clade isolated from 
multiple different host and vector species was identified, confirming our sampling of intra-
TcI genetic diversity has not yet reached saturation (Lima et al., 2014).  In Bolivia, a cohort 
of patient samples from the three highland study sites is needed to corroborate the link 
between highland domestic and sylvatic gene flow; a putative, hybridization zone in northern 
Cochabamba also warrants further attention (Messenger et al., accepted). Characterization of 
new patient isolates from Central America will be critical to define the geographical range of 
TcIDOM which currently extends from Venezuela to northern Argentina (Zumaya-Estrada et 
al., 2012).   
In addition to the inherent problems of T. cruzi isolation (section 3.1.2), sylvatic sampling is 
also logistically difficult and intrinsically biased. Certain species are notoriously 
overrepresented in trapping efforts, e.g. Didelphimorphia, and due to their characteristically 
high circulating parasitaemias, facilitate greater parasite isolation rates (Legey et al., 2003; 
Llewellyn et al., 2009a). The importance of a particular host to disease ecology will depend 
on the balance between T. cruzi prevalence and relative local abundance; if a species with 
high infection rates represents only a negligible proportion of the total population then its role 
in transmission is lesser compared to a second species that displays a lower disease 
prevalence but is significantly more abundant in the area.  
An improved understanding of sylvatic transmission dynamics would be advantageous both 
in terms of Chagas disease control and as well as habitat conservation. Serological 
surveillance of targeted peridomestic populations has been initiated in Brazil (Jansen and 
Roque, 2010), Argentina (Gürtler! et al., 2007), Venezuela (Crisante et al., 2006), Mexico 
(Estrada-Franco et al., 2006) and the USA (Tenny et al., 2014), using these hosts as 
bioindicators (sentinels) of T. cruzi transmission risk, considering high seroprevalence in 
these species usually precedes the emergence of local human Chagas disease (Roque et al., 
2008; Jansen and Roque, 2010). In parallel, detectable reductions in parasite genetic diversity 
as a direct result of human disruption, highlights the potential to exploit such measurements 
as proxies for overall ecosystem health (Messenger et al., accepted; Lima et al., 2014). 
The three papers included in this chapter demonstrate the significant impact human activity 
has had on the evolution of T. cruzi. Direct habitat destruction, especially deforestation, 
provides ample opportunities for synanthropic mammalian species (especially marsupials, 
rodents and bats) and triatomines, to colonize peridomestic areas seeking shelter and food 
(Walsh et al., 1993; Abad-Franch and Monteiro, 2007). The corresponding reduction in 
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parasite genetic diversity, has potential implications for human Chagas disease with respect 
to parasite virulence, transmissibility and drug susceptibility. Future studies could incorporate 
in vitro and in vivo characterization of these homogeneous strains in comparison with their 
‘undisturbed’ sylvatic counterparts, to determine whether these isolates possess a phenotypic 
advantage. It seems likely that such a phenomenon may exist with TcIDOM strains, 
considering their historical maintenance among small, highly dynamic human populations, 
and extensive contemporary geographical distribution. 
Unlike genetic exchange in other typanosomatid species, which involves Mendelian 
segregation of parental alleles (Jenni et al., 1986; Peacock et al., 2011; Akopyants et al., 
2009), T. cruzi is known to possess an unorthodox set of potentially alternate recombination 
mechanisms (Gaunt et al., 2003; Lewis et al., 2011; Messenger et al., 2012; Ramirez et al., 
2012; Baptista et al., 2014). Mitochondrial introgression was detected among a minority of 
strains in all three studies and appears to be a natural, non-obligatory occurrence among TcI 
populations (Messenger et al., 2012; Ramírez et al., 2012).  
In Bolivia, introgression was observed between arboreal populations, in Brazil within a single 
isolate from D. albiventris in Caatinga, and in the TcIDOM study, one human strain in Mexico. 
No reciprocal nuclear hybridization was identified among these recombinant isolates, which 
may reflect a mating system involving asymmetric mitochondrial inheritance. Considering 
the fundamental role T. cruzi maxicircles play in parasite metabolism and development in the 
triatomine vector and the observation that these parasite populations were principally 
structured by ecological fitting, it is not implausible to suggest that such a mechanism might 
facilitate host range extension and/or resource tracking. Similarly, in Bolivia, excess 
heterozygosity was observed among highland strains, potentially indicative of another recent 
hybridization event (Messenger et al., accepted). Alternatively, sustained, conserved 
heterozygosity has been proposed to provide an adaptive fitness advantage in triatomine bugs 
through metabolic flexibility over a range of environmental temperatures (Widmer et al., 
1987). Both introgression and heterozygous recombinant strains are also candidates for in 
vitro and in vivo characterization to elucidate the impact of hybridization on T. cruzi 
phenotype. 
The occurrence of non-canonical, alternate mating systems in T. cruzi complicates the 
interpretation of many conventional population genetics indices (Ramírez and Llewellyn, 
2014). The use of model-based population assignment software, e.g. STUCTURE (Pritchard 
et al., 2000) and BAPS (Corander et al., 2003), is contraindicated as these programs are 
based on algorithms which assume Hardy-Weinberg allele frequencies and complete linkage 
equilibrium between genetic markers, two criteria that are largely violated by clonal 
reproduction in T. cruzi. With regards to detecting hybridization, sample population 
allocation is crucial; grouping of divergent non-recombining subgroups (in the case of T. 
cruzi, distinct DTUs) can inflate genetic linkage statistics and mask recombination events 
occurring between more closely related individuals (Smith et al., 1993). Recent observations 
of the Wahlund effect obscuring Hardy-Weinberg allele frequencies and linkage equilibrium 
within Brazilian TcII strains, caution the interpretation of statistics derived from 
inappropriately assigned parasite populations (Baptista et al., 2014). 
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To circumvent these limitations, in the Bolivia study, natural parasite groupings were defined 
by submitting clones a priori to two different clustering methodologies, both independent of 
Hardy-Weinberg assumptions, and congruence was compared between outputs. This strategy 
is not ideal and highlights the need to develop new statistical tools and/or adapt those used to 
define population structures in other organisms with more covert unorthodox mating systems 
(Hickman et al., 2013; Ni et al., 2013)  
Few studies, including those described herein, have had the capacity and expertise to 
undertake intensive, representative parasite isolation from all available mammalian and 
vector species in a local ecosystem. An integrated landscape genetics approach (Biek and 
Real, 2010; Manel and Holderegger, 2013), measuring geospatial biotic (e.g. local fauna 
diversity, relative species abundances, etc.) and abiotic parameters (e.g. temperature, 
humidity, water availability etc.), complemented by improved population genetics analyses, 
may represent a promising new strategy to examine the complex interplay between T. cruzi, 
its mammalian hosts and ecological niches.  
 
 
 
 
 
 
 
 
 
 
 
103 
 
5. Detection of genetic exchange among natural T. cruzi populations  
 
5.1 Background 
5.1.1. Natural genetic exchange in T. cruzi 
The principal mode of reproduction among a number of parasitic protozoan species is the 
subject of an ongoing, intense, decades-old debate (Tibayrenc et al., 1990; Tibayrenc and 
Ayala, 1991; 2012; 2013; 2014a; 2014b; Ramírez and Llewellyn, 2014; Tomasini et al., 
2014a; 2014b). At the two extremes are the preponderate clonal evolution (PCE) model, 
which suggests that genetic exchange is too infrequent to break the predominant pattern of 
clonality, such that only ‘restrained recombination’ occurs on an evolutionary scale 
(Tibayrenc and Ayala, 2012; 2013; 2014a; 2014b), and the counter-proposition that 
hybridization is pervasive, albeit challenging to detect, among some natural disease foci 
(Ramírez and Llewellyn, 2014). T. cruzi often fulfills key assumptions of PCE, namely 
strong linkage disequilibrium (LD), deviations from Hardy-Weinberg allele frequencies and 
structuring of populations into stable, discrete genetic clusters, all of which have been cited 
as compelling evidence that it is essentially a clonal organism (Tibayrenc and Ayala, 2012; 
2013).  
With improved sampling strategies and the use of more resolutive genotyping techniques, a 
growing amount of field data now indicate that natural recombination in T. cruzi may be 
frequent, non-obligatory and idiosyncratic, potentially involving independent exchange of 
kinetoplast and nuclear genetic material, as well as canonical meiotic mechanisms (Table 
5.1). At the inter-lineage level, DTUs TcV and TcVI are unequivocal hybrids of TcII and 
TcIII, which resemble diploid Mendelian F1 progeny, sharing intact alleles from their 
parental strains (Machado and Ayala, 2001; Brisse et al., 2003; Barnabé et al., 2011; Lewis et 
al., 2009b; 2011; Yeo et al., 2011). The status of TcIII and TcIV as ancient recombinants is 
more contentious, but supported by some nuclear markers (Westenberger et al., 2005) and the 
sharing of mitochondrial haplotypes (Lewis et al., 2011; Messenger et al., 2012).  
At the intra-lineage level, genetic exchange is increasingly reported, particularly among TcI 
populations, but it is unclear whether this is due to the examination of isolates that are 
minimally subdivided spatially and temporally, and therefore more likely to undergo 
hybridization, or whether it truly reflects the analysis of strains that are more permissive to 
recombination (Ramírez and Llewellyn, 2014). The underlying cytological mechanisms of 
natural intra-TcI recombination are unresolved and vary between studies and genetic markers 
used (Table 5.1).  
Mitochondrial introgression is emerging as a common feature of natural transmission cycles 
especially within TcI populations (Messenger et al., 2012; accepted; Zumaya-Estrada et al., 
2012; Lima et al., 2014) but also between major lineages (Lewis et al., 2011; Messenger et 
al., 2012; Barnabé and Breniere, 2012; Roellig et al., 2013) (Table 5.1). The evidence for 
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unequivocal reciprocal nuclear recombination among introgression strains is thus far lacking. 
One explanation, given their role in growth, development and metabolism, is that asymmetric 
mitochondrial introgression may facilitate host range extension, satisfying the elevated 
necessity to escape Muller’s ratchet compared to the nuclear genome (Messenger et al., 
accepted; Neiman and Taylor, 2009; Ramírez and Llewellyn, 2014). However, these 
observations have been interpreted by others as attributable to gross differences in 
evolutionary pressures and molecular clocks between non-coding microsatellites and coding 
maxicircle genes (Tibayrenc and Ayala, 2013).  
It is clear that to improve detection of natural recombination, the use of multiple, different 
types of molecular markers (nuclear and mitochondrial, coding and non-coding) are required 
in combination with targeted investigation of potential ‘hybridization’ zones, i.e. areas where 
recently diverged, genetically distinguishable subpopulations come into regular contact 
(Messenger et al., accepted; Ramírez and Llewellyn, 2014). The value of such high density 
sampling has already been demonstrated in defining the population structures of other 
trypanosomatid species, e.g. T. b. gambiense (Koffi et al., 2009), T. congolense (Morrison et 
al., 2009a), L. braziliensis (Rougeron et al., 2009) and L. guyanensis (Rougeron et al., 2011), 
including establishing putative levels of genetic exchange.  
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5.1.2. In vitro recombination in T. cruzi 
The generation of intra-TcI hybrids in vitro strongly support the premise that at least some T. 
cruzi strains have an extant capacity for genetic exchange (Gaunt et al., 2003). The putative 
parental isolates identified by Carrasco et al., were transformed with episomal recombinant 
plasmids containing either hygromycin B or neomycin resistance genes and co-passaged 
through in vitro (mammalian cell cultures) and in vivo (mice and triatomine bugs) life cycles 
(Gaunt et al., 2003). Isolation of six clones by double drug selection from in vitro axenic 
cultures, and subsequent genetic characterization by MLEE, karyotyping, microsatellites and 
nucleotide sequencing of housekeeping genes, demonstrated that these intra-lineage 
recombinants had inherited all parental alleles at most loci and one parental maxicircle 
genotype.  
By analogy with Candida albicans (Bennett and Johnson, 2003; Forche et al., 2008), it was 
proposed that nuclear fusion had created a tetraploid intermediate, followed by homologous 
recombination, gradual genome erosion and reversion to aneuploidy. FACs analysis of hybrid 
isolates indicated a stable DNA content, on average, 69% higher than parental strains (Lewis 
et al., 2009b). Subsequent prolonged maintenance in axenic cultures demonstrated a gradual, 
progressive decline in DNA content, with no evidence of any true meiotic reductive division; 
to date these experimental hybrids remain sub-tetraploid (Lewis et al., 2010).  
While this parasexual mechanism of genetic exchange has a precedent in fungal species, it is 
challenging to reconcile with both the patterns of allele inheritance observed among natural 
T. cruzi populations (Table 5.1) as well as the conservation of meiosis-specific orthologues 
within the T. cruzi genome (Ramesh et al., 2005). A similar paradox exists in T. b. brucei 
where canonical meiotic recombination (Peacock et al., 2011), including the formation of 
haploid life cycle stages (Peacock et al., 2014), has been explicitly described in vitro, but is 
not the exclusive mechanism reported from transmission cycles (Duffy et al., 2013). 
Likewise, experimental hybridization in Leishmania resembles meiosis (Akopyants et al., 
2009; Inbar et al., 2013) but both aneuoploidy and inbreeding are frequent in nature 
(Rougeron et al., 2009; 2011; Sterkers et al., 2011; 2014; Calvo-Álvarez et al., 2014; Rogers 
et al., 2014).  
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5.2 Objectives 
The aim of this chapter was to exploit the phylogenetic markers developed in chapter 3 to 
measure the frequency of natural genetic exchange, identify any potential underlying 
mechanisms and examine its impact on T. cruzi population structuring.  
Specific objectives were to: 
a. Investigate the principal mating strategy of TcI within an intensively-sampled 
endemic disease focus in Colombia.  
b. Compare incongruence between nuclear and mitochondrial topologies to uncover 
mitochondrial introgression events occurring among TcI populations.  
c. Examine the inheritance patterns of natural hybrids strains from Colombia to 
resolve their putative status as novel recombinants. 
d. Characterize intra-TcV and TcVI genetic diversity across its expanding 
geographical range 
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5.3 Results 
5.3.1 Cryptic sexuality in T. cruzi 
The majority of field evidence suggests T. cruzi does not conform to strict clonality 
(Tibayrenc and Ayala, 1991) or panmixia (Harvey and Keymer, 1987) and that 
recombination is frequent, non-obligate and idiosyncratic, potentially involving independent 
exchange of kinetoplastid and nuclear genetic material (Carrasco et al., 1996; Machado and 
Ayala, 2001; Ocaña-Mayorga et al., 2010; Messenger et al., 2012; Lewis et al., 2011; Roellig 
et al., 2013; Baptista et al., 2014). However, the relative contributions of alternate mating 
strategies to T. cruzi population structures are still strongly debated (Lewis et al., 2011; 
Tibayrenc and Ayala, 2012; 2013; Ramirez and Llewellyn, 2014) 
To examine the predominant mode of parasite reproduction among natural populations, high 
resolution nuclear (Llewellyn et al., 2009a) and mitochondrial (Messenger et al., 2012) 
genotyping was used to characterize 269 TcI biological clones isolated from domestic, 
peridomestic and sylvatic transmission cycles in three Colombian provinces (Boyaca, 
Casanare and Santander).  
This study is reported in full below in Ramírez, et al. 2012. 
In summary: 
- Measurements of Ar demonstrated uniformly high genetic diversity across all study sites 
(Ar = 2.958-3.778) with the exception of a sylvatic population in Boyaca (Ar = 1.633), 
which was likely attributable to local human-mediated habitat degradation.  
- MLGs were rarely repeated which was consistent with intense local parasite transmission. 
Strongly significant multilocus linkage disequilibrium (MLD) (IA = p<0.0001 for all 
populations) indicated that clonal propagation was the predominant mode of nuclear 
reproduction. 
- Non-parametric nuclear clustering and phylogenetic analyses supported a clear genetic 
subdivision between domestic and sylvatic populations; most peridomestic strains were 
poorly differentiated from those found in local sylvatic environments. The majority of 
domestic isolates were robustly grouped together (TcIDOM).  
- A subset of Colombian patients were ‘super-infected’, i.e. harbored a mixture of different 
clones, some of which had sylvatic origins.  Isolation of only TcI from a neonate born to 
a co-infected TcI-TcII mother, suggests parasite DTU may also influence congenital T. 
cruzi transmission. 
- Gross nuclear-mitochondrial phylogenetic incongruence identified multiple, independent 
mitochondrial introgression events among ~20% of isolates, challenging clonality as the 
predominant mating strategy in Colombia. No evidence of reciprocal nuclear 
recombination was observed among any recombinant strains. This may reflect an 
alternate mating system involving asymmetric mitochondrial inheritance or the relative 
sampling amount of each genome (20% of the mitochondrial genome vs. <0.1% of the 
nuclear genome).  
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- A mosaic maxicircle sequence was detected in a human isolate from Santander by the 
presence of a recombination breakpoint within a contiguous region of the MURF1 gene, 
and confirmed by allele-specific PCR, to exclude PCR error and/or Taq polymerase 
template switching. Inter-molecular mitochondrial recombination represents another 
method of generating novel genetic diversity and may function to prevent the 
accumulation of deleterious mutations following clonal expansion (‘Muller’s Ratchet’). 
- Bayesian skyline plots (BSPs) constructed from mitochondrial sequence data indicated 
that Colombian TcIDOM strains emerged 23,000 ± 12,000 years ago, and underwent 
population expansion, broadly coinciding with the earliest human migration into South 
America. 
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Abstract
Clonal propagation is considered to be the predominant mode of reproduction among
many parasitic protozoa. However, this assumption may overlook unorthodox, infre-
quent or cryptic sexuality. Trypanosoma cruzi, which causes Chagas disease, is known to
undergo non-Mendelian genetic exchange in the laboratory. In the field, evidence of
extant genetic exchange is limited. In this study, we undertook intensive sampling of
T. cruzi Discrete Typing Unit I in endemic eastern Colombia. Using Fluorescence-
activated cell sorting, we generated 269 biological clones from 67 strains. Each clone was
genotyped across 24 microsatellite loci. Subsequently, 100 representative clones were
typed using 10 mitochondrial sequence targets (3.76 Kbp total). Clonal diversity among
humans, reservoir hosts and vectors suggested complex patterns of superinfection and ⁄or
coinfection in oral and vector-borne Chagas disease cases. Clonal diversity between
mother and foetus in a congenital case demonstrates that domestic TcI genotypes are
infective in utero. Importantly, gross incongruence between nuclear and mitochondrial
markers is strong evidence for widespread genetic exchange throughout the data set.
Furthermore, a confirmed mosaic maxicircle sequence suggests intermolecular recombi-
nation between individuals as a further mechanism of genetic reassortment. Finally,
robust dating based on mitochondrial DNA indicates that the emergence of a widespread
domestic TcI clade that we now name TcIDOM (formerly TcIa ⁄VENDom) occurred
23 000 ± 12 000 years ago and was followed by population expansion, broadly corre-
sponding with the earliest human migration into the Americas.
Keywords: disease biology, empirical evolution of sex, molecular evolution, parasitology, popu-
lation genetics, protists
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Introduction
Several models exist to describe the population genetic
structure of parasitic organisms. At the extremes of the
spectrum are panmixia (Harvey & Keymer 1987) and
pure clonality (Tibayrenc & Ayala 1991), but also several
intermediates exist, tailored to particular epidemiologi-
cal scenarios within the same species (Maynard
Smith et al. 1993). Population data collected from the
field, as well as experimental crosses in the laboratory,
now suggest that such intermediates provide the ‘best-
fit’ for many parasitic protozoa. Occasional (or perva-
sive) sex and associated random segregation between
genetic markers are reported variously among Plasmo-
dium, Giardia, Leishmania, Toxoplasma, Trypanosoma brucei
ssp. and Trypanosoma cruzi (Jenni et al. 1986; Grigg &
Suzuki 2003; Mzilahowa et al. 2007; Akopyants et al.
2009; Birky 2011; Ocana-Mayorga et al. 2011). However,
while laboratory crosses demonstrate a capacity for
genetic exchange, field evidence from allele frequencies
among natural populations can be limited and equivocal.
Parasite population geneticists commonly rely on rap-
idly evolving short tandem repeat (STR) loci at local
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spatial and temporal scales to detect genetic exchange
(Rougeron et al. 2009; Ocana-Mayorga et al. 2011).
However, data interpretation is hampered by blunt sta-
tistical tools whose models deal poorly with partial clo-
nality and ⁄ or non-Mendelian genetic exchange at a
population level. Important theoretical advances have
been made in the interpretation of such statistics (De Me-
eus et al. 2006). However, complementary approaches
examining extranuclear genomes are required to bolster
such data and provide compelling evidence that sex
among some species is extant, frequent and epidemio-
logically important, even if it does not conform to classic
Hardy–Weinberg expectations.
Trypanosoma cruzi is a zoonotic kinetoplastid proto-
zoan and the agent of Chagas disease in Latin America.
Transmission to humans occurs mostly via the infected
faeces of domiciliated triatomine species. However,
important nonvectoral transmission routes are also rec-
ognized, including oral transmission via contaminated
fruit products and congenital transmission.
Structured genetic diversity in other medically impor-
tant trypanosomatids has led to the designation of spe-
cies [Leishmania sp. (Miles et al. 2009)] or subspecies
[T. brucei spp. (Hide & Tait 2009)]. Similarly, divergent
T. cruzi taxonomic units are defined as discrete typing
units (DTUs). Six DTUs have been described: TcI–TcVI
(Zingales et al. 2009). The distribution of these DTUs is
related to several ecological and epidemiological vari-
ables, including host, geography and transmission cycle
[wild (henceforth ‘sylvatic’) vs. domestic]. Among the
DTUs, TcI is the most abundant and widely dispersed.
TcI has also been the focus of recent attempts to charac-
terize genetic diversity at the sub-DTU level and several
epidemiologically important findings have emerged
(Herrera et al. 2007; Llewellyn et al. 2009; Ocana-May-
orga et al. 2011; Ramı´rez et al. 2011a). The ability to iso-
late multiple T. cruzi clones from individual hosts
means that patterns of superinfection and infrapopula-
tion diversity within TcI can now be examined (Llewel-
lyn et al. 2011).
A defining feature of kinetoplastid protozoa is the
kinetoplast, the organelle which contains the trypano-
some’s mitochondrial (mt) DNA. Kinetoplast DNA
comprises a network of tens of thousands of interlock-
ing c. 1 kb minicircles, interlaced with 20–50 larger
(c. 25 Kb) maxicircles. In T. cruzi, minicircle populations
are highly heterogenous within a single clone (Telleria
et al. 2006). However, next generation sequencing
reveals that maxicircles are relatively homogeneous by
comparison, at least within their coding region (Messen-
ger et al. 2012). This feature, and the availability of
three complete maxicircle sequences, has enabled
mtDNA multilocus sequence typing of T. cruzi and
revealed minor coding heteroplasmy (Messenger et al.
2012). Among animals, the mtDNA mutation rate is an
order of magnitude higher than that of the nuclear gen-
ome (Haag-Liautard et al. 2008). A similar mutation
rate differential is apparently true for T. cruzi (Machado
& Ayala 2001; Messenger et al. 2012), with correspond-
ing power to distinguish closely related clones.
On the basis of limited laboratory (Gaunt et al. 2003)
and field (Machado & Ayala 2001) data, maxicircle
inheritance in T. cruzi is thought to be uniparental. Sev-
eral studies have now shown evidence for cases of
interlineage mitochondrial introgression, whereby the
maxicircle genome from one DTU is present alongside
an apparently nonrecombinant nuclear genome from a
different DTU (Machado & Ayala 2001; Messenger et al.
2012). Clear incongruence between nuclear and mito-
chondrial phylogenies results.
In this study, we evaluated diversity at 24 nuclear
STR loci across 269 TcI clones and 10 mitochondrial
sequence loci (3.76 Kbp) across a subset of 100 clones,
most from a restricted disease focus in Colombia. We
identified frequent incongruence between nuclear and
mitochondrial clustering as the first robust evidence
that TcI is undergoing genetic exchange repeatedly in
natural transmission cycles. Furthermore, Bayesian sky-
line plots (BSPs) of an expanded mtDNA data set indi-
cated that the emergence of a widespread domestic
clade (TcIDOM) occurred c. 23 000 years ago, broadly
corresponding with the first human arrivals in South
America.
Methods
Study area, parasite cloning and Trypanosoma cruzi
genotyping
Three provinces (Boyaca, Casanare and Santander) were
sampled in north-eastern Colombia (Fig. S1, Supporting
information). Multiple triatomines and mammals were
captured at domestic (within dwellings), peridomestic
(near dwellings) and sylvatic (>10 m from dwellings)
sites. Trypanosomes from patients were isolated after
written informed consent and with local ethical clear-
ance approved by National Institute of Health (CTIN
012 ⁄ 08). For a full list of isolates and clones see Table
S1 (Supporting information). Parasites were cloned from
culture either into Liver Infused Tryptone containing
wells on 96-well plates using a BD FACSAria flow
cytometer or via limiting dilution (Ramı´rez et al. 2011b).
Clones for analysis were selected at random among
those that grew in the plates. DNA was extracted using
a Qiamp DNA isolation kit. Trypanosoma cruzi DTU was
preliminarily defined via a 400 bp glucose phosphate
isomerase (GPI) gene fragment (primers in Table S3,
Supporting information), for which a wealth of
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comparative data are available from the literature (Brou-
tin et al. 2006; Lewis et al. 2011). Two hundred and sev-
enty sequences were deposited in GenBank.
Microsatellite analysis
Twenty-four microsatellite loci, distributed across eight
putative chromosomes, were amplified as described
previously (Llewellyn et al. 2009) (Table S2, Supporting
information). Prior to population genetic analysis, iso-
lates were grouped a priori into seven populations: Boy-
aca domestic (BD), Boyaca peridomestic (BP), Boyaca
sylvatic (BS), Casanare domestic (CD), Casanare perido-
mestic (CP), Casanare sylvatic (CS) and Santander
domestic (SD). Statistics were calculated for each popu-
lation as previously (Table S3, Supporting information)
(Ocana-Mayorga et al. 2011).
Individual level sample clustering was defined via a
neighbour-joining tree based on pairwise distances
between multilocus genotypes MLGs [evaluated using
DAS (1 ) proportion of shared alleles at all loci ⁄n)] cal-
culated in MICROSAT (Minch et al. 1995). To define a
posteriori the number of putative populations in the data
set using a nonparametric (free from Hardy-Weinberg
constraints) approach, we employed a K-means cluster-
ing algorithm, implemented in adegenet. As described
in Jombart et al. 2010; the ‘true’ number of populations
can be defined by reference to the Bayesian Information
Criterion (BIC), which reaches a minimum when the
best supported assignment of individuals to the appro-
priate number of clusters is approached Jombart et al.
2010. In practice, this number is selected at the ‘elbow’
of the BIC curve (Fig. 1). The relationship between
these clusters and the individuals within them can be
evaluated via a discriminant analysis of principal com-
ponents (DAPC), again as in (Jombart et al. 2010). We
chose to retain the number of principal components
(PCs) that represented the first 80% of the total varia-
tion in the data set. DAPC results are presented as mul-
tidimensional scaling plots in Figs 1 and 2.
Multilocus mtDNA (maxicircle) sequence analysis
One hundred clones representative of the total nuclear
diversity were selected for multilocus mtDNA sequence
analysis. Ten mitochondrial maxicircle DNA fragments
were sequenced and concatenated as in Messenger et al.
(2012) (Table S2, Supporting information). This data set
was evaluated in MODELTEST 3.7 (Posada & Crandall
1998) where the most appropriate evolutionary model
was selected based on the Akaike Information Criterion.
A maximum composite likelihood analysis using a
Tamura-3 parameter model and the neighbour-joining
algorithm was run in RAXML 7.2.5. To evaluate the
robustness of the nodes in the resulting phylogenetic
tree, 1000 bootstrap replicates were performed. The
final tree was rooted with Esmeraldo (TcII) and CANIII
(TcIV) sequences. Sequences were deposited in Gen-
Bank.
The mtDNA data set was submitted to RDP (Martin
et al. 2005) to identify potential mosaic recombinants.
Several algorithms were implemented including GEN-
ECONV, BOOTSCAN ⁄RECSCAN and MaxChi. Putative
mosaics were confirmed by eye and empirically via alle-
lic specific PCR (ASP) using specially designed primers
for regions flanking the putative breakpoints (Fig. S3,
Supporting information).
Molecular dating using mtDNA sequences
To provide a date for the emergence of the key human
TcI clade, we used a Bayesian Markov chain Monte
Carlo (MCMC) method implemented in the Bayesian
evolutionary analysis by sampling trees (BEAST) pack-
age (Drummond et al. 2005). Excluding three divergent
and ⁄ or recombinant clones, a final 3.7 Kbp alignment of
concatenated maxicircle sequence from 97 TcI single-
celled clones was assembled for analysis. We included
nine further TcI ⁄TcIV isolates from Messenger et al.
(2012) including several from North ⁄Central America,
as well as from the TcIDOM clade (VENDom ⁄TcIa) (Lle-
wellyn et al. 2009; Herrera et al. 2007). A full list of
samples used is included in Table S1 (Supporting infor-
mation). Further details of methodology are included in
Table S5 (Supporting information).
Results
Genetic diversity, heterozygosity and linkage
Two hundred and sixty-nine clones were genotyped
against 24 microsatellite loci (Table S4, Supporting
information) and we identified 212 distinct MLGs. Esti-
mates of allelic richness indicate comparable and high
genetic diversity among populations (BD, BP, CD, CP,
CS, SD, Ar = 2.958–3.778, Table S3, Supporting informa-
tion), but showed a marked reduction in BS (1.633,
Table S3, Supporting information). Over loci, FIS values
indicate a widespread deficit in heterozygosity, corrobo-
rated by significant deviation from H-W allele frequen-
cies at individual loci (FIS = 0.37–0.17, 55–52%
polymorphic loci with significant deficit in heterozygos-
ity, Table S3, Supporting information). Again, BS repre-
sents a clear outlier with strongly negative values for
FIS ()0.65, Table S3, Supporting information) and corre-
sponding high heterozygosity (41% of loci with signifi-
cant excess). Multilocus linkage disequilibrium,
manifest in strongly significant values for the IA across
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all sufficiently diverse populations, suggests (mislead-
ingly) that clonal reproduction prevails throughout the
data set.
Across the final, 3680 bp concatenated maxicircle
fragment, we identified 243 variable sites within TcI.
Clustering based on nuclear data
Thirty clusters were defined among the 269 clones sub-
jected to DAPC, once 41 PCs had been retained (80% of
the total variation) and subjected to analysis. A full list
of the assignments of individual clones to DAPC popu-
lations is included in Table S1 (Supporting information).
A neighbour-joining (NJ) tree was constructed from the
same data set for comparison (Fig. 1). Broad congru-
ence was observed between the two methodologies;
however, DAPC provided the additional benefit of
allowing better visualization of the relative distances
between groups. As such, the majority of populations
made up of nonhuman isolates tended to group
together (most notably those defined by the label ‘x’,
Fig. 1). However, among sylvatic clones some clear out-
liers are evident, most notably clones from BS (pale
green, NJ Tree, Fig. 1) and a subset (group 20) from CS
Fig. 1 Genetic clustering among 269 Colombian TcI clones including oral, congenital and vector borne human disease cases. Top –
Multidimensional scaling plot is based on a DAPC for 30 clusters defined via K-means clustering (109 iterations, 41 PCs (80% of vari-
ation) retained, BIC curve inserted – error bars represent SD about the mean of five independent runs). Clusters are defined by dis-
tinct colours and inertia ellipses, dots represent individual clones. Clusters 14, 15 and 16 contain clones defined as belonging to
nuclear Cluster 6 (nuclear) in Fig. 2. Bottom – Unrooted neighbour-joining tree constructed using individual pairwise DAS values.
Closed circles indicate clades with bootstrap stability ‡70% across 1000 replicates. Branch colours correspond to province and trans-
mission cycle: red – Casanare domestic, pink – Boyaca domestic, orange – Santander domestic (SD), dark blue – Casanare peridomes-
tic, pale blue – Boyaca Peridomestic, green – Casanare sylvatic, pale green – SD. Human symbols indicate where clones from human
cases are located on the tree. Red human symbols indicate co ⁄ superinfecting clones of likely sylvatic origin that cooccur in the same
patient as clones from groups 14, 15 and 16. Arrows indicate congruence between the two clustering techniques and broadly define
clades ⁄ clusters comprised of a majority of sylvatic (green) or domestic (red) clones.
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(dark green, NJ Tree, Fig. 1). Peridomestic strains from
BP (pale blue, NJ Tree, Fig. 1) and CP (pale blue, NJ
Tree, Fig. 1) are poorly differentiated from those that
occur in the local sylvatic environment as are a number
of strains isolated from domestic vectors. The great
majority of those clones isolated from humans (TcIDOM)
are clustered in four populations 14, 15, 16 and 21.
However, there are numerous instances where human
clones from BD and SD are scattered across other popu-
lations linked to sylvatic and ⁄or peridomestic transmis-
sion. Crucially, as indicated by red symbols on the NJ
tree (Fig. 1), human patients are commonly infected
with a mixture of clones, some belonging to the
expected 14, 15, 16 and 21 groups, others highly diver-
gent and nested among sylvatic clones (e.g. populations
2, 17 and 8).
Detection of mtDNA introgression events and mosaics
With the aim of identifying introgression events
between nuclear and mitochondrial genomes, a second
DAPC was conducted based on nuclear STR loci from
the 100 isolates for which mtDNA sequences were
available. In this case, 27 different PCs were retained
and a total of 13 clusters identified among the data
(Fig. 2). Group six corresponds to human clones from
populations 14, 15 and 16 in the previous DAPC. These
13 groups were subsequently compared to patterns of
clustering derived from maximum-likelihood composite
(MLC) analysis of the mtDNA sequences (Fig. 2). Only
MLC tree clades with >80% bootstrap support were
treated as robust clusters. The mtDNA phylogeny sup-
ported the presence of significant diversity among
Fig. 2 Widespread mitochondrial introgression among 100 Colombian TcI clones. Left – Multidimensional scaling plot is based on a
discriminant analysis of principal components for 13 clusters defined via K-means clustering (109 iterations, Bayesian Information
Criterion minimum reached at K = 13) across 24 nuclear microsatellite markers. Twenty-seven principal components were retained,
constituting 80% of the total variation present. Clusters are defined by distinct colours and inertia ellipses, dots represent individual
clones. Right – Rooted maximum composite likelihood tree constructed using neighbour joining under a Tamura-3 parameter model
derived from 10 mtDNA gene fragments. Bootstraps indicate instability across 1000 pseudoreplicates. Coloured polygons at branch
tips indicate nuclear cluster identity. Cluster 6 (green, black border) corresponds to TcIDOM. Red stars indicate clear instances of max-
icircle introgression between genetically distinct nuclear clades. Isolate marked ‘H’ represents a mosaic hybrid (SEVcl11) maxicircle,
confirmed via allele specific PCR (Fig. S3, Supporting information), and derived from parents labelled ‘P1’ and ‘P2’.
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those isolates examined. Indeed, two highly divergent
groups were present among the data: one apparently
basal and closer to the TcII ⁄TcIV outgroup and
another, more populous, containing multiple well-
defined subclades. Introgression was a pervasive phe-
nomenon, and we identified multiple instances, among
which the most striking are highlighted with red stars
(Fig. 2). To rule out the possibility of ‘hidden’ or low
frequency heteroplasmy across the two major mtDNA
clades, we designed specific primers for ND1 and 9S
sequences for the basal clade and attempted amplifica-
tion of these sequences from key clones (AAC1cl3,
TmPA1cl8, NR1cl3, YAS1cl3, primers in Table S2, Sup-
porting information). No unexpected PCR products
were observed.
In addition to detecting multiple signatures of mito-
chondrial introgression among clones, we uncovered a
mosaic maxicircle sequence in LERcl11, FACS cloned
from a patient in Santander province, using RDP v.3.0.
Two parental clones were identified [LERcl12 (P1) and
N5P14cl14 (P2), P = 0.0374]. Two recombination break
points (break in and out) were found between at posi-
tion 1196 (in) and 1379 (out), across a region spanning
14 SNPs. The mosaic was located in the MURF1 gene,
within a continuous sequence fragment generated as
part of the mMLST. To confirm the validity of the
result, and in order to exclude PCR error and ⁄or Taq
polymerase template switching, we developed an ASP
assay. Two distinct primer pairs were synthesized to
amplify specifically each parent. Subsequently, forward
P2 primer and reverse P1 primer were shown to
amplify specifically LERcl11 but not parents in a
touchdown PCR (Fig. S3; Table S2, Supporting infor-
mation).
BSP and TcIDOM genotype emergence estimation
Both nuclear and mitochondrial data sets indicate the
presence of a strongly bootstrap supported human
domestic TcI genotype, TcIDOM, corresponding to TcIa
(Herrera et al. 2007) or VENDom (Llewellyn et al. 2009).
We used a Bayesian MCMC coalescent strategy to date
the emergence of this genotype in the history of TcI in
South America using maxicircle sequence data. Bayes
factors identify expansion growth as the most appropri-
ate demographic model under a strict molecular clock
(log BF = 5.01, Table S5, Supporting information). The
tMRCA of TcIDOM was estimated at 23 000 years (95%
highest posterior density (HPD) 37 000–13 000 years) (ln
)15234.235). A BSP corroborates this date and indicates
a sharp reduction in effective population size approxi-
mately 27 000 years ago followed by a gradual expan-
sion from 23 000 years ago until the present (Fig. 3).
Discussion
This study represents the most detailed attempt to doc-
ument Trypanosoma cruzi population genetic diversity to
date and combines high density spatiotemporal sam-
pling, including multiple samples from the same host,
with the application of high resolution genotyping of
both nuclear and mitochondrial genomes to the result-
ing clones. A wealth of biologically, epidemiologically
and evolutionarily important phenomena emerges.
Fig. 3 Bayesian skyline plot estimating
effective populations size fluctuations in
the history of the domestic TcI genotype
(TcIa ⁄ VENDom). Twenty million itera-
tions were run to generate the highest
credibility Bayesian tree based on the
expansion growth model. Ninety-five
per cent highest posterior density confi-
dence intervals are presented, as well as
a timeline.
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Nuclear genetic diversity, population subdivision,
superinfection and oral infection
Nuclear genetic diversity across the data set was uni-
formly high at all study sites and transmission cycles
examined, with the exception of sylvatic isolates from
Boyaca province. Repeated MLGs were surprisingly
uncommon in the data set (57 ⁄ 269), given the number
of samples that were clones from the same stock. Crisci-
one & Blouin (2006) interpret high infrapopulation
(within host) and intrapopulation (within study site)
MLG diversity as evidence of low rates of clonal extinc-
tion at the population level among parasitic worms
(Criscione & Blouin 2006). As with Plasmodium sp.
(Schoepflin et al. 2009), we suggest this indicates
intense local parasite transmission, consistent with
extraordinary levels of TcI diversity also present in the
Venezuelan ‘Llanos’ plains (Llewellyn et al. 2009, 2011),
a continuous ecoregion linking western Venezuela and
eastern Colombia that drains into the great Orinoco
River. Using the same logic, reduced transmission and
transmission efficiency should be accompanied by
reduced parasite diversity. Sylvatic sites in Boyaca
examined are heavily degraded and transformed by
human activities. As such sylvatic mammal and triato-
mine capture success rates were significantly reduced.
Deforestation and habitat destruction has been shown
to significantly reduce parasite prevalence in sylvatic
mammals in north-western Argentina (Ceballos et al.
2006). It seems a similar anthropogenic phenomenon
could be negatively impacting sylvatic parasite diversity
in Boyaca.
We chose to calculate population genetic statistics
from clone corrected (identical MLGs deleted) groups
of individuals assigned to populations a priori by study
site and transmission cycle. Population assignment via
DAPC and NJ DAS clustering (adopted as a ‘model free’
approach, see Methods) indicates these groupings are in
many cases genetically subdivided (Fig. 1). This is espe-
cially true for domestic and peridomestic populations,
whereby a subset of clones is scattered among sylvatic
parasite clades, while others group strongly together
regardless of study site. Thus, widespread homozygos-
ity in these populations might be attributed to Wahlund
effects. Clones from CS form a more cohesive group in
genetic terms. DAPC populations comprised of these
isolates tend to cluster together, especially those making
up group x in Fig. 1. Thus, we can perhaps give greater
credence to significant homozygosity found therein.
Several explanations compete to explain allelic homozy-
gosity observed in trypanosome populations (Llewellyn
et al. 2009; Rougeron et al. 2009). Most aim to account
for the lack of a Meselson effect, which is thought to
drive the emergence of extreme heterozygosity in the
absence of sex over the long term (Mark Welch &
Meselson 2000). From our reading of the literature, the
Meselson effect seems to be an exception, rather than
the rule for ‘clonal’ trypanosome population structures
(Llewellyn et al. 2009; Rougeron et al. 2009; Gelanew
et al. 2010; Barnabe et al. 2011; Kuhls et al. 2011; Lle-
wellyn et al. 2011). In general, we urge caution in the
interpretation of heterozygosity statistics at STR loci in
the context of parasite sexuality, especially given that
strong evidence for linkage disequilibrium often accom-
panies both negative and positive values for FIS. The
current data set is no exception. For TcI in particular,
however, we note with interest that excess heterozygos-
ity and low genetic diversity appear to go hand in hand
at the population level (Llewellyn et al. 2009; Barnabe
et al. 2011). This is also true for BS in our study,
although we refrain from speculation as to the causes
in the absence of more samples and better genomic cov-
erage of the clones involved.
While nuclear STR loci alone in this study do little to
enhance our understanding of parasite mating systems,
patterns of clustering do assist source attribution of
human and domestic T. cruzi clones. We have demon-
strated that domestic and sylvatic TcI populations were
highly distinct in Venezuela and eastern Colombia
(Herrera et al. 2007; Llewellyn et al. 2009) despite fre-
quent invasion of the domestic setting by infected vec-
tor species. STR data presented here also support the
existence of the same distinct domestic TcI clade – TcI-
DOM. Comparisons between mitochondrial data sets
support identity between this group and VENDom
(human isolates from across Venezuela (Llewellyn et al.
2009; Messenger et al. 2012)) as well as TcIa (Herrera
et al. 2007, p. 24). Previously, we interpreted sylvatic–
domestic subdivision in the context of poor stercorarian
transmission, whereby multiple exposures to contami-
nated domestic triatomine faeces were necessary to
disperse the parasite, rather than opportunistic feeds by
invasive sylvatic vectors (Llewellyn et al. 2009). None-
theless, we were also able to demonstrate a low
frequency of human symptomatic infection with
sylvatic-type strains (Llewellyn et al. 2009). These new
data clearly show that humans (e.g. EB, SEV and SP)
can be infected simultaneously by both sylvatic and
domestic-type T. cruzi clones. In regions highly ende-
mic for Chagas disease, exposure commonly begins in
early childhood. As with most other parasitic diseases,
superinfection is thus a likely outcome and intrahost
parasite diversity should accumulate with age, assum-
ing a sufficient force of infection, incomplete cross-geno-
typic immunity and no density dependent factors
influencing the ability of secondary infections to estab-
lish. No apparent relationship between age and infec-
tion multiplicity exists in our data set, and simultaneous
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coinfection is also a likely source of intrahost parasite
diversity. Furthermore, we have probably sampled
only a proportion of intrahost diversity. In patients
EM and EB, for example, mother and child respec-
tively where congenital transmission has occurred,
some MLGs are present in the child but not the
mother. Two other points of interest relate to this con-
genital case. The first is proof that clones from the
TcIDOM can be transmitted congenitally, a phenomenon
of wider importance throughout the region given its
frequency among human cases (Herrera et al. 2007;
Llewellyn et al. 2009; Cura et al. 2010). The second is
that EM was coinfected with both TcI and TcII (GPI
sequence identified), yet only TcI was isolated in EB.
As such our data suggest infection multiplicity cannot
be ignored when evaluating the link between T. cruzi
genotype and congenital transmission. Finally, we can
confirm clones from several linked oral cases in Sant-
ander are likely to originate from the local sylvatic
environment (patients EH, LER and SMA). However,
domestic TcI clones within some of these individuals
(LJVP and CACQ), suggest the foodstuff was contami-
nated by a mixed infection from a domestic vector(s).
All cases were acute and symptomatic (patient EH
died) inconsistent with the normal experimental out-
come of T. cruzi superinfection and point to coinfec-
tion instead.
Mitochondrial introgression is not consistent
with Trypanosoma cruzi clonality
Sexual activity in trypanosomes facilitates the emer-
gence of successful epidemic clones and the spread of
human infectivity in Trypanosoma brucei subspecies
(Balmer et al. 2011), and new phenotypic traits in
Leishmania (Volf et al. 2007). In T. cruzi, significant
genetic exchange events that have shaped population
structure – specifically those that have given rise to
successful domestic DTUs TcV and TcVI – date to
early human history (Lewis et al. 2011). It is known
that T. cruzi possesses an extant capacity for (perhaps
nonmeiotic) genetic exchange (Gaunt et al. 2003; Lewis
et al. 2011). How the complex molecular toolkit for
such a capacity might be retained, given its supposed
infrequency of use, is a mystery. The solution pre-
sented herein is that TcI, at least, uses this machinery
all the time. Figure 2 provides proof in the form of
widespread incongruence between nuclear and mtDNA
phylogenies, consistent with frequent genetic exchange
between closely related, but distinguishable clones.
Potentially common selfing events prevent a precise
frequency estimate within our data set, however,
examining Fig. 2, suggests a minimum of 17 events
among 100 clones.
Introgression events are common among animal para-
sites. In both platyhelminthes [Schistosoma sp. (Huyse
et al. 2009)] and nematodes [Ascaris sp., (Criscione et al.
2007)], mitochondrial introgression indicates contempo-
rary hybridization between human and domestic animal
species. Such events are evolutionarily advantageous in
terms of expanding host ranges. Interestingly, as with
our data, such events are frequently asymmetric,
whereby little nuclear genetic exchange accompanies
the invasive plastid genome (Steinauer et al. 2008).
Asymmetric progeny from interspecies genetic crosses
could result from chromosomal incompatibility between
divergent parents (Lewis et al. 2011) or via chromo-
somal rearrangements between closely related strains.
However, back crossing of hybrids into one parental
population may also explain nuclear asymmetry in
Schistosoma sp., as well as in T. cruzi. Similarly, we can-
not rule out some nuclear exchange (Fig. S2, Support-
ing information), and while we have sampled perhaps
20% of the mitochondrial genome, we have sampled
<0.1% of the nuclear genetic material from each clone.
Recombination among yeast, animal and plant mito-
chondrial genomes is widely reported (Rokas et al.
2004; Marechal & Brisson 2010; Solieri 2010). However,
the maxicircle–maxicircle fusion and recombination
detected and confirmed in our data set is a first among
trypanosomes. Biparental inheritance of maxicircles is
reported from experimental T. brucei crosses (Gibson
et al. 2008). However, it is assumed that one population
of maxicircles is lost stochastically in subsequent rounds
of mitotic division. Patterns of maxicircle inheritance in
our data set suggest an analogous mechanism pervades
in 99% of cases. However, a 1% rate of maxicircle
fusion translates into a significant number of potential
recombinants population-wide. This result is hardly
surprising given that mitochondrial genomes have a
greater need than most to escape from Muller’s Ratchet
because of their elevated mutation rate.
TcIDOM population expansion coincides
with the earliest human colonization of South America
Human colonization of South America is thought to
have occurred via the Isthmus of Panama rapidly along
the Pacific coastline before lateral migration eastwards
into the interior. There are different reports of settle-
ments in the late Pleistocene in South America and esti-
mations of human arrival and settlement in South
America fluctuate around 12 500 years ago (reviewed in
Goebel et al. 2008). Remarkably, the colonization of
North America via the Bering Land Bridge occurred a
mere c. 2000 years earlier. The southerly migration of
humans into South America coincides with the pattern
of diversity we see in TcIDOM, whereby nuclear and
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mitochondrial markers suggest a link with sylvatic
strains from Northern and Central America (Llewellyn
et al. 2009; Cura et al. 2010; Messenger et al. 2012). The
date we derive for the emergence of TcIDOM
(23 000 years, 95% HPD 37 000–13 000) corresponds
broadly with the arrival of the earliest humans in the
Americas and mirrors the level of uncertainty around
the human molecular data [30 000–13 000 years ago (Go-
ebel et al. 2008)]. Furthermore, the reduction in Ne
observed in this group, followed by a gradual expan-
sion, fits with a pattern that might be expected during
the colonization of a new host species ⁄ transmission
cycle. Taken together, these observations suggest that
early humans must have first domesticated this TcI
genotype in North ⁄Central America, prior to codisper-
sion and coexpansion into South America. Indeed, SL-IR
genotyping suggests a distribution that now extends as
far south as the Argentine Chaco (Cura et al. 2010).
Conclusions
Next generation sequencing advances will shortly her-
ald the arrival of the first protozoan parasite population
genomic studies. However, this study demonstrates that
classic population genetic studies can still be informa-
tive, especially where there is sufficient sample density
in space, time, as well as from within each host or vec-
tor. Furthermore, we show that plastid vs. nuclear gen-
ome comparisons can provide important insight into
the presence and mechanism of genetic exchange.
Indeed, this data set provides probably the first ‘hard
proof’ that genetic exchange in Trypanosoma cruzi
occurs frequently in natural populations. Whole nuclear
genomic comparisons will assist in identifying how
asymmetrical such events truly are between parental
strains. We hope these data will promote efforts to
identify where genetic exchange occurs in the T. cruzi
transmission cycle, as well as provide a model for iden-
tifying recombination among other cryptically sexual
organisms.
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5.3.2. Origins of natural hybrids in Colombia 
T. cruzi TcV and TcVI are known to be recent, natural inter-lineage hybrids, characterized by 
heterozygosity and minimal distinction, sharing intact alleles from their parental progenitors 
(TcII and TcIII) (Machado and Ayala, 2001; Brisse et al., 2003; Barnabé et al., 2011; Lewis 
et al., 2011; Yeo et al., 2011). The origin(s) of TcV and TcVI is unresolved; molecular dating 
indicates that these lineages evolved recently, within the last 60,000 years (Lewis et al., 
2011), possibly from human disruption of sylvatic transmission cycles in the Southern Cone, 
suggesting there is continuous risk of genetic exchange driving the emergence of 
recombinant genotypes. 
With increased sampling, the geographical range of TcV and TcVI appears to be significantly 
more extensive than previously suggested. On the basis of limited sequencing markers (GPI, 
cytochrome b and 18S rDNA), putative hybrid strains were identified among a minority of 
domestic and peridomestic strains from Colombia (Guhl and Ramírez, 2013), representing 
the first report of these lineages this far north; it remains unclear whether these are ‘bona 
fide’ TcV and TcVI strains or progeny of contemporary recombination events. 
 
To resolve the putative status of these Colombian hybrids as novel recombinants, high 
resolution nuclear (Llewellyn et al., 2009a; Yeo et al., 2011; Diosque et al., 2014) and 
mitochondrial (Messenger et al., 2012) genotyping was used to characterize 24 novel 
Colombian strains (including 14 hybrid clones) in comparison to 33 additional reference 
isolates (TcII, TcIII, TcV and TcVI), from across South America.  
 
This study is reported in full below in Messenger et al., submitted. 
In summary: 
- Based on MLMT data, all TcV and TcVI isolates were highly heterozygous (54.6% and 
41.7% polymorphic loci with significant excess in heterozygosity, respectively) and 
displayed lower levels of genetic diversity (DAS = 0.15 and 0.24; Ar = 2.38 and 2.46, 
respectively) and fewer private alleles (PA/L = 0.16 and 0.43, respectively) compared to 
TcII and TcIII parental strains (DAS = 0.44 and 0.48; Ar = 3.94 and 4.26; PA/L = 1.76 and 
2.35; 29.2% and 4.5% polymorphic loci with significant excess in heterozygosity, 
respectively). In this regard these lineages fulfil all of the expectations for progeny from a 
recent recombination event(s) with Mendelian allele inheritance.  
- Haplotype resolution of five nuclear MLST targets demonstrated that, excluding 
infrequent incidences of LOH, each TcV and TcVI clone possessed intact TcII and TcIII 
alleles at every locus. Importantly, haplotypes in Colombian hybrids were either 
indistinguishable or closely related to those identified in reference TcVI strains, with 
minimal affinity to either TcII or TcIII Colombia-specific alleles.   
- Mitochondrial MLST indicated that all Colombian hybrids had inherited a TcIII-type 
maxicircle, divergent from local TcIII mitochondria. A single Colombian isolate from a 
peridomestic dog, classified as TcVI by nMLST and MLMT, shared its maxicircle 
haplotype with southern TcV reference strains.  
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- The majority of mitochondrial and microsatellite genotyping data confirmed that all 14 
suspected Colombian hybrids were ‘bona fide’ TcVI clones, not novel recombinant 
strains, but were distinct from TcVI reference isolates from the Southern Cone. 
- Based on independent inheritance patterns of microsatellite loci, this dataset principally 
supported the hypothesis that two independent recombination events led to the formation 
of TcV and TcVI. However, a more parsimonious explanation for the sharing of 
mitochondrial haplotypes between Southern Cone TcV isolates and a Colombian TcVI 
strain may be that Colombian hybrids are a sibling group to their southern counterparts, 
which diverged and dispersed northwards, following a single hybridization event with 
biparental mitochondrial inheritance between heterozygous TcII and TcIII isolates. 
- Of the genotyping markers evaluated in this study, MLMT afforded the highest 
resolution, distinguishing all TcV and TcVI isolates and exposing intra-strain 
multiclonality among Colombian hybrids. mtMLST was also highly discriminatory, 
particularly among TcV isolates, but should not be used in the absence of comparative 
nuclear data. Among the five nMLST targets assessed, only TcAPX should be considered 
for future TcV and TcVI genotyping (DP=0.5 and 0.33, respectively). 
- The origin(s) of these Colombian TcVI strains remains unresolved. Additional sampling 
efforts are required to identify the primary vector species and explore local disease 
ecology, in order to assess the epidemiological risk of human Chagas disease associated 
with this hybrid lineage, considering its successful, epidemic establishment among 
domestic transmission cycles in the Southern Cone.  
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Abstract 13"
Background The principal reproduction strategy of Trypanosoma cruzi, the aetiological 14"
agent of Chagas disease, is the subject of an intense, decades-old debate. Despite the 15"
existence of two recent natural hybrid lineages (TcV and TcVI), which are sympatric with 16"
severe human disease in southern endemic areas, a pervasive view is that recombination has 17"
been ‘restrained’ at an evolutionary scale and is of little epidemiological relevance to 18"
contemporary parasite populations. With increased sampling, the geographical range of TcV 19"
and TcVI is expanding, with putative hybrids identified as far north as Colombia. 20"
Methods High resolution nuclear (25 microsatellite loci and 5 housekeeping gene fragments) 21"
and mitochondrial (10 loci) genotyping of hybrid clones from Colombia was undertaken, in 22"
comparison to representative reference strains from across South America, to resolve their 23"
putative status as novel recombinants.  24"
Results All 14 suspected Colombian hybrids were highly heterozygous, minimally diverse 25"
and possessed intact parental alleles (TcII and TcIII) at each loci. Compared to local 26"
Colombian isolates, hybrid haplotypes were distinct from, but more closely related to, those 27"
identified in reference TcVI strains from the Southern Cone. Based on independent 28"
inheritance patterns of microsatellite loci, our data support the hypothesis that two separate 29"
recombination events led to the formation of TcV and TcVI. However, more private alleles 30"
among Colombian hybrids and the sharing of mitochondrial haplotypes between southern 31"
TcV isolates and a Colombian TcVI strain, suggests the evolution of these recombinant 32"
lineages may be more complicated than previously assumed.   33"
Conclusions The origin of these Colombian hybrids is unclear; they are unlikely to be 34"
predecessors of southern TcVI strains, but are also not clear descendants, and may instead 35"
2"
"
represent a sibling group, which diverged and dispersed northwards, following a single 36"
hybridization event between heterozygous TcII and TcIII isolates in the Southern Cone. 37"
Importantly, the geographical range expansion of TcVI has potential implications for human 38"
Chagas disease in Colombia, considering the successful, epidemic establishment of this 39"
lineage among domestic transmission cycles in the Southern Cone.  40"
 41"
Introduction 42"
Many eukaryotic pathogenic microorganisms (both fungal and protozoan) that were 43"
previously assumed to reproduce clonally have retained non-obligate, cryptic sexual cycles 44"
(Heitman, 2010). Genetic exchange has the potential to drive the evolution of novel 45"
recombinant strains with epidemiologically significant traits, including increased 46"
pathogenicity, transmissibility and drug resistance (Awadalla, 2003).  However, limiting 47"
sexual reproduction allows the generation of host-adapted clonal populations that retain the 48"
ability to hybridize in response to selective pressures. The conservation of meiotic gene 49"
orthologues among several basally divergent protists, including Giardia (Poxleitner et al., 50"
2008), Entamoeba (Ramesh et al., 2005) and Trichomonas (Malik et al., 2008) suggests that 51"
the common ancestor of all eukaryotes was capable of meiotic recombination. 52"
Chagas disease is the most important vector-borne parasitic infection in Latin America, 53"
affecting an estimated 8-10 million individuals, with a further 90 million at risk (Hotez et al., 54"
2008). The aetiological agent, Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae), is a 55"
complex vector-borne zoonosis, transmitted by more than 100 species of hematophagous 56"
triatomine bugs (Hemiptera: Reduviidae: Triatominae) (Lent and Wygodzinsky, 1979; 57"
Galvão et al., 2003) and maintained by mammalian reservoir hosts ranging from the southern 58"
United States to Argentinean Patagonia (Noireau et al., 2009). Human Chagas disease is 59"
principally restricted to areas where individuals are exposed to infected vector faeces through 60"
contact with intact mucosae or abraded skin (Coura and Dias, 2009).  In the absence of 61"
chemotherapy, the majority of infected individuals are asymptomatic for life. However, over 62"
a period of 10-30 years, approximately 20-30% will develop irreversible, potentially fatal 63"
cardiac syndromes, or more rarely, dilatation of the gastrointestinal tract (megaoesophagus or 64"
megacolon) (Rassi Jr et al., 2010).  65"
T. cruzi displays remarkable genetic diversity, which has long been considered a principal 66"
factor underlying the major clinical variation observed in Chagas disease (Miles et al., 2009). 67"
Current international consensus recognizes a minimum of six stable genetic lineages or 68"
discrete typing units (DTUs): TcI-TcVI (Zingales et al., 2009). Molecular analyses indicate 69"
that T. cruzi has a predominantly clonal population structure, interspersed with infrequent 70"
genetic exchange events. DTUs TcI-TcIV form monophyletic clades and TcV and TcVI are 71"
known to be recent natural inter-lineage hybrids (Machado and Ayala, 2001; Lewis et al., 72"
2011). Multilocus sequence typing (MLST) supports these designations with TcI-TcIV 73"
characterized by substantial allelic homozygosity, likely resulting from recurrent, genome-74"
wide and dispersed gene conversion. TcV and TcVI display natural heterozygosity and 75"
3"
"
minimal distinction, sharing intact alleles from their parental progenitors (TcII and TcIII), 76"
(Machado and Ayala, 2001; Brisse et al., 2003; Barnabé et al., 2011; Lewis et al., 2011; Yeo 77"
et al., 2011).  78"
The origin(s) of TcV and TcVI is unresolved and it is presently contested whether they arose 79"
from two independent genetic exchange events (de Freitas et al., 2006; Lewis et al., 2011) or 80"
a single incidence of hybridization followed by clonal divergence (Westenberger et al., 2005; 81"
Sturm and Campbell, 2010; Flores-López and Machado, 2011). Molecular dating indicates 82"
that these lineages evolved recently, within the last 60,000 years (Lewis et al., 2011), 83"
possibly from human disruption of sylvatic transmission cycles in the Southern Cone, 84"
suggesting there is continuous risk of genetic exchange driving the emergence of novel 85"
recombinants (Flores-López and Machado, 2011; Lewis et al., 2011).   86"
Currently, the frequency of natural recombination in T. cruzi is still debated, as are the 87"
underlying cytological mechanisms (Tibayrenc and Ayala, 2012; 2013; Ramírez and 88"
Llewellyn, 2014). Characterization of experimental intra-TcI hybrids suggests that 89"
hybridization may occur within the mammalian host and is analogous to the parasexual cycle 90"
of Candida albicans; nuclear fusion creates a tetraploid intermediate, followed by 91"
homologous recombination, gradual genome erosion and reversion to aneuploidy (Gaunt et 92"
al., 2003; Lewis et al., 2009). However, this unusual mating system differs from canonical 93"
meiosis and is challenging to reconcile with both the presence of highly conserved meiotic 94"
orthologues within the T. cruzi genome (Ramesh et al., 2005) and the existence of natural 95"
diploid heterozygous lineages, which resemble Mendelian F1 progeny (TcV and TcVI) 96"
(Lewis et al., 2009; 2011).  97"
Historically, most T. cruzi DTUs have had broadly distinct, but often overlapping, 98"
geographical and ecological distributions (Miles et al., 2009; Zingales et al., 2012). In 99"
general, TcI, TcII, TcV and TcVI are frequently isolated from domestic cycles and are 100"
responsible for the majority of human infections. TcI is the principal cause of human Chagas 101"
disease in northern South America (Anez et al., 2004; Ramírez et al., 2010; Carrasco et al., 102"
2012).  By comparison, TcII, TcV and TcVI are largely confined to domestic transmission 103"
cycles in southern parts of South America, overlapping with severe human Chagas disease, 104"
(Corrales et al., 2009; Burgos et al., 2010; Bisio et al., 2011). The sylvatic reservoirs of these 105"
three DTUs are not fully defined, although TcII has been increasingly isolated from primates 106"
in Brazil (Fernandes et al., 1999; Lisboa et al., 2007; Araújo et al., 2011); peridomestic dogs 107"
are emerging as potential hosts of TcV and TcVI (Maffey et al., 2012; Enriquez et al., 2013; 108"
Fernandez et al., 2014).  109"
With increased sampling, the geographical range of TcV and TcVI appears to be significantly 110"
more extensive than previously suggested. On the basis of limited sequencing markers (GPI, 111"
cytochrome b and 18S rDNA), putative hybrid strains were identified among a minority of 112"
domestic and peridomestic strains from Colombia (Guhl and Ramírez, 2013), representing 113"
the first report of these lineages this far north; it remains unclear whether these are ‘bona 114"
fide’ TcV and TcVI strains or progeny of a novel recombination event. Elucidating the 115"
4"
"
molecular epidemiology of TcV and TcVI is complicated by limited sample collections and 116"
difficulties distinguishing these strains from each other (Venegas et al., 2011) or even their 117"
parental lineages (TcII and TcIII) (Yeo et al., 2011; Diosque et al., 2014). However, an 118"
improved understanding of the frequency of genetic exchange in T. cruzi and the impact of 119"
hybridization on parasite genetic diversity, natural population structures and their ecological 120"
and geographical distributions, are crucial to provide an accurate assessment of the 121"
epidemiological risk associated with recombinant genotypes. 122"
 123"
In this study we performed high resolution nuclear and mitochondrial genotyping of novel 124"
natural hybrid clones from Colombia in comparison to reference strains from across South 125"
America to resolve their putative status as novel recombinants. Additionally an in-depth 126"
analysis of allele inheritance of three different type of molecular markers was undertaken to 127"
characterize intra-TcV and TcVI genetic diversity across their expanding geographical range. 128"
 129"
Materials and methods 130"
Parasite strains and DTU assignment 131"
A panel of 57 T. cruzi biological clones was assembled for analysis, including 24 132"
uncharacterized strains from North Colombia and 33 additional reference clones (TcII, TcIII, 133"
TcV and TcVI) (Table 1; Figure 1). Colombian strains were isolated from human patients 134"
(adults and suspected congenitally-infected infants), triatomine bugs (Panstrongylus 135"
geniculatus, Rhodnius prolixus and Triatoma venosa) and sylvatic mammalian hosts 136"
(Dasypus species). Supporting reference clones were derived from a range of hosts and 137"
vectors from locations representative of both intra-lineage genetic diversity and geographical 138"
distribution of each DTU (Figure 1).   139"
Biological clones were obtained from primary cultures by either fluorescence-activated cell 140"
sorting (Valadares et al., 2012) or plate cloning (Yeo et al., 2007). Colombian isolates were 141"
initially assigned to DTU-level via PCR amplification of the SL-IR, 24Sα rDNA and 18S 142"
rDNA subunits according to Guhl and Ramírez, 2013. Putative hybrid strains were identified 143"
by either a double 24Sα rDNA amplicon (125 and 140 bp) (TcV) or single 24Sα rDNA 144"
amplicon (140 bp) and amplification of the A10 fragment of the18S rDNA subunit (TcVI) 145"
(525 or 630 bp), and confirmed by sequencing glucose-6-phosphate isomerase (GPI), as 146"
previously described (Guhl and Ramírez, 2013). 147"
 148"
Nuclear Multilocus Sequence Typing (nMLST) 149"
Five nuclear housekeeping genes (glutathione peroxidase GPX; GTP-binding protein RAB7 150"
GTP; metacyclin-II Met-II; ascorbate-dependent haemoperoxidase TcAPX; and mitochondrial 151"
peroxidase TcMPX), selected from two multilocus sequence typing schemes on the basis of 152"
5"
"
their intra-TcV and TcVI discriminatory powers (Yeo et al. 2011; Lauthier et al. 2012), were 153"
amplified and sequenced across all samples according to Yeo et al. 2011.  154"
Nucleotide sequences were assembled manually in BioEdit v7.1.3.0 sequence alignment 155"
editor software (Ibis Biosciences, USA) (Hall, 1999) and unambiguous consensus sequences 156"
were produced for each isolate. Heterozygous SNPs were visually identified by the presence 157"
of two coincident peaks at the same locus (‘split peaks’), verified in forward and reverse 158"
sequences, and manually scored according to the one-letter nomenclature for nucleotides 159"
from the International Union of Pure and Applied Chemistry (IUPAC).  160"
Initially, diploid sequence data were analysed per locus in MLSTest (Tomasini et al. 2013); 161"
heterozygous single nucleotide polymorphisms (SNPs) were handled as average states. 162"
Individual Neighbour-Joining (NJ) trees were constructed for each gene and the extent of 163"
phylogenetic incongruence between targets was evaluated visually. Isolates were classified 164"
into DTUs and sequence types (ST), discriminatory powers (DP) and typing efficiencies (TE) 165"
were calculated per locus for the complete dataset and separately for Colombian strains 166"
(Table 2).  167"
For each isolate, diploid sequence data were then concatenated in order of their relative 168"
chromosomal positions (Met-II, GTP, TcMPX, TcGPX and TcAPX, on chromosomes 6, 12, 169"
22, 35 and 36, respectively). In MLSTest, phylogenetic incongruence between loci was 170"
assessed using the BIO-Neighbour Joining Incongruence Length Difference test (BIONJ-171"
ILD) and evaluated by a permutation test with 1000 replicates. A final NJ tree was 172"
constructed and statistical support was evaluated by 1000 bootstrap replications. Incongruent 173"
branches in the concatenated NJ tree were identified using the Neighbour-Joining Localized 174"
Incongruence Length Difference (NJ-LILD) test.  175"
To examine patterns of TcII and TcIII allele inheritance in TcV and TcVI isolates, haplotypes 176"
for each gene were inferred using PHASE software version 2.1 (Stephens et al., 2001) 177"
implemented in DnaSP v5.10.1 (Librado and Rozas, 2009). For isolates where PHASE was 178"
unable to adequately resolve haplotypes (uncertainty probability p<0.95), PCR products were 179"
cloned and sequenced to experimentally confirm predicted gene phase. PCR products were 180"
cloned using the pGEM®-T Easy Vector system I (Promega, UK), according to the 181"
manufacturer’s instructions. Plasmids were sequenced from a minimum of six colonies per 182"
isolate using standard T Easy Vector primers T7 (5’-TAATACGACTCACTATAGGG-3’) 183"
and Sp6 (5’-ATTTAGGTGACACTATAG-3’) (Promega, UK). In cases where haplotypes 184"
remained ambiguous, a further six colonies were picked and processed, as described. 185"
Following haplotype resolution, the most appropriate nucleotide substitution model for each 186"
gene was selected from 1,624 candidates, based on the Akaike Information Criterion (AIC), 187"
in jMODELTEST 2.1.4 (Darriba et al., 2012) and used to construct individual Maximum-188"
Likelihood (ML) phylogenies in MEGA 6 (Tamura et al., 2013).  Bootstrap support for clade 189"
topologies was estimated following the generation of 1000 pseudo-replicate datasets. 190"
Bayesian phylogenetic analysis was performed per loci with MrBAYES, implemented 191"
through TOPALi v2.5, using the best-fit model, based on the Bayesian Information Criterion 192"
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(BIC) (Milne et al., 2009).  Five independent analyses were run for one million generations, 193"
with sampling every 100 simulations (25% burn-in). Statistically-supported topological 194"
incongruence between individual ML and Bayesian phylogenies was evaluated using 195"
Kishino-Hasegawa (KH) (Kishino and Hasegawa, 1989) likelihood tests in PAML v.4 (Yang, 196"
2007).   197"
Multilocus Microsatellite Typing (MLMT) 198"
Twenty-five nuclear microsatellite loci were amplified as previously described by Llewellyn 199"
et al., 2009. These markers are distributed across eleven putative chromosomes, including 200"
five groups of physically linked loci (Weatherly et al., 2009).  A full list of microsatellite 201"
targets and primers are given in Table S2.  Allele sizes were determined using an automated 202"
capillary sequencer (AB3730, Applied Biosystems, UK), in conjunction with a fluorescently 203"
tagged size standard (GeneScanTM – 500 LIZ®, Applied Biosystems, UK), and manually 204"
checked for errors in GeneMapper® software v3.7.  All isolates were typed ‘blind’ to control 205"
for user bias (Supplementary file S1). 206"
Individual-level sample clustering was initially defined using a Neighbour-Joining (NJ) tree 207"
based on pair-wise distances (DAS: 1 – proportion of shared alleles at all loci/n) between 208"
microsatellite genotypes calculated in MICROSAT v1.5d (Minch et al., 1997) under the 209"
infinite-alleles model (IAM).  To accommodate multi-allelic genotypes (≥3 alleles per locus), 210"
a script was written in Microsoft Visual Basic to generate random multiple diploid re-211"
samplings of each multilocus profile. A final pair-wise distance matrix was derived from the 212"
mean across multiple re-sampled datasets and used to construct a NJ phylogenetic tree in 213"
PHYLIP v3.67 (Felsenstein, 1989).  Majority rule consensus analysis of 10,000 bootstrap 214"
trees was performed in PHYLIP v3.67 by combining 100 bootstraps generated in 215"
MICROSAT v1.5d, each drawn from 100 respective randomly re-sampled datasets. 216"
A single randomly sampled diploid dataset was used for all subsequent analyses. DTU-level 217"
genetic diversity was evaluated using sample size corrected allelic richness (Ar) in FSTAT 218"
2.9.3.2 (Goudet, 1995). Sample size corrected private (lineage-specific) allele frequency per 219"
locus (PA/L) was calculated in HP-Rare (Kalinowski, 2005). DTU-level heterozygosity 220"
indices were calculated in ARLEQUIN v3.11 and associated significance levels for p-values 221"
derived after performing a sequential Bonferroni correction to minimise the likelihood of 222"
Type 1 errors (Rice, 1989). All population genetics parameters were derived for both the 223"
complete dataset and separately for Colombian strains (Table 3). 224"
Microsatellite allele inheritance among all TcV and TcVI isolates was examined manually. 225"
At each locus genotypes were classified as hybrid (TcII/TcIII), or non-hybrid (TcII/TcII or 226"
TcIII/TcIII) based on presence or absence of TcII- and TcIII-specific alleles among parental 227"
strains. A separate analysis was performed for Colombian hybrid clones, based on the 228"
identification of Colombia-specific parental alleles.  229"
 230"
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Mitochondrial Multilocus Sequence Typing (mtMLST) 231"
For all isolates, ten mitochondrial gene fragments were amplified, sequenced and 232"
concatenated according to Messenger et al., 2012 and are available from GenBank under the 233"
accession numbers listed in Table S1. The most appropriate nucleotide substitution model 234"
was selected from 1,624 candidates, based on the AIC, in jMODELTEST 2.1.4 (Darriba et 235"
al., 2012). Alternate Maximum-Likelihood (ML) phylogenies were constructed using the 236"
GTR+G model (nine substitution rate categories) in MEGA 6 (Tamura et al., 2013).  237"
Bootstrap support for clade topologies was estimated following the generation of 1000 238"
pseudo-replicate datasets.  Bayesian phylogenetic analysis was performed with MrBAYES, 239"
implemented through TOPALi v2.5, using the best-fit model, based on the Bayesian 240"
Information Criterion (BIC) (HKY+G) (Milne et al., 2009).  Five independent analyses were 241"
run for one million generations, with sampling every 100 simulations (25% burn-in). Using 242"
the concatenated dataset (excluding indels), STs, DPs and TEs were calculated for all isolates 243"
and separately for Colombia strains (Table 2). 244"
Results 245"
nMLST 246"
Diploid sequence data were concatenated across all five loci to produce a gap free alignment 247"
of 2439 bp. A total of 44 unique STs and 74 variable sites (VSs) were identified (~3.03% 248"
sequence diversity). All TcV and TcVI isolates consistently displayed heterozygous profiles. 249"
Complete loss of heterozygosity (LOH) was observed among a subset of hybrid strains at 250"
four loci: within GPX for P251 cl7 (loss of TcII-type allele), GTP for AACf2 cl11 (loss of 251"
TcIII-type allele), Met-II for Para6 cl4 (loss of TcIII-type allele) and TcMPX for 7/8 TcV 252"
isolates (excluding PAH179 cl5) (loss of TcIII-type allele) and two TcVI clones (LHVA cl4 253"
and P251 cl7) (loss of TcII-type allele). Partial LOH was observed within Met-II for EPV20-254"
1 cl1 (5’ loss of TcIII-type allele).  255"
Individual genes varied with respect to sequence diversity, ranging from 7.2% for Met-II to 256"
1.58% for TcMPX. Number of sequence types (STs), typing efficiency (TE) and 257"
discriminatory power (DP) per locus and DTU are given in Table 2.  Of the five MLST 258"
targets evaluated, GPX, Met-II and TcAPX were the most discriminatory (DP = 0.3, 0.33 and 259"
0.35, respectively), identifying 17, 19 and 20 unique STs (from 57 clones), respectively. At 260"
the intra-DTU level these three loci were also highly resolutive (Table 2), in particular, for 261"
TcV and TcVI, TcAPX distinguished the most STs (DP = 0.5 and 0.33, respectively).  262"
In general, TcV and TcVI were characterized by the lowest levels of intra-lineage genetic 263"
diversity; for the former, two out of five genes (GPX and GTP) were monomorphic. When 264"
considering Colombian strains separately, TcII isolates were the most homogeneous 265"
(identical across all five MLST loci). Intra-strain clonal diversity was generally low, but 266"
detected among some Colombian TcVI strains (2/2, 3/5 and 2/4 unique genotypes for strains 267"
PG98, Rp540 and VS, respectively). As expected the concatenated dataset afforded higher 268"
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intra-lineage resolution than individual loci, discriminating the most unique intra-DTU STs 269"
(10/15 TcII, 13/13 TcIII, 5/8 TcV and 16/21 TcVI) (Table 2). 270"
A Neighbour-Joining phylogeny constructed from concatenated sequence data (Figure 2A) 271"
robustly identified TcII (99%) and TcIII (100%) as monophyletic clades. All TcV isolates, 272"
with the exception of Para6 cl4, grouped together (70%), while TcVI strains were clustered 273"
basally to TcII and TcV with poorly-supported internal branching. Moderate statistically-274"
supported incongruence was detected between loci (BIONJ-ILD p<0.001) and localized 275"
among TcV and TcVI branch nodes, likely attributable to irregular LOH, and accounting for 276"
the failure to recover these DTUs as discrete clades within the concatenated tree. 277"
Following in silico and experimental haplotype resolution, Maximum-Likelihood and 278"
Bayesian phylogenies were generated for each locus individually (an example is given in 279"
Figure 2B). In all cases, excluding the aforementioned instances of LOH, TcV and TcVI 280"
clones each possessed one TcII- and one TcIII-derived haplotype. In Figure 2B, haplotypes 281"
for Met-II were robustly clustered into two major clades corresponding to TcII (94/0.98) and 282"
TcIII (99/1.0). For this locus all TcV and TcVI strains possessed a TcII-like haplotype, which 283"
was unique to each DTU and distinct from other TcII reference clones, but shared their TcIII 284"
allele with geographically-disparate TcIII reference isolates. Other variations of allele 285"
inheritance were observed across the other four genes, for example, for GTP and TcGPX, 286"
TcII- and TcIII-type haplotypes were shared across both hybrid DTUs (data not shown).   287"
With regards to the geographical origin of hybrid TcII and TcIII alleles, for some genes 288"
insufficient genetic diversity was present (GTP, TcMPX) to derive any correlation, while 289"
others (GPX, Met-II and TcAPX) supported a putative association of hybrid TcIII-type 290"
haplotypes with those observed in southern TcIII clones from Bolivia, Peru and Paraguay. 291"
Importantly, at all five loci, the majority of Colombian haplotypes were either 292"
indistinguishable from or closely related to those identified in reference TcVI strains, with 293"
minimal affinity to either TcII or TcIII Colombia-specific alleles. 294"
MLMT 295"
Twenty-five microsatellite loci afforded the highest resolution of any type of marker; all 296"
isolates were characterized by unique multilocus genotypes (MLGs), with the exception of 297"
EB cl4 and cl6 (Figure 3 and Table 3). Based on both nMLST and MLMT datasets, all 298"
putative Colombian hybrids were classified as TcVI (Table 1).  299"
Consistent with nMLST data, TcV and TcVI displayed lower levels of genetic diversity (DAS 300"
= 0.15 and 0.24; Ar = 2.38 and 2.46, respectively), private alleles (PA/L = 0.16 and 0.43) and 301"
heterozygosity (54.6% and 41.7% polymorphic loci with significant excess in heterozygosity, 302"
respectively) compared to their parental lineages (DAS = 0.44 and 0.48; Ar = 3.94 and 4.26; 303"
PA/L = 1.76 and 2.35; 29.2% and 4.5% polymorphic loci with significant excess in 304"
heterozygosity for TcII and TcIII, respectively), supporting their hybrid status (Table 3). 305"
However, when considering only Colombian isolates, TcII clones emerged as the least 306"
diverse (DAS = 0.062; Ar = 1.65), in agreement with the nMLST data. Colombian clones also 307"
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possessed more private alleles per locus but lower levels of allelic richness compared to 308"
reference TcVI strains (PA/L = 0.86; Ar = 1.87 and PA/L = 0.43; Ar = 2.46, respectively). 309"
A NJ tree based on DAS values robustly separated each DTU (Figure 3). The TcIII clade was 310"
strongly-subdivided (99%), corresponding to a northern (Brazil and Colombia) and a 311"
southern (Bolivia, Paraguay and Peru) group. Substructuring was also evident among TcII 312"
clones; Colombian isolates were grouped apart from all other reference strains (83%).  By 313"
comparison, within the TcVI clade, all Colombian clones were unique but most were 314"
interspersed among reference strains; a subset of domestic isolates was strongly separated 315"
(96%). 316"
Patterns of TcII and TcIII allele inheritance were examined for all isolates and specifically for 317"
Colombian hybrids. Alleles were classified as TcII-specific, TcIII-specific, shared between 318"
TcII and TcIII or private to either TcV or TcVI. Most loci were heterozygous for either a TcII 319"
allele and a TcIII allele, one parental allele and one shared allele or two shared alleles; a 320"
minority were homozygous for one of either parental alleles or one shared allele. Fixed inter-321"
lineage genotypic differences were observed at 84% (21/25) of microsatellite loci and of the 322"
alleles that distinguished between hybrid DTUs, 70.4% (38/54) were shared by parental 323"
strains. 324"
For TcV isolates, 25.1% of alleles were TcII-specific, 29.9% TcIII-specific, 39.8% shared 325"
between TcII and TcIII and 5.08% private. For TcVI strains, 18.3% of alleles were TcII-326"
specific, 29.5% TcIII-specific, 41.9% shared between TcII and TcIII and 10.2% private. 327"
Considering only Colombian hybrids, 14.4% of alleles were TcII-specific, 27% TcIII-328"
specific, 42.9% shared between TcII and TcIII, 1.45% Colombian TcII-specific, 1.74% 329"
Colombian TcIII-specific and 12.5% private. 330"
mtMLST 331"
Ten maxicircle gene fragments were sequenced across all strains and concatenated to produce 332"
a 3647 bp alignment; no phylogenetic incongruence was observed between individual loci. 333"
Thirty-six unique haplotypes were identified from a total of 774 variable sites (~21.2% 334"
sequence diversity).  Numerous small indels (1-3 bp) were identified, as well as a large 335"
deletion of 245 bp within ND1, shared among 5/15 TcII clones (3/6 Colombian), and within 336"
MURF1 fragment b, a 17 bp deletion common to the same TcII strains, and a 27 bp insertion 337"
unique to CM25 cl2. By comparison to TcIII, intra-lineage diversity in TcII, TcV and TcVI 338"
was markedly lower (Table 2). 339"
Maximum-Likelihood and Bayesian phylogenies were constructed from the concatenated 340"
maxicircle data and were not significantly incongruent (Figure 4). Isolates were grouped into 341"
two monophyletic clades, corresponding to TcII (100/1.0) and TcIII+TcV+TcVI (100/1.0). 342"
Within the TcII clade, Colombian clones were separated into two strongly-supported 343"
subgroups; no clear correlation by host or geography was identified. Human Colombian TcII 344"
isolates clustered with a subset of domestic strains (both from humans and T. infestans) from 345"
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Brazil and Paraguay (99/1.0), while domestic triatomine clones were grouped with others 346"
from Chile and Bolivia (100/1.0).  347"
Robust internal branching was also observed within the TcIII+TcV+TcVI clade; clones from 348"
each DTU were clustered together in subclades. All TcVI strains were grouped together, 349"
however, Colombian maxicircle haplotypes were diverse between study sites and noticeably 350"
distinct from reference TcVI isolates. Interestingly, AACf2 cl11, a new peridomestic 351"
Colombian isolate from a dog, which was unequivocally classified as a TcVI by nMLST and 352"
MLMT, appeared to possess a TcV-type maxicircle haplotype (Figure 4).  Both TcV and 353"
TcVI mitochondrial haplotypes were most closely related to TcIII-type maxicircles found in 354"
domestic/peridomestic strains from Peru and Paraguay (SABP19 cl1 and X9/3 and X109/2, 355"
respectively). 356"
Discussion 357"
This study exploited high resolution nuclear and mitochondrial genotyping to establish 358"
whether putative hybrid strains from Colombia were the progeny of a novel recombination 359"
event or, more likely, an extension of lineage geographical range. Additionally, we undertook 360"
a detailed analysis of intra-TcV and TcVI genetic diversity, at overlapping levels of 361"
resolution, to further characterize two of the most poorly described T. cruzi DTUs. 362"
TcV and TcVI intra-lineage genetic diversity 363"
Consistent with previous reports (Machado and Ayala, 2001; Brisse et al., 2003; 364"
Westenberger et al., 2005; Lewis et al., 2011; Yeo et al., 2011), TcV and TcVI isolates were 365"
heterozygous, possessed intact parental alleles at an approximate 1:1 ratio, and displayed 366"
lower levels of genetic diversity and fewer private alleles/SNPs compared to parental DTUs; 367"
in this regard these lineages fulfilled all of the expectations of progeny from a recent 368"
recombination event(s) with Mendelian allele inheritance. The minority of homozygous loci 369"
detected by nMLST and MLMT can be explained by random LOH resulting from gene 370"
conversion, which has been described in T. cruzi at varying frequencies (Yeo et al., 2011; 371"
Barnabé et al., 2011; Diosque et al., 2014). These observations caution reliance on a single 372"
locus for DTU assignment of suspected hybrids, particularly in areas where these lineages are 373"
sympatric with their parental genotypes. 374"
The failure by others to separate TcV and TcVI isolates likely reflects the number and 375"
discriminatory power of different genotyping targets used (de Freitas et al., 2006; Venegas et 376"
al., 2011; Barnabé and Breniere, 2012; Perez et al., 2013). To our knowledge, this study 377"
employed the most loci to date, exposing intra-strain multiclonality among Colombian 378"
hybrids, suggesting there is additional, un-sampled genetic diversity hidden at the hybrid 379"
intra-lineage level. Of the markers assessed, the MLMT scheme afforded the highest 380"
resolution, discriminating between all TcV and TcVI isolates. Individual housekeeping genes 381"
were unable to distinguish most hybrid strains; of the five under evaluation, only TcAPX 382"
warrants consideration for future characterization of TcV/TcVI DTUs. The concatenated 383"
mitochondrial dataset was more resolutive, enabling the identification of all TcV strains, but 384"
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should not be used in the absence of comparative nuclear data as, in agreement with previous 385"
studies, all hybrid strains had inherited a TcIII-type maxicircle haplotype (Machado and 386"
Ayala, 2001; Westenberger et al., 2005; de Freitas et al., 2006; Lewis et al., 2011; Barnabé 387"
and Breniere, 2012). 388"
 389"
Evolutionary origins of Colombian hybrids and TcV and TcVI 390"
The majority of genotyping data confirmed that all 14 suspected Colombian hybrids were 391"
‘bona fide’ TcVI clones and not novel recombinant strains. Examination of nuclear 392"
haplotypes across five loci demonstrated that Colombian hybrid TcII and TcIII alleles were 393"
shared amongst other TcVI strains from the Southern Cone and not closely related to unique 394"
parental alleles from Colombia. MLMT also supported this pattern of inheritance, with only a 395"
minority of Colombian private parental alleles shared by hybrids from the same area.  A 396"
number of Colombian TcII- (nine alleles among eight loci) and TcIII (14 alleles among 11 397"
loci) -specific alleles were identified, and most of these differed from reference alleles by up 398"
to 15 bp, suggesting homoplasy was unlikely to hinder our detection of any parental 399"
contributions to hybrids. By mitochondrial loci, Colombian TcVI isolates were also divergent 400"
from local TcIII maxicircle haplotypes. 401"
All three genotyping schemes demonstrated that Colombian TcVI clones were related to, but 402"
distinct from, TcVI reference strains from the Southern Cone, raising the question of where 403"
these hybrids originated from? Colombian TcVI clones had more private microsatellite 404"
alleles compared to their southern counterparts, tentatively suggesting they may be ancestral. 405"
This is not supported by allelic richness measurements among these hybrids, which were 406"
lower than other TcVI clones, although this might be attributable to sampling bias; multiple 407"
clones per Colombian strain (between two to five) from a restricted study area were examined 408"
vs. single references clones from across a much wider geographical range. 409"
Currently, the origins of TcV and TcVI are the subject of a popular, on-going debate. Based 410"
on multiple nuclear and mitochondrial sequencing markers, it has been suggested that these 411"
DTUs were the product of two independent genetic exchange events between TcII and TcIII 412"
(de Freitas et al., 2006; Lewis et al., 2011); investigation of only nuclear loci supports a 413"
scenario where a single incidence of hybridization was followed by clonal divergence 414"
(Westenberger et al., 2005; Flores-López and Machado, 2011). Overall, our data concur with 415"
the former hypothesis; TcV and TcVI have distinct nuclear and mitochondrial MLST 416"
genotypes, related but independent microsatellite allelic profiles and the majority of alleles 417"
that distinguish between hybrid DTUs were also shared by parental strains. If inter-lineage 418"
differences were the result of clonal divergence, at rapidly evolving microsatellite loci, a 419"
much higher frequency of private alleles would be expected. However, the identification of a 420"
TcV-type maxicircle within a TcVI Colombian strain (AACf2 cl11) introduces a slight 421"
degree of uncertainty; all isolates in this study were biological clones, ruling out mixed 422"
infections as possible confounders. 423"
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Considering Colombian TcVI clones were unlikely to be predecessors of TcVI strains from 424"
the Southern Cone, where there is compelling evidence to suggest hybrids and parents are of 425"
local origin (Westenberger et al., 2006; Lewis et al., 2011), but were also not clear 426"
descendants, a more parsimonious explanation might be that they are a sibling group. 427"
Assuming T. cruzi mitochondrial inheritance, under exceptional (or perhaps conventional) 428"
circumstances can be biparental (as observed in Colombian TcI isolates (Ramírez et al., 429"
2012)), and that TcV and TcVI evolved from the beneficiaries of different alleles during a 430"
single hybridization event between heterozygous parents, then the presence of a TcV-type 431"
maxicircle in a Colombian TcVI clone may simply be the result of incomplete lineage 432"
sorting. An indistinguishable pattern of inheritance would also be observed following a recent 433"
mitochondrial introgression event from TcV into TcVI which either left undetectable 434"
signatures of nuclear hybridization by our markers, or possibly none at all (Messenger et al., 435"
2012; Ramírez et al., 2012). However, genetic exchange has not been described in hybrid 436"
DTUs previously, but might be expected to be more permissive between closely related 437"
strains (Ramírez and Llewellyn, 2014). Nor has TcV been unequivocally identified in 438"
Colombia, given the single putative isolate (AACf2 cl11) identified previously (Guhl and 439"
Ramírez, 2013) was genotyped in this study as a TcVI. It is noteworthy that AACf2 cl11 was 440"
isolated from a peridomestic dog; genetic exchange in T. cruzi has been proposed to arise 441"
within mammalian cells (Gaunt et al., 2003) and mixed infections in such hosts are a 442"
common (Crisante et al., 2006; Ramírez et al. 2013a), potentially provide opportunities for 443"
recombination to occur. Without additional hybrid samples from northern Brazil and 444"
Venezuela, it is impossible to confirm either hypothesis or infer the directionality of hybrid 445"
dispersal.  446"
Implications for human Chagas disease in Colombia 447"
With parallel improvements in sampling strategies and genotyping techniques, our 448"
understanding of the geographical and ecological distribution of each T. cruzi DTU is 449"
changing. Currently, in Colombia, human Chagas disease is principally associated with TcI 450"
(Ramírez et al., 2010; Guhl and Ramírez, 2013), to a lesser extent TcII (Zafra et al., 2008; 451"
Mantilla et al., 2010; Ramírez et al., 2010), and TcIV during microepidemic oral outbreaks 452"
(Ramírez et al., 2013b). While hybrid infections can be more challenging to distinguish from 453"
their parental progenitors, TcVI does not thus far appear to play a prominent role in local 454"
disease transmission.   455"
In this study, Colombian hybrids were isolated from P. geniculatus, R. prolixus and from two 456"
human infections, one associated with congenital transmission, the other more likely vector-457"
borne. Further intensive sampling efforts are required to identify the primary domestic vector 458"
species and transmission cycle ecology of TcVI in Colombia, in order to accurately assess the 459"
epidemiological risk of human Chagas disease associated with this hybrid lineage, 460"
considering its successful, epidemic establishment among domestic transmission cycles in the 461"
Southern Cone.  462"
 463"
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Figure 1. Map showing geographical distributions of TcII, TcIII, TcV and TcVI clones. 752"
 A panel of 57 T. cruzi biological clones was assembled for analysis, including 24 isolates from North 753"
Colombia and 33 additional reference strains, derived from a range of hosts and vectors representative 754"
of both intra-lineage genetic diversity and geographical distribution of each DTU. Colombian strains 755"
were isolated from human patients (adults and suspected congenitally-infected infants), triatomine 756"
bugs (Panstrongylus geniculatus, Rhodnius prolixus and Triatoma venosa) and sylvatic mammalian 757"
hosts (Dasypus species). Closed circles indicate origin of biological clones and colours denote isolate 758"
DTU (TcII, TcIII, TcV or TcVI) (see legend). 759"
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Figure 2. A: Unrooted Neighbour-Joining tree based on five concatenated diploid sequences. 
B: Maximum-Likelihood tree constructed from Met-II haplotypes. 
A: A Neighbour-Joining tree was constructed using concatenated nuclear sequences for all 
clones Colombian and reference clones. Bootstrap values were calculated as the mean across 
1000 randomisations and those >70% are shown for relevant nodes. TcII and TcIII form 
robust monophyletic clades and all TcV strains are clustered together with the exception of 
Para6 cl4. Colombian hybrids cluster basally to TcII and TcV with poorly-supported internal 
structuring. These branches were identified as statistically-incongruent between MLST loci 
(BIONJ-ILD p<0.001). 
B: Maximum-Likelihood topologies were constructed for each locus individually. The 
phylogeny generated for Met-II, the most polymorphic target, is given as an example. The 
most appropriate nucleotide substitution model was TrNef+G (three substitution rate 
categories) based on the AIC.  Statistical support for major clades is given as equivalent 
bootstraps and posterior probabilities from consensus Maximum-Likelihood (1000 pseudo-
replicates) and Bayesian trees (based on the HKY+G model), respectively. Haplotypes cluster 
robustly into two major clades corresponding to TcII and TcIII. Colombian haplotypes were 
either indistinguishable from or closely-related to those identified in reference TcVI strains, 
with minimal affinity to either TcII or TcIII Colombia-specific alleles. 
For both figures, branch colours indicate isolate DTU (TcII, TcIII, TcV or TcVI). Colombian 
strain labels are underlined.  
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Figure 3. Unrooted Neighbouring-Joining DAS tree based on 26 microsatellite loci. 
DAS-based bootstrap values were calculated as the mean across 1000 random diploid re-
samplings of the dataset and those >70% are shown for relevant nodes. Branch colours 
indicate isolate DTU (TcII, TcIII, TcV or TcVI). Colombian strain labels are underlined.  
MLMT affords the highest marker resolution; all isolates are characterized by unique MLGs, 
with the exception of EB cl4 and cl6. All four DTUs are strongly separated in the DAS tree. 
Within the TcVI clade, all Colombian clones were unique but interspersed among reference 
TcVI strains from the Southern Cone. 
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Figure 4. Maximum-Likelihood tree constructed from concatenated maxicircle sequences for 
22 Colombian clones and 35 additional isolates from across the Americas.  
A Maximum-Likelihood topology was constructed from concatenated maxicircle sequences 
for all Colombian and reference clones. The most appropriate nucleotide substitution model 
was GTR+G (nine substitution rate categories) based on the AIC.  Statistical support for 
major clades are given as equivalent bootstraps and posterior probabilities from consensus 
Maximum-Likelihood (1000 pseudo-replicates) and Bayesian trees (based on the HKY+G 
model), respectively. Branch colours indicate isolate DTU (TcII, TcIII, TcV or TcVI). 
Colombian strain labels are underlined. 
Isolates group into two monophyletic clades corresponding to TcII and TcIII+TcV+TcVI. 
Within the latter, all TcVI strains group together, however Colombian hybrid maxicircle 
haplotypes are diverse between study sites and distinct from reference TcVI isolates. Note 
strain AACf2 cl11 is phylogenetically incongruent between nuclear DAS and ML 
mitochondrial topologies, appearing to possess a TcV-type maxicircle haplotype. 
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Table 1. Panel of Colombian biological clones and reference clones assembled for analysis. 
Strain Code# Host/Vector# State Country DTU 
Colombian 
Clones  
EB cl4 Homo sapiens 
neonate (suspected 
congenital 
infection) 
Boyaca Colombia TcII 
EB cl6 Homo sapiens 
neonate (suspected 
congenital 
infection) 
Boyaca Colombia TcII 
EB cl20 Homo sapiens 
neonate (suspected 
congenital 
infection) 
Boyaca Colombia TcII 
PGPA2 
cl6 
Panstrongylus 
geniculatus 
Casanare Colombia TcII 
PGPA2 
cl7 
Panstrongylus 
geniculatus 
Casanare Colombia TcII 
PGPA2 
cl10 
Panstrongylus 
geniculatus 
Casanare Colombia TcII 
CM17 Dasypus sp. Carimaga Colombia TcIII 
CM25 cl2 Dasypus fugilinosa Carimaga Colombia TcIII 
SLDN1 
cl6 
Dasypus 
novemcinctus 
Casanare Colombia TcIII 
TV cl9 Triatoma venosa Boyaca Colombia TcIII 
AACf2 
cl11 
Canis familiaris Casanare Colombia TcVI 
DA cl1 Homo sapiens Boyaca Colombia TcVI 
DA cl2 Homo sapiens Boyaca Colombia TcVI 
PG98 cl1 Panstrongylus 
geniculatus 
Antioquia Colombia TcVI 
PG98 cl7 Panstrongylus Antioquia Colombia TcVI 
27#
#
geniculatus 
Rp540 
cl4 
Rhodnius prolixus Casanare Colombia TcVI 
Rp540 
cl6 
Rhodnius prolixus Casanare Colombia TcVI 
Rp540 
cl7 
Rhodnius prolixus Casanare Colombia TcVI 
Rp540 
cl8 
Rhodnius prolixus Casanare Colombia TcVI 
Rp540 
cl9 
Rhodnius prolixus Casanare Colombia TcVI 
VS cl6 Homo sapiens adult 
(suspected 
congenital 
transmitter) 
Boyaca Colombia TcVI 
VS cl7 Homo sapiens adult 
(suspected 
congenital 
transmitter) 
Boyaca Colombia TcVI 
VS cl8 Homo sapiens adult 
(suspected 
congenital 
transmitter) 
Boyaca Colombia TcVI 
VS cl10 Homo sapiens adult 
(suspected 
congenital 
transmitter) 
Boyaca Colombia TcVI 
Reference 
Clones  
CBB cl2 Homo sapiens Tulahuén Chile TcII 
Chaco23 
col4 
Triatoma infestans Pr. Hayes Paraguay TcII 
Esm cl3 Homo sapiens São Felipe Brazil TcII 
IVV cl4 Homo sapiens Cuncumen Chile TcII 
Pot7a cl1 Triatoma infestans San Martin Paraguay TcII 
Pot7b cl5 Triatoma infestans San Martin Paraguay TcII 
28#
#
Rita cl5 Homo sapiens São Felipe Brazil TcII 
T665 cl1 Triatoma infestans Pr. Hayes Paraguay TcII 
Tu18 cl2 Triatoma infestans Tupiza Bolivia TcII 
85/847 
cl2 
Dasypus 
novemcinctus 
Alto Beni Bolivia TcIII 
ARMA13 
cl1 
Dasypus 
novemcinctus 
Campo Lorro Paraguay TcIII 
ARMA18 
cl3  
Dasypus 
novemcinctus 
Campo Lorro Paraguay TcIII 
JA2 cl2 Monodelphis sp. Amazonas Brazil TcIII 
M5631 
cl5 
Dasypus 
novemcinctus 
Marajo Brazil TcIII 
M6421 
cl6 
Homo sapiens Belém Brazil TcIII 
SABP19 
cl1 
Triatoma infestans Vitor Peru TcIII 
X109/2 Canis familiaris Makthlawaiya Paraguay TcIII 
X9/3 Canis familiaris Makthlawaiya Paraguay TcIII 
92.80 cl2 Homo sapiens Santa Cruz Bolivia TcV 
Bug 2148 
cl1 
Triatoma infestans Rio Grande do Sul Brazil TcV 
Chaco2 
cl3 
Triatoma infestans Chaco Paraguay TcV 
PAH179 
cl5 
Homo sapiens Chaco Argentina TcV 
Para4 cl3 Triatoma infestans Paraguari Paraguay TcV 
Para6 cl4 Triatoma infestans Paraguari Paraguay TcV 
Sc43 cl1 Triatoma infestans Santa Cruz Bolivia TcV 
Vinch101 
cl1 
Triatoma infestans Limari Chile TcV 
Chaco17 Triatoma infestans Chaco Paraguay TcVI 
29#
#
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CL 
Brener 
Triatoma infestans Rio Grande do Sul Brazil TcVI 
EPV20-1 
cl1 
Triatoma infestans Chaco Argentina TcVI 
LHVA 
cl4 
Triatoma infestans Chaco Argentina TcVI 
P251 cl7 Homo sapiens Cochabamba Bolivia TcVI 
Tula cl2 Homo sapiens Tulahuén Chile TcVI 
VFRA1 
cl1 
Triatoma infestans Francia Chile TcVI 
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T
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14/15 [5/6] 
0.44 ± 0.23 
[0.062 ± 0.053] 
24 [15] 
1.76 ± 0.20 
[0.68 ± 0.14] 
3.94 ± 0.29 
[1.65 ± 0.12] 
0.58 [0.91] 
0.65 [0.58] 
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20.8 [0] 
T
cIII 
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0.48 ± 0.15 
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T
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T
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0.49 [0.54] 
41.7 [40.0] 
16.7 [15.0] 
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5.4 Discussion 
A clear understanding of the frequency and impact of genetic exchange on the ecological and 
geographical distributions of T. cruzi populations is crucial to establish the epidemiological 
risk associated with recombinant genotypes and to reconcile the implications hybridization 
has for T. cruzi at both the generational and evolutionary scales. Detecting recombination 
among natural populations is principally complicated by sampling strategies and marker 
resolution, considering that strains most likely to be recombining may be highly related and 
potentially indistinguishable. 
 
The papers included in this chapter describe the characterization of genetic exchange events 
and hybrid strains from two different parasite populations in North Colombia. Within TcI 
disease foci, pervasive, indiscriminant mitochondrial introgression was observed affecting 
~20% of the study cohort (Ramírez et al., 2012). This is the highest frequency of 
recombination reported from any natural T. cruzi population to date and is probably 
attributable to the examination of multiple, intensely sampled and minimally subdivided, 
biological clones per host (Prugnolle and De Meeus, 2010). Similar strategies have now been 
adopted to explore the sylvatic determinants of TcI genetic diversification in Bolivia 
(Messenger et al., accepted). The precedent in experimental design established by these 
studies may represent the most promising intermediary in T. cruzi population genetics until 
imminently superseded by comparative population genomics. 
As discussed previously, the failure to detect evidence of reciprocal nuclear hybridization 
among recombinant Colombian strains may be indicative of an asymmetric, cryptic genetic 
exchange mechanism, or perhaps more likely, a reflection of the minor amount of nuclear 
genetic information sampled; without whole nuclear genome sequences for introgression 
hybrids and putative parental strains, it is impossible to distinguish between these two 
hypotheses. However, by analogy to other medically-important trypanosome species, the 
presence of alternate, covert sexual mechanisms within the same species is not entirely 
unexpected (Rougeron et al., 2009; 2011; Duffy et al., 2013; Hickman et al., 2013; Rogers et 
al., 2014; Ramírez and Llewellyn, 2014). 
By comparison, newly isolated TcVI clones from Colombia satisfied all the expectations of 
canonical Mendelian F1 progeny, namely, high heterozygosity, minimal genetic diversity, 
few private alleles and intact parental haplotypes at an approximate 1:1 ratio (Messenger et 
al., submitted (b)). While not the product of a novel recombination event between local TcII 
and TcIII strains, the origin(s) of the Colombian hybrids is not unequivocal nor is their status 
as predecessors to or descendants from Southern Cone TcVI strains. The sharing of 
mitochondrial haplotypes between southern TcV isolates and a single Colombian TcVI may 
be the first report of mitochondrial introgression occurring between hybrids lineages. A more 
parsimonious explanation, based on private alleles and allelic richness measurements, might 
be that Colombian TcVI strains are siblings which diverged and dispersed northwards, 
following a single hybridization event between heterozygous TcII and TcIII isolates in the 
Southern Cone. All six T. cruzi DTUs have now been reported from North Colombia at 
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varying prevalences (Guhl and Ramírez, 2013), incriminating this region as a potential 
location for prospective hybridization events. 
Interestingly, both studies in this chapter identified biparental mitochondrial inheritance as a 
putative consequence of genetic exchange events. A mosaic maxicircle sequence was 
detected in a human Colombian TcI isolate and the presence of a recombination breakpoint 
confirmed by allele-specific PCR. Such a sequence is expected to arise following inter-
molecular maxicircle recombination, which necessitates the inheritance of mixed 
mitochondrial complements. Likewise, sharing of TcV and TcVI mitochondria among 
Colombian TcVI isolates can be explained if biparental maxicircle inheritance preceded 
incomplete lineage assortment. Uniparental inheritance of highly heteroplasmic maxicircles 
might present an indistinguishable scenario but reported mitochondrial heteroplasmy is T. 
cruzi is thus far low (Messenger et al., 2012) and, at least in the case of the latter isolate, 
unlikely to bear such homology to a different DTU, even with significant convergent 
evolution. Parallel observations from experimental crosses of T. b. brucei (Turner et al., 
1995; Gibson et al., 2008), suggest that biparental mitochondrial inheritance might be a 
fundamental, as yet, uncharacterized, biological phenomenon in trypanosomatids. 
Importantly, the effects of genetic exchange on parasite phenotype are unknown. The 
successful establishment of TcV and TcVI among domestic transmission cycles in the 
Southern Cone, suggests these isolates may possess a phenotypic advantage (heterosis) 
and/or the ability to outcompete other genotypes. Similarly, if mitochondrial introgression is 
exploitable as a mechanism of host range extension, recombinants might be expected to 
present higher mammalian infectivity and growth rates, especially in vectors. The 
pathological implications of low diversity genotypes in human infections with regards to 
virulence, transmissibility and drug susceptibility are also largely unknown but warrant 
consideration, in conjunction with improved methods of detection and isolation of natural 
hybrids.  
The two studies presented in this chapter indicate that natural genetic exchange in T. cruzi is 
both contemporary and historical, responsible for shaping current parasite population 
structures, as well as the evolution of distinct T. cruzi DTUs. Together these observations 
challenge the traditional paradigm of PCE in T. cruzi and highlight the need for additional, 
intensive and appropriately sampled field surveys, complemented by high resolution, 
combined nuclear and mitochondrial population genetics analyses.  
!
!
!
!
!
!
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6. Summary of outputs and future research priorities for Chagas disease 
 
Elucidating the complex epidemiology, phylogeography and clinical variation underlying 
Chagas disease requires a clear understanding of T. cruzi genetic diversity, mechanisms of 
genetic re-assortment and their impact on natural parasite population structures. The papers 
herein describe recent developments in T. cruzi genotyping techniques and advances in our 
understanding of parasite ecology and natural genetic exchange mechanisms. The key outputs 
are: 
- Following the establishment of a standardized nuclear MLST protocol, this four marker 
scheme (GPI, HMCOAR, RHO1 and TcMPX) represents a viable, highly discriminatory 
and reproducible technique to characterize isolated T. cruzi strains to DTU-level; 
expansion of this panel to include three additional targets (LAP1, RB19 and SODB) has 
the potential to facilitate intra-lineage discrimination. 
 
- Illumina sequencing of the maxicircle genome from the TcI reference strain (Sylvio 
X10/1) at 183X coverage, provided the first evidence of heteroplasmy in the 
mitochondrial coding region at a ~10 fold lower abundance compared to the consensus 
genome. It is likely that the frequency of minor heteroplasmic maxicircles may be higher 
in recently sampled field strains, which have been minimally sub-passaged. However, this 
level of intra-strain maxicircle diversity does not appear to be sufficiently divergent to 
adversely affect genotyping using multi-copy mitochondrial genes.  
 
- Combined mitochondrial MLST and MLMT affords the highest intra-lineage resolution 
with the advantages of identifying cryptic genetic exchange events, undetectable by 
nuclear loci, as evidenced by nuclear-mitochondrial phylogenetic incongruence. Among 
geographically dispersed TcI populations, multiple intra-TcI and inter-DTU (TcI and 
TcIII/TcIV) mitochondrial introgression events were observed without any apparent 
reciprocal nuclear hybridization. 
 
- Illumina amplicon deep sequencing of clinical isolates revealed an unprecedented level of 
intra-host parasite multiclonality and highlighted potential diversifying selection affecting 
antigenic surface proteases; genetic diversity within this multi-gene family may facilitate 
survival in the mammalian host. However, this study was unable to identify any 
relationship between multiplicity of infection and patient sex, age or clinical 
manifestations. 
 
- High resolution nuclear and mitochondrial genotyping of contemporaneous TcI clones 
from Bolivia demonstrated that ecological host fitting was the predominant mechanism 
structuring parasite populations among arboreal and terrestrial transmission cycles. 
Reduced genetic diversity, accelerated parasite dissemination between densely populated 
areas and mitochondrial gene flow between domestic and sylvatic parasite populations, 
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suggests humans may have played a crucial role in T. cruzi dispersal across the Bolivian 
highlands. 
 
- The significant impact human activity can have on parasite population structures was also 
observed in Brazil where reduced TcI genetic diversity among Atlantic Forest 
populations was attributed to ongoing anthropogenic habitat fragmentation.  
 
- Genetic characterization of TcIDOM isolates in comparison to TcI strains from across its 
endemic range, indicated that these human-associated, genetically homogeneous 
genotypes likely originated in North/Central America before dissemination southwards. 
Molecular dating of TcIDOM clones from Colombia confirmed that this clade emerged 
23,000 ± 12,000 years, coinciding with the earliest human migration into South America. 
 
- Gross nuclear-mitochondrial phylogenetic incongruence affecting ~20% of TcI clones 
from Colombia suggests that mitochondrial introgression is a common mechanism of 
genetic exchange among natural parasite populations. Similar intra-TcI introgression 
events were also observed at lower frequencies among intensively-sampled sylvatic 
transmission cycles in Bolivia and Brazil.  
 
- A mosaic maxicircle detected in a Colombia patient may be the result of inter-molecular 
mitochondrial recombination, suggesting biparental mitochondrial inheritance can occur 
during some genetic exchange events. This phenomenon would also explain the 
mitochondrial heteroplasmy observed in the TcI mitochondrial genome sequence, as 
following hybridization, one maxicircle population is lost stochastically during mitotic 
division, but may never be eliminated entirely. 
 
- Hybrid isolates in Colombia were distinct from, but related to, TcVI reference strains 
from the Southern Cone, incriminating them as ‘bona fide’ TcVI clones and confirming 
that the geographical range of this DTU is much more extensive than previously assumed. 
The origin(s) of these Colombian hybrids remains unresolved; the sharing of 
mitochondrial haplotypes between southern TcV strains and a Colombian TcVI clone, 
may be explained if Colombian hybrids are a sibling group to southern TcVI isolates, 
which diverged and dispered northwards, following a single hybridization event with 
biparental mitochondrial inheritance between heterozygous TcII and TcIII isolates. 
The results described herein highlight a number of prospective avenues of investigation. 
Establishing any relationship between T. cruzi genetic diversity and clinical outcome will 
require significant improvements in both clinical genotyping and patient sampling. Detection 
of multiple distinct parasite clones within Colombian patients by combined mtMLST and 
MLMT, indicated that super-infection may be a common feature of some transmission foci. It 
is highly probable that those patients sampled as part of the Illumina deep sequencing study 
were not recently exposed to high forces of infection given vector transmission had been 
interrupted in Goiás, Brazil 10-20 years ago (Marsden et al., 1994) and severely reduced in 
Cochabamba, Bolivia in the mid-2000s (Espinoza et al., 2014).  
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This strategy to examine intra-patient multiclonality warrants additional evaluation, 
preferably within hyperendemic populations, in comparison with age-matched cohorts 
without vector exposure. If multiplicity of infection is associated with severity of cardiac 
disease, this might alone, or in combination with other blood-based biomarkers of disease 
progression (Requena-Méndez et al., 2013), justify targeted benznidazole treatment among 
the subset of chronic adults at high risk of mortality (provided efficacy to prevent advanced 
cardiomyopathy in adults is demonstrated by the BENEFIT and TRAENA trials (Marin-Neto 
et al., 2009)). 
Furthermore, application of this technology to investigate the interaction between parasite 
multiclonality and host immune response among longitudinal groups of patients could 
enhance our understanding T. cruzi immune evasion. Unlike African trypanosomiasis, where 
mechanisms of antigenic variation of variant surface glycoproteins (VSGs) are well 
established (Borst and Cross, 1982; Pays, 2005, Morrison et al., 2009b; Jackson et al., 2012), 
the role of the large, highly repetitive, surface molecule gene families, which make up ~50% 
of the T. cruzi genome (Andersson, 2011), in parasite persistence, is largely unknown. With 
improved genome assemblies of reference strains (Weatherly et al., 2009; Aslett et al., 2010), 
it is now feasible to reconstruct the more conserved gene families into chromosomal contigs 
that could be used to examine genomic architectural re-arrangements and/or variations in 
copy number of antigenic surface molecules during chronic infections, when combined with 
sequential patient sampling (Urban et al., 2011; Minning et al., 2011; Sterkers et al., 2011; 
Pavia et al., 2012).  
All of these potential studies are contingent on parallel improvements in direct clinical 
genotyping. As demonstrated by the Illumina study, PCR amplification and parasite 
hemoculturing steps are not ideal and introduced an unquantifiable but unavoidable number 
of biases. The exploitation of recent techniques designed to enrich pathogen DNA for field-
based genome sequencing of other parasite protozoa, such as selective methylation-
dependent degradation of human DNA (Oyola et al., 2013), whole genome bead-capture 
(Bright et al., 2012), RNA aptamer-based ligand capture (Nagarkatti et al., 2012) and WGA, 
(Morrison et al., 2007; Nair et al., 2014) should be considered for future T. cruzi clinical 
sampling.  
To improve our knowledge of sylvatic transmission dynamics, mammalian host associations 
and natural parasite population structures, landscape genetics (Biek and Real, 2010; Manel 
and Holderegger, 2013), combined with intensive spatio-temporal sampling, may represent a 
promising new strategy, especially if complemented with parasite whole genome sequencing 
(WGS), as has been initiated with field isolates of Leishamania (Downing et al., 2011; 
Rogers et al., 2014). All study sites described herein merit further sampling efforts, 
particularly the ecologically-rich biomes of Brazil and Bolivia and domestic transmission 
cycles in North Colombia.  
The mechanisms of genetic exchange identified among field populations are challenging to 
reconcile with those observed experimentally (Ramírez and Llewellyn, 2014). Among the 
majority of field data presented herein, mitochondrial introgression was detected as a 
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common feature of natural transmission cycles (Messenger et al., 2012; Ramírez et al., 2012; 
Zumaya-Estrada et al., 2012; Lima et al., 2014; Messenger et al., accepted); the failure to 
detect any reciprocal nuclear hybridization likely reflects the amount of each genome 
sampled (20% of the mitochondrial vs. <0.1% of the nuclear genome). To determine whether 
a genuine alternate mating system, involving asymmetric mitochondrial inheritance, exists in 
T. cruzi, WGS of introgression isolates in comparison with putative nuclear parents and 
mitochondrial donors could be undertaken. Resulting genome-wide SNP and heterozygosity 
distributions, copy number variations and chromosomal arrangements could be used to 
resolve the relative contribution of nuclear material to hybrid strains and to characterize the 
patterns of genetic inheritance following recombination. 
To investigate whether meiosis is actively occurring as a mechanism of genetic exchange, 
considering the resemblance of hybrid DTUs to Mendelian F1 progeny, a similar approach to 
Peacock et al., 2011; 2014 could be attempted in T. cruzi, involving fluorescent tagging of 
the N-termini of conserved meiotic orthologues known to function during recombination in 
T. b. brucei (DMC1, HOP1, MND1 and SPO11). Tracking of meiosis gene expression 
throughout in vitro and in vivo life cycles may resolve their contributions to genetic exchange 
mechanisms or potentially expose novel protein functions; C. albicans exploits SPO11 to 
facilitate recombination between sister chromatids during its non-meiotic parasexual cycle 
(Forche et al., 2008) and Giardia co-opts its meiotic orthologues to undergo homologous 
recombination during karyogamy (Poxleitner et al., 2008).  
Importantly, the effects of genetic exchange on parasite phenotype are unknown. Few studies 
have focused on phenotyping recently-isolated T. cruzi field strains; most are reliant on 
historical reference collections, whose behaviour is known to change after significant time in 
culture (Moreira et al., 2012), and those performed on handfuls of newer isolates have 
reported significant variation between DTUs and even among closely related strains 
(Andrade and Magalhães, 1997; Martínez-Díaz et al., 2001).  
In vitro characterization of both parental and hybrid T. cruzi strains has the potential to reveal 
inheritance patterns of phenotypic traits and facilitate accurate assessments of the 
epidemiological risk associated with recombinant genotypes. To develop high-throughput, T. 
cruzi phenotyping, an analogous approach to those used for genetic crosses of other 
trypanosomatids could be adopted; parasite clones expressing either a fluorescent (Akopyants 
et al., 2009; Sadlova et al., 2011; Bouvier et al., 2013; Inbar et al., 2013) or bioluminescent 
reporter gene (Henriques et al., 2012; 2014; Lewis et al., 2014), could be evaluated for 
parameters such as in vitro growth rate, mammalian cell infectivity, rate of metacyclogenesis, 
vector permissibility among different species of triatomine bug, and in vivo parasitaemia, 
infection course, tissue sequestration and drug susceptibility. Advantages of using a 
transgenic reporter system include easier and more accurate parasite quantification by FACs 
and highly sensitive real-time imaging of infection experiments (Lewis et al., 2014).  
This technique could be used to compare the biological behaviour of a number of 
epidemiological important T. cruzi genotypes. For example, hybrid (TcV and TcVI) and 
parental representatives (TcII and TcIII), TcIDOM vs. sympatric sylvatic TcI isolates as well as 
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strains that have undergone mitochondrial introgression compared to their nuclear parents 
and mitochondrial donors. This system could then be expanded to investigate the interaction 
between distinct genotypes, expressing different reporter genes and selectable markers, 
during competitive mixed or sequential infections, in vitro, in vectors and in mice, with the 
potential to recover novel hybrid strains under double drug pressure. 
Lastly, unraveling mitochondrial inheritance is complicated due to our inability to generate a 
transgenic cell line with all multi-copy maxicircles fluorescently tagged. An alternate 
approach to directly address the cytological mechanisms of mitochondrial segregation to 
progeny cells, might be to isolate individual parasites by FACs, immediately following 
genetic crosses, amplify genetic material by WGA, and characterize using single cell 
genomics (as has been recently pioneered to dissect multiclonal malaria infections (Nair et 
al., 2014)).  
This PhD project contributed to the further development of new methods to resolve the 
complex population genetics of T. cruzi, specifically, the establishment of the first panel of 
mitochondrial MLST markers, formalization of a transferable nuclear MLST scheme and 
design of Illumina deep sequencing markers. Application of the latter to patient isolates 
revealed extensive T. cruzi intra-host multiclonality, with implications for enhanced 
understanding of transmissibility and clinical presentation. Similarly, analyses of field 
populations using a combination of mitochondrial and nuclear MLST and MLMT, provided 
new insights into the distribution of major genotypes and their associations with diverse 
domestic transmission cycles and sylvatic ecologies. Unanticipated occurrence of widespread 
intra- and inter-DTU mitochondrial introgression was observed, reaffirming the importance 
of genetic exchange in influencing the evolution of T. cruzi. 
There is intense international research interest in trypanosomatids because of their shared 
unusual, and often, unique biological features, as well as considerable public health 
importance. The outputs from this PhD have the potential to contribute to resolving several 
enigmas of T. cruzi biology, including, a comprehensive understanding of parasite 
phylogeography; the relationship between T. cruzi DTUs, parasite multiclonality and 
congenital transmission or clinical prognosis; the identification of novel, non-canonical 
genetic mechanisms; and the epidemiological implications of parasite hybridization.  
Some of the emerging findings from T. cruzi research are reminiscent of observations from 
other pathogens, for example the parasexual and sexual genetic exchange mechanisms of 
fungi, and the epidemiology of clonal and hybrid lineages of Toxoplasma gondi.  It is 
important to sustain and nurture dialogue between research disciplines, across pathogens, and 
through international networks and technology transfer. The ability to improve our 
understanding of the genetic diversity of T. cruzi and other pathogens is clearly demonstrated 
by outputs of this research project. In addition to the prospective studies described herein, the 
future research agenda for Chagas disease needs to be considered in the context of changing 
disease epidemiology. Over the last 20-30 years, concomitant with successful trans-national 
vector control programmes and significant infrastructure and social development throughout 
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Latin America, Chagas disease has shifted from a neglected endemic disease of the rural poor 
to an urbanized chronic infection and now a potentially emergent global health problem.  
!
It is estimated that by 2030, 90% of the population in Latin American will inhabit cities 
(Kates and Parris, 2003), where chronic indeterminate individuals, infected decades ago, are 
of particular concern. In the absence of affordable, efficacious chemotherapy for chronic 
disease, research priorities must focus on the development of methods to detect the 20-30% 
of patients at risk of disease progression and the evaluation of novel compounds for chronic 
stage treatment. In parallel, congenital transmission among such populations now accounts 
for 25% of new infections (Jannin and Salvatella, 2006), is challenging to preempt, but 
comparatively easy to control if identified early. 
The rapid advancements in molecular biology technology, genomics, proteomics, 
microbiomics, etc, and parallel plummeting reagent costs, present the ideal opportunity to 
adopt a multidisciplinary approach to expand our academic understanding of T. cruzi and 
translate these improvements for the direct benefit of Chagas disease patients. Until then, 
presented herein are some of the highest resolution genotyping techniques developed in T. 
cruzi to date which have the potential to expand our current understanding of parasite genetic 
diversity and its relevance to natural population structures and the clinical outcome of Chagas 
disease.  
 
 
!
!
!
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 Chapter 19 
 Molecular Genotyping of  Trypanosoma cruzi for Lineage 
Assignment and Population Genetics 
 Louisa  A.  Messenger ,  Matthew  Yeo ,  Michael  D.  Lewis , 
 Martin  S.  Llewellyn , and  Michael  A.  Miles 
 Abstract 
 Trypanosoma cruzi , the etiological agent of Chagas disease, remains a major public health problem in Latin 
America. Infection with  T. cruzi is lifelong and can lead to a spectrum of pathological sequelae ranging 
from subclinical to lethal cardiac and/or gastrointestinal complications. Isolates of  T. cruzi can be assigned 
to six genetic lineages or discrete typing units (DTUs), which are broadly associated with disparate ecolo-
gies, transmission cycles, and geographical distributions. This extensive genetic diversity is also believed to 
contribute to the clinical variation observed among chagasic patients. Unravelling the population structure 
of  T. cruzi is fundamental to understanding Chagas disease epidemiology, developing control strategies, 
and resolving the relationship between parasite genotype and clinical prognosis. 
 To date, no single, widely validated, genetic target allows unequivocal resolution to DTU-level. In 
this chapter we present standardized methods for strain DTU assignment using PCR-restriction fragment 
length polymorphism analysis (PCR-RFLP) and nuclear multilocus sequence typing (MLST). PCR-RFLPs 
have the advantages of simplicity and reproducibility, requiring limited expertise and few laboratory con-
sumables. MLST data are more laborious to generate but more informative; DNA sequences are readily 
transferable between research groups and amenable to recombination detection and intra-lineage analyses. 
We also recommend a mitochondrial (maxicircle) MLST scheme and a panel of 28 microsatellite loci for 
higher resolution population genetics studies. 
 Due to the scarcity of  T. cruzi in blood and tissue, all of these genotyping techniques have limited 
sensitivity when applied directly to clinical or biological specimens, particularly when targets are single 
(MLST) or low copy number (PCR-RFLPs). We therefore describe essential protocols to isolate parasites, 
derive biological clones, and extract  T. cruzi genomic DNA from fi eld and clinical samples. 
 Key words  Trypanosoma cruzi ,  PCR ,  Genotyping ,  Phylogenetics ,  Microsatellites ,  MLST ,  RFLP , 
 Mitochondria ,  Sequencing 
1  Introduction 
 Chagas disease is the most important parasitic infection in Latin 
America, where an estimated 10–12 million individuals are 
infected, with a further 80 million at risk [ 1 ]. The etiological 
agent,  Trypanosoma cruzi , is a complex zoonosis, with a broad 
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endemic range that extends from the southern United States to 
Argentinean Patagonia. Disease transmission primarily occurs in 
areas where humans are exposed to the contaminated feces of 
domiciliated triatomine bug vectors. In the absence of chemo-
therapy, infection with  T. cruzi is life-long and can lead to a spec-
trum of pathological sequelae ranging from subclinical to 
debilitation and death by irreversible cardiac and/or gastrointesti-
nal syndromes [ 2 ]. Diagnosis and treatment options are further 
complicated by disproportionate distributions of disease patholo-
gies; cardiomyopathies occur throughout South and Central 
America, whereas gastrointestinal complications are more common 
south of the Amazon. It has been suggested that this geographical 
heterogeneity is associated with genetic variation among  T. cruzi 
strains [ 3 – 5 ]. However, the relationship between parasite geno-
type and clinical outcome remains controversial. 
 T. cruzi displays remarkable genetic diversity and a range of 
markers can be used to delineate this species. Typing of genetic 
polymorphisms in conserved housekeeping genes can defi ne major 
genetic lineages [ 6 – 8 ], while analysis of hypervariable loci, such as 
microsatellites [ 9 – 11 ] or kDNA minicircle sequences [ 12 – 14 ], 
potentially allows identifi cation of profi les specifi c to individual 
strains. Historically, the study of  T. cruzi has been hindered by a 
lack of standardized molecular typing methods and the use of vari-
ous alternative nomenclatures (recently reviewed in [ 15 ]). One 
useful conceptual development has been that of the discrete typing 
unit (DTU) which groups isolates using shared molecular charac-
teristics but without explicitly defi ning their evolutionary related-
ness [ 16 ]. For  T. cruzi multilocus genotyping has consistently 
identifi ed six DTUs, which are each correlated with distinct but 
not exclusive ecologies and geographical distributions [ 17 ] . 
Recently, DTU nomenclature has been revised by international 
consensus to refl ect the current understanding of  T. cruzi genetic 
diversity [ 18 ]. 
 Molecular analyses suggest that  T. cruzi has a predominantly 
clonal population structure, punctuated by infrequent genetic 
exchange events. DTUs TcI-TcIV form monophyletic clades and 
TcV and TcVI are known to be recent inter-lineage hybrids [ 19 ]. 
Multilocus sequence typing (MLST) data support these designa-
tions with TcI-TcIV characterized by substantial allelic homozy-
gosity, likely resulting from recurrent, genome-wide and dispersed 
gene conversion, while TcV and TcVI display natural heterozygos-
ity and minimal distinction, sharing intact alleles from their paren-
tal progenitors (TcII and TcIII) [ 20 – 22 ]. The origin(s) of these 
hybrid lineages is unresolved and it is presently contested whether 
they arose from two independent genetic exchange events [ 19 , 
 23 ], or a single incidence of hybridization followed by clonal diver-
gence [ 24 ] (recently reviewed in [ 25 ]). 
 The epidemiological relevance of the  T. cruzi DTUs has also 
been the subject of considerable debate, with evidence emerging 
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to support historical and contemporary associations of particular 
lineages with different transmission ecologies. In general, TcI, 
TcII, TcV, and TcVI are frequently isolated from domestic cycles 
and are responsible for the majority of human infections. The dis-
tribution of domestic TcI extends from the Amazon Basin north-
wards, where it is the primary cause of Chagas disease in Venezuela 
and Colombia [ 26 ,  27 ]. TcI is also ubiquitous among arboreal 
sylvatic transmission cycles throughout Latin America [ 28 ,  29 ], 
and commonly isolated from  Didelphis species and the triatomine 
tribe  Rhodniini [ 30 ]. By contrast, TcII, TcV, and TcVI appear 
restricted to domestic transmission in southern parts of South 
America. Strains from these three DTUs are rarely isolated from 
sylvatic reservoirs and their ecological niches are largely unde-
fi ned [ 17 ]. TcIII has a dispersed terrestrial distribution that ranges 
from Amazonia to Argentina, where it is primarily transmitted by 
 Panstrongylus geniculatus to  Dasypus novemcinctus and other bur-
rowing mammals [ 31 – 33 ]. TcIV is poorly understood, principally 
because several genotyping methods fail to distinguish this lineage 
from others, particularly from TcIII [ 6 ]. However, TcIV is known 
to circulate sympatrically with TcI in wild primates [ 34 ] and 
 raccoons [ 29 ] in Amazonia and North America, respectively. It is 
also increasing in epidemiological importance and has been impli-
cated in recent oral outbreaks in Amazonia [ 34 ,  35 ] and as a 
 secondary agent of Chagas disease in Venezuela [ 3 ]. As yet, TcIII 
and TcIV only sporadically invade domestic transmission cycles, 
but this may refl ect inadequate and/or inappropriate sampling and 
the insensitivity of conventional genotyping methods. Furthermore 
some of these ecological associations are complicated by overlap-
ping sylvatic and domestic transmission cycles and frequent mixed 
infections in individual humans [ 36 ,  37 ], mammalian reservoirs 
[ 32 ,  38 ], and triatomine vectors [ 8 ,  39 – 41 ]. 
 Elucidating the population structure and genetic diversity of  T. 
cruzi is critical to furthering our understanding of the complex 
transmission dynamics, clinical variability and phylogeography 
underlying Chagas disease. Secondarily, detecting recombination 
among  T. cruzi populations is also of profound epidemiological 
importance considering the expansion of the hybrid lineages within 
the domestic niche and the capacity for genetic exchange to drive 
the evolution of novel virulent recombinant strains. As yet, no sin-
gle marker affords complete, unequivocal DTU resolution, and 
reliance on only one target is inadvisable given the potential con-
founding infl uence of hybridization [ 12 ,  21 ]. In this chapter we 
describe genotyping methods to assign  T. cruzi isolates to DTU- 
level and those that can be used for higher resolution intra-lineage 
diversity studies. 
 For optimal genotyping results we strongly recommend the 
use of biologically cloned material, wherever possible. Multiclonality 
within individual  T. cruzi strains can manifest as mixed infections 
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of different DTUs [ 37 – 39 ,  41 ,  42 ] or multiple variants of the same 
genetic lineage [ 41 ,  43 ]. Infra-population genetic diversity is largely 
determined by levels of super-infection from discrete sources [ 44 ], 
inbreeding among closely related genotypes [ 45 ] and simultane-
ous transmission of mulitclonal populations between hosts [ 38 ]. 
We describe routine protocols to isolate  T. cruzi parasites from 
infected patients/mammals and triatomine bugs. We then recom-
mend methods to derive biological clones from  T. cruzi strains, 
including plating on a solid medium [ 41 ], limiting dilution or 
micromanipulation of individual parasites [ 46 ] and also suggest 
techniques to extract genomic DNA from resulting axenic cultures 
as well as directly from clinical and fi eld isolates. 
 To genotype  T. cruzi isolates to DTU-level we recommend a 
standardized triple-assay comprising PCR product size polymor-
phism analysis of the 24Sα rRNA gene (LSU rDNA) and 
 PCR- restriction fragment-length polymorphism analysis (PCR-
RFLP) using heat shock protein 60 ( HSP60 ) and glucose-6-phos-
phate isomerase ( GPI ) [ 47 ]. These PCR-based assays have the 
advantages of being easily reproducible and implemented with lim-
ited expertise, technical resources, and sample material. However, 
this methodology was developed using a panel of biologically 
cloned reference isolates and is reliant on the presence/absence of 
specifi c single- nucleotide polymorphisms (SNPs) and may be 
insensitive to mutations in as yet untested strains. In addition, both 
PCR-RFLPs are based on low copy targets and were evaluated 
using culture- extracted DNA and thus their sensitivity against fi eld 
or clinical specimens and for resolving mixed infections may vary. 
The repertoire of PCR-based  T. cruzi genotyping techniques is 
ever expanding and those recently described by D’Avila et al. [ 48 ], 
Burgos et al. [ 49 ], and Van der Auwera et al. [ 50 ] may be more 
appropriate for the aforementioned sample types. 
 Another technique that we advocate to unambiguously assign 
isolates to DTU-level is nuclear multilocus sequence typing 
(MLST). This is a sequence-based approach, which exploits 
 conserved nucleotide diversity present in four single-copy 
h ousekeeping genes (3-hydroxy-3-methylglutaryl-CoA reductase 
( HMCOAR ), glucose-6-phosphate isomerase ( GPI ), mitochon-
drial peroxidase ( TcMPX ), and rho-like GTP binding protein 
( RHO1 )) [ 20 ,  51 ] and can be used as an adjunct to DTU alloca-
tion, in the rare cases when PCR-RFLPs fail to unequivocally gen-
otype samples. MLST data offer minimal subjectivity in analysis 
and are transferable and electronically portable, allowing for inter- 
laboratory comparisons without the exchange of reference isolates. 
Our research group, along with others [ 51 ], is presently expanding 
this panel of loci with the aim of formalizing an MLST scheme that 
can be used for high resolution genetic diversity studies [ 52 ] . 
 We anticipate that with the rapid advancement of sequencing 
technology, current genotyping methods will imminently be 
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superseded by comparative genomics of multiple representatives 
from each  T. cruzi DTU [ 53 ]. However, in the interim, we rec-
ommend the use of a panel of 28 microsatellite loci (multilocus 
microsatellite typing, MLMT) and ten mitochondrial gene frag-
ments (maxicircle MLST) to address intra-lineage population 
genetic hypotheses using appropriately assembled isolate cohorts. 
Microsatellites are short, neutrally evolving, codominant tandem 
repeats, with mutation rates several orders of magnitude higher 
than protein-coding genes [ 54 ]. These hypervariable markers pro-
vide a method of identifying and tracking individual strains as well 
as assessing the frequency of alleles in a given population. This 
MLMT scheme is highly discriminatory and has previously been 
used to describe intra-TcI and -TcIII population structuring on a 
continental scale [ 10 ,  33 ], to reveal genetic exchange within TcI 
domestic/peridomestic populations in Ecuador [ 11 ] and to 
expose the role of mammalian reservoirs in the diversifi cation of  T. 
cruzi genotypes [ 38 ]. Potential drawbacks associated with MLMT 
include limited transferability between laboratories and genotyp-
ing errors arising from homoplasy (when alleles are identical in 
sequence but not descent), allelic dropout, misprinting, artifact 
peaks, and stutter patterns [ 55 ]. Maxicircle MLST exploits inher-
ent features of mitochondrial DNA, specifi cally uniparental inheri-
tance and a faster mutation rate (compared to nuclear DNA), to 
detect directional gene fl ow among closely related isolates. 
Maxicircle MLST can be used in parallel with nuclear loci (MLMT 
and/or nuclear MLST) to identify phylogenetic incongruence, 
which is indicative natural recombination. This combined 
approach has uncovered novel mitochondrial introgression events 
occurring across geographically dispersed TcI populations [ 56 ] 
and revealed pervasive genetic exchange within Colombian TcI 
transmission cycles [ 44 ]. 
 Herein, we describe the protocols used to (1) isolate  T. cruzi 
samples from infected patients, mammalian hosts and triatomine 
bugs, (2) derive biological clones from  T. cruzi strains by micro-
manipulation, plating on solid medium, or limiting dilution, (3) 
extract parasite DNA from cultured epimastigotes, human/mam-
malian hemocultures, or triatomine bug intestinal homogenates, 
(4) assign isolates to DTU-level using PCR-RFLP analysis, (5) 
amplify, sequence and analyze nuclear and maxicircle MLST tar-
gets, and (6) amplify, multiplex, and analyze microsatellite allele 
sizes. 
2  Materials 
 Prepare all solutions using ultrapure water (purify deionized water 
to attain a resistivity of 18 MΩ cm at 25 °C) and analytical grade 
reagents. 
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 All experimental work which involves handling live  T. cruzi 
parasites should be conducted in a designated laboratory and in 
accordance with locally approved standard operating procedures 
(SOPs). All manipulation of live material should be carried out 
within a Class II microbiological safety cabinet. Accidental infec-
tion with  T. cruzi can arise from inoculation of a single infectious 
metacylic trypomastigote or bloodstream-form trypomastigote 
and at least sixty-fi ve cases of laboratory transmission have been 
recorded [ 57 ]. However, the risk of laboratory-acquired infection 
is minimal if appropriate guidelines are adhered to ( see  Note 1 ). 
 Here we present possible protocols for the isolation of  T. cruzi , 
techniques for biologically cloning resulting parasites and methods 
of extracting  T. cruzi genomic DNA. Choice of technique will 
depend upon the original source of the parasite and quality of 
DNA template required for downstream applications ( see  Note 2 ). 
 To maximize the likelihood of isolate recovery and minimize 
loss of clonal diversity, we strongly recommend processing all fi eld 
and clinical samples by simultaneously (1) inoculating strains into 
axenic culture (proceed to (2) before the fi rst re-passage), (2) bio-
logically cloning strains, and (3) directly extracting genomic DNA 
( see Fig.  1 ).
  1.  Blood agar base (Sigma-Aldrich, UK). 
  2.  Agar (Sigma-Aldrich, UK). 
  3.  Tryptone (Sigma-Aldrich, UK). 
2.1  Isolation 
of  T. cruzi 
2.1.1  Direct Hemoculture 
from Patients/Mammals
Triatomine bug Patient/MammalSource of T.cruzi
Isolation of T.cruzi 
T. cruzi genomic DNA extraction
Hind-gut dissection
DNAzol® Solution
Axenic culture
Gentra Puregene
tissue kit
Xenodiagnosis
Hemoculture
Roche High Pure
PCR template 
preparation kit
Biological Cloning
Biological cloning of T.cruzi by: 
•Micromanipulation
•Plating on solid-media
•Limiting dilution
 Fig. 1  Schematic of  T. cruzi strain isolation, cloning, and DNA extraction protocols 
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  4.  Sodium chloride, NaCl (Sigma-Aldrich, UK). 
  5.  Sterile defi brinated rabbit blood. 
  6.  Gentamycin (Sigma-Aldrich, UK). 
  7.  5-Fluorocytosine (Sigma-Aldrich, UK). 
  8.  Liver infusion broth (Difco™, Becton Dickinson, USA). 
  9.  Glucose (Sigma-Aldrich, UK). 
  10.  Potassium chloride, KCl (Sigma-Aldrich, UK). 
  11.  Disodium hydrogen phosphate, Na 2 HPO 4 (Sigma-Aldrich, UK). 
  12.  Hemin (Sigma-Aldrich, UK). 
  13.  Sodium hydroxide, NaOH (Sigma-Aldrich, UK). 
  14.  Heat-inactivated fetal calf serum (Sigma-Aldrich, UK). 
  15.  Ketamine hydrochloride (Sigma-Aldrich, UK). 
  16.  Absolute ethanol (analytical reagent grade). 
  17.  Iodine (Sigma-Aldrich, UK). 
  18.  Guanidine hydrochloride (Sigma-Aldrich, UK). 
  19.  Ethylenediaminetetraacetic acid (EDTA) disodium salt dihy-
drate (Sigma-Aldrich, UK). 
  20.  Refrigerated centrifuge. 
  21.  Sterile 15 ml centrifuge tubes (Greiner Bio-One, UK). 
  22.  Sterile Nunclon™ Δ fl at sided tubes (#734-2068, Nunc, UK). 
  23.  Rubber caps from sodium heparin vacutainer tubes (#368480, 
Scientifi c Laboratory Supplies, UK). 
  24.  Parafi lm (VWR, UK). 
  25.  Sterile 1, 2, 5, and 20 ml BD Plastipak™ syringes with needles 
(Becton Dickinson, USA). 
  26.  BD Vacutainer ® plus plastic K 2 EDTA tubes (Becton Dickinson, 
USA). 
  27.  28 °C humidifi ed incubator. 
  28.  Inverted microscope. 
  29.  Sterile glycerol (VWR, UK). 
  30.  Sterile cryovials (Nunc, Denmark). 
  1.  Uninfected triatomine bug colony. 
  2.  Mercuric chloride, HgCl 2 (Sigma-Aldrich, UK). 
  3.  Hydrochloric acid sp.gr.1.18, HCl (VWR, UK). 
  4.  Sodium chloride, NaCl (Sigma-Aldrich, UK). 
  5.  Absolute ethanol (analytical reagent grade). 
  6.  Gentamycin (Sigma-Aldrich, UK). 
  7.  5-Fluorocytosine (Sigma-Aldrich, UK). 
  8.  Blood agar base (Sigma-Aldrich, UK). 
2.1.2  Isolation 
from Triatomine Bugs 
(Xenodiagnosis)
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  9.  Agar (Sigma-Aldrich, UK). 
  10.  Tryptone (Sigma-Aldrich, UK). 
  11.  Sterile defi brinated rabbit blood. 
  12.  Sterile Nunclon™ Δ fl at sided tubes (#734-2068, Nunc, UK). 
  13.  Rubber caps from sodium heparin vacutainer tubes (#368480, 
Scientifi c Laboratory Supplies, UK). 
  14.  Parafi lm (VWR, UK). 
  15.  Sterile broad forceps (Scientifi c Laboratory Supplies, UK). 
  16.  Sterile Watchmakers’ forceps (Scientifi c Laboratory Supplies, 
UK). 
  17.  Perspex dissection screen. 
  18.  Sterile microscope slides (VWR, UK). 
  19.  Sterile 13 mm microscope cover glasses (VWR, UK). 
  20.  Sterile broad microspatula (Scientifi c Laboratory Supplies, UK). 
  21.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  22.  Sterile 1 ml plastic Pasteur pipettes (Scientifi c Laboratory 
Supplies, UK). 
  23.  28 °C humidifi ed incubator. 
  24.  Inverted microscope. 
  1.  Blood agar base (Sigma-Aldrich, UK). 
  2.  Agar (Sigma-Aldrich, UK). 
  3.  Tryptone (Sigma-Aldrich, UK). 
  4.  Sodium chloride, NaCl (Sigma-Aldrich, UK). 
  5.  Sterile defi brinated rabbit blood. 
  6.  Gentamycin (Sigma-Aldrich, UK). 
  7.  5-Fluorocytosine (Sigma-Aldrich, UK). 
  8.  Mercuric chloride, HgCl 2 (Sigma-Aldrich, UK). 
  9.  Hydrochloric acid sp.gr.1.18, HCl (VWR, UK). 
  10.  Absolute ethanol (analytical reagent grade). 
  11.  Sterile microcapillary tubes (Sigma-Aldrich, UK). 
  12.  Bunsen burner (Scientifi c Laboratory Supplies, UK). 
  13.  Microscope slides (VWR, UK). 
  14.  Sterile 13 mm microscope cover glasses (VWR, UK). 
  15.  Sterile 7 ml Bijou tubes (Sterilin, UK). 
  16.  Disposable hemocytometers (Immune Systems, UK). 
  17.  Sterile Watchmakers’ forceps (Scientifi c Laboratory Supplies, UK). 
  18.  28 °C humidifi ed incubator. 
  19.  Inverted microscope. 
2.2  Biological 
Cloning of  T. cruzi 
2.2.1  Micromanipulation
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  1.  RPMI-1640 liquid medium (Sigma-Aldrich, UK #R0883). 
  2.  Tryptone (Sigma-Aldrich, UK). 
  3.  HEPES sodium salt (Sigma-Aldrich, UK). 
  4.  Hemin (Sigma-Aldrich, UK). 
  5.  Sodium hydroxide, NaOH (Sigma-Aldrich, UK). 
  6.  Heat-inactivated fetal calf serum (Sigma-Aldrich, UK). 
  7.  Sodium glutamate (Sigma-Aldrich, UK). 
  8.  Sodium pyruvate (Sigma-Aldrich, UK). 
  9.  Streptomycin (Sigma-Aldrich, UK). 
  10.  Penicillin (Sigma-Aldrich, UK). 
  11.  Blood agar base (Sigma-Aldrich, UK). 
  12.  Agar (Sigma-Aldrich, UK). 
  13.  Sterile defi brinated rabbit blood. 
  14.  Disposable hemocytometers (Immune Systems, UK). 
  15.  Low melting point (LMP) agarose (Sigma-Aldrich, UK). 
  16.  Sodium chloride, NaCl (Sigma-Aldrich, UK). 
  17.  Gentamycin (Sigma-Aldrich, UK). 
  18.  Parafi lm (VWR, UK). 
  19.  Sterile 90 mm petri dishes (Sterilin, UK). 
  20.  Sterile 200 μl pipette tips (Star Laboratories, UK). 
  21.  Sterile 48-well cell culture plates (Becton Dickinson, USA). 
  22.  28 °C humidifi ed incubator. 
  23.  Inverted microscope. 
  1.  RPMI-1640 liquid medium (Sigma-Aldrich, UK #R0883). 
  2.  Tryptone (Sigma-Aldrich, UK). 
  3.  HEPES sodium salt (Sigma-Aldrich, UK). 
  4.  Hemin (Sigma-Aldrich, UK). 
  5.  Sodium hydroxide, NaOH (Sigma-Aldrich, UK). 
  6.  Heat-inactivated fetal calf serum (Sigma-Aldrich, UK). 
  7.  Sodium glutamate (Sigma-Aldrich, UK). 
  8.  Sodium pyruvate (Sigma-Aldrich, UK). 
  9.  Streptomycin (Sigma-Aldrich, UK). 
  10.  Penicillin (Sigma-Aldrich, UK). 
  11.  Disposable hemocytometers (Immune Systems, UK). 
  12.  Sterile 96-microwell culture plates (Nunc, UK). 
  13.  28 °C humidifi ed incubator. 
  14.  Inverted microscope. 
2.2.2  Plating 
on Solid Medium
2.2.3  Limiting Dilution
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  1.  Gentra Puregene tissue kit (Qiagen, UK). 
  2.  High Pure PCR template preparation kit (Roche, UK). 
  3.  DNAzol ® solution (Life Technologies, UK). 
  4.  Centrifuge. 
  5.  Microcentrifuge. 
  6.  Vortex. 
  7.  Water bath. 
  8.  Phosphate-buffered saline (PBS) (Sigma-Aldrich, UK). 
  9.  Absolute isopropanol (analytical reagent grade). 
  10.  Absolute ethanol (analytical reagent grade). 
  11.  Sodium hydroxide, NaOH (Sigma-Aldrich, UK). 
  12.  Sterile 15 ml centrifuge tubes (Greiner Bio-One, UK). 
  13.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  14.  Spectrophotometer. 
  1.  Oligonucleotides to amplify the D7 divergent domain of the 
24Sα rRNA gene (LSU rDNA), heat shock protein 60 ( HSP60 ), 
and glucose-6-phosphate isomerase ( GPI ) ( see Table  1 ).
  2.  T. cruzi genomic DNA. 
  3.  10× NH 4 buffer (Bioline, UK). 
  4.  50 mM MgCl 2 solution (Bioline, UK). 
  5.  Deoxynucleotide solution mix (10 mM stock of each dNTP) 
(New England Biolabs, UK). 
  6.  BIOTAQ™ DNA polymerase (Bioline, UK). 
2.3  Preparation 
of Parasite Genomic 
DNA
2.4  PCR-RFLP 
Amplifi cation
 Table 1 
 PCR-RFLP gene fragments and primer details 
 PCR-RFLP 
target  Primer name  Primer Sequence (5′ → 3′) 
 LSU rDNA a  D71  AAGGTGCGTCGACAGTGTGG (20) 
 D72  TTTTCAGAATGGCCGAACAGT (21) 
 HSP60  b  HSP60 _for  GTGGTATGGGTGACATGTAC (20) 
 HSP60 _rev  CGAGCAGCAGAGCGAAACAT (20) 
 GPI c  GPI _for  GGCATGTGAAGCTTTGAGGCCTTTTTCAG (29) 
 GPI _rev  TGTAAGGGCCCAGTGAGAGCGTTCGTTGAATAGC (34) 
 a Primer sequences according to Brisse et al. [ 73 ] 
 b Primer sequences according to Strurm et al. [ 74 ] 
 c Primer sequences according to Gaunt et al. [ 75 ] 
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  7.  Sterile 0.2 ml 96-well PCR reaction plates and adhesive plate 
seals (Fisher Scientifi c, UK) or 0.2 ml PCR tube strips and caps 
(VWR, UK). 
  8.  PCR machine. 
  9.  Microcentrifuge. 
  10.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  1.  Oligonucleotides to amplify 3-hydroxy-3-methylglutaryl-CoA 
reductase ( HMCOAR ), glucose-6-phosphate isomerase ( GPI ), 
mitochondrial peroxidase ( TcMPX ), and rho-like GTP binding 
protein ( RHO1 ) ( see Table  2 ).
  2.  T. cruzi genomic DNA. 
  3.  5× colorless GoTaq ® reaction buffer (Promega, UK). 
  4.  Deoxynucleotide solution mix (10 mM stock of each dNTP) 
(New England Biolabs, UK). 
  5.  GoTaq ® DNA polymerase (Promega, UK). 
  6.  Sterile 0.2 ml 96-well PCR reaction plates and adhesive plate 
seals (Fisher Scientifi c, UK) or 0.2 ml PCR tube strips and caps 
(VWR, UK). 
  7.  PCR machine. 
  8.  Microcentrifuge. 
  9.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  1.  Oligonucleotides to amplify ten maxicircle gene fragments ( see 
Table  3 and Fig.  2 ).
  2.  T. cruzi genomic DNA. 
  3.  10× NH 4 buffer (Bioline, UK). 
  4.  50 mM MgCl 2 solution (Bioline, UK). 
  5.  Deoxynucleotide solution mix (10 mM stock of each dNTP) 
(New England Biolabs, UK). 
  6.  BIOTAQ™ DNA polymerase (Bioline, UK). 
  7.  Sterile 0.2 ml 96-well PCR reaction plates and adhesive plate 
seals (Fisher Scientifi c, UK) or 0.2 ml PCR tube strips and caps 
(VWR, UK). 
  8.  PCR machine. 
  9.  Microcentrifuge. 
  10.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  1.  Oligonucleotides to amplify 28 microsatellite loci. Five fl uo-
rescent dyes with different emission spectra are used to label 
the forward primers: 6-FAM and TET (Proligo, Germany) and 
NED, PET, and VIC (Applied Biosystems, UK) ( see Table  4 
and Fig.  3 ).
2.5  Nuclear MLST 
PCR Amplifi cation
2.6  Maxicircle MLST 
PCR Amplifi cation
2.7  MLMT PCR 
Amplifi cation
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  2.  0.5× TE buffer (10 mM Tris–HCl and 1 mM EDTA (pH 8)) 
(both Sigma-Aldrich, UK). 
  3.  T. cruzi genomic DNA. 
  4.  10× ThermoPol reaction buffer (New England Biolabs, UK). 
  5.  50 mM MgCl 2 solution (Bioline, UK). 
  6.  Deoxynucleotide solution mix (10 mM stock of each dNTP) 
(New England Biolabs, UK). 
  7.  Taq DNA polymerase (New England Biolabs, UK). 
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 Table 4 
 T. cruzi microsatellite loci and primer sequences 
 Chromosome a  Primer code  Repeat type  Forward/reverse primer (5′–3′) 
 6  6529(CA)a  (CA) n  TGTGAAATGATTTGACCCGA 
 AGAGTCACGCCGCAAAGTAT 
 6  6529(TA)b  (TA) n  TGAAGGAGATTCTCTGCGGT 
 CTCTCATCTTTTGTTGTGTCCG 
 6  mclf10  (CA) n A(CA) n  GCGTAGCGATTCATTTCC 
 ATCCGCTACCACTATCCAC 
 10  6855(TA)(GA)  (TA) n (GA) n  TGTGATCAACGCGCATAAAT 
 TTCCATTGCCTCGTTTTAGA 
 15  11863(CA)  (CA) n  AGTTGACATCCCCAAGCAAG 
 CCCTGATGCTGCAGACTCTT 
 19  TcUn3  Unknown  CTTAAAGAGATACAAGAGGGAAGG 
 CTGTTATTTCAATAACACGGGG 
 19  10101(TA)  (TA) n  AACCCGCGCAGATACATTAG 
 TTCATTTGCAGCAACACACA 
 24  8741(TA)  (TA) n  TGTAACGGTAGGTCTCAATTCG 
 TTGCACTTGTGTATCTCGCC 
 27  10101(TC)  (TC) n  CGTACGACGTGGACACAAAC 
 ACAAGTGGGTGAGCCAAAAG 
 27  10101(CA)c  (CA) n  GTGTCGTTGCTCCCAAACTC 
 AAACTTGCCAAATGTGAGGG 
 27  10101(CA)a  (CA) n  GTCGCCATCATGTACAAACG 
 CTGTTGGCGAATGGTCATAA 
 34  6559(TC)  (TC) n  CGCTCTCAAAGGCACCTTAC 
 ATATGGACGCGTAGGAGTGC 
 37  10187(TTA)  (TTA) n  GAGAGAGATTCGGAAACTAATAGC 
 CATGTCCCTTCCTCCGTAAA 
 37  10187(CA)(TA)  (CA) n (TA) n  CATGTCATTAAGTGGCCACG 
 GCACATGTTGGTTGTTGGAA 
 37  10187(TA)  (TA) n  AGAAAAAGGTTTACAACGAGCG 
 CGATGGAGAACGTGAAACAA 
 37  10187(GA)  (GA) n  GTCACACCACTAGCGATGACA 
 ACTGCACAATACCCCCTTTG 
(continued)
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  8.  Sterile 0.2 ml 96-well PCR reaction plates (Fisher Scientifi c, 
UK) and adhesive plate seals or 0.2 ml PCR tube strips and 
caps (VWR, UK). 
  9.  PCR machine. 
  10.  Microcentrifuge. 
  11.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  1.  Molecular grade agarose (Bioline, UK). 
  2.  NuSieve™ GTG™ agarose (Lonza, UK). 
  3.  1× TAE buffer (40 mM Tris–HCl, 20 mM acetic acid, and 
1 mM EDTA (pH 8)) (Sigma-Aldrich, UK). 
  4.  10 mg/ml ethidium bromide (Sigma-Aldrich, UK) ( see  Note 3 ). 
  5.  Molecular weight ladders: Hyperladder ™ IV and V (Bioline, UK). 
  6.  5× DNA loading buffer blue (Bioline, UK). 
2.8  Agarose Gel 
Electrophoresis
Table 4
(continued)
 Chromosome a  Primer code  Repeat type  Forward/reverse primer (5′–3′) 
 37  TcUn2  Unknown  AACAAAATCTAGCGTCTACCATCC 
 GGTGTTGGCGTGTATGATTG 
 39  6925(TG)b  (TG) n  GAAACGCACTCACCCACAC 
 GGTAGCAACGCCAAACTTTC 
 39  7093(TC)  (TC) n  CCAACATTCAACAAGGGAAA 
 GCATGAATATTGCCGGATCT 
 39  6925(CT)  (CT) n  CATCAAGGAAAAACGGAGGA 
 CGGTACCACCTCAAGGAAAG 
 39  7093(TA)c  (TA) n  CGTGTGCACAGGAGAGAAAA 
 CGTTTGGAGGAGGATTGAGA 
 39  6925(TG)a  (TG) n  TCGTTCTCTTTACGCTTGCA 
 TAGCAGCACCAAACAAAACG 
 39  7093(TCC)  (TCC) n  AGACGTTCATATTCGCAGCC 
 AGCCACATCCACATTTCCTC 
 40  11283(TCG)  (TCG) n  ACCACCAGGAGGACATGAAG 
 TGTACACGGAACAGCGAAG 
 40  11283(TA)b  (TA) n  AACATCCTCCACCTCACAGG 
 TTTGAATGCGAGGTGGTACA 
 a Chromosomal assignment based on Weatherly et al. [ 79 ] 
Louisa A. Messenger et al.
313
  7.  Gel electrophoresis equipment (e.g., Jencons midi-horizontal 
gel electrophoresis system with 16-well combs and 13 × 15 cm 
casting trays) and power pack. 
  8.  Microwave. 
  9.  UV transilluminator. 
  1.  QIAquick PCR purifi cation kit (Qiagen, UK). 
  2.  Absolute ethanol (analytical reagent grade). 
  3.  Absolute isopropanol (analytical reagent grade). 
  4.  0.5× TE buffer (10 mM Tris–HCl and 1 mM EDTA (pH 8)) 
(both Sigma-Aldrich, UK). 
  5.  Microcentrifuge. 
2.9  PCR Purifi cation
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  6.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  7.  Sterile 0.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  1.  Eco RV restriction endonuclease, corresponding 10× buffer 
and 100× bovine serum albumin (BSA) (New England 
Biolabs, UK). 
  2.  Hha I restriction endonuclease, corresponding 10× buffer and 
100× BSA (New England Biolabs, UK). 
  3.  Microcentrifuge. 
  4.  Sterile 1.5 ml graduated microcentrifuge tubes (Anachem, UK). 
  5.  37 °C incubator. 
  1.  BigDye™ Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems, UK). 
  2.  PCR machine. 
  3.  Absolute ethanol (analytical reagent grade). 
  4.  96-well optical reaction plates with barcodes (Applied 
Biosystems, UK). 
  5.  Hi-Di™ deionized formamide (Applied Biosystems, UK). 
  6.  Refrigerated centrifuge. 
  7.  Vortex. 
  8.  16-Capillary 3730 DNA Analyzer (Applied Biosystems, UK) 
( see  Note 4 ). 
  1.  96-well optical reaction plates with barcodes (Applied 
Biosystems, UK). 
  2.  GeneScan™-500 LIZ™ size standard (Applied Biosystems, UK). 
  3.  Hi-Di™ deionized formamide (Applied Biosystems, UK). 
  4.  16-Capillary 3730 DNA Analyzer (Applied Biosystems, UK). 
3  Methods 
  1.  Prepare biphasic 4 N (USMARU) culture medium by adding 
4 % (w/v) blood agar base, 0.6 % (w/v) agar, 0.6 % (w/v) 
NaCl, and 0.5 % (w/v) tryptone (all Sigma-Aldrich, UK) 
to H 2 O and dissolve by autoclaving (121 °C for 15 min). Cool 
the medium to 50 °C and aspectically add 10 % (v/v) sterile 
defibrinated rabbit blood, 150 μg/ml gentamycin, and 
150 μg/ml 5-fluorocytosine (both Sigma-Aldrich, UK) 
( see  Note 5 ). 
  2.  Aliquot 2 ml of biphasic 4 N culture medium into the bottom 
of a sterile Nunclon™ Δ fl at sided tube (Nunc, UK) and allow 
to set at an angle, forming a slope. 
2.10  Restriction 
Enzyme Digestions
2.11  Dye Terminator 
DNA Sequencing
2.12  MLMT PCR 
Product Multiplexing 
and Allele Size 
Determination
3.1  Isolation 
of  T. cruzi 
3.1.1  Direct Hemoculture 
from Patients/Mammals
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  3.  Once set, overlay each culture with 500 μl of 0.9 % sterile 
NaCl, containing 150 μg/ml gentamycin and 150 μg/ml 
5-fl uorocytosine. 
  4.  Prepare liver infusion tryptose (LIT) medium by dissolving 25 g 
liver infusion broth (Difco™, Becton Dickinson, USA), 5 g 
tryptone, 4 g NaCl, 2 g glucose (Sigma-Aldrich, UK), 0.4 g KCl 
(Sigma-Aldrich, UK), and 3.15 g Na 2 HPO 4 (Sigma- Aldrich, 
UK) in 900 ml H 2 O and adjust the pH to 7.4. Autoclave 
(121 °C for 15 min) and cool the medium to 50 °C. Add 25 g 
hemin, dissolved in 1 ml 1 N NaOH and 100 ml heat-inacti-
vated fetal calf serum (both Sigma-Aldrich, UK). 
  5.  For adult human samples, extract 15 ml venous blood using a 
sterile 20 ml BD Plastipak™ syringe with needle (Becton 
Dickinson, USA) and transfer to a BD Vacutainer ® plus plastic K 2 
EDTA tube (Becton Dickinson, USA) to prevent coagulation. 
  6.  If isolating from mammals, take 1–2 ml blood by cardiac punc-
ture, using a sterile 5 ml BD Plastipak™ syringe with needle (or 
1 ml/2 ml syringes for smaller animals), after anesthetising the 
mammal by intramuscular administration of ketamine hydro-
chloride (100 mg/kg body weight) (Sigma-Aldrich, UK) and 
sterilizing the thorax fi rst with iodised 70 % (v/v) ethanol (5 g 
iodine/l) and then non-iodized 70 % (v/v) ethanol. 
  7.  For patient samples, transfer blood into a sterile 15 ml centri-
fuge tube (Greiner Bio-One, UK) and centrifuge for 10 min at 
1,200 ×  g and 4 °C.
 (a)  Discard all but 0.5 ml plasma and packed red cells. 
 (b)  Add 8 ml LIT medium to packed red cells. 
 (c)  Centrifuge for 10 min at 1,200 ×  g and 4 °C. 
 (d)  Carefully discard the supernatant. 
 (e)  Resuspend in 6 ml LIT medium. 
 (f)  Aliquot 2 ml of packed red cells to three separate 4 N cul-
ture tubes. 
 (g)  Seal each tube with a rubber cap from a 10 ml vacutainer tube 
(Scientifi c Laboratory Supplies, UK) and secure with Parafi lm 
(VWR, UK). Rubber caps must be autoclaved prior to use. 
 (h)  Incubate cultures at 28 °C for 3–6 months, depending on 
strain growth rate. Once logarithmic phase cells become 
microscopically visible, parasites can be seeded into sup-
plemented RPMI-1640 axenic culture medium (as 
described in Subheading  3.2.2 ). 
 (i)  For long-term cryopreservation of parasites, supplement 
late logarithmic phase cultures with sterile 10 % glycerol 
(v/v) (VWR, UK) and prepare aliquots in sterile cryovials 
(Nunc, Denmark). Store cryovials at –70 °C for 24 hours, 
before transfer to liquid nitrogen. 
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  8.  For mammal samples, inoculate the blood directly into several 
4 N culture tubes. 
  9.  If biologically cloning directly from blood (as described in 
Subheading  3.2 ), leave the whole blood to settle for 1 h in the 
BD Vacutainer ® EDTA tube or centrifuge at a low speed (40 ×  g 
for 5 min) and then incubate at 37 °C for 45 min to ensure 
motile trypomastigotes have dispersed throughout the plasma, 
prior to cloning. 
  10.  If directly extracting parasite genomic DNA from blood (as 
described in Subheading  3.3.2 ), dilute packed red cells in gua-
nidine-EDTA (6 M guanidine, 0.2 M EDTA) (Sigma- Aldrich, 
UK) at a 1:1 ratio and store at 4 °C. 
 Xenodiagnosis can be undertaken by feeding up to 10–20 unin-
fected colony-reared triatomine bugs (third or fourth nymphal 
instars) on each suspected patient/mammal before isolating para-
sites after ~3 weeks as described below:
  1.  Prepare biphasic 4 N culture medium in sterile Nunclon™ Δ 
fl at sided tubes as described in Subheading  3.1.1 . 
  2.  Prepare White’s solution consisting of 0.025 g HgCl 2 ( see 
 Note 6 ), 0.65 g NaCl (both Sigma-Aldrich, UK), 0.125 ml 
conc. HCl (sp. gr. 1.18) (VWR, UK), 25 ml absolute ethanol, 
and 75 ml H 2 O. 
  3.  Immerse the bugs in White’s solution for 10 min, rinse in 
0.9 % sterile NaCl containing 300 μg/ml gentamycin and 
300 μg/ml 5-fl uorocytosine and dry (all Sigma-Aldrich, UK). 
  4.  Aseptically dissect the intestinal contents of each bug into ster-
ile saline (containing 300 μg/ml gentamycin and 300 μg/ml 
5-fl uorocytosine) on a sterile microscope slide (VWR, UK), 
behind a protective screen in a Class II microbiological safety 
cabinet. Dissection can be performed by holding the bug 
upside down in a pair of broad forceps, then using a pair of 
watchmakers’ forceps (both Scientifi c Laboratory Supplies, 
UK) to pull the last abdominal segment away, extruding the 
gut onto a microscope slide. 
  5.  Homogenize the intestinal contents using a sterile broad 
microspatula (Scientifi c Laboratory Supplies, UK) and discard 
the abdomen apex. 
  6.  Remove the majority of intestinal homogenate from the dis-
section slide to a sterile 1.5 ml graduated microcentrifuge tube 
(Anachem, UK), using a sterile 1 ml plastic Pasteur pipette 
(Scientifi c Laboratory Supplies, UK) and place a sterile micro-
scope cover glass over the remainder. 
  7.  Examine slide microscopically and if parasites are observed, 
transfer 20 μl of inoculum to a 4 N culture tube. 
3.1.2  Isolation 
from Triatomine Bugs 
(Xenodiagnosis)
Louisa A. Messenger et al.
317
  8.  Incubate cultures at 28 °C for 3–6 months, depending on strain 
growth rate. Once logarithmic phase cells become microscopi-
cally visible, parasites can be seeded into supplemented RPMI- 
1640 axenic culture medium (as described in Subheading  3.2.2 ). 
  9.  If biologically cloning directly from triatomine intestinal con-
tents (as described in Subheading  3.2 ), there is a high risk of 
contamination; ensure that 150 μg/ml gentamycin and 150 μg/
ml 5-fl uorocytosine are added to the relevant cloning medium. 
  1.  Prepare biphasic 4 N culture medium as described in 
Subheading  3.1.1 but without gentamycin and 5-fl uorocytosine. 
  2.  Aliquot 2 ml of biphasic 4 N culture medium into the bottom 
of sterile 7 ml Bijou tubes (Sterilin, UK) and leave to set. Once 
set, overlay each culture with 750 μl of 0.9 % sterile NaCl, con-
taining 100 μg/ml gentamycin (Sigma-Aldrich, UK) and 
100 μg/ml 5-fl uorocytosine (Sigma-Aldrich, UK). 
  3.  Empirically prepare a dilute solution of logarithmic-phase  T. 
cruzi epimastigotes (from axenic culture, patient blood or 
infected triatomine bug intestinal contents) such that micro-
drops delivered from microcapillaries contain a single parasite 
or no parasites ( see  Note 7 ). 
  4.  Prepare fi ne microcapillaries by rotating a microcapillary tube 
(Sigma-Aldrich, UK) in a Bunsen fl ame, removing, and pulling 
apart the two ends to form a fi ne intervening microcapillary 
(each original microcapillary tube yields two microcapillaries). 
  5.  On a microscope slide, place a sterile 13 mm microscope cover 
glass onto a small drop of sterile H 2 O (for adhesion); dispense 
a microdrop of diluted culture onto the cover glass from a 
microcapillary tube and cover the drop with a second cover 
glass. Drops which occupy no more than one microscopic fi eld 
at 400× magnifi cation are ideal. 
  6.  Microscopically examine the drop through multiple planes of 
vision, for the presence of parasites. 
  7.  Transfer cover glass pairs with drops containing no organisms 
(control cultures) or a single parasite to 4 N cultures using 
sterile watchmakers’ forceps. Discard all microdrops which 
contain more than one parasite. 
  8.  Incubate all cultures at 28 °C for 3–6 months, depending on 
strain growth rate. Discard the entire series if any of the con-
trol cultures become positive. Once logarithmic phase cells 
become microscopically visible, parasites can be seeded into 
supplemented RPMI-1640 axenic culture medium (as 
described in Subheading  3.2.2 ). 
 Variations of this protocol, including different under- and over-lay 
media are published in full in [ 41 ]. We describe below a protocol 
which favors growth of  T. cruzi strains from all DTUs:
3.2  Biological 
Cloning of  T. cruzi 
3.2.1  Biological Cloning 
of Parasites by 
Micromanipulation
3.2.2  Biological Cloning 
of Parasites on Solid 
Medium
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  1.  Prepare sterile stock solutions (100×) of tryptone (0.175 g/ml, 
autoclaved), HEPES (1 M, pH 7.2, fi lter-sterilized), and 
hemin (2.5 mg/ml in 0.01 M NaOH, autoclaved) (all Sigma-
Aldrich, UK). 
  2.  Supplement RPMI-1640 medium (Sigma-Aldrich, UK 
#R0883) with 0.5 % (w/v) tryptone, 20 mM HEPES buffer 
(pH 7.2), 30 mM hemin, 10 % (v/v) heat-inactivated fetal calf 
serum, 2 mM sodium glutamate, 2 mM sodium pyruvate, 
250 μg/ml streptomycin, and 250 U/ml penicillin (all Sigma- 
Aldrich, UK). Filter-sterilize the glutamine/pyruvate/penicil-
lin solution before use. 
  3.  Prepare blood agar plates by adding 10.8 ml biphasic 4 N cul-
ture medium (with 100 μg/ml gentamycin and 100 μg/ml 
5-fl uorocytosine) as described in Subheading  3.1.1 to sterile 
90 mm petri dishes (Sterilin, UK). 
  4.  Measure parasite density using a disposable hemocytometer 
(Immune Systems, UK). 
  5.  Mix 10 2 –10 3 logarithmic phase cells with 2.4 ml (w/v) supple-
mented RPMI-1640 medium and 0.6 ml molten 3 % (w/v) LMP 
agarose containing 0.9 % NaCl (w/v) (all Sigma-Aldrich, UK). 
  6.  Pour this overlay onto a blood agar plate and allow to set. 
  7.  Seal plates with Parafi lm (VWR, UK) to minimize evaporation 
and incubate at 28 °C in a humidifi ed atmosphere of 5 % CO 2 . 
  8.  Once colonies become visible (after 3–6 months, depending 
on strain growth rate), examine microscopically and remove 
clones using sterile 200 μl pipette tips. Inoculate each colony 
into 1 ml supplemented RPMI-1640 medium in a 48-well cell 
culture plate (Becton Dickinson, USA). 
  1.  Serially dilute logarithmic phase cells to achieve a fi nal concen-
tration of 0.5 parasites/ml in a total volume of 20 ml supple-
mented RPMI-1640 medium (as described in Subheading  3.2.2 ). 
  2.  Aliquot 200 μl of dilute culture into each well of a sterile 
96-microwell culture plate (Nunc, UK). 
  3.  Examine each well microscopically and mark those containing 
single organisms. 
  4.  Seal each plate with Parafi lm (VWR, UK) and incubate at 
28 °C in an atmosphere of 5 % CO 2 . 
  5.  After 4–8 weeks, expand marked wells with suffi cient numbers 
(~10 6 /ml) of dividing cells into larger axenic culture volumes. 
 Extraction of genomic DNA from 10 ml epimastigote cultures 
can be achieved using a Gentra Puregene tissue kit (Qiagen, UK), 
according to a modifi ed version of the manufacturer’s protocol 
( see  Note 8 ). Additional necessary reagents are PBS (Sigma-
Aldrich, UK), absolute isopropanol, and absolute ethanol. Cell 
3.2.3  Biological Cloning 
of Parasites by Limiting 
Dilution
3.3  Preparation of 
Parasite Genomic DNA
3.3.1  Parasite Genomic 
DNA Extraction 
from Epimastigote Culture
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lysis buffer, protein precipitation solution, and DNA hydration 
solution are all stored at room temperature. Proteinase K and 
RNase A are both stored at 4 °C. The modifi ed manufacturer’s 
protocol is as follows:
  1.  Centrifuge 10 ml of late log phase culture (~10 7 –10 8 trypano-
somes) in a sterile 15 ml centrifuge tube (Greiner Bio-One, 
UK) at 800 ×  g for 10 min. 
  2.  Discard the supernatant by inverting tubes onto absorbent 
paper and resuspend fully in PBS, then centrifuge again as 
previously. 
  3.  Resuspend in 3 ml cell lysis buffer (incubate at 37 °C and/or 
vortex to remove clumps, if necessary). 
  4.  Cell suspensions are now stable and can be stored at −20 °C for 
1–2 weeks. 
  5.  Add 15 μl proteinase K solution (100 μg/ml) and incubate at 
55 °C for 1 h, inverting periodically. 
  6.  Leave to cool to room temperature. 
  7.  Add 15 μl RNase A solution (20 μg/ml), invert 25 times and 
incubate at 37 °C for 15–60 min. 
  8.  Cool on ice for 3 min and then add 1 ml protein precipitation 
solution (room temperature). 
  9.  Vortex tubes vigorously for 20 s and then centrifuge at 2,000 ×  g 
for 10 min (ensure a tight pellet forms). 
  10.  Remove the supernatant and transfer to a new sterile 15 ml 
centrifuge tube. 
  11.  Precipitate DNA by the addition of 3 ml absolute isopropanol 
(room temperature) and invert 50 times. 
  12.  Centrifuge at 2,000 ×  g for 3 min and discard the supernatant 
by inverting tubes onto absorbent paper. 
  13.  Wash the DNA pellet in 3 ml 70 % (v/v) ethanol (room tem-
perature), invert 10 times and centrifuge at 2,000 ×  g for 1 min. 
  14.  Carefully remove the supernatant by inverting tubes and drain-
ing onto absorbent paper. 
  15.  Air-dry the DNA pellet with tubes inverted at an angle for a 
maximum of 15 min. 
  16.  Resuspend the DNA pellet in 250 μl DNA hydration solution, 
incubate at 65 °C for 1–2 h and then at room temperature 
overnight. 
  17.  Estimate the DNA yield by spectrophotometry. Successful 
DNA extractions will yield 100 ng/μl or more and an 
A260/280 of 1.8–2.0. 
  18.  Store extracted genomic DNA at −20 °C. 
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 Extraction of genomic DNA from clinical hemocultures can be 
achieved using a High Pure PCR template preparation kit (Roche, 
UK), according to the manufacturer’s protocol. Additional neces-
sary reagents are PBS (Sigma-Aldrich, UK), absolute isopropanol, 
and absolute ethanol. Tissue lysis buffer, binding buffer, inhibitor 
removal buffer, wash buffer, and elution buffer are all stored at 
room temperature. Add absolute ethanol to the inhibitor removal 
buffer and the wash buffer, as instructed. Proteinase K is stored at 
4 °C. Before beginning the DNA extraction, preheat the elution 
buffer to 70 °C. The manufacturer’s protocol is as follows:
  1.  To a sterile 1.5 ml graduated microcentrifuge tube (Anachem, 
UK) mix 200 μl sample material (1:1 blood/guanidine-EDTA) 
with 600 μl binding buffer and 100 μl Proteinase K and incu-
bate at 70 °C for 10 min. 
  2.  Add 200 μl absolute isopropanol and mix well by vortexing. 
  3.  Apply 550 μl to a High Pure fi lter tube and centrifuge at 
8,000 ×  g for 1 min. 
  4.  Discard the fl ow-through. 
  5.  Repeat  steps 3 and  4 using the same High Pure fi lter tube. 
  6.  Add 500 μl inhibitor removal buffer and centrifuge at 8,000 ×  g 
for 1 min. 
  7.  Discard the fl ow-through. 
  8.  Add 500 μl wash buffer and centrifuge at 8,000 ×  g for 1 min. 
  9.  Discard the fl ow-through. 
  10.  Repeat  steps 7 and  8 . 
  11.  Centrifuge at 13,000 ×  g for 10 s. 
  12.  Place the High Pure fi lter tube in a clean 1.5 ml graduated 
microcentrifuge tube. 
  13.  Add 200 μl pre-warmed elution buffer and centrifuge at 
8,000 ×  g for 1 min. 
  14.  Estimate the DNA yield by spectrophotometry. Successful 
DNA extractions will yield 3 ng/μl or more and an A260/280 
of 1.8–2.0. 
  15.  Store extracted genomic DNA at −20 °C. 
 DNAzol ® solution (Life Technologies, UK) can be used to extract 
 T. cruzi genomic DNA from triatomine bug feces, following hind- 
gut dissection. Store DNAzol ® solution, absolute ethanol, and 
NaOH at room temperature.
  1.  Lyse 50–100 μl of triatomine bug intestinal homogenate in a 
sterile 1.5 ml graduated microcentrifuge tube (Anachem, UK) 
by the addition of 1 ml DNAzol ® solution. 
  2.  Invert twice and incubate at room temperature for 3 min. 
3.3.2  Parasite Genomic 
DNA Extraction 
from Patient Hemoculture
3.3.3  Parasite Genomic 
DNA Extraction 
from Triatomine Bug Feces
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  3.  Precipitate DNA by the addition of 0.5 ml absolute ethanol 
(room temperature). 
  4.  Pellet DNA by centrifuging at 13,000 ×  g for 4 min. 
  5.  Discard the supernatant and wash twice with 1 ml 70 % (v/v) 
ethanol ensuring not to disturb the pellet. 
  6.  Resuspend the DNA pellet in 50 μl 8 mM NaOH (Sigma- 
Aldrich, UK). 
  7.  Estimate the DNA yield by spectrophotometry. Successful 
DNA extractions will yield 100 ng/μl or more and an 
A260/280 of 1.8–2.0. 
  8.  Store extracted genomic DNA at −20 °C. 
  1.  Amplify the 24Sα rRNA (LSU rDNA) in a standard reaction 
containing: 1× NH 4 reaction buffer, 1.5 mM MgCl 2 (Bioline, 
UK), 0.2 mM dNTPs (New England Biolabs, UK), 1 pmol/μl 
of D71 and D72 primers ( see Table  1 ), 1 U BIOTAQ™ DNA 
polymerase (Bioline, UK), and 10–100 ng of  T. cruzi genomic 
DNA, made up to a total volume of 25 μl. 
  2.  Reaction conditions for the 24Sα rRNA (LSU rDNA) are an 
initial denaturation step of 94 °C for 3 min and then 27 ampli-
fi cation cycles (94 °C for 1 min, 60 °C for 1 min, 72 °C for 
1 min), followed by a fi nal elongation step at 72 °C for 5 min. 
  3.  Amplify both  HSP60 and  GPI in a standard reaction contain-
ing: 1× NH 4 reaction buffer, 2 mM MgCl 2 (Bioline, UK), 
0.2 mM dNTPs (New England Biolabs, UK), 1 pmol/μl of 
HSP60_for and HSP60_rev primers (for  HSP60 ) or GPI_for 
and GPI_rev (for  GPI ) ( see Table  1 ), 1 U BIOTAQ™ DNA 
polymerase (Bioline, UK), and 10–100 ng of  T. cruzi genomic 
DNA, made up to a total volume of 25 μl. 
  4.  Reaction conditions for both  HSP60 and  GPI use a touch-
down PCR strategy comprising an initial denaturation step of 
3 min at 94 °C, followed by four cycles (94 °C for 30 s, 64 °C 
for 30 s, 72 °C for 1 min), followed by 28 cycles (94 °C for 
30 s, 60 °C for 30 s, 72 °C for 1 min), and then a fi nal elonga-
tion step at 72 °C for 10 min. 
  1.  Visualize 10 μl of each 24Sα rRNA PCR product by gel elec-
trophoresis using 3.5 % NuSieve™ GTG™ agarose gels (Lonza, 
UK) containing 0.5 μg/ml ethidium bromide (Sigma-Aldrich, 
UK) ( see  Note 9 ). 
  2.  Visualize 5 μl of each  HSP60 and  GPI PCR product by gel 
electrophoresis using 1.5 % agarose gels (Bioline, UK) contain-
ing 0.5 μg/ml ethidium bromide. 
  3.  Load samples into gel wells with 1 μl of 5× DNA loading buf-
fer (Bioline, UK) and run 5 μl of Hyperladder™ V (for 24Sα 
3.4  PCR-RFLP
3.4.1  PCR Amplifi cation
3.4.2  Agarose Gel 
Eletrophoresis
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rRNA) or IV (for  HSP60 and  GPI ) (Bioline, UK) as a molecular 
weight marker. 
  4.  Run all gels at 100 V for 1–2 h in 1× TAE buffer and visualize 
under UV illumination, ensuring that the user is protected 
from the light source behind a UV shield. 
  5.  If necessary, prior to restriction digestion, purify  HSP60 and 
 GPI PCR products using a QIAquick PCR purifi cation kit 
(Qiagen, UK) to remove nonspecifi c products, as described in 
Subheading  3.4.3 . 
 Purifi cation of all PCR products can be achieved using a QIAquick 
PCR purifi cation kit (Qiagen, UK) with spin columns to remove 
contaminating primers, nucleotides, DNA polymerases etc. ( see 
 Note 10 ) All of the necessary reagents are included within the kit 
(add ethanol to buffer PE as instructed) and are stored at room 
temperature. The manufacturer’s protocol is as follows:
  1.  Add 5 volumes of buffer PB to 1 volume of the PCR reaction 
and mix. 
  2.  Apply the sample to a QIAquick spin column placed in a 2 ml 
collection tube and centrifuge at >13,000 ×  g for 30–60 s. 
  3.  Discard the fl ow-through. 
  4.  Add 0.75 ml of buffer PE (with ethanol added) to the QIAquick 
column and centrifuge at >13,000 ×  g for 30–60 s. 
  5.  Discard the fl ow-through and recentrifuge for 1 min at maxi-
mum speed. 
  6.  Place the QIAquick column in a clean 1.5 ml graduated micro-
centrifuge tube (Anachem, UK). 
  7.  To elute the DNA, add between 30 and 50 μl of buffer EB 
(10 mM Tris-Cl, 1 mM EDTA (pH 8)) to the center of the 
QIAquick membrane, incubate for 1–5 min and then centri-
fuge at >13,000 ×  g for 1 min ( see  Note 11 ). 
  8.  Purifi ed PCR products can be stored at −20 °C until required. 
  1.  Digest 10 μl of  HSP60 or  GPI PCR products (typically ~1 μg) 
in a reaction containing 0.25 U/μl of  Eco RV or  Hha I restric-
tion endonucleases (New England Biolabs, UK), 100 ng/μl 
BSA and 1× quantity of the manufacturer’s recommended 
reaction buffer in a total volume of 20 μl. 
  2.  Incubate reactions at 37 °C for 4 h. 
  1.  Visualize 10 μl of each reaction using either 1.5 % ( GPI / Hha I) or 
3 % agarose gels ( HSP60 / Eco RV) (Bioline, UK) containing 
0.5 μg/ml ethidium bromide (Sigma-Aldrich, UK) ( see  Note 12 ). 
  2.  Load samples into agarose wells with 1 μl of 5× DNA loading 
buffer (Bioline, UK) and run 5 μl of Hyperladder™ V (for 
3.4.3  PCR Purifi cation
3.4.4  Restriction Enzyme 
Digestion
3.4.5  Restriction 
Fragment Length 
Polymorphism Analysis
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24Sα rRNA), IV ( HSP60 ), or I ( GPI ) (Bioline, UK) as a 
molecular weight ladder. 
  3.  Run all gels at 100 V for 1–2 h in 1× TAE buffer and visualize 
under UV illumination, ensuring that the user is shielded from 
the light source ( see  Note 13 ). 
  4.  The genotype assignment system based on the number and size 
of the restriction fragment bands is shown in Table  5 , Figs.  4 
and  5 . For additional details please refer to Lewis et al. [ 47 ].
  1.  Amplify each MLST target ( HMCOAR ,  GPI, TcMPX and 
 RHO1 ) in a standard reaction containing: 10 μl 5× colorless 
GoTaq ® reaction buffer (Promega, UK), 0.2 mM dNTPs 
(New England Biolabs, UK), 0.2 μM of respective forward and 
reverse primers ( see Table  2 ), 1 U GoTaq ® DNA polymerase 
(Promega, UK), and 10–100 ng of  T. cruzi genomic DNA, 
made up to a total volume of 50 μl. 
  2.  Reaction conditions for all targets are an initial denaturation 
step of 94 °C for 5 min and then 35 amplifi cation cycles (94 °C 
for 1 min, 55 °C for 1 min, 72 °C for 1 min), followed by a 
fi nal elongation step at 72 °C for 5 min. 
  1.  Visualize 5 μl of each PCR product by gel electrophoresis 
using 1.5 % agarose gels (Bioline, UK), as described in 
Subheading  3.4.2 . 
  1.  Purify all PCR products, as described in Subheading  3.4.3 . 
 Bidirectional sequencing can be performed using a BigDye™ 
Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, UK). 
All of the necessary reagents are included within the kit. Big Dye 
Sequencing RR-100 is stored at −20 °C and sequencing buffer is 
stored at 4 °C ( see  Note 14 ). The modifi ed version of the manu-
facturer’s protocol is as follows:
  1.  Use 0.5–2 μl of PCR reaction template (~5–20 ng) in a stan-
dard reaction containing 0.5 μl Big Dye sequencing RR-100, 
1.7 μl sequencing buffer, and 3.2 pmol of forward or reverse 
PCR primer ( see  Note 15 ), made up to a total volume of 10 μl. 
  2.  Reaction conditions are as follows: 25 cycles of rapid thermal 
ramp to 96 °C (1 °C/s), 96 °C for 30 s, rapid thermal ramp to 
55 °C (1 °C/s), 55 °C for 20 s, rapid thermal ramp to 60 °C 
(1 °C/s), and 60 °C for 4 min. 
  3.  Purify samples in sterile 96-well optical reaction plates with 
barcodes (Applied Biosystems, UK). 
  4.  Precipitate DNA by the addition of 8 μl of H 2 O followed by 
32 μl ice-cold 95 % (v/v) ethanol. 
3.5  Nuclear MLST
3.5.1  PCR Amplifi cation
3.5.2  Agarose Gel 
Eletrophoresis
3.5.3  PCR Purifi cation
3.5.4  Dye Terminator 
DNA Sequencing
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  5.  Incubate samples at 4 °C for 15 min and then centrifuge for 
45 min at 3,000 ×  g and 4 °C. 
  6.  Remove the supernatant by inverting plates onto absorbent 
paper and centrifuging at 20 ×  g for 10 s. 
  7.  Wash DNA pellets by the addition of 50 μl ice-cold 70 % (v/v) 
ethanol and briefl y vortex. 
  8.  Spin plates for 30 min at 3,000 ×  g and 4 °C. 
 Fig. 4  Examples of PCR-RFLP genotyping profi les. ( a ) LSU rDNA. ( b )  HSP60/Eco RV digestion products are 
shown. ( c )  GPI/Hha I digestion products are shown. For all gels, Lanes: ( 1 ) Sylvio X10/1 (TcI), ( 2 ) Esm cl3 (TcII), 
( 3 ) M5631 (TcIII), ( 4 ) CanIII cl1 (TcIV), ( 5 ) 92122102R (TcIV NA), ( 6 ) Sc43 cl1(TcV), ( 7 ) CL Brener (TcVI), ( 8 ) nega-
tive control 
LSU rDNA
PCR product
!!" bp
only
!#$ bp
only
!!" bp
only
!#" bp* !!" bp or 
!!" + !#$ bp
!#$ bp
only
HSP!"-EcoRV
PCR-RFLP ! band ! band # bands ! band % bands
% bands
GPI-HhaI
PCR-RFLP
# bands % bands # bands % bands** & bands & bands 
TcI TcII TcIII TcIV TcV TcVI
*TcIV(NA) = !%"bp
**TcIV(NA) = # bands
 Fig. 5  Recommended triple-assay for discriminating  T. cruzi DTUs 
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  9.  Discard supernatants as previously. 
  10.  Dry pellets at room temperature until no visible ethanol 
remains ( see  Note 16 ). 
  11.  Resuspend DNA pellets in 10 μl Hi-Di™ deionized formamide 
(Applied Biosystems, UK) ( see  Note 14 ). 
  12.  DNA pellets can be stored at −20 °C until required. 
  13.  Analyze DNA sequences using an automated 16-capillary 
3730 DNA Analyzer (Applied Biosystems, UK) ( see  Note 4 ). 
 Nucleotide data can be assembled manually in BioEdit v7.0.9.0 
sequence alignment editor software (Ibis Biosciences, USA) [ 58 ] 
and ambiguous peripheral regions of aligned sequences discarded 
to produce unambiguous consensus sequences for each isolate. 
Heterozygous positions are identifi ed by the presence of two coin-
cident peaks at the same locus (“split peaks”), verifi ed in forward 
and reverse sequences and scored according to the one-letter 
nomenclature for nucleotides from the International Union of Pure 
and Applied Chemistry (IUPAC). If data for multiple gene targets 
have been generated, sequences can be concatenated for each iso-
late ( see  Note 17 ). Distance-based phylogenies can be constructed 
using individual or concatenated heterozygous diploid sequence 
data in SplitsTree4 (select the average states parameter to handle 
ambiguous sites) [ 59 ] . To aid DTU assignment, a reference panel 
of sequences from Yeo et al. [ 20 ] is electronically available to down-
load from GenBank. In the absence of a formalized nuclear MLST 
scheme for population genetic studies, three additional targets 
( LAP ,  RB19 , and  SODB ), described in [ 20 ,  51 ,  52 ] can be used for 
higher resolution genetic diversity studies. Additional analyses are 
described with accompanying software by Tomasini et al. [ 80 ]. 
  1.  Prepare a 96-well PCR reaction plate (Fisher Scientifi c, UK) 
containing maxicircle primer stocks at 10 pmol/μl ( see Table  3 ) 
arranged according to Fig.  2 . 
  2.  Amplify all ten maxicircle genes in standard PCR reactions 
each containing: 1× NH 4 reaction buffer, 1.5 mM MgCl 2 
(Bioline, UK), 0.2 mM dNTPs (New England Biolabs, UK), 
and 1 U BIOTAQ™ DNA polymerase (Bioline, UK), made to 
a fi nal volume of 17 μl. 
  3.  Prepare a PCR mastermix for 90 samples without DNA tem-
plate and aliquot 145 μl per well across the fi rst plate row of a 
sterile 96-well PCR reaction plate (A01-A10). 
  4.  Use a 10–100 μl twelve-channel pipette to transfer 17 μl mas-
termix per well down the 96-well PCR reaction plate (A01- 
H01, A02-H02, etc.). 
  5.  Add 1 μl of DNA template (10–100 ng of  T. cruzi genomic 
DNA) for each isolate across the plate (sample 1 in A01-A10, 
sample 2 in B01-B10, etc.). 
3.5.5  Analysis of Nuclear 
MLST Data
3.6  Maxicircle MLST
3.6.1  PCR Amplifi cation
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  6.  Use a 0.5–10 μl twelve-channel pipette to transfer 1 μl of each 
forward and 1 μl of each reverse primer per well from the respec-
tive primer plates to the corresponding row on the PCR reaction 
plate (A01-A10, B01-B10, etc.) ( see  Notes 18 and  19 ). 
  7.  PCR reactions are performed with an initial denaturation step 
of 3 min at 94 °C, followed by 30 amplifi cation cycles (94 °C 
for 30 s, 50 °C for 30 s, 72 °C for 30 s) and a fi nal elongation 
step at 72 °C for 10 min. 
  1.  Visualize 5 μl of each PCR product by gel electrophoresis 
using 1.5 % agarose gels (Bioline, UK), as described in 
Subheading  3.4.2 . 
  1.  Purify all PCR products, as described in Subheading  3.4.3 . 
  1.  Use a 10–100 μl eight-channel pipette to transfer PCR prod-
ucts to a 96-well optical reaction plates with barcodes (Applied 
Biosystems, UK) for purifi cation ( see  Note 19 ). 
  2.  Sequence all PCR products, as described in Subheading  3.5.4 . 
 Assemble sequence data as described for nuclear loci ( see 
Subheading  3.5.5 ). For each isolate maxicircle sequences can be 
concatenated according to their structural arrangement ( 12S 
rRNA ,  9S rRNA ,  CYT b ,  MURF1 ,  ND1 ,  COII ,  ND4 , and  ND5 ) 
and in the correct coding direction ( see  Note 17 ). The best-fi t 
model of nucleotide substitution can be inferred in jMODELT-
EST 1.0 [ 60 ]. Phylogenies of increasing computational complexity 
can be constructed using MEGA 5 [ 61 ] (distance-based phyloge-
nies), PhyML [ 62 ] (Maximum-Likelihood topologies) or 
MrBAYES v3.1 [ 63 ] (Bayesian topologies). A reference panel of 
maxicircle sequences is electronically available to download from 
GenBank under the accession numbers JQ581059-JQ581370 and 
JQ581403-JQ581480. For additional analyses please refer to 
Messenger et al. [ 56 ]. 
  1.  Prepare a 96-well PCR reaction plate (Fisher Scientifi c, UK) 
with microsatellite primers diluted to 1 pmol/μl in 0.5× TE 
buffer ( see Table  4 ) and arranged according to Fig.  3 . 
  2.  Amplify all microsatellite loci in a standard reaction containing: 
1× ThermoPol Reaction Buffer (New England Biolabs, UK), 
4 mM MgCl 2 , 34 μM dNTPs, 1 U  Taq polymerase (New 
England Biolabs, UK), and 1 ng of genomic DNA, made up to 
a fi nal volume of 7 μl. 
  3.  Prepare one PCR mastermix (for 32 loci) per DNA isolate and 
aliquot 74 μl per well across A01-A04 of a sterile 96-well PCR 
reaction plate. 
3.6.2  Agarose Gel 
Eletrophoresis
3.6.3  PCR Purifi cation
3.6.4  Dye Terminator 
DNA Sequencing
3.6.5  Analysis 
of Maxicircle MLST Data
3.7  MLMT
3.7.1  PCR Amplifi cation
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  4.  Each PCR plate can be used to amplify microsatellite loci for 
three DNA samples; distribute the mastermixes for isolates 2 
and 3 across A05-A08 and A09-A12, respectively. 
  5.  Use a 0.5–10 μl twelve-channel pipette to transfer 8.5 μl mas-
termix per well from A01-A12 down the PCR reaction plate 
(A01-H01, A02-H02, etc.) 
  6.  Use a 0.5–10 μl twelve-channel pipette to transfer 1.5 μl of each 
premixed primer pair from the primer plate to the correspond-
ing row on the PCR reaction plate (A01-A04, B01-B04, etc.). 
  7.  Repeat  step 6 , instead transferring primers to columns 5–8 
and 9–12. 
  8.  PCR reactions for all loci are performed with an initial dena-
turation step of 4 min at 95 °C, then 30 amplifi cation cycles 
(95 °C for 20 s, 57 °C for 20 s, 72 °C for 20 s) and a fi nal 
elongation step at 72 °C for 20 min. 
  1.  Use a 10–100 μl eight-channel pipette to combine columns 2, 
3, and 4 into column 1, columns 6, 7, and 8 into column 5, 
and columns 10, 11, and 12 into column 9. 
  2.  Transfer the contents of column 1, 5, and 9 into columns 1, 2, 
and 3 of a new sterile 96-well PCR reaction plate ( see Fig.  6 ) to 
form a stock plate.
  3.  Each 96-well stock plate can hold multiplexed microsatellite 
PCR products from 12 DNA samples. 
  4.  Mix 25 μl GeneScan™-500 LIZ™ fl uorescent size standard 
(Applied Biosystems, UK) with 950 μl Hi-Di™ deionized for-
mamide (Applied Biosystems, UK) and aliquot 82 μl per well 
across A01-A12 of a sterile 96-well optical reaction plate with 
barcode (Applied Biosystems, UK) ( see  Note 20 ). 
  5.  Use a 0.5–10 μl twelve-channel pipette to distribute 9.75 μl of 
GeneScan™/Hi-Di™ solution into each well from A01-A12 
down the 96-well optical reaction plate. 
  6.  Use a 0.5–10 μl twelve-channel pipette to transfer 0.5 μl of 
sample PCR product from the stock plate into each corre-
sponding row of the optical reaction plate (A01-A12, B01-
B12, etc.). 
  7.  Determine allele sizes using an automated 16-capillary 
sequencer (AB3730, Applied Biosystems, UK), with a stan-
dard injection time of 10 s. 
 Allele sizes can be assembled in GeneMapper ® v 4.0 (Applied 
Biosystems, UK) and isolates should be typed “blind” to control for 
user bias and checked manually for errors. A set of allele sizes for 
reference strains and bin sizes for each microsatellite locus are 
available online at:  http://  www.ki.se/chagasepinet/mlmt.html 
3.7.2  MLMT Multiplexing 
and Allele Size 
Determination
3.7.3  Analysis 
of MLMT Data
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Microsatellite data are highly amenable to quantitative analysis. 
Population structures between different geographical areas and 
transmission cycles can be inferred using pair- wise distance-based 
measurements, such as  D AS (infi nite alleles model of (IAM)) or δμ 2 
(stepwise mutation model (SMM)) which can be calculated in 
MICROSAT v1.5d [ 64 ].  D AS values can be assembled into a distance 
matrix and used to construct Neighbor- Joining trees in PHYLIP 
v3.67 [ 65 ]. Support for nodes in the Neighbor-Joining tree can be 
generated in PHYLIP v3.67 using 1000 bootstrap replicates of the 
data generated in MICROSAT v1.5d. The mean number of alleles 
per locus (MNA) and the sum number of occurrences of specifi c 
alleles for each locus can be calculated using the Microsatellite Toolkit 
add-in [ 66 ] for MS Excel. The software FSTAT 2.9.3.2 [ 67 ] can be 
used to estimate sample- size corrected allelic richness (A r ) and the 
inbreeding coeffi cient  F IS. Heterozygosity indices, including devia-
tions from Hardy–Weinberg equilibrium, and the extent of popula-
tion differentiation ( F ST ) can be calculated in ARLEQUIN v3.0 [ 68 ]. 
Multilocus linkage disequilibrium, estimated by the Index of 
Association (I A ), can be calculated in MULTILOCUS v1.3b [ 69 ]. 
Mantel’s test to compare pair-wise geographical and genetic distances 
can be executed in GENALEX 6 [ 70 ]. 
 We strongly discourage the use of model-based population 
assignment software (e.g., STRUCTURE and BAPS) as these pro-
grams use algorithms which assume Hardy–Weinberg expectations 
within populations and complete linkage equilibrium between 
genetic markers, two criteria that are largely violated by clonal 
reproduction in  T. cruzi . Instead population subdivisions can also 
be inferred using a nonparametric (without Hardy–Weinberg con-
straints)  K -means clustering algorithm [ 71 ], implemented in ade-
genet within the R 2.13 software package [ 78 ]. The number of 
“true” populations can be defi ned using the Bayesian Information 
Criterion (BIC) and the relationship between clusters can be evalu-
ated using a Discriminant Analysis of Principal Components 
(DAPC), which fi rst transforms allele frequencies at individual loci 
into uncorrelated variables (principal components), via a Principal 
Component Analysis (PCA) [ 72 ]. 
4  Notes 
  1.  Infection with  T. cruzi can only occur via direct inoculation or 
contamination of broken skin/intact mucosal membranes 
(conjunctiva, nose and mouth). Transmission via inhalation is 
highly unlikely as organisms do not readily aerosolize. In addi-
tion, parasites do not survive desiccation and are not free- 
living. Furthermore the predominant, but not exclusive form 
in exponentially growing axenic cultures is the non-infective 
epimastigote stage. To minimize risk of infection:
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 (a)  Wear appropriate Personal Protective Equipment (PPE) at 
all times, including a Howie laboratory coat, eye-protec-
tion, and close-fi tting disposable gloves. 
 (b)  Conduct all manipulations of live material in a Class II 
microbiological safety cabinet, which should be fumigated 
regularly to prevent bacterial and fungal contamination. 
 (c)  Do not touch the face or any exposed area while wearing 
contaminated gloves or handling live material. 
 (d)  Routinely decontaminate work surfaces/cabinets with 
70 % ethanol after use. 
 (e)  Dispose of all contaminated material by immersing in 
70 % ethanol or 10 % chloros (sodium hypochlorite) 
overnight. 
 (f)  Restrict the use of sharps and glassware to avoid the risk of 
direct inoculation and dispose of all contaminated sharps 
in an appropriate sharpsafe bin. 
 (g)  Avoid any procedures, e.g., centrifugation in open tubes 
or grinding of infected tissues, which may generate drop-
let suspensions. 
 (h)  If necessary, wear a face visor or use a protective screen 
when directly handling infectious material, e.g., dissecting 
infected triatomine bugs. 
 (i)  Establish full written risk assessments and emergency 
accident procedures before commencing work with live 
 T. cruzi . 
  2.  T. cruzi genomic DNA can be extracted from cultured epimas-
tigotes, human hemocultures, or triatomine bug feces. The 
Gentra Puregene tissue kit (Qiagen, UK) and High Pure PCR 
template preparation kit (Roche, UK) both produce high qual-
ity template but with some loss of DNA yield and are most 
appropriate to extract DNA from cultured parasites and human 
clinical samples, respectively. DNA extracted using DNAzol ® is 
typically of a higher yield but of lesser quality and is thus more 
suitable for extracting DNA from samples with low parasite 
density, including those derived from bug feces homogenate. 
  3.  Ethidium bromide is mutagenic and toxic, so PPE must be 
worn at all times when handling this reagent. 
  4.  We assume that the researcher has access to an automated fl uo-
rescent sequencer either through affi liations with an academic 
institution or by outsourcing to a commercial sequencing 
company. 
  5.  Ideally, sterile test 5 % of each 4 N culture batch, by incubating 
at 37 °C for 3 days and checking for contamination. 
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  6.  Mercuric chloride is highly toxic and must be handled while 
wearing PPE (Howie laboratory coat, disposable gloves, and 
eye-protection) and with extreme care. 
  7.  Some  T. cruzi strains have a predilection to grow in clumps, 
therefore cultures should be checked microscopically and if 
clumpy, parasites can be separated by low-speed centrifugation 
(~200 ×  g ) prior to cloning. 
  8.  Parasite genomic DNA can also be extracted from smaller cul-
ture volumes using the Gentra Puregene tissue kit. This proto-
col can be modifi ed to extract DNA from 1 ml of  T. cruzi 
culture in 1.5 ml graduated microcentrifuge tubes, by decreas-
ing reagent volumes tenfold and performing all centrifugation 
steps in a microcentrifuge at >13,000 ×  g . 
  9.  Prepare NuSieve™ GTG™ low melting temperature agarose 
(Lonza, UK) by fi rst soaking the agarose in chilled 1× TAE 
buffer for 15 min; this prevents the agarose from foaming dur-
ing heating. Heat the agarose and buffer in a microwave on 
medium power for 2 min. Gently swirl the solution to resus-
pend any settled powder/gel pieces and reheat on high power 
until the solution begins to boil. Hold at boiling point for 
1 min or until all of the agarose particles are dissolved. Allow 
the solution to cool to 50–60 °C prior to the addition of 
0.5 μg/ml ethidium bromide and casting. 
  10.  If consumable costs are restricted, PCR products can also be 
purifi ed using absolute isopropanol. Add an equal volume of 
absolute isopropanol to PCR product in a sterile 0.5 ml 
 graduated microtubes (Anachem, UK). Incubate at room tem-
perature for 15 min. Spin tubes at >13,000 ×  g in a microcen-
trifuge for 20 min and discard the supernatant. Wash the pellet 
in 70 % (v/v) ethanol by spinning for 10 min. Discard the 
supernatant and air-dry the pellet. Resuspend the pellet in 
H 2 O or 0.5× TE buffer. 
  11.  Heating buffer EB to 55 °C before applying to the column and 
incubating for 1–5 min, prior to elution, can increase the yield 
from QIAquick columns. 
  12.  If PCR-RFLP genotyping will be routinely performed it may 
be useful to prepare a stock of digested DNA size standards 
from  T. cruzi reference isolates for each DTU. These can be 
stored at −20 °C and run as positive controls alongside 
unknown samples where necessary. 
  13.  Ideally,  GPI- RFLP gels should be run for long as possible in 
order to clearly separate bands at 490 and 447 bp (TcV and 
TcVI genotypes). In addition, the smallest  HSP60 band (118–
148 bp; TcIII, TcV, and TcVI genotypes) can be diffi cult to 
Louisa A. Messenger et al.
333
visualize, in which case it may be necessary to run a larger vol-
ume of digest reaction. 
  14.  Aliquot both the Big Dye Sequencing RR-100 (e.g., 20 μl/
aliquot) and Hi-Di™ deionized formamide (e.g., 1 ml/aliquot) 
and store at −20 °C in order to minimize the number of freeze–
thaw and exposure cycles for each tube. An appropriate volume 
aliquot will receive less than fi ve freeze–thaw cycles and contain 
suffi cient quantity for 1 week’s worth of reactions. 
  15.  This modifi ed protocol is for a reaction that is half the manu-
facturer’s recommended volume. In addition, the reagent mix 
(Big Dye Sequencing RR-100) has been reduced by one- 
eighth of the recommended amount to save considerable costs. 
  16.  It is important to ensure that no ethanol remains in the 
sequencing reaction plate but equal care must be taken not to 
overdry the DNA pellets as this may inhibit their resuspension 
in Hi-Di™ deionized formamide. 
  17.  Ensure that in the nucleotide alignment, isolate sequences are 
placed in the same order for each gene, otherwise it is very easy 
to mistakenly concatenate sequences from different isolates 
across multiple loci. 
  18.  To speed manipulations, we strongly recommend the use of 
eight- and twelve-channel multichannel pipettes. Although it 
is possible to perform all pipetting individually, the multichan-
nel renders the process much less laborious and more robust. 
Our current choice of pipette is the ErgoOne ® range (Star 
Labs, UK) and we use 0.5–10 μl twelve-channel (S7112- 0510), 
10–100 μl twelve-channel (S7112-1100), and 10–100 μl 
eight-channel pipettes (S7108-1100) for maxicircle MLST 
and MLMT PCR amplifi cations. 
  19.  When transferring between plates ensure that the plates are 
fi rst lined up in the same orientation as each other (A01 to A01 
and H12 to H12) as it is remarkably easy to accidentally reverse 
a plate. 
  20.  It may be useful to create a set of allele size standards prepared 
from reference strains to run alongside samples as internal 
controls. 
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Comparative genomic analysis of human infective
Trypanosoma cruzi lineages with the bat-restricted
subspecies T. cruzi marinkellei
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Abstract
Background: Trypanosoma cruzi marinkellei is a bat-associated parasite of the subgenus Schizotrypanum and it is
regarded as a T. cruzi subspecies. Here we report a draft genome sequence of T. c. marinkellei and comparison with
T. c. cruzi. Our aims were to identify unique sequences and genomic features, which may relate to their distinct
niches.
Results: The T. c. marinkellei genome was found to be ~11% smaller than that of the human-derived parasite
T. c. cruzi Sylvio X10. The genome size difference was attributed to copy number variation of coding and
non-coding sequences. The sequence divergence in coding regions was ~7.5% between T. c. marinkellei and
T. c. cruzi Sylvio X10. A unique acetyltransferase gene was identified in T. c. marinkellei, representing an example of a
horizontal gene transfer from eukaryote to eukaryote. Six of eight examined gene families were expanded in
T. c. cruzi Sylvio X10. The DGF gene family was expanded in T. c. marinkellei. T. c. cruzi Sylvio X10 contained ~1.5 fold
more sequences related to VIPER and L1Tc elements. Experimental infections of mammalian cell lines indicated
that T. c. marinkellei has the capacity to invade non-bat cells and undergo intracellular replication.
Conclusions: Several unique sequences were identified in the comparison, including a potential subspecies-specific
gene acquisition in T. c. marinkellei. The identified differences reflect the distinct evolutionary trajectories of these
parasites and represent targets for functional investigation.
Background
The subgenus Schizotrypanum harbors the type species
Trypanosoma cruzi, which is the causative agent of Cha-
gas disease in humans. Other members of the
Schizotrypanum subgenus are often referred to as T.
cruzi-like species as they are morphologically similar or
indistinguishable from T. cruzi [1]. With the exception
of the human infecting parasite, members of Schizotry-
panum are restricted to bats (order Chiroptera) and occur
in high prevalence among bats in Latin America and else-
where in the world [1-4]. There is no evidence that T.
cruzi-like parasites are harmful to bats, although this may
reflect a paucity of data. Most infected bats are insectivor-
ous and infection is thought to take place either through
ingestion of infected arthropods or via stercorarian trans-
mission from bat-feeding bugs [5,6]. The genetic diversity
of T. cruzi-like species and their evolutionary relation-
ships are yet to be determined.
Trypanosoma cruzi marinkellei is a bat-associated
subspecies of T. cruzi [1]. The human infective parasite
T. cruzi should accordingly be referred to as the nominate
subspecies T. cruzi cruzi (T. c. cruzi) [1]. T. c. marinkellei
is prevalent among bats in Central and South America,
which are its only known mammalian hosts [1,5]. It dif-
fers from T. c. cruzi in terms of isoenzyme electrophoresis
patterns and buoyant DNA densities. T. c. marinkellei
does not infect immunocompetent mice [1,5], nor does it
provide immunological protection against challenge with
T. c. cruzi [1], suggesting that the infection is character-
ized by distinct antigenic profiles. Sequence-based phylo-
genies have confirmed a relatively close relationship with
T. c. cruzi [5,7-9] and estimated the divergence time at
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~6.5-8.5 MYA [10-12]. Cavazzana et al. reported that
T. c. marinkellei was associated with phyllostomid spe-
cies (insectivorous, frugivorous, carnivorous and haema-
tophagous bats) [5] and transmission is thought to occur
when triatomine bugs of the genus Cavernicola feed on
bats [13]. However, the natural transmission cycle among
bats is not well characterized and there might be other
vectors or direct transmission mechanisms. Some genetic
substructure within the T. c. marinkellei population has
been reported [14], but the strength of correlation be-
tween parasite lineage and host remains to be defined.
Moreover, bat-restricted parasites are of evolutionary
interest, since it has been proposed that T. c. cruzi may
have originated from an ancestral bat-lineage that jumped
into terrestrial mammals [15]. The present day human
lineage, T. c. cruzi, has been in contact with humans for
no more than 10,000 to 30,000 years, which is the period
of human presence in the Americas [16].
T. c. cruzi strains are currently sorted into six lineages
or discrete typing units (DTUs), which illustrate the gen-
etic diversity of this parasite [17]. Several strains have to
date been subjected to genome sequencing, among these
are CL Brener and Sylvio X10. The CL Brener strain was
selected for the original genome project and belongs to
DTU VI. The size of the CL Brener genome was ~110
Mb and it was assembled mostly with Sanger paired-end
reads. The CL Brener strain was shown to be a genetic
hybrid of two diverged haplotypes named Esmeraldo-like
and non-Esmeraldo-like [18]. The hybrid and repetitive
nature of this genome complicated sequence assembly
and finishing, leaving the genome in many gaped scaf-
folds and contigs. Weatherly et al. later compiled scaf-
folds into more complete chromosome-wide sequences
[19]. Second-generation sequencing facilitates more cost-
effective and rapid sequencing efforts. Recently, 454-
sequencing was applied on the genome of the DTU I
strain Sylvio X10 [20], revealing a slightly smaller but still
repeat-rich genome.
Little is known about genomic variation among organ-
isms within the Schizotrypanum genus. Genomic in-
sights can provide information on evolutionary adaptation
of these parasites, as well as being useful for advancing
population genetics. Thus, exploring genomic diversity
could reveal important genetic and biological character-
istics, and potentially clues as to how these parasites re-
late to the human disease. Here we describe the genome
of T. c. marinkellei B7, a bat-associated parasite origin-
ally isolated from a colony of the pale spear-nosed bat
Phyllostomus discolor roosting in a hollow tree [1]. The
parasite was isolated in São Felipe, Bahia state, Brazil in
1974 and has since then been stored under cryogenic
conditions with occasional short periods of in vitro cul-
tivation. We combined Roche/454 and Illumina se-
quencing to generate a draft genome sequence of
T. c. marinkellei. This is the first whole genome analysis
of a T. c. cruzi-like species that is not associated with
human infections. In addition, we also report re-assembly
and re-annotation of the human infective strain T. c. cruzi
Sylvio X10 [20], a commonly used reference strain of T.
c. cruzi I [21], using additional sequence data.
The comparative analyses with T. c. cruzi revealed that
the genomes contain the same repertoire of housekeep-
ing genes. Moreover, T. c. marinkellei contains an add-
itional gene that appears to be an example of recent
horizontal gene transfer. In addition, the genomes also
exhibit copy number variation and diversification of
gene families, which potentially give rise to a large num-
ber of strain-specific protein isoforms.
Results and discussion
Sequencing and Assembly of T. c. marinkellei and T. c.
cruzi Sylvio X10
In the text, we refer to Trypanosoma cruzi marinkellei
as Tcm, Trypanosoma cruzi cruzi Sylvio X10 as Tcc X10
and Trypanosoma cruzi cruzi CL Brener as Tcc CLBR.
Genomic sequence reads were generated from Tcm and
Tcc X10 using 454 and Illumina sequencing (Table 1).
454 sequencing (single end; long reads) was performed
on genomic DNA from Tcm, which produced sequence
reads with an average length of ~357 nt. The 454 data
from Tcc X10 was the same as previously described [20].
In addition, one ~2 kb insert library (2×100-nt reads)
was prepared for Tcm and Tcc X10 respectively, using a
modified version of the Illumina mate-pair protocol
(Materials and Methods). The modified Illumina proto-
col was chosen to enable 100 nt read lengths, as Illu-
mina does not recommend its own protocol for mate-
pair sequencing with read lengths >36 nt. This generated
71,948,029 and 84,638,048 read-pairs from Tcm and Tcc
X10 respectively. Not all read-pairs translated to the
expected insert size of ~2 kb. Long insert libraries often
contain a significant proportion of short insert fragments
(corresponding to paired-end reads). Most often this is
due to non-optimal biotin enrichment causing some frag-
ments not to circularize and therefore become sequenced
with much shorter insert. We determined the number of
Table 1 Raw sequence data
T. c. marinkellei T. c. cruzi Sylvio X10
454 a Illumina b 454 a Illumina b
# reads (106) 1.3 23.0 1.3 28.7
# nt (109) c 0.47 35.6 0.52 44.3
Average read length (nt) d 357 77 393 77
~ Coverage e 12 91 9 103
a Single end 454 reads.b No. Read-pairs (true mate-paired reads after adapter
trimming).c Billion nucleotides.d The average read length (after adapter
trimming).e The theoretical genome coverage based on known genome sizes
and the number of sequenced nucleotides.
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true mate-pairs from the obtained data using an R-script
previously published by Van Nieuwerburgh et al. [22].
The script determines the location of the LoxP linker
sequence in the read, and then uses this information
to classify read-pairs as true mate-pairs, paired-end,
single-end or linker-negative. True mate-pairs should
contain the LoxP sequence close to the 30 end in at
least one read, indicating that circularization has taken
place. In our data, 32% (23,055,208/71,948,029) and 34%
(28,781,049/84,638,048) of the read-pairs were classi-
fied as true mate-pairs from Tcm and Tcc X10 respec-
tively (LoxP sequence close to the 30 end in at least
one of the reads). 38% (27,890,116/71,948,029) and 35%
(30,076,419/84,638,048) read-pairs were classified as
paired-end from Tcm and Tcc X10 respectively. The re-
maining read-pairs were either unpaired or LoxP-negative,
meaning that the linker was present in the unsequenced
part of the fragment or that the fragment did not contain
a linker. Hence, despite an improved protocol, a sub-
stantial number of paired-end and single-end reads were
obtained. The causes of this has previously been dis-
cussed [22].
The 454 and Illumina data were subsequently as-
sembled (Figure 1). In order to take platform dependent
sequencing artifacts into consideration, 454 and Illumina
reads were assembled separately using different assembly
programs (Figure 1; Table 2; Materials and Methods).
Insertion-deletion errors in the 454 assemblies were
identified and corrected using alignments with Illumina
reads, which corrected 12,358 and 7,277 positions of
Tcm and Tcc X10 respectively. The most common error
was one or two missing bases (~90% of the corrected
positions). The resulting assemblies were subsequently
merged into a non-redundant assembly. Distance infor-
mation from mate-pair reads was used to arrange con-
tigs into scaffolds. Where possible, the distance between
two adjacent contigs in a scaffold was inferred by com-
parison with Tcc CLBR, i.e. if two contigs flanking each
side of a gap could be aligned with one of the CL Brener
haplotypes, then the approximate gap length could be
inferred from CL Brener. As a final assembly step, both
Tcm and Tcc X10 were subjected to gap closure using
the IMAGE pipeline [23] and the sorted paired-end
reads (see above). Prior to feeding scaffolds into IMAGE,
paired-end reads were quality filtered. IMAGE uses it-
erative mapping of reads to contig ends, followed by
local assembly and alignment to close gaps and extend
contigs. Eight IMAGE iterations were completed for
each genome, which improved each assembly by adding
653,655 (Tcm) and 534,614 (Tcc X10) base pairs, which
closed 261 and 171 gaps and extended 2,426 and 2,510
contig ends from Tcm and Tcc X10 respectively.
The combined assembly lengths were 38.6 Mb and
43.4 Mb for Tcm and Tcc X10 respectively. The assembly
size of Tcc X10 was very similar to our previous estimate
from extrapolation of unassembled data [20] and flow
cytometry [24]. Flow cytometry analysis estimated the
haploid size of Tcm to ~39 Mb (Additional file 1: Figure
S1), which was close to the in silico assembly length.
Thus, assembly sizes were consistent with experimental
measurements. Moreover, this confirmed that the Tcm
genome was ~4.8 Mb smaller than that of Tcc X10. The
percentage of assembled bases in each assembly was very
similar: Tcm 88.6% (34.2 Mb/38.6 Mb); Tcc X10 88.7%
(38.5 Mb/43.4 Mb). We analyzed 29,422 unused 454
reads of Tcm with RepeatMasker, which identified 13,108
reads corresponding to kinetoplastid sequences. The re-
maining reads were analyzed with BLAST, showing them
to correspond multicopy genes or other repeats.
868 (Tcm) and 987 (Tcc X10) scaffolds were longer
than 5 kb, which corresponded to 25.7 and 26.8 Mb (in-
cluding gaps). The longest scaffolds were 335 kb (Tcm)
and 384 kb (Tcc X10). Some 200 gaps could be closed
from the apparent overlap of adjacent contigs. Com-
pared with 454 reads alone, addition of mated reads
provided longer contigs and scaffolds, corrected 454 se-
quence errors and allowed accurate estimation of gen-
ome heterozygosity and copy number variation.
Comparison of heterozygosity and multicopy genes
The level of heterozygosity among populations of med-
ically important trypanosomes is likely to reflect the
impact of key evolutionary processes such as gene con-
version and genetic exchange. In the present study we
estimated the amount of heterozygosity in Tcm and Tcc
Assembly of
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Assembly of
454 reads 
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Homopolymer error
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Figure 1 Schematic overview of the sequence assembly.
Schematic overview of the genome assembly steps. Illumina reads
were assembled into contigs with Velvet. Unused reads were
extracted and used for a second Velvet assembly with a different
kmer length. 454 reads were assembled with CELERA. The
454-assembly was then subjected to homopolymer error correction
with Illumina reads. The Illumina and 454 assemblies were merged
into a non-redundant assembly using the Zorro pipeline. The
assembly was then subjected to scaffolding using SSPACE and
physical distance information. The final step involved gap closure
with the IMAGE pipeline.
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X10 by aligning Illumina and 454 reads back to the as-
semblies and subsequently identifying high quality mis-
matches between the consensus sequence and aligned
reads. In order to increase the confidence, only nucleo-
tide positions with 10 to 80X coverage were included and
contigs shorter than 5 kb were ignored. This resulted in
19,015,919 and 20,468,447 positions of Tcm and Tcc X10
that permitted analysis, which represented 49.2% (19.0
Mb/38.6 Mb) and 47.0% (20.4 Mb/43.4 Mb) of each
genome respectively. Furthermore, a mismatch had to
be supported by at least 9 reads in order to call the po-
sition heterozygous. The search identified 37,894 posi-
tions of Tcm and 46,001 positions of Tcc X10 that were
heterozygous. Taken together, genome heterozygosity levels
of Tcm and Tcc X10 were ~0.19% (37,894 bp/19,015,919 bp)
and ~0.22% (46,001 bp/20,468,447 bp), of which 38.8%
(14,712 bp/37,894 bp) and 42.4% (19,513 bp/46,001 bp)
were located in protein-coding genes. 7,976 and 10,596
heterozygous positions of Tcm and Tcc X10 were located
at non-synonymous sites. Gene Ontology analysis was
performed on genes containing at least one polymorph-
ism at a non-synonymous site, resulting in two signifi-
cantly enriched categories (p<0.05): GO:0009451 (RNA
modification) and GO:0009982 (pseudouridine synthase
activity). Overall, the estimated level of heterozygosity of
Tcc X10 was slightly higher than previously reported
[20], likely due to the increased sequence depth in the
present study. In order to identify regions with higher
density of heterozygosity, i.e. clustering of heterozygous
sites, we counted the number of heterozygous positions
inside 1,000 bp windows. This indicated that heterozy-
gosity often, but not exclusively, was located in clusters
(Figure 2). In conclusion, heterozygosity of the Tcm and
Tcc X10 were ~0.19% and ~0.22%, with some regions
exhibiting higher than average heterozygosity. In con-
trast, the heterozygosity level of Tcc CLBR was ~1 to 4%
(since it is a hybrid). In comparison to other kinetoplas-
tids, the heterozygosity level is similar to that of
Leishmania braziliensis but higher than L. major and L.
infantum [25]. The generally low levels of heterozygosity
found in many protozoans is difficult to explain in terms
of a strictly clonal propagation model [10]. Such organ-
isms would be expected to observe extensive divergence
of homologous genomic copies, which is the case for
bdelloid rotifers [26]. In perspective, the B lineage of the
human parasite Giardia intestinalis exhibits relatively
Table 2 Genome assembly statistics and summary
Genome Step Software Size a # contigs b # scaffolds Average length c N50 d N90 e
Tcm 454 assembly CELERA 37.3 30,737 - 1,216 1,670 539
Illumina assembly Velvet (kmer 43) 16.7 9,247 - 1,813 2,378 851
Assembly of non-assembled Illumina reads Velvet (kmer 53) 1.17 2,094 - 562 536 418
Assembly merging Zorro 33.5 24,799 f - 1,353 2,218 549
Scaffolding SSPACE 38.8 23,813 f 1,835 2,296 25,044 576
Gap closure IMAGE 38.6 23,000 1,774 2,302 25,781 583
Tcc X10 454 assembly CELERA 41.8 33,686 - 1,243 1,516 549
Illumina assembly Velvet (kmer 43) 17.0 8,523 - 1,997 2,742 904
Assembly of non-assembled Illumina reads Velvet (kmer 53) 1.14 2,116 - 543 523 416
Assembly merging Zorro 38.0 28,389 f - 1,339 1,869 560
Scaffolding SSPACE 43.7 27,605 f 2,476 2,162 14,067 589
Gap closure IMAGE 43.4 26,889 2,423 2,158 14,516 592
a The length when sequences are combined (Mb).
b The number of contigs/scaffolds.
c The average contig length (bp). For the SSPACE row, this refers to the average scaffold length.
d The length N for which half of all bases are in a sequence of this length or longer.
e The length N for which 90% of all bases are in a sequence of this length or longer.
f Contigs >500 bp.
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Figure 2 Distribution of heterozygosity along a genomic
segment of T. c. marinkellei. Distribution of heterozygosity and
sequence coverage along scaffold 143 of T. c. marinkellei B7.
Heterozygosity was counted in non-overlapping sliding windows of
1000 bp (red line). Coverage is shown as the log10-scaled average
coverage of the 1000 bp window (turquoise line). The x-axis shows
the start position of the window along the sequence and the y-axis
shows the number of heterozygous nucleotide positions per
window or log10-scaled average coverage of the window.
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high heterozygosity (~0.5%) [27] whereas A and E lin-
eages exhibit low heterozygosity (~0.01%) [28]. The
genome of the free-living amoeboflagellate Naegleria
gruberi was described as mosaic of homozygous and
heterozygous regions, with an average polymorphism rate
of 0.58% [29]. Interestingly, asexual lineages of Daphnia
exhibit low levels of allelic divergence and appear to
employ ameiotic recombination to eliminate heterozy-
gosity faster than it accumulates [30]. The mechanism for
maintaining low heterozygosity in trypanosomatids re-
mains unknown, but could involve cryptic sexuality,
frequent local gene conversion or chromosome-wide con-
version. The former can be evaluated via an assessment
of population-level inter-locus linkage disequilibrium.
Nevertheless, descriptive data may not be sufficient to
explain the causes of this phenomenon.
T. c. cruzi contain several highly expanded and com-
plex gene families [31,32], comprised of transcribed
genes and pseudogenes. Several of these families have
been reported to vary in copy number between strains
[18,20,33-35]. In the present study we compared gene
family content between Tcm and Tcc X10 using the
depth of aligned short reads. Initially, repeat boundaries
were determined using RepeatMasker. Subsequently, the
percentages of reads mapping to repeat families were
calculated (Table 3). The statistical significance was as-
sessed in the following way: an empirical distribution
of genome-wide read-depth differences was established
using regions of homology between Tcm and Tcc X10
(Additional file 2: Figure S2). The software promer was
used to find homologous regions. In each homologous
region, the percentage read coverage was calculated for
Tcm and Tcc X10. These numbers were then corrected
for the genome size and the coverage difference for each
homologous region was computed. 17,290 regions were
included, with mean 1.380393e-07 and standard devi-
ation 5.83481e-07. The logspline function of the R pack-
age with the same name was used to fit a smoothed
density curve to the data, and the plogspline function
was used to determine p-values. Six out of eight examined
gene families were expanded in Tcc X10: trans-sialidase;
mucin-associated surface protein; retrotransposon hot
spot protein; TcMUC mucin; ABC Transporter; and RNA
binding protein. On the contrary, GP63 and dispersed
gene family 1 (DGF) were contracted in Tcc X10. The
observation that DGF was contracted in Tcc X10 was
consistent with previous data when Tcc X10 was com-
pared with Tcc CLBR [20], which suggests a recent loss
of DGF-related sequences in the lineage leading to Tcc
X10. Further examination of several DTU I strains may
resolve if this is a general feature of this lineage. It is clear
that at least part of the genome size difference can be
attributed to expansion and/or contraction of these gene
families. We performed a closer examination of the
TcMUCII mucin gene family. TcMUCII mucin genes of
the same genome were frequently found to be too dif-
ferent to align. We constructed entropy plots from align-
ment positions that were deemed as accurate, which
revealed, as expected that 50 and 30 termini were more
conserved and the internal parts of these genes were
hypervariable (Additional file 3: Figure S3).
Kinetoplastid DNA (maxicircle)
The mitochondrial genomes (maxicircles) of T. c. cruzi
strains X10 (DTU I), Esmeraldo (DTU II) and CLBR
(DTU VI) have been sequenced, and have provided in-
sights into the structure and organization of kinetoplastid
DNA of these strains [36]. The T. c. marinkellei maxicircle
Table 3 Comparison of gene family content
T. c. marinkellei T. c. cruzi Sylvio X10
Gene family a Size in assembly b % Short reads c Size in assembly b % Short reads c SE d
DGF 2,129,983 (6.22 %) 3.433 1,265,650 (3.28 %) 1.324 Tcm
TS 2,109,163 (6.16 %) 6.291 2,953,602 (7.65 %) 6.298 Tcc X10
MASP 540,360 (1.58 %) 1.317 727,537 (1.88 %) 1.434 Tcc X10
RHS 521,665 (1.52 %) 2.234 1,314,589 (3.41 %) 2.915 Tcc X10
GP63 452,732 (1.32 %) 1.229 514,422 (1.33 %) 0.898 Tcm
TcMUC mucin 273,890 (0.80 %) 0.557 334,544 (0.87 %) 0.515 Tcc X10
ABC 37,490 (0.11 %) 0.124 42,072 (0.11 %) 0.162 Tcc X10
RBP 25,946 (0.08 %) 0.080 26,732 (0.07 %) 0.074 Tcc X10
a Gene family abbreviations: DGF=Dispersed Gene Family, TS=trans-sialidase, MASP=Mucin-associated surface protein, GP63=Surface protease,
RHS=Retrotransposon Hot Spot protein, ABC=ABC Transporter, RBP=RNA Binding Protein.
b The combined number of base pairs of this gene family that was identified in the assembly. Sequences were identified using RepeatMasker and a repeat library
of coding sequences from the Tcc CLBR genome. These numbers include partial coding sequences. The number inside parenthesis refers to the percentage of
total assembly size.
c The percentage of short reads that mapped to these features.
d SE=Significantly Enriched. Refers to if one genome contained significantly more of this gene family. The significance was determined from an empirical
distribution of read depth differences from homologous regions of Tcm and Tcc X10, corrected for genome size. The empirical distribution was used to calculate a
p-value.
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was identified as a 20,037 bp contig from the 454 as-
sembly. The length of this sequence was slightly longer
(~ 5 kb) than those previously reported, and the differ-
ence was attributed to variability in the repetitive region.
The coding region of the Tcm maxicircle was syntenic
with the coding regions of the three complete T. c. cruzi
maxicircle genomes, beginning with the 12S rRNA gene
and ending with the ND5 gene. The lengths of the indi-
vidual genes within the Tcm maxicircle coding region
were comparable to those of the three T. c. cruzi strains
(Additional file 4: Table S1). The length of the complete
maxicircle coding region (beginning at 12S rRNA and
ending after ND5) for Tcm was 15,438 bp and began
after 4,599 bp of non-coding sequence. With respect to
coding sequences, the average maxicircle nucleotide
identity between Tcm and Tcc X10 was (mean ± sd):
85.12% ± 6.1, between Tcm and Tcc CLBR was 85.4% ±
6.2 and between Tcm and Tcc Esmeraldo was 85.3% ±
6.1 (Additional file 4: Table S1). Phylogenetic reconstruc-
tion of the maxicircles from Tcm, Tcc X10, Tcc CLBR
and Tcc Esmeraldo confirmed that the Tcm maxicircle
was slightly closer to Tcc Esmeraldo than Tcc X10/CLBR
(Additional file 5: Figure S4). The topology of the tree
suggests that the Esmeraldo maxicircle might represent
the ancestral maxicircle lineage of T. c. cruzi.
The consensus maxicircle genome sequence is derived
from the predominant nucleotide present across mul-
tiple read alignments at each position. However, this
criterion disregards low abundance single nucleotide poly-
morphisms (SNPs) and therefore masks minor maxicircle
haplotypes (heteroplasmy), which has previously been
reported from Tcc X10 [37]. Illumina reads were used to
assess the presence/absence of minor Tcm maxicircle
haplotypes. In total, this identified 19,821 reads that
aligned to the Tcm maxicircle. Low levels of hetero-
plasmy were observed in the Tcm maxicircle protein-
coding region. Twenty SNPs were identified among four
genes (ND8, MURF1, COI and ND3) and one intergenic
region (between CR4 and ND4). Average read depth for
each SNP site was 47. At heterozygous sites, the minor
nucleotide was present among an average of 9.5% (± 3.3%)
of reads. All SNPs were bi-variable except for at two in-
tergenic positions, where two minor nucleotides were
present. These observations imply the occurrence of at
least two minor mitochondrial haplotypes.
Gene content analysis and comparison
The Tcm and Tcc X10 genomes were annotated using a
semi-automatic strategy, which relied on the previous
annotation of the reference genome Tcc CLBR [18]. Gene
models were transferred from Tcc CLBR to Tcm and Tcc
X10 using Perl scripts, reciprocal BLASTp searches to-
gether with positional information (Materials and Meth-
ods). In addition, gene prediction was performed and
gene models were kept if one or more of the following
criteria were satisfied: (i) the gene was conserved in a
syntenic position in Tcc CLBR; (ii) the gene shared hom-
ology with one or more gene families in Tcc CLBR; and
(iii) the gene was longer than 250 amino acids. Gene
models with complete overlap with another gene were
discarded. The final annotations were manually inspected
and refined with the Artemis Comparison Tool [38].
After this procedure, the genome sequences contained
10,342 (Tcm) and 11,112 (Tcc X10) protein coding gene
annotations, of which 60.5% (6,267/10,342) and 57.7%
(6,416/11,112) were syntenic with Tcc CLBR, Tcm and
Tcc X10 respectively. With respect to coding sequences,
the average nucleotide identity between Tcm and Tcc X10
was 92.5% ± 3.2 (Figure 3). When Tcm was compared
with Tcc CLBR Esm and non-Esm the average nucleotide
identity was 92.8% ± 3.4 and 92.6% ± 3.2. These identities
are based on a total of 6,283 (Tcm:Tcc X10), 5,441 (Tcm:
Tcc CLBR Esm) and 5,617 (Tcm:Tcc CLBR non-Esm)
orthologous gene pairs. ~86% (14,997/17,332) of the ana-
lyzed ortholog pairs had a nucleotide identity of 90% or
higher. The ratio of non-synonymous and synonymous
nucleotide substitutions (ω=dN/dS) was 0.31 ± 0.21 in
0
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Figure 3 Histogram of pairwise nucleotide identities between
orthologous genes. Histogram of pairwise nucleotide identities
between orthologs of T. c. marinkellei B7 and T. c. cruzi CL Brener
non-Esmeraldo-like haplotype. 5618 orthologs were included in the
comparison, for which the average nucleotide identity was 92.6% ±
3.3 (Tcm vs Tcc CLBR non-Esm). The genes included in this analysis
mainly comprised the non-repetitive component of these genomes.
Orthologs were defined as the best reciprocal BLASTp hit between
the genomes. Nucleotide sequences were aligned with ClustalW
version 2.1. Mismatches (single nucleotide polymorphisms) within
each alignment were identified and counted using a Perl script.
Pairwise orthologs with lower identity than 80% were excluded from
the analysis.
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average (Tcm versus Tcc CLBR non-Esm), indicating as
expected that most genes were under purifying (stabiliz-
ing) selection. A total of 69 genes showed ω values > 1.1,
indicating positive selection (Additional file 6: Table S2).
In order to identify isolate-specific genes, we compared
the gene complements of the three genomes (Tcm, Tcc
X10 and Tcc CLBR) using BLAST. Initially, the predicted
proteomes of Tcm and Tcc X10 were queried with
BLASTp against the predicted proteome of Tcc CLBR
using the E-value threshold 1e-20. This resulted in 237
(Tcm) and 290 (Tcc X10) proteins longer than 250 amino
acids that were not found in the Tcc CLBR proteome.
These protein sequences were queried using tBLASTn
against the Tcc CLBR genome to exclude the possibility
that these putative genes were present as non-annotated
open reading frames, using the same E-value threshold.
This decreased the number of hits to 22 (Tcm) and 3 (Tcc
X10). The composition of the 22 putative Tcm-specific
genes were as follows: 11 TcMUCII mucin genes; 1 acet-
yltransferase (MOQ_006101); 5 putative genes with weak
hits to microbial sequences (MOQ_006053, MOQ_007485,
MOQ_009774, MOQ_006631, MOQ_003304); and 5 puta-
tive genes with no hits in public databases (MOQ_ 003636,
MOQ_009528, MOQ_006983, MOQ_009799, MOQ_
005225). For Tcc X10, one of the specific genes corre-
sponded to a diverged mucin-associated surface protein
(TCSYLVIO_008353). The remaining two putative genes
did not show any significant hits in public databases
(TCSYLVIO_011068 and TCSYLVIO_008789). Thus, the
improved Tcc X10 genome sequence facilitated the detec-
tion of two putative Tcc X10-specific protein-coding
genes not apparent in the earlier version. The two un-
known genes were found to also be present in the previ-
ously reported draft genome sequence of Tcc X10 [20].
We used the same strategy to perform the reversed
search, i.e. searching for genes specific for Tcc CLBR.
This resulted in 344 and 206 protein sequences that were
not found in Tcm and Tcc X10. Searches using tBLASTn
towards Tcm and Tcc X10 further decreased this number
to 70 and 100, and of these 52 and 21 were mucin-
associated surface proteins or TcMUCII mucin. 8 (Tcm)
and 26 (Tcc X10) contained low complexity repeats. The
remaining 10 (Tcm) and 53 (Tcc X10) genes were queried
against the raw 454 reads of Tcm and Tcc X10, which fur-
ther decreased the number of Tcc CLBR specific genes to
3 that were not present in Tcm (Tc00.1047053511585.110,
Tc00.1047053509525.260, Tc00.1047053510073.24). The
3 genes were uncharacterized (hypothetical). The Tcc
CLBR-specific genes, compared with Tcc X10, were iden-
tical to those previously reported [20]. In conclusion, the
total number of specific genes was remarkably low in re-
lation to the number of coding sequences in these gen-
omes. As a perspective, comparative genomics of T.
brucei brucei and T. brucei gambiense did not identify
any gene that could explain the ability to infect different
species, despite interspecific pathological variation [39].
A specific acetyltransferase gene in T. c. marinkellei
As mentioned above, a 1,662 bp acetyltransferase gene
(MOQ_006101) was found among the 22 unique genes
in Tcm. This gene was identified in a single copy on
scaffold 2842 and was missing in T. c. cruzi. Align-
ment of scaffold 2842 from Tcm with Tcc CLBR showed
that it aligned close to the end of chromosome 37 and
was flanked by VIPER elements and an ATPase gene
(Figure 4). To exclude the possibility that MOQ_006101
was not properly assembled in T. c. cruzi, we searched
raw 454/Illumina reads from Tcc X10 and raw Sanger
ATPase
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Figure 4 Genomic location of the T. c. marinkellei-specific acetyltransferase gene (MOQ_006101). Screenshot from Artemis Comparison
Tool of a ~19 kb homologous region of T. c. marinkellei B7 (contig 2842) and T. c. cruzi CL Brener (non-Esmeraldo-like haplotype; chr 37).
Vertical black lines in each frame represent stop codons. Genes with shared homology in both genomes are shown in blue and the specific
T. c. marinkellei gene (MOQ_006101) is shown in green. Red stripes represent regions with high sequence similarity between the two genomes.
Abbreviations: ETIF (eukaryotic translation initiation factor 3 subunit 8, putative); HP (hypothetical protein); PDI (protein disulfide isomerase);
CO (cytochrome c oxidase subunit IX); AT (acetyltransferase); and RP (U1A small nuclear ribonucleoprotein).
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reads from Tcc CLBR. This confirmed that MOQ_ 006101
was not present in these genomes. Domain searches of
MOQ_006101 revealed the presence of a Cas1p domain
(pfam07779, E-value=9e-66) and multiple trans-membrane
domains. In GenBank, the best hit from protein BLAST
was to the green algae Chlamydomonas reinhardtii, con-
taining 44% sequence identity over 496 amino acids (E-
value < 4e-125). 4 iterations of PSI-BLAST resulted in
hits to various species of plants and algae. The best ten
hits were to the enzyme O-acetyltransferase, displaying
protein identities between ~37-39% (Table 4). This indi-
cated that MOQ_006101 has either diverged since the
transfer to Tcm or that it has been transferred from a
species not contained in GenBank, of which the latter
seems the most likely. Furthermore, transcription of
MOQ_006101 was detected with reverse transcriptase
quantitative polymerase chain reaction (RT-qPCR).
Phylogenetic reconstruction of MOQ_006101 dem-
onstrated that the closest known homologs were from
various species of algae and plants (Figure 5A), and the
absence of exon-intron boundaries suggested that it was
transferred as a spliced mRNA. No homologs were
found in Trypanosoma rangeli (Edmundo C. Grisard,
Personal communication), Rhodnius prolixus (insect vec-
tor) or Myotis lucifugus (a bat species). The GC content
of MOQ_006101 was 42.8%, which was significantly
lower than the average of 52.7% ± 5.8 (Figure 5B). The
GC content of the first, second and third codon posi-
tions were 42.2%, 37.7% and 48.6%, in contrast to the
global levels: 57.5% ± 5.4 (GC1), 45.0% ± 6.2 (GC2) and
55.7% ± 11.0 (GC3). Hence, the GC content of MOQ_
006101 was unusually low in relation to the global GC
content of all Tcm genes. In conclusion, this suggested
that the nucleotide composition of MOQ_006101 was
distinct compared with all other genes of the Tcm gen-
ome. The unusual GC content can be interpreted as an
imprint from the originating genome.
Codon Adaptation Index (CAI) is a measure of syn-
onymous codon usage bias and can be used to evaluate
the extent of which codon usage of a supposed foreign
gene is similar to highly expressed genes in the host
genome [40]. CAI can range between 0 and 1 and val-
ues closer to 0 imply equal use of synonymous codons
whereas values closer to 1 imply strong codon usage
bias. MOQ_006101 displayed a CAI value of 0.518
(Figure 5C). In contrast, the median CAI across all genes
was 0.545 ± 0.05 (median ± median absolute deviation).
Thus, CAI was lower than the mean but still within the
expected range, suggesting that the gene has conformed
to the host genome.
Overall, these findings point to that MOQ_006101 was
acquired by the lineage leading to Tcm rather than lost
in T. c. cruzi and demonstrates an example of horizontal
gene transfer between a photosynthesizing organism and
a protozoan parasite. Interestingly, a genome compari-
son of two strains of the protozoan Giardia intestinalis
also identified a strain-specific acetyltransferase [28].
Finally, the biological function of MOQ_006101, if any,
remains to be determined.
Comparison of synteny reveals putative rearrangements
T. c. cruzi has previously been reported to exhibit exten-
sive DNA content and karyotype variability [24,41-43].
We investigated sequence co-linearity of the assembled
data and compared with the current chromosome-level
assembly of Tcc CLBR. Scaffolds >25 kb were extracted
from the assemblies, which resulted in 307 and 229 scaf-
folds for Tcm and Tcc X10 respectively, amounting to
50.7% (19.6 Mb/38.6 Mb) and 44.7% (19.4 Mb/43.4 Mb)
of the genomes. In order to identify putative inter- and
intra-chromosome rearrangements, scaffolds were quer-
ied against Tcc CLBR (non-Esm) using the alignment
program promer [44]. The number of chromosome hits
per scaffold was plotted and the results were inspected.
Table 4 List of hits obtained from PSI-BLAST after 4 iterations querying MOQ_006101 against GenBank non-redundant
database
Species Description Accession CDD hit a % Identity BLAST E-value
Populus trichocarpa Predicted protein XP_002298511.1 Cas1_AcylT 38% 0
Arabidopsis thaliana Putative O-acetyltransferase NP_568662.1 Cas1_AcylT 39% 0
Arabidopsis thaliana AT5g46340/MPL12_14 AAL11600.1 Cas1_AcylT 38% 0
Arabidopsis thaliana O-acetyltransferase-like protein NP_180988.3 Cas1_AcylT 37% 0
Populus trichocarpa Predicted protein XP_002317300.1 Cas1_AcylT 37% 0
Vitis vinifera CAS1 domain-containing protein 1-like XP_002272126.2 Cas1_AcylT 38% 0
Arabidopsis lyrata subsp. Lyrata O-acetyltransferase family protein XP_002879497.1 Cas1_AcylT 37% 0
Arabidopsis lyrata subsp. Lyrata Hypothetical protein XP_002863407.1 Cas1_AcylT 39% 0
Ricinus communis O-acetyltransferase, putative XP_002519732.1 Cas1_AcylT 38% 0
Glycine max CAS1 domain-containing protein 1-like XP_003532649.1 Cas1_AcylT 38% 0
a The best hit from the NCBI Conserved Domain Database.
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A total of 73 (Tcm) and 114 (Tcc X10) scaffolds con-
tained hits to more than one chromosome from Tcc
CLBR. However, manual examination showed that the
vast majority of these hits were to gene family members
(e. g. DGF, trans-sialidase, TcMUCII mucin) or other re-
peats. Hence, these were not likely to be rearrangements
between chromosomes. 4 scaffolds were identified from
Tcm (244, 732, 1101 and 2169) and 6 from Tcc X10 (94,
737, 1353, 2784, 2065 and 2359) that were involved in
inter-chromosome rearrangements (Additional file 7:
Figure S5). Moreover, Tcm and Tcc X10 both contained
rearrangement in a region on chromosome 34, con-
taining a repeat-like composition in Tcc CLBR. Scaffold
1101 from Tcm aligned with chromosomes 34 and 27.
Scaffold 94 from Tcc X10 aligned with chromosomes
34 and 12. Also, scaffold 732 from Tcm aligned with the
distal parts of Tcc CLBR chromosomes 22 and 42. In
Tcm, VIPER elements were frequently found in regions
where synteny was discontinued. Regions where rearran-
gements had occurred were frequently found inside uni-
directional gene clusters.
Intra-chromosome rearrangements were searched for
using the same strategy. This identified 23 and 13 scaffolds
in Tcm and TccX10 respectively, where intra-chromosome
rearrangements were identified. Frequently, one or sev-
eral genes were found to have shifted location and were
found to be located distally on the same chromosome. In
a few cases, a certain structural variant was present in
Tcm and Tcc X10 but not in Tcc CLBR, suggesting that it
was introduced in the lineage leading to Tcc CLBR. Tcm
scaffold 836 contained a large inverted region, flanked by
VIPER elements. This inversion causes disruption of a
head-to-head strand switch region. The larger number of
structural rearrangements in Tcm likely reflects its phylo-
genetic distance from T. c. cruzi.
PCR validation was performed in order to validate
the accuracy of the assembly and some of the identified
rearrangements. Representative regions were selected
from Tcm, Tcc X10 and Tcc CLBR and targeted for PCR
amplification. The size of the PCR product was com-
pared with the in silico expected size and confirm as-
sembly consistency. In total, 3 of 4 genomic regions were
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Figure 5 Analyses of the T. c. marinkellei-specific acetyltransferase gene. (A) Maximum likelihood phylogenetic tree of the T. c. marinkellei B7
specific gene (MOQ_006101) based on protein sequences. Phylogenetic inference was done on a protein dataset extracted with Blast Explorer
(E-value <1e-40). The multiple sequence alignment was done with ClustalW version 2.1 and filtered with Gblocks. The final alignment, which the
tree is based on, contained 62 columns. The phylogeny was inferred using RAxML version 7.0.4 with the PROTGAMMAJTT model and 100
bootstrap replicates. Only bootstrap values >40 are shown. Accession numbers for protein sequences are shown in parenthesis after species
names. The Tcm gene is shown in red. (B) GC content analysis of MOQ_006101 in relation to all genes. Error bars represent one standard
deviation. The white dot represents all genes and the blue dot represents MOQ_006101. GC1, GC2 and GC3 refer to the %GC content at the first,
second and third codon positions. 10,342 coding sequences were included in the analysis. (C) Histogram of Codon Adaptation Index (CAI) for all
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(0.518). CAI was calculated using emboss programs cai and cusp.
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successfully amplified from Tcm, 2 of 2 from Tcc X10 and
1 of 2 from Tcc CLBR (Additional file 8: Figure S6). Of
which Tcm yielded the following PCR product sizes: 4,
0.5 and 0.8 kb. The first and second PCR products
spanned across assembly gaps and therefore did not
allow estimation of the expected sizes, but confirmed
contigs to be accurately linked together. The third PCR
reaction from Tcm resulted in the expected product size
of 0.8 kb. Tcc X10 resulted in PCR products of sizes 0.8
kb and 1 kb, which were expected. The Tcc CLBR reac-
tion resulted in the expected product size of 3 kb. Two
PCR reactions did not work, which could either be due
to non-optimal PCR conditions, formation of primer-
secondary structures/duplexes or misassembly.
It is important to note that the present analyses are
limited by the sequence continuity of the particular scaf-
fold and therefore the presented numbers of observed
rearrangements are likely to be underestimates. In con-
clusion, the majority of analyzed genomic regions from
Tcm and Tcc X10 exhibited conserved local synteny with
Tcc CLBR. However, insertions, deletions or other types
of structural alterations occasionally interrupted synteny.
These observations suggest that different T. c. cruzi lin-
eages contain distinct karyotypes and other types of
structural features, which have been fixed in a certain
lineage. The cause of these rearrangements could either
be due to random processes, i.e. oxidative stress or mis-
takes introduced by spontaneous cellular processes or
perhaps less likely, physiological processes. Clearly, the
presence of genetic variation other than SNPs provides
an additional layer of complexity to studies of T. c. cruzi
genetic variability.
Widespread occurrence of copy number variation in Tcm
and Tcc X10
Copy number variation has been reported from T. c.
cruzi strains [33,34,45]. Such variation may represent im-
portant strain-specific characteristics, yet little is known
about how T. cruzi lineages differ in this aspect. In the
present study we investigated the occurrence of copy
number variation in Tcm and Tcc X10 using short read
depth (coverage). RT-qPCR was used to confirm some of
the identified variations. Illumina reads were aligned to
scaffolds >50 kb and a sliding window analysis was used
to identify regions which exhibited higher than average
coverage. Coverage was calculated in 100 bp windows
with 50 bp overlap, i.e. the coverage of each position in
the window was summed and log10-scaled. The baseline
coverage was determined for each genome and was used
to assess if a region displayed elevated coverage compared
to the rest of the genome. The baseline was calculated as
the median and median absolute deviation (mad) of
log10-scaled coverage from all windows of one genome.
This resulted in the baseline coverage (median ± mad)
3.39 ± 0.35 and 3.39 ± 0.33 for Tcm and Tcc X10 re-
spectively. A duplicated region was defined as a stretch
of 1,000 bp containing at least 5 windows above 2X the
median standard deviation from the baseline. If two or
more stretches were adjacent to each other, these were
merged and counted as one region. This identified 142
and 182 duplicated regions in Tcm and Tcc X10. The
duplicated region was not always restricted to one gene.
On scaffold 1093 (Tcm), the amplified region was 6 kb
and contained four coding sequences, including a nu-
cleoside transporter and a dynein gene (Figure 6). The
same region was also found amplified in Tcc X10 (scaf-
fold 1531; Figure 6). Interestingly, a nucleoside transporter
has been implicated in drug resistance in Trypanosoma
brucei [46]. Housekeeping-genes were also found ampli-
fied, for example, paraflagellar rod protein 3 (MOQ_
003131) from Tcm gave rise to a CNV signal. RT-qPCR
with primers targeting this gene resulted in Ct=13.60,
compared with Ct=15.3 for 8-oxoguanine DNA glyco-
sylase (MOQ_000430), which lacked a CNV signal.
Moreover, the prostaglandin F2 alpha synthase gene
(MOQ_004364) gave rise to a CNV signal, and RT-qPCR
resulted in Ct=12.41. In Tcc X10, one example of CNV is
in the epsilon tubulin gene (TCSYLVIO_007352), for
which RT-qPCR resulted in Ct=9.29. Surface antigens
were frequently found amplified; a mucin-like gene on
scaffold 1070 (Tcm), a surface protease GP63 on scaffold
1108 (Tcm). Scaffold 1109 (Tcm) contains an amplifica-
tion of cystathionine beta-synthase, scaffold 1420 (Tcm)
contains an amplification of NAD(P)-dependent steroid
dehydrogenase, scaffold 143 (Tcm) contains an amplifica-
tion of ferric reductase. There was also evidence of differ-
ential copy number variation, suggesting amplification in
one genome but not the other. One example is the ampli-
fication of a pyruvate phosphate dikinase on scaffold
1101 in Tcm, which does not give rise to a CNV signal in
Tcc X10.
In order to identify chromosomal aneuploidies, we
calculated the baseline coverage for each scaffold. Scaf-
folds with a median <3.2 and median absolute deviation
<0.7 were extracted (empirically determined thresholds).
This identified 7 scaffolds in Tcm with a lower average
coverage: 950, 938, 79, 78, 70, 2392 and 2744. These ge-
nomic regions were homologous with chromosomes 25,
25, 12, 12, 12 and 7 in Tcc CLBR. No scaffolds with low
overall coverage were identified in Tcc X10. This sug-
gested the existence of monosomic chromosomes in Tcm
but not in Tcc X10. As expected, heterozygosity was
absent in these putatively monosomic Tcm regions. How-
ever, the homologous region in Tcc X10 displayed hetero-
zygosity. This further supported the likely monosomic
state of these regions in Tcm. Genomic qPCR with a pri-
mer pair targeting scaffold 78 in Tcm resulted in
Ct=17.81 for the putative monosomic scaffold, whereas
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for putative disomic regions on scaffold 1093 and 1101 Ct
was 15.08 and 15.30. Moreover, we searched for evidence
of higher ploidy levels. Scaffolds with median > 3.5 were
extracted. This identified 14 and 5 scaffolds in Tcm and
Tcc X10 respectively, with an increased overall coverage.
These scaffolds showed homology with large mega-base
chromosomes from Tcc CLBR, suggesting that higher
ploidy levels may bemore common in larger chromosomes.
The presented analysis confirms that copy number var-
iation is a common feature of the Tcm and Tcc X10 gen-
omes. In theory, copy number variation would not be
beneficial for the parasite as it increases the amount of
DNA that needs to be replicated and the energy cost of
the cell. The evolutionary benefit of having such an ex-
cessive amount of genes would seem to be limited. It is
possible that copy variation does not infer any evolution-
ary advantage for the parasite, but is only a consequence
of sloppy or non-perfect DNA replication mechanisms of
these parasites.
Retrotransposons, repetitive elements and low
complexity repeats
Transposons are present in most eukaryotes and contrib-
ute to genome size and plasticity [47]. Trypanosomatid
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Figure 6 Duplicated regions of T. c. marinkellei and T. c. cruzi Sylvio X10 inferred from short reads. Short read coverage on assembly
scaffolds of T. c. marinkellei B7 and T. c. cruzi Sylvio X10. Coverage was counted in 100 bp sliding windows along the scaffolds, with 50 bp step
size. Each dot represents a 100 bp window. The horizontal axis shows the position of the window along the scaffold and the vertical axis shows
the log10-scaled coverage of each window. Coverage was incremented by 1 to avoid infinite values for empty regions. Red lines show the global
median coverage and blue lines show +/− 2X of the median absolute deviation. On scaffold 1093 (Tcm) the amplified region contained a dynein
light chain protein, a nucleoside transporter and two genes of unknown function. On scaffold 1101 the first amplified region was 3 kb and
contained a gene of unknown function, the second region was 3.7 kb and contained a pyruvate phosphate dikinase gene, the third region was
1.2 kb and contained a gene of unknown function. Scaffold 1531 (Tcc X10) contained a 4.7 kb amplification which contained a nucleoside
transporter. Scaffold 1556 (Tcc X10) contained two genes of unknown function. Scaffold 3025 (Tcc X10) contained a 5 kb amplification with a
copper-transporting ATPase gene. Scaffold 78 from Tcm showed evidence of aneuploidy, as the mean coverage was lower than for the other
scaffolds.
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genomes contain several families of dead and presum-
ably active retrotransposons [48]. Tcm and Tcc X10 were
searched for 11 classes of repetitive elements, including
retrotransposons. 6.5% (2,344,982 Mb/34,233,090 Mb)
and 9.9% (3,852,782 Mb/38,598,156 Mb) of the assembled
bases corresponded to repetitive elements in Tcm and
Tcc X10 respectively (Table 5). 8 of 11 repeat categories
were more abundant in Tcc X10, with a total expansion
factor of 1.26 in this genome compared with Tcm (8.2%/
6.5%, Table 5).
The Long Terminal Repeat (LTR)-like retroelement
VIPER [49] belongs to the superfamily tyrosine recom-
binase retrotransposons [50] and was the most abundant
element in Tcm and Tcc X10 respectively, representing
24.5% (574,697 Mb/2,344,982 Mb) and 28.9% (1,116,378
Mb/3,852,782 Mb) of the repetitive elements (Table 5).
The large amount of sequence related to these elements
suggested that large-scale proliferation occurred before
the split of T. c. cruzi and T. c. marinkellei. Furthermore,
phylogenetic reconstruction based on a multiple se-
quence alignment (MSA) indicated some substructure
between Tcc X10 and Tcc CLBR, whereas Tcm in large
formed a more distant clade (Additional file 9: Figure S7).
69% (3,450/4,968) of the MSA sites were too diverged to
be included in the multiple-alignment, suggesting that
these elements have been inactive for a substantial time.
The human infecting lineage does contain a larger
amount of these elements, possibly due to a loss of
VIPER-related sequences in Tcm. In conclusion, repeti-
tive elements explain in part the smaller genome size of
Tcm. 3 repeat categories were on the contrary expanded
in Tcm; the 2 low-abundance repeats NARTc and C6
and the abundant DIRE (degenerate Ingi/L1Tc-related
retroelement) element.
De novo repeat discovery was performed in order to
identify unique sequence repeats, using the program
RepeatScout [51] and RepeatMasker [52]. RepeatScout
identified 2,225 (Tcm) and 2,263 (Tcc X10) repeats of
variable lengths. These repeats were then filtered using
these criteria; i) removal of repeats shorter than 50 bp, ii)
removal of repeats containing more than 50% low com-
plexity sequence, iii) removal of repeats with fewer than
10 genomic copies, iv) removal of known repeats (i.e.
present in Tcc CLBR). This decreased the number of hits
to 20 (Tcm) and 3 (Tcc X10) using the outlined criteria.
Manual examination of the Tcm repeats revealed that 12
corresponded to diverged Tcc CLBR sequences, includ-
ing a spliced leader sequence and sequences related to
MASP and TcMUCII mucin. We searched for these 8
repeats in the genome assemblies of Tcc X10 and Tcc
CLBR as well as in raw reads, which decreased the num-
ber of Tcm-specific repeats to 7. The length of the iden-
tified Tcm-specific repeats varied between 60 to 896 bp,
and BLAST searches resulted in non-significant hits to
sequences of metazoan origin. These repeats were found
exclusively on short contigs (0.5-1 kb), corroborating the
idea that the repetitive components of these genomes
have evolved faster. We estimated the copy number of
the two longest repeats, Tcm-Rep1 (825 bp) and Tcm-
Rep2 (896 bp) from the depth of 454 read coverage
mapped on these sequences. The average 454 read cov-
erage (12x) was then used to estimate copy number. The
average read coverage was 1974 reads/position for Tcm-
Rep1 and 1,494 reads/position for Tcm-Rep2. Hence, the
Table 5 Comparison of repetitive elements
T. c. marinkellei T. c. cruzi Sylvio X10
Element # bp a % Short reads b # bp a % Short reads b SE c
VIPER 574,697 (1.679 %) 1.535 1,116,378 (2.892 %) 1.811 Tcc X10
DIRE 433,619 (1.267 %) 1.156 655,064 (1.697 %) 0.907 Tcm
L1Tc 432,474 (1.263 %) 1.168 805,885 (2.088 %) 2.158 Tcc X10
TcTREZO 382,416 (1.117 %) 1.024 481,685 (1.248 %) 1.081 Tcc X10
E22 223,679 (0.653 %) 0.630 281,491 (0.729 %) 0.590 Tcc X10
SIRE 176,724 (0.516 %) 0.497 238,914 (0.619 %) 0.527 Tcc X10
SZ23 94,765 (0.277 %) 0.224 151,879 (0.393 %) 0.275 Tcc X10
CZAR 18,338 (0.054 %) 0.104 102,810 (0.266 %) 0.203 Tcc X10
NARTc 4,705 (0.014 %) 0.010 10,936 (0.028 %) 0.020 Tcm
C6 2,944 (0.009 %) 0.006 167 (0.000 %) 0.000 Tcm
TCSAT1 621 (0.002 %) 0.149 7,573 (0.020 %) 0.628 Tcc X10
Total 2,344,982 (6.851%) 6.503% 3,852,782 (9.98%) 8.200%
a The sum of masked base pairs in the assembly. The number inside parenthesis refers to the percentage of assembled bases.
b The percentage of short reads that was mapped on these features.
c SE=Significantly Enriched. Refers to if one genome contained significantly more of this gene family. The significance was determined from an empirical
distribution of read depth differences from homologous regions of Tcm and Tcc X10, corrected for genome size. The empirical distribution was used to calculate a
p-value.
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estimated copy number became 164 and 124 for Tcm-
Rep1 and Tcm-Rep2 respectively. Taken together, these
two repetitive elements contribute ~250 kb of sequences
to the Tcm genome and also represent a large set of pu-
tative Tcm-specific sequences. Since the repeats were not
found in Tcc X10 and Tcc CLBR, it is possible that a loss
has occurred in the lineage leading to the human infect-
ive T. c. cruzi.
T. c. marinkellei invades non-bat epithelial cells in small
numbers and divides intracellularly
Experimental infections were performed on three mam-
malian cell lines to further understand the potential of
Tcm to invade non-bat derived cells. The following lines
of epithelial cells were used; Vero cells (kidney cells from
African green monkey), OK cells (from a North Ameri-
can opossum) and Tb1-lu cells (bat lung). Tcm metacyc-
lic trypomastigotes were incubated overnight with cells
from each cell line (Materials and Methods). Extra- and
intracellular parasites were immunolabelled using Tcm
and Tcc positive sera and anti-whole cell body antibody
(Figure 7). In parallel, intracellular parasites were stained
with Giemsa dye. Both experiments independently
showed that Tcm is capable of invading each of the three
cell lines. Tcm did not show a particular preference for
the bat cell line.
We also investigated the ability of Tcm to replicate
intracellularly using the same cell lines. The human in-
fective Tcc was included as a positive control. Infected
cells were incubated over a 5 day time course, the devel-
opment of intracellular amastigotes during this period
indicated that Tcm is capable of intracellular prolifera-
tion (Figure 7). Amastigogenesis and amastigote prolif-
eration of Tcm following metacyclic invasion appeared
to be analogous to Tcc controls. These data suggested
that Tcm is capable of infecting other cells than strictly
those from bats, and hence, that the infection is not
blocked by species-specific host cell tropism mediated at
the level parasite entry. In conclusion, the infection bar-
rier must therefore arise in a different context, though
whether this relates to different aspects of Tcm specific
biology or as physiological or immunological differences
between hosts, or as a combination of both, remains to
be elucidated.
Conclusions
This study is the first genome analysis of a non-human
associated member of Schizotrypanum. Our aim was to
identify genome sequence differences that may relate to
host specificity or other phenotypical differences, as well
as to further understand the evolution of these parasite
lineages. We found a slightly smaller genome of T. c.
marinkellei compared with the human infective strains,
although it remains an open question if this is a general
tendency among bat-associated trypanosomes. T. c.
marinkellei and T. c. cruzi shared the same set of core
genes, i.e. there were no missing coding sequences in
terms of housekeeping genes. On the contrary, several
gene families were expanded in T. c. cruzi Sylvio X10,
contributing to the larger genome size. This suggested
that T. c. cruzi Sylvio X10 have a more versatile toolbox
of surface antigens, which may reflect an adaptation to
its host. Interestingly, one subspecies specific acetyl-
transferase gene was identified in T. c. marinkellei, con-
taining detectable homology with genes from
photosynthesizing organisms. It appears likely that this
gene was acquired after the split of T. c. cruzi and T. c.
marinkellei, since the gene was missing from T. c. cruzi
strains Sylvio X10 and CL Brener. The gene represents a
rare example of gene transfer between distantly related
eukaryotes and may provide additional functionality to
T. c. marinkellei. Future efforts will be required to
understand its function. Considering the divergence time
between T. c. marinkellei and T. c. cruzi (~6.5-8.5 MYA
[10-12]), remarkably few absolute gene differences were
present. This suggests that the core gene content of T.
cruzi lineages is relatively stable, whereas the repetitive
component is allowed to undergo more rapid changes.
The low number of subspecies specific genes suggests
that phenotypic variation, like host specificity, might be en-
codedbymorediscretevariation,e.g.vianon-synonymousnu-
cleotide variants leading to specific protein isoforms. The
difficulty to explain how the genome encodes phenotypes
like host-specificity is further illustrated by our finding that
T. c. marinkellei invades non-bat cells, which indicates that
the machinery to invade host cells is functionally conserved.
The two subspecies T. c. marinkellei and T. c. cruzi were on
average ~7.5% diverged in coding sequences with respect to
single nucleotide differences. The large number of small
nucleotide differences may have implications on phenotypic
variation via the formation of new alleles. The present study
has provided many new candidate genes, including putative
antigens that can provide starting points for functional in-
vestigation of phenotypic variation of these parasite
lineages.
Extensive copy number variation of various genes was
identified. Copy number variation has been suggested
as means for the parasite to increase gene expression
in the absence of transcriptional regulation. These find-
ings are not surprising and are corroborated by the long-
standing knowledge of genomic variability in T. c. cruzi
[24,33,41-43]. It is possible that phenotypes may be
encoded at the transcriptional level. Interestingly, the
T. c. marinkellei and T. c. cruzi genomes also contained
variation in the amounts of non-coding repeats, related
to retroelements and other previously uncharacterized
repeats. As these differences were substantial, it remains
plausible that whole chromosomes or chromosomal
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chunks have been lost in T. c. marinkellei. None of the
larger chromosomes were missing, suggesting that smal-
ler chromosomes harboring surface antigens or other
repeats have been lost. The plasticity of the T. cruzi
karyotype is further demonstrated by the fact that certain
chromosomes appear to be monosomic in one subspecies
but not in the other. The existence of such monosomic
chromosomes reduces allelic redundancy and might have
implications on transcript abundance. Karyotype varia-
bility therefore stands as another possible source of
phenotypic variation. Finally, the amount of intraspecific
genetic variation identified in this study is likely to
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Figure 7 Cell invasion assay. (A) Intracellular T. c. marinkellei parasites stained with Giemsa. Scale bars correspond to: 10 μm (field) and 5 μm
(enlarged). (B) Immunolabelled intracellular and extracellular T. c. marinkellei parasites. Intracellular parasites were labelled with anti-WCB antibody
(green), while extracellular parasites were labelled with anti-WCB antibody (green) and anti-T. c. marinkellei serum (red), which superimposed gives
the yellow color. Nuclei and kinetoplasts were counter stained in DAPI (blue). (C) Number of intracellular T. c. marinkellei parasites in the Giemsa
assay. (D) Number of intracellular T. c. marinkellei parasites in the immunolabeling assay. (E) Intracellular T. c. cruzi and T. c. marinkellei parasites in
three different cell types. T. c. cruzi and T. c. marinkellei parasites were incubated for 5 days with Vero (monkey), OK (opossum) and Tb1-Lu cells
before Giemsa staining. Two hundred cells were assayed in 3 independent experiments for Giemsa and immunolabeling assays. The scale bars
correspond to 5 μm.
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represent only the tip of the iceberg in terms of the ac-
tual genetic variation present in natural reservoirs.
Taken together, the presented draft genomes raise fur-
ther questions about genome evolution and diversity in
this group of protozoa, and the putative functional
implications of this variation. Further exploration of the
genetic diversity within Schizotrypanum should therefore
be a future priority as this may help to resolve complex
relationships between parasites, vectors and hosts. The
decreasing cost and time for whole genome sequencing
should therefore pave the way for further large-scale ef-
forts to understand the underlying genetic basis of these
parasites.
Methods
Accession numbers
Sequence data and annotations have been deposited in NCBI
GenBank under the accession numbers AHKC01000000
(T. c. marinkellei B7) and ADWP02000000 (T. c. cruzi
Sylvio X10). The data can also be downloaded from
http://www.ki.se/chagasepinet/genomes.html.
Cell culture, library preparation and sequencing
T. c. marinkellei B7 clone 11 and T. c. cruzi Sylvio X10
clone 1 were cultured using standard conditions (supple-
mented RPMI + 10% FBS). Parasite DNA was extracted
using the Puregene kit. Genome size estimation of T. c.
marinkellei was performed using flow cytometry as
described by Lewis et al. [24]. Illumina sequencing: The
Tcm and Tcc X10 mate pair libraries were prepared
according to Van Nieuwerburgh et al. [22]. Initially, the
paired-end protocol for 3 kb libraries from Roche/454
was used until circularized. After circularization, the li-
braries were prepared following the Illumina mate-pair
protocol: 5 μg of genomic DNA was sheared to approxi-
mately 3 kb and end-polished. Fragments were then li-
gated to the Roche/454 circularization adapters and size
selected using AMPure beads (Beckman Coulter). The
ligated DNA was circularized using Cre-recombinase
and then exonuclease treated. All enzymes were ob-
tained from New England Biolabs. The circular DNA
was fragmented using Covaris S2, end-repaired and puri-
fied using streptavidin coated magnetic beads. The DNA
was then A-tailed and ligated with sequencing adapters
and PCR amplified. The post-circularization steps were
performed using the reagents either supplied or refer-
enced by the Illumina mate-pair protocol. The clustering
was performed on a cBot cluster generation system using
a HiSeq paired-end read cluster generation kit. The sam-
ples were sequenced on an Illumina HiSeq2000 as
2x100-nt reads (one lane for each genome). Base conver-
sion was done using Illumina OLB v1.9. 454 sequencing:
Prepared according to the manufacturer’s instructions
and sequenced on a 454 instrument with Titanium
chemistry.
Sequence assembly
Illumina reads were quality filtered and trimmed using
the fastq_quality_filter program of the fastx toolkit (para-
meters: -q 20 -p 95). Illumina reads were assembled with
Velvet v1.1.04 [53], using the empirically determined
kmer length of 43 and a minimum contig length of 500
bp. velveth and velvetg were called with the following
commands, respectively: ‘<name> 43 -fastq -shortPaired1
input.fastq’ and ‘<name> −min_contig_lgth 500 -exp_cov
auto -ins_length 2000 -ins_length_sd 2000 -amos_file no
-scaffolding no -unused_reads yes’. Unused reads were
extracted and subjected to a second round of Velvet as-
sembly using a kmer length of 53 (empirically deter-
mined) and a minimum contig length of 400 bp (velvetg:
‘-min_contig_lgth 400 -exp_cov auto -ins_length 10 -ins_
length_sd 5000 -scaffolding no’). 454 reads were
assembled with CELERA v6.1 [54] (default settings). 454-
related insertion-deletion errors in the assembly were
corrected using the Illumina reads: Illumina reads were
aligned with bwa [55], and the resulting SAM file was
then scanned in order to identify indels. In order to cor-
rect a position, at least 10 Illumina reads were required
to support the change. The three assemblies (i. Illumina
Velvet 1; ii. Illumina Velvet 2; iii. 454 CELERA) were
pooled and merged into a non-redundant assembly. As-
sembly merging was performed using the Zorro pipeline
[56], relying on minimus2 and mummer to split and
merge contigs. The merged assembly was filtered to in-
clude only contigs longer than 500 bp. Maxicircle (mito-
chondrial) sequences were identified using megablast
and removed. Minicircle (mitochondrial) sequences were
identified and removed by searching for the TCKIN2 sig-
nature sequence. Distance information from mate-pairs
were used to order and orient contigs into scaffolds. The
software SSPACE was used for scaffolding [57]. A small
number of intra-scaffold gaps (~200/genome) could be
closed using the overlap between adjacent contigs. The
final assembly was subjected to gap closure using the
IMAGE pipeline [23].
Bioinformatics analyses
Annotation: Gene models were transferred from Tcc
CLBR using Perl scripts, and additional genes were
called using GeneMarkS [58]. Annotations were manu-
ally curated using the Artemis Comparison Tool [38].
Orthologous genes were identified using the best recip-
rocal BLASTp hit (E-value 1e-10). Unique genes were
identified using BLASTp and tBLASTn searches. Genes
in synteny were determined using homology of sur-
rounding genes. At least one adjacent homologous gene
was required to be present in order to call a gene
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syntenic. dN and dS values [59] were calculated using
the yn00 program of the PAML package [60]. Rearrange-
ments: Chromosomal re-arrangements were identified
from alignments generated using promer [44]. Repeats:
Sequence repeats were identified with RepeatMasker
[52], Repbase [61] and Tandem Repeat Finder [62].
Phylogenetic analysis of the candidate horizontal gene
transfer: A dataset was extracted with Blast Explorer
[63] (E-value <1e-40). Multiple sequence alignment was
done with ClustalW v2.1 [64] and filtered with Gblocks
[65] to remove ambiguous positions. Alignments were
manually inspected in Jalview [66]. A maximum likeli-
hood tree was generated with RAxML v7.0.4 [67], using
the PROTGAMMAJTT model and 100 bootstrap repli-
cates. Multicopy genes: Genome sequence reads (Illu-
mina) were mapped back to the assembly using bwa
(default settings) [55] and the coverage was calculated.
Sequence entropy was calculated using bio3d [68]. Copy
number variation: Genome sequence reads (Illumina)
were mapped back to the assembly and the reference se-
quence was divided into 100 bp windows with 50 bp
overlap. The sum of coverage for each position in the
window was computed, log10-scaled and plotted. Hetero-
zygosity: Reads were aligned with the assembly and sam-
tools [69] and awk were used to extract polymorphic
positions. Maxicircle analysis: Manual annotation of
maxicircle coding regions was performed by comparison
to the published CLBR (GenBank: DQ343645), Esmer-
aldo (GenBank: DQ343646) and Sylvio X10/1 (GenBank:
FJ203996) maxicircle coding sequences. Sequence iden-
tity was calculated using BioEdit v7.0.9.0 [70]. Hetero-
plasmy was called with samtools mpileup [69]. A SNP
was defined as a nucleotide variant present in at least 5
independent reads (with parameters: 20X coverage and
mapping quality, 30). All scripts are available from the
authors on request.
Normal PCR and quantitative real-time PCR
Normal PCRs: Primers were selected with Primer3 [71]
and synthesized by Sigma-aldrich. Amplification was
performed using the Phire Hot Start II DNA polymerase
kit (Finnzymes). The targets were amplified in a mixture
containing 1X Phire Reaction Buffer, 0.2 mM of dNTPs
(Fermentas), 0.4 μM of each primer, 2% DMSO, 50 ng of
genomic DNA, 0.4 μl of Phire Hot Start II DNA poly-
merase and water to a final volume of 20 μl. The cycling
conditions were as follows: Initial denaturation at 98°C
for 2 minutes, 35 cycles of 98°C for 10 seconds, 60–68°C
for 10 seconds and 72°C for 10 seconds and a final exten-
sion step at 72°C for 2 minutes. The Tc_CLB1 amplicon
of 3 kb size uses a 45 seconds extension step, in compari-
son with the other amplicons that uses just 10 seconds.
Amplicons were visualized using a 1.3% agarose gel
stained with ethidium bromide. Quantitative Real-
time PCR (RT-qPCR) on the specific acetyltransferase
gene in Tcm: RNA extraction was performed using the
RNeasy Mini kit (Qiagen). RNA was converted to cDNA
with reverse transcriptase and random hexamer primers.
Reactions were performed using Power SYBR Green
MasterMix (Life Technologies) under standard condi-
tions. Template concentration was 50 ng/μl and 1 μl of
template was used in each reaction. Primer concentration
was 0.2 μM in 20 μl of final volume. Each experiment
was performed in triplicate and the average cycle thresh-
old (Ct) value was used as a measurement of initial tem-
plate abundance. All reactions were performed on an
ABI 7300 Real-time PCR system. The following primer
pairs were selected for the experiment (50 to 30); unique
gene: TTGCAGCATATGTGTGGATG (F), ACGTT
AAAGAAACGGCTGCT (R), hypoxanthine-guanine
phosphoribosyltransferase: GCCTTCATGTCAACCCTCTT
(F), AAGACGTGACACCTTCACCA (R), 18S rRNA:
TTACGTCCCTGCCATTTGTA (F), TTCGGTCAAGT
GAAGCACTC (R). RT-qPCR to validate copy number
variation: Experimental conditions were similar as for the
previous experiment, except that genomic DNA was used
(20 ng/μl, 1 μl loaded).
Cell invasion assay
Vero cells were maintained in DMEM + glutaMAX
(Gibco, Invitrogen, UK) supplemented with 10% fetal
calf serum (PAA laboratories, UK), 5mM l-glutamine, 50
μg/ml streptomycin and 50 units/ml penicillin. Tb1 lu
cells (HPACC, UK) were maintained in MEM (ATCC,
UK) and supplemented as described above. OK cells
(HPACC, UK) were maintained in MEM (Sigma-Aldrich,
UK) with 10% fetal calf serum, 5 mM l-glutamine, 50
μg/ml streptomycin and 50 units/ml penicillin and 5%
non-essential amino acids. T. c. marinkellei epimasti-
gotes from lineage B7 cl11 were grown in Liver Infusion
Tryptose (LIT) and T. c. cruzi strain M6241 was grown
in RPMI for 2 weeks prior to experiments. Each cell line
was seeded at a density of 105 per ml onto 13 mm diam-
eter coverslips and allowed to grow overnight. Cells were
then washed and the growth media replaced with media
containing 105 metacyclic T. c. marinkellei and incu-
bated at 37°C for either overnight or 5 days. The media
was removed and cells were washed twice with PBS and
either fixed with 4% paraformaldehyde for 20 min or ice
cold methanol. Methanol fixed cells were stained with
Giemsa for 10 min and imaged with a Zeiss Axioplan 2
microscope and a Zeiss AxioCam Hrc camera. Parafor-
maldehyde fixed cells were blocked in 10% goat serum
and labelled with T. c. marinkellei positive serum for 1 h
before incubating with AffiniPure Fab fragments (Stra-
tech Scientific Ltd., UK) for 10 min, these epitopes were
then recognised by anti-rabbit Alexa Fluor 568. The cells
were blocked again in 10% goat serum and permeabilised
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in 1% NP40 for 3 min before labelling with anti-whole
cell body (WCB) antibody [72] (kindly provided by Prof.
K. Gull) for 1 h recognised by anti-mouse Alexa Fluor
488 and finally DAPI stained before mounting in Fluoro-
mount (Sigma-Aldrich, UK). Antibody labelled cells were
visualised by a Zeiss Axioplan 2 microscope and Zeiss
AxioCam MRm camera all image processing was done
with Axiovision 4.7 software. Two hundred cells were
assayed in the overnight experiments and the results are
expressed as an average of three independent experiments.
Additional file
Additional file 1: Figure S1. Flow cytometry analysis of the T. c.
marinkellei genome size. Description: Fluorescence emission histograms
for propidium iodide-labelled epimastigotes showing relative DNA
contents of T. c. cruzi Esm/3 (TcII), T. c. cruzi Sylvio X10/4 (TcI) and
T. c. marinkellei B7/11.
Additional file 2: Figure S2. Histogram and smoothed density estimate
of assembly-wide coverage differences between Tcm and Tcc X10.
Description: (A) Histogram of percentage short read coverage differences
from homologous regions. Percentages have been corrected for genome
size. Vertical red lines indicate the lower and upper 2.5% quantiles.
(B) Smoothed kernel density estimate of the left histogram created using
logspline R package.
Additional file 3: Figure S3. Sequence variation of the TcMUCII mucin
gene family. Description: Entropy plots of the TcMUCII mucin gene
family. TcMUCII mucin genes were extracted from Tcm, Tcc X10 and Tcc
CLBR non-Esm. Sequences were aligned with ClustalW v2.1. Sequence
entropy was calculated using the entropy function of the R package
bio3d. Only alignment positions with less than 10% gaps were included
in the analysis. The normalized entropy score was then plotted as a
function of alignment position, where conserved sites (low entropy)
score 1 and diverse (high entropy) sites score 0. The analysis indicated
that 50 and 30 termini of TcMUCII mucin genes generally are the most
conserved in all three genomes and that the central region is the most
variable.
Additional file 4: Table S1. Maxicircle gene coordinates and metrics.
Description: Gene metrics for T. c. cruzi and T. c. marinkellei maxicircles.
Including coordinates, average identity and length.
Additional file 5: Figure S4. Maxicircle phylogenetic tree. Description:
Maximum likelihood phylogenetic tree of the maxicircle sequences from
T. c. marinkellei, T. c. cruzi Sylvio X10, T. c. cruzi CL Brener, T. c. cruzi
Esmeraldo using T. brucei and L. tarentolae as outgroups. The full
maxicircle sequences were aligned with ClustalW v2.1 and the
subsequent alignment was filtered using Gblocks (default settings). The
tree was inferred using MEGA v5.1 from 13,731 (49%) alignment
positions.
Additional file 6: Table S2. Ratio of non-synonymous and synonymous
nucleotide substitutions. Description: Orthologous gene pairs between
T. c. marinkellei and T. c. cruzi CL Brener displaying elevated dN/dS (> 1.1).
The yn00 program was used to calculate dN and dS.
Additional file 7: Figure S5. Disruption of sequence co-linearity.
Description: Disruption of chromosomal co-linearity between T. c.
marinkellei and T. c. cruzi CL Brener non-Esmeraldo-like (A) as well as
between T. c. cruzi Sylvio X10 and T. c. cruzi CL Brener non-Esmeraldo-like
(B). Black chromosomes prefixed with ‘Chr’ represent sequences from Tc
CL Brener whereas white chromosomes prefixed ‘contig’ represent
sequences from Tcm and Tcc X10 assemblies. Alignments were generated
using the promer software (Kurtz et al., 2004). Chromosomal stretches
marked with green color represent gaps in the assembly. Only gaps
larger than 5 kb are shown. The most outer numbers are sequence
identifiers.
Additional file 8: Figure S6. PCR validation of synteny breaks.
Description: PCR validation results from a few regions containing synteny
breaks in T. c. marinkellei and T. c. cruzi Sylvio X10.
Additional file 9 Figure S7. Phylogenetic tree of VIPER elements.
Description: Maximum likelihood phylogenetic tree of VIPER
retroelements from T. c. marinkellei, T. c. cruzi CLBR, T. c. cruzi X10. The
colors correspond to; blue (Tcm), green (Tcc CLBR), red (Tcc X10). VIPER
elements were identified with RepeatMasker and only elements longer
than 2000 bp were included: 209 sequences in total (35 from Tcm, 57
from Tcc X10 and 117 from Tcc CLBR). The average branch lengths were;
0.0682 (Tcm), 0.039 (Tcc X10), 0.0455 (Tcc CLBR). The alignment was
constructed with ClustalW and manually inspected. Gblocks was used to
remove ambiguities from the alignment, which resulted in a total of 1518
positions that were used for inferring the phylogeny. The maximum
likelihood tree was inferred with RAxML using the GTRCAT model and
100 bootstrap replicates.
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Oral outbreaks of Chagas disease are increasingly 
reported in Latin America. The transitory presence of Try-
panosoma cruzi parasites within contaminated foods, and 
the rapid consumption of those foods, precludes precise 
identification of outbreak origin. We report source attribu-
tion for 2 peri-urban oral outbreaks of Chagas disease in 
Venezuela via high resolution microsatellite typing. 
Rapid urbanization presents new challenges for Chagas disease control in Latin America. Foci of disease are 
now reported in slums surrounding several Andean cities 
(1–3). Oral transmission is believed responsible for recent 
outbreaks of Chagas disease, most of which were charac-
terized by atypically severe symptoms (4,5). Many cases 
have occurred in urban settings (5,6), amplifying the size 
and effect of the outbreaks.
Sources of orally transmitted disease outbreaks 
vary, but contaminated food and juices are often blamed. 
However, after a contaminated food is eaten, it may take 
weeks for the onset of clinical signs and symptoms, and 
direct molecular and cytological incrimination of a par-
ticular batch of food/beverage has not been possible (5). 
Thus, evidence pointing to particular foodstuffs is often 
circumstantial.
Molecular epidemiologic analyses of human and en-
vironmental isolates are routinely used to track the source 
of outbreaks caused by foodborne pathogens. High-
resolution molecular markers have been developed and 
validated for Trypanosoma cruzi, the parasite that causes 
Chagas disease (7,8). These markers, used in conjunction 
with careful sampling, can identify the source of food-
borne outbreaks.
The Study
We studied 2 outbreaks of orally transmitted Chagas 
disease (120 cases, 5 deaths). The first occurred in Chich-
iriviche, Vargas State, a coastal community (population 
≈800 persons) ≈50 km northwest of Caracas, Venezuela. 
The outbreak occurred at a primary school where food was 
prepared on site. In early April 2009, a total of 71 children 
(6–13 years of age) who attended the morning school shift 
and 14 adults became ill. Exposure of these persons to T. 
cruzi was established by use of IgM and IgG ELISA. Para-
sitemia was observed in 33 of the patients with serologic 
results positive for T. cruzi infection (9,10). 
The second outbreak occurred in Antimano, a peri-
urban slum southwest of central Caracas (online Technical 
Appendix Figure 1, wwwnc.cdc.gov/EID/article/19/7/12-
1576-Techapp1.pdf ). In May 2010, 35 patients with sus-
pected T. cruzi infection were examined at Hospital Miguel 
Perez Carreno in Caracas. Patients reported that they regu-
larly ate at the same local communal canteen. Among the 
patients tested, 15 were positive for T. cruzi IgM and IgG 
(9). Parasitemia in 14 patients was confirmed indirectly by 
hemoculture. Of the 35 patients, 21 (2 adults, 19 children) 
were hospitalized. 
To enable outbreak source attribution, we undertook 
intensive additional sampling of contemporary, nonhuman 
sources local to each outbreak and of human and nonhu-
man sources from more distant localities throughout Ven-
ezuela. In total, 246 T. cruzi strains and clones were typed 
for 23 microsatellite markers (online Technical Appendix 
1 Table) (8). A list of the samples and their sites of origin 
is in online Technical Appendix 2 (wwwnc.cdc.gov/EID/
article/19/7/12-1576-Techapp1.xlsx).
Individual level sample clustering was defined first by 
constructing a neighbor joining tree based on pairwise dis-
tances between multilocus genotypes (Figure 1). A second 
analysis used K-means clustering and discriminant analysis 
of principal components (Figure 2) (11). To assess con-
nectivity between human and nonhuman outbreak cases, 
pairwise genetic differentiation (FST) was calculated (Table 
1). Population-level genetic diversity was assessed first by 
calculating allelic richness then private allele frequency 
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over loci between each human–nonhuman population pair 
(Table 2). Geographic sampling distribution is shown in 
online Technical Appendix 1 Figure 2.
Clustering results determined by discriminant analysis 
of principal components and neighbor joining were broadly 
congruent. In the former, 19 clusters were defined; sample 
allocations are included in online Technical Appendix 2. 
Substantial overlap existed between some clusters, espe-
cially those from Capital and Vargas States (e.g., those la-
beled “x” in Figure 2), while others were highly distinct 
(e.g., cluster 8 in Figure 2). Human isolates from both oral 
outbreaks are extremely distinct from non-orally transmit-
ted isolates collected from humans throughout Venezuela. 
Almost all these presumably vector-transmitted strains are 
closely related to one another, despite their geographic dis-
persal (cluster 8 in Figure 2). By comparison, oral outbreak 
strains that were isolated a mere 50 km apart (clusters 2, 5, 
7, 9, 15–17) are far more globally diverse. Unlike most hu-
man isolates in Venezuela, which are distinct from nonhu-
man strains, oral outbreak isolates are interspersed among 
nonhuman strains from Venezuela. Furthermore, samples 
from both outbreaks clustered among nonhuman strains lo-
cal to that outbreak, clearly indicating a local origin. Oral 
samples from each outbreak are polyphyletic with respect 
to strains from their immediate environment, a finding con-
sistent with multiple contamination events or multiclonal 
infection sources.
FST values further support connectivity between out-
break and local environmental samples in both Antimano 
and Chichiriviche (Table 1). A lack of private alleles be-
tween human and nonhuman isolates also supports a local 
source for the Chichiriviche outbreak (Table 2). FST val-
ues in the 4-way comparison between outbreak and local 
environmental strains are, however, somewhat equivocal 
with respect to the entire dataset (Table 1). Cluster analysis 
showed that the human and nonhuman strains from Chich-
iriviche interspersed with strains from other states in Ven-
ezuela (Figure 2). Thus, we cannot confirm a uniquely local 
origin for the Chichiriviche outbreak, despite a low value 
for FST, and it is possible that some contaminating strains 
originated elsewhere.
Conclusions
This study demonstrates the value of rigorous mo-
lecular epidemiologic analysis of orally transmitted T. 
cruzi outbreaks, including the importance of appropriate 
sampling to identify the origin of the infecting strains. The 
foodstuff that propagated the peri-urban outbreak in Anti-
mano was certainly contaminated locally. An active nonhu-
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Figure 1. Unrooted neighbor joining tree showing genetic 
clustering among Trypanosoma cruzi isolates from 2 outbreaks 
of oral disease in northern Venezuela. Based on pairwise genetic 
distances (1 - proportion of shared alleles) between multilocus 
microsatellite profiles (23 loci) generated from 246 isolates and 
clones. Black circles indicate nodes with >60% bootstrap support. 
Branch color key is shown. Dashed boxes indicate isolates 
associated with the outbreaks.
 
Table 1. FST values in a 4-way comparison for differentiation between Trypanosoma cruzi isolates derived from humans and the local 
environment during an outbreak of orally transmitted Chagas disease in 2 areas of Venezuela* 
Isolate, location 
Human isolates from 
 
Nonhuman isolates from 
Antimano Chichiriviche Antimano Chichiriviche 
Human      
 Antimano  0.000  0.000 0.000 
 Chichiriviche 0.201   0.000 0.004 
Nonhuman      
 Antimano 0.093 0.170   0.000 
 Chichiriviche 0.088 0.053  0.079  
*Lower left shows linearized FST (genetic differentiation) values; upper right shows associated p values. 
 
man transmission cycle in the slums of Caracas, maintained 
by Rattus rattus rodents and Panstrongylus geniculatus tri-
atomines, is the likely source. The Chichiriviche outbreak, 
however, has potential sources both in and outside the im-
mediate area. As found in Chagas disease outbreaks linked 
to açaí palm fruit in Brazil (12), the T. cruzi parasite can 
survive for several days in some foodstuffs (13). Also, tri-
atomines can survive for months in harvested crops; thus, 
multiple hygiene interventions are potentially necessary 
along the food production line (14). Nonetheless, if the 
foodstuff implicated was prepared locally, local contami-
nation represents the most likely source of the outbreak. 
Study of additional nonhuman strains from Chichiriviche 
is necessary to support this assertion.
Crucial to understanding parasite transmission in gen-
eral, we believe, are genetic differences between strains 
from orally and non-orally transmitted human cases. All TcI 
strains appear to be infective to humans and adapted to long-
term carriage (8). However, the presence of a common, re-
duced-diversity TcI genotype cluster (TcIDOM) among a high 
proportion of human Chagas disease cases in South Ameri-
ca is also well established (7,8). We originally hypothesized 
that TcIDOM was maintained, despite the presence of sym-
patric and infective sylvatic strains, because of low para-
site transmission efficiency by invasive sylvatic vectors (8). 
Oral transmission is likely to be much more efficient. Thus, 
unlike TcIDOM strains, those from orally transmitted T. cruzi 
cases demonstrated high genetic diversity and clearly origi-
nated from local nonhuman T. cruzi populations. However, 
it is also true that all TcIDOM strains we isolated originated 
from patients with chronic infection, and all orally transmit-
ted cases were in the acute phase. We cannot, therefore, rule 
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Table 2. Sample size corrected diversity between Trypanosoma cruzi isolates derived from humans and the local environment during 
an outbreak of orally transmitted Chagas disease in 2 areas of Venezuela* 
Isolate, location No. isolates/no. genotypes 
Sample size corrected allelic 
richness ± SE 
Mean no. private 
alleles/locus ± SE 
Human    
 Antimano 30/26 2.735 ± 0.291 0.32 ± 0.113 
 Chichiriviche 12/9 3.459 ± 0.412 0 
Nonhuman    
 Antimano 107/91 2.946 ± 0.320 0.86 ± 0.203 
 Chichiriviche 13/13 3.443 ± 0.409 0 
 
 
Figure 2. Discriminant analysis of principal components showing genetic clustering among Trypanosoma cruzi isolates from 2 outbreaks 
of oral disease in northern Venezuela. Six principal components were retained, explaining 80% of the diversity. Ellipses correspond to the 
optimal (as defined by the Bayesian information criterion minimum) number of population clusters among the genotypes analyzed. Images 
indicate sample host origin (human, rodent, marsupial, or triatomine), while colors correspond to the key in Figure 1. A full list of samples 
and population assignments (numbered boxes) is included in online Technical Appendix 2 (wwwnc.cdc.gov/EID/article/19/7/12-1576-
Techapp1.xlsx). Dashed box indicates the isolates associated with the outbreaks.
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out a role for immune selection in driving the frequency of 
TcIDOM infections among humans; such selection represents 
an intriguing topic for future enquiry.
Molecular tools and reference datasets are now avail-
able to determine the source of acute Chagas disease out-
breaks within days of their occurrence. The plummeting 
cost of such analyses means it is time to apply population 
genetic techniques and markers developed for trypano-
somes as genuine epidemiologic tools.
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Abstract  28"
We report an imported case of chronic chagasic cardiomyopathy reactivation in the USA, caused 29"
by the TcIDOM subpopulation of Trypanosoma cruzi. Our results dispel the misconception that 30"
infection with TcI is benign, and reemphasize the need for increased surveillance, both in 31"
endemic areas and in the USA. 32"
 33"
 34"
 35"
 36"
 37"
 38"
 39"
 40"
 41"
Chagas disease, caused by Trypanosoma cruzi, is the most important parasitic disease in 42"
Latin America, where it affects millions [1]. Moreover, it constitutes an emerging global public 43"
health problem, since thousands of T. cruzi- infected Latin Americans migrated during the last 44"
few decades and now live in North America, Europe, Australia, Japan and other regions [2]. 45"
A spectrum of clinical manifestations may result from human infection with T. cruzi, ranging 46"
from a total absence of symptoms to extremely debilitating and often deadly cardiac or digestive 47"
syndromes [3], and T. cruzi’s genetic diversity is suspected to play a key role in the clinical 48"
outcome. Six major genetic lineages or discrete typing units (DTUs) are currently recognized 49"
(named TcI through TcVI), each displaying different biological characteristics [4]. Although no 50"
proven associations between T. cruzi genetic lineages and the clinical presentations of the disease 51"
exist at present, DTUs TcII, V and VI have been frequently reported to be present in serious 52"
chronic manifestations in the Southern Cone of South America [4], while TcI has been suggested 53"
to be benign, where the observed chronic chagasic cardiomyopathy (CCC) in TcI-infected 54"
patients is instead  attributable to coinfection with other T. cruzi DTUs [5-8]. TcI exhibits high 55"
intra-lineage diversity, with specific populations (termed TcIDOM) associated with human 56"
infection [9], although no direct link with clinical manifestations has been established. 57"
The patient 58"
A 43 year old chagasic male from El Salvador was admitted to Massachusetts General Hospital 59"
to undergo orthotropic heart transplantation. Immunofluorescence assay performed at the Centers 60"
for Disease Control & Prevention (CDC, Atlanta, USA) was positive at >1:256 (cut off =1:32). 61"
His cardiac symptoms corresponded to New York Heart Association class IV and he had a 62"
biventricular pacemaker/defibrillator for complete heart block.  Orthotropic heart transplantation 63"
was successful. Pathologic examination of the explanted heart revealed findings consistent with 64"
end-stage CCC, including dilatation with near complete atrophy of the left ventricular wall, 65"
endocardial fibrosis, diffuse myocardial fibrosis, and mononuclear infiltrates with some 66"
eosinophils and neutrophils. The infiltrate (lymphocytic myocarditis) was composed of 67"
lymphocytes (many CD3 T cells, more CD8 than CD4, few CD20 B cells) plus many CD68 68"
macrophages. Amastigotes were not identified on multiple sections examined; however, T. cruzi 69"
kinetoplast DNA was detected by PCR in frozen tissue submitted to the Parasitic Diseases and 70"
Diagnostics Branch of the CDC. Weekly microscopic examination of his blood was performed 71"
after transplant, screening for early detection of reactivation disease; this was positive with rare 72"
trypomastigotes detected at week six after transplant. He was given nifurtimox for 10 weeks, and 73"
developed severe peripheral neuropathy with anorexia. He was switched to benznidazole for 30 74"
days, which he tolerated well. He was monitored monthly for parasitemia for approximately one 75"
year after the end of therapy, with no evidence of further infection. 76"
The study 77"
Work was approved by MGH´s Internal Review Board. Genotyping directly from 78"
patient’s blood samples and parafinized heart explants using a nested PCR-RFLP for the 1f8 79"
flagellar protein and digestion with Alw 21I restriction enzyme (Van der Auwera, unpublished) 80"
assigned parasites to DTU TcI (Technical Annex 1). Hemoculture six and eight weeks after 81"
transplant yielded epimastigotes, which were cloned in solid medium.  Cultured parasites and 82"
clones were determined to belong to DTU TcI by polymerase chain reaction and restriction 83"
fragment length polymorphism (PCR-RFLP) as in [10] ( Technical Annex 2). Intra-TcI 84"
genotyping was performed with nuclear microsatellites [11] and maxicircle multilocus sequence 85"
typing [12]. Intriguingly, microsatellite data indicate a close relationship with TcIDOM, a distinct 86"
genotype within DTU TcI which is common among human cases in Latin America (Figure 2A), 87"
while the maxicircle sequence analysis indicates an origin among wild / non-human isolates for 88"
North and Central America (Figure 2B).  89"
Finally, although patient´s serum reacted against T. cruzi antigen in three different 90"
commercial serological tests (Chagatek-Biomerieux, Chagas III-Abbott BiosChile and Chagatest 91"
Recombinante 3.0-Wiener Lab), it did not recognize synthetic peptides derived from the TSSA 92"
antigen specific for DTUs TcII, IV or V/VI described in [13]. 93"
Conclusions 94"
TcI constitutes the most abundant and widespread T. cruzi DTU [4] and is the 95"
predominant (although not the only) DTU in the Amazon region and countries North of it [1].  96"
However, inability to detect TcI in a predominantly TcII endemic region, led to the 97"
misconception that TcI was not a cause of CCC. For our patient, only TcI DTU parasites were 98"
detectable in the clinical samples, hemocultures, and clones. Furthermore, antibodies against 99"
TCII, IV or V/VI specific epitopes were not detectable in serum, suggesting the absence of co-100"
infection or previous infection with those lineages. Although no TcIII-specific antigen is 101"
currently available, TcIII infects humans only in exceptional cases, and no reports in Central 102"
America exist [4]. Therefore, our data strongly support the conclusion that the observed CCC 103"
was caused exclusively by TcI parasites [5-7]. Previous reports implicating TcI in CCC [14] 104"
have either depended heavily on serological approaches which are currently known to be flawed 105"
[13] or not tested for the presence of coinfection with other lineages [15]. TcIDOM has not 106"
previously been reported from cardiac tissues in CCC cases, as it has been merely detected in 107"
peripheral blood or hemoculture, where coinfection with parasites from other genetic lineages 108"
residing in cardiac tissue and being the actual cause of CCC cannot be ruled out. 109"
TcI has considerable intra-DTU diversity [11]; specific genotypes within TcI are 110"
associated with human infection [9]. Based on nuclear microsatellite information, the patient was 111"
infected by TcIDOM, a genotype associated with many human infections in regions north of the 112"
Amazon. Conversely, mitochondrial genotyping suggests a closer relationship with isolates form 113"
North and Central America, consistent with local, possibly sylvatic, origin of the infecting strain. 114"
Given the proclivity for mitochondrial introgression into TcIDOM  [12] we suggest our 115"
observation is yet another of such hybridizations, in this case between TcIDOM and a local strain, 116"
highlighting the need for control strategies aimed at domiciliary and extrinsic parasite 117"
populations as sources of human infection. 118"
 Our results demonstrate that TcI, can cause end-stage CCC and dispels the long-held bias 119"
that infection with this lineage is benign [5-7]. Considering the wide distribution of TcI (the only 120"
T. cruzi DTU ranging from the Southern United States to Argentina and Chile) and the frequency 121"
with which TcI strains are associated with human infection [4], there is need for greater 122"
surveillance in TcI endemic regions like Central America.  Around 22 million people from 123"
Chagas endemic countries live in the US, and most of these immigrants come from Mexico 124"
(74%) and El Salvador (6.4%) [2], where TcI is known to predominate [4]. Thus, a significant 125"
proportion of the estimated 300,000 T. cruzi infections among immigrants in the U.S.A. are 126"
predicted to involve the DTU TcI, adding to the growing economic burden of medical care and 127"
interventions associated with Chagas’ disease in the U.S.A., including transplantation for end-128"
stage heart disease. 129"
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Figure 1. Neighbour joining dendrogram based on pairwise inverse allele sharing 200"
which shows the relationship between parasite clones isolated from the patient 201"
and others from North, Central and South America. Branch colours indicate strain 202"
origin and values at important nodes indicate percentage of bootstrap support over 203"
1000 trees. Further details of strains and analytical strategy can be found in [9]. 204"
 205"
 Figure 2. Maxicircle sequence-based typing of strain isolated from patient.  206"
Maxicircle sequences for one biological clone were concatenated according to [12], 207"
aligned against 70 TcI strains encompassing TcI genetic diversity from across North, 208"
Central and South America [9] and used to assemble a Maximum-Likelihood topology in 209"
PhyML.  The best-fit model of nucleotide substitution was selected from 88 models and 210"
its significance evaluated according to the Akaike Information Criterion (AIC) in 211"
jMODELTEST 1.0. The best fit model selected for this dataset was GTR+G.  Bootstrap 212"
support for clade topologies was estimated following the generation of 100 pseudo-213"
replicate datasets.  214"
 215"
 216"
Technical Annex 1. Molecular typing from clinical samples. DNA was extracted 217"
from blood samples and parafinized heart explants. Typing was performed using a 218"
nested PCR-RFLP strategy for amplification of the 1f8 flagellar protein and digestion 219"
with Alw 21I (Van der Auwera, et al., unpublished data).  H = DNA extracted from 220"
parafinized heart explant tissue, B and B2= blood samples taken 10 days apart during 221"
reactivation of disease, TcI-TcVI correspond to DTU controls, NC1 corresponds to 222"
negative control for the PCR and NC2 for the nested-PCR. Lanes corresponding to Alw 223"
21I restriction digest products are labeled with an asterisk (*). Only restriction products 224"
are shown for controls. 225"
 226"
 227"
 228"
 229"
 230"
 231"
 232"
 233"
 234"
 235"
 236"
 237"
 238"
 239"
 240"
 241"
 242"
 243"
 244"
Technical Annex 2. Molecular typing for cultured parasites and parasite clones. 245"
DNA was extracted from epimastigote hemocultures (HC) and five derived clones (CL1-246"
CL5). TcI-TcVI correspond to DTU controls, NC corresponds PCR negative control. 247"
Lanes containing restriction products are labeled with an asterisk (*). Only restriction 248"
products are shown for controls. A. DNA was analyzed by the PCR-RFLP scheme 249"
proposed by Lewis, et al., 2009 [10]: as indicated by the brackets on the right side, 250"
fragments from the LSUrDNA, HSP60 and GPI genes were amplified by PCR. GPI and 251"
HSP60 products were digested with HhaI and EcoRV restriction enzimes, respectively. 252"
B. Results were confirmed by amplifying strategy the 1f8 flagellar protein and digesting 253"
the amplicons with Alw 21I restriction enzyme (Van der Auwera, et al., unpublished 254"
data). 255"
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Abstract
Background: Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a serious public health
issue in Latin America. Genetically diverse, the species is sub-divided into six lineages, known as TcI–TcVI, which have
disparate geographical and ecological distributions. TcII, TcV, and TcVI are associated with severe human disease in the
Southern Cone countries, whereas TcI is associated with cardiomyopathy north of the Amazon. T. cruzi persists as a chronic
infection, with cardiac and/or gastrointestinal symptoms developing years or decades after initial infection. Identifying an
individual’s history of T. cruzi lineage infection directly by genotyping of the parasite is complicated by the low parasitaemia
and sequestration in the host tissues.
Methodology/Principal Findings: We have applied here serology against lineage-specific epitopes of the T. cruzi surface
antigen TSSA, as an indirect approach to allow identification of infecting lineage. Chagasic sera from chronic patients from a
range of endemic countries were tested by ELISA against synthetic peptides representing lineage-specific TSSA epitopes
bound to avidin-coated ELISA plates via a biotin labelled polyethylene glycol-glycine spacer to increase rotation and ensure
each amino acid side chain could freely interact with their antibodies. 79/113 (70%) of samples from Brazil, Bolivia, and
Argentina recognised the TSSA epitope common to lineages TcII/TcV/TcVI. Comparison with clinical information showed
that a higher proportion of Brazilian TSSApep-II/V/VI responders had ECG abnormalities than non-responders (38% vs 17%;
p,0.0001). Among northern chagasic sera 4/20 (20%) from Ecuador reacted with this peptide; 1/12 Venezuelan and 1/34
Colombian samples reacted with TSSApep-IV. In addition, a proposed TcI-specific epitope, described elsewhere, was
demonstrated here to be highly conserved across lineages and therefore not applicable to lineage-specific serology.
Conclusions/Significance: These results demonstrate the considerable potential for synthetic peptide serology to
investigate the infection history of individuals, geographical and clinical associations of T. cruzi lineages.
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Introduction
Chagas disease (South American trypanosomiasis) is still
considered to be the most important parasitic disease in Latin
America, despite notable success with control of household
infestation by the triatomine insect vectors. Up to 8 million
people are estimated to be chronically infected with the causative
agent Trypanosoma cruzi, of whom at least 30% are likely to develop
chagasic cardiomyopathy, in some cases with megasyndromes of
the intestinal tract [1,2]. Vector borne transmission is usually by
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contamination of mucous membranes or abraded skin with T. cruzi
infected triatomine faeces and sporadic oral outbreaks occur due
to triatomine contamination of food [3]. Infection can also be
propagated by congenital transmission and blood or organ
donation, and this may arise among migrant populations far
beyond the endemic regions in Latin America [4].
The species T. cruzi is remarkably diverse genetically and is
currently described as comprising six distinct lineages or discrete
typing units (DTUs, TcI-TcVI) [5]. The six lineages have complex
disparate but partially overlapping geographical and ecological
distributions and are circumstantially associated with different
epidemiological features [6,7]. TcI is the principal agent North of
the Amazon, in association with chagasic heart disease but where
megasyndromes are considered to be rare. TcII is one of three
principal agents of Chagas disease in the Southern Cone region of
South America, where chagasic cardiomyopathy, megaoesophagus
and megacolon are found. TcIII is seldom isolated from humans
but is widely distributed with the natural armadillo host Dasypus
novemcinctus. TcIV is a sporadic secondary agent of Chagas disease
in Venezuela [8]. TcV and TcVI, like TcII, are also agents of
Chagas in the Southern Cone region, and are known to be
relatively recent hybrids of TcII and TcIII [7,9].
Parasitological diagnosis in the acute phase of T. cruzi infection
is by microscopy of fresh blood films, thin blood films, thick blood
films or by haematocrit centrifugation and examination of the
buffy coat, the latter being recommended particularly for
congenital cases. In the chronic phase recovery of live organisms
may be attempted by multiple blood cultures or xenodiagnosis
with colony bred triatomine bugs but with limited sensitivities, or
parasite DNA may be detectable by amplification.
Serological diagnosis of T. cruzi infection is usually performed by
either indirect immunofluorescence (IFAT) or indirect haemaglu-
tination (IHA) or enzyme-linked immunosorbent assay (ELISA),
giving .94% sensitivity and specificity [2]. There are several
commercially available diagnostic kits, including rapid lateral flow
tests but sensitivities may not be equivalent, particularly when they
are used in regions where non-homologous genetic lineages of T.
cruzi are prevalent [8–10]. These serological methods give no
information on the genetic lineage or lineages that a patient
carries, and are not designed for that purpose.
A key objective of Chagas research therefore remains to follow
up in detail the circumstantial evidence of a relationship between
infecting T. cruzi lineage and the clinical outcome [6,7,11].
However, such analysis is complex and vulnerable to multiple
confounders, including diversity of host susceptibility. Even if T.
cruzi isolates can be recovered from the infected blood by
parasitological diagnosis or if DNA can be amplified from blood,
genotyping methods [12,13] do not provide an entire profile of the
infecting lineages in an individual patient, because distinct T. cruzi
lineages may be sequestered in the tissues [14]. An approach to
overcoming this limitation is to identify infecting T. cruzi lineage in
a more indirect way. One strategy to achieve this is by serological
detection of antibodies that are produced in response to lineage-
specific antigens.
Di Noia et al [15] described the trypomastigote small surface
antigen (TSSA), encoded by a member of the TcMUCIII mucin
gene family, expressed on the mammalian bloodstream trypomas-
tigote stage of the T. cruzi life cycle. The authors reported that
TSSA is dimorphic in sequence, with TSSA-I being present in
TcI, and TSSA-II found in TcII-TcVI. On the basis of this finding
the authors pioneered lineage-specific serology for Chagas disease
through application of a TSSA-II recombinant antigen to serology
with patients from the Southern Cone region of South America.
Chagasic patients were only TSSA-II seropositive, which led to the
suggestion that TcI could be benign. However, this suggestion was
in conflict with the geographical predominance of TcI North of
the Amazon and the acute and chronic clinical presentations of
known TcI infections [16,17]. In subsequent publications E. coli-
produced recombinant TSSA proteins have been used more
widely for serology with humans and animals [18–23].
We have previously analysed TSSA diversity among a panel of
T. cruzi isolates representing a broad geographical and ecological
range of lineages TcI-TcVI [24]. We found a greater lineage-
specific diversity than had previously been described. Lineages
TcII, TcV, and TcVI were shown to share a common TSSA
sequence. However, in both of the hybrid lineages TcV and TcVI
we found that two TSSA alleles were present at an heterozygous
locus within the polymorphic epitope: one haplotype was shared
with TcII and in the second haplotype a Thr was replaced by Ala
at position 44 of the protein. Lineage-specific TSSA sites were also
found in TcIII and TcIV strains [24]. Ca´nepa et al [25] suggested
a functional significance for this diversity in that the TcII/TcV/
TcVI form of TSSA, but not the TcI form, has the property of
binding surface receptor(s) and inducing signalling pathways in
host cells prior to parasite internalisation.
Recently, Mendes et al [26] used a bioinformatic analysis of the
reference genome of the TcVI strain CL Brener [27] to identify
candidate peptides for differential screening with sera from mice
experimentally infected with single, known T. cruzi lineages. A
resultant peptide, derived from a putative RNA-binding protein,
was reported to be applicable for TcI serology [26].
Here, we have used our expanded knowledge of the range of
TSSA diversity to design and synthesise lineage-specific peptides.
We assess the capacity of these peptides to provide antigens for
lineage-specific serology by ELISA and thus reveal which lineages
have infected individual patients during their lifetime. Further-
more, we examine the geographical and clinical distribution of
recognition of the synthetic peptide epitopes. In addition, we also
investigate the diversity of the gene coding for the peptide
described [26] as applicable for TcI-specific serology.
Author Summary
Chagas disease remains a significant public health issue in
Latin America. Caused by the single-celled parasite
Trypanosoma cruzi, the main route of infection is via
contact with contaminated faeces from blood-sucking
triatomine bugs, but following successful insecticide
spraying campaigns, congenital, food-borne, and transfu-
sion/transplantation routes of infection have become
more relevant. In the absence of successful chemotherapy,
T. cruzi usually persists in the body for life, and in
symptomatic cases may lead to death or debilitation by
heart failure and/or gastrointestinal megasyndromes. As a
species, T. cruzi displays great genetic diversity, and is
subdivided into lineages called TcI - TcVI. Associating T.
cruzi lineage with clinical symptoms is a key goal of Chagas
disease research. Direct isolation and typing of T. cruzi
from chronically infected patients is hampered by the
sequestration of the parasite in host tissues. Identifying
lineage-specific antibodies in serum provides an alterna-
tive approach to determining an individual’s history of
infection. Here, we performed lineage-specific serology
using samples from a range of South American countries.
We show that lineage-specific seropositivity is associated
with geographical distributions and clinical outcome.
These findings have wide implications for further diagnos-
tics development and improved understanding of the
epidemiology of Chagas disease.
Lineage-Specific Serology in Chronic Chagas Disease
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Materials and Methods
Ethics statement
Human sera were collected as part of routine diagnostic
examination, with local institutional ethical approvals, and in
accord with EC ethical standards established as part of the
ChagasEpiNet international collaboration. All human sera were
anonymised and coded by letters and numbers that did not reveal
patient identities. Production of mouse sera adhered to the
European 3Rs policy of Refinement, Reduction and Replacement
(99/167/EG: Council decision of 25/1/99), took place in
authorised animal facilities by licensed staff in agreement with
the European Directive 86/609/EEC, and with review and
approvals under UK Home office regulations [Animals (Scientific
Procedures) Act 1986; project licence number 70/6997 to the
London School of Hygiene and Tropical Medicine].
Mouse and human sera
Mouse sera were from mice previously inoculated intraperito-
neally with 106 organisms from stationary phase cultures
containing infective metacyclic trypomastigotes, of known biolog-
ical clones of T. cruzi representing the lineages. Sera were
separated from whole mouse blood by allowing clotting at room
temperature, overnight storage at 4uC, centrifugation at 120006g
for 10 mins and removal of the supernatant serum. Serum samples
were stored 1:1 with glycerol at 220uC.
Human sera were from chronic cases of Chagas disease,
confirmed by a combination of parasitological and serological
diagnosis. As shown in Table 1, 113 samples were from the
Southern Cone countries, Brazil, Bolivia and Argentina, and 66
samples were from countries North of the Amazon, Colombia,
Ecuador, Venezuela, where TcI has been considered to predom-
inate. Brazilian sera were from patients who had a positive
parasitological diagnosis at the time of serum collection, together
with a full clinical history, their geographical origin, age and sex.
Institutes providing sera were: Hospital das Clinicas, Goiaˆnia,
Brazil; Universidad Mayor de San Simon, Cochabamba, Bolivia;
Universidad Nacional de Salta, Argentina; Universidad Central de
Venezuela, Caracas, Venezuela; Universidad de los Andes,
Bogota´, Colombia; Pontificia Universidad Cato´lica del Ecuador,
Quito, Ecuador. Endemic healthy controls were from the Hospital
das Clinicas, Goiaˆnia, Brazil, and additional controls were 17 sera
from Colombia that were serologically negative to T. cruzi lysate.
Synthesis of lineage-specific peptides
The synthetic peptides were prepared with an amino terminal
biotin molecule linked via a polyethylene glycol-glycine spacer so
that they could be bound to avidin-coated ELISA plates.
Importantly, this method increased their rotation and ensured
that each amino acid side chain could freely interact with
antibodies, as opposed to being adsorbed onto the solid phase
where some amino acid side chains would be unavailable, as
discussed previously [28].
Design of the peptides was based on the T. cruzi TSSA lineage-
specific amino acid sequences previously described [24]; chimeric
peptides comprised by TSSA-I and TSSA-II sequences were also
designed and synthesised (Results; Figure 1). Synthetic peptides
were prepared at the 20 mM scale on 100–200 mesh-size Fmoc-
Cys(Trt) Wang resin (0.5 mmol/g) (856006: Novabiochem, UK)
using a Zinsser Analytic SMPS 350 (Zinsser Analytic, UK) or
Advanced Chemtech Apex 396 (Advanced Chemtech, USA)
robotic multiple peptide synthesizer. Aspartamide formation of
aspartic acid residues was reduced by the use of OMpe-protected
Fmoc-Asp(OMpe)-OH (852104: Novabiochem, UK). The
coupling steps were performed using 0.5 M Fmoc-protected
amino acids diluted in 6.76% (wt/vol) 1-hydroxybenzotriazole
(HOBt)/dimethylformamide (DMF) (Activotec, UK/Rathburn
Chemicals Ltd., UK) activated using 0.5 M N,N,N9,N9-tetra-
methyl-O-(1H-benzotriazol-1-yl)uranium hexafluorophosphate
(HBTU) (851006: Novabiochem, UK) with 1M N,N-diisopropy-
lethylamine (DIPEA) (Rathburn Chemicals Ltd., UK), while the
deprotection steps were performed using 20% (vol/vol) piperi-
dine/DMF (Rathburn Chemicals Ltd., UK). The carboxyl- and
amino- regions flanking the core epitope sequences contained
additional glycine (G) residues to increase rotation (high dihedral
(y against Q) angles) of their carboxyl-terminal cysteine (C) residue
and their amino-terminal spacer and molecular label. Their amino
termini were labelled via a polyethylene glycol (PEG) spacer
(Fig 1A) through sequential couplings with 0.5 M Fmoc-NH-
(PEG)2-COOH (13 atoms or 20 atoms) (851034 or 851031:
Novabiochem, UK) followed by 0.5 M biotin (B4501: Sigma
Aldrich, UK) using the more efficient coupling agent, 0.5 M
N,N,N9,N9-tetramethyl-O-(7-azabenzotriazol-1-yl)uranium hexa-
fluorophosphate (HATU) (851013: Novabiochem, UK) containing
1 M DIPEA. The final peptides were each washed 5 times with
dichloromethane and then methanol (Rathburn Chemicals Ltd.,
UK) before being dried in a freeze-drier (Edwards, UK). Peptide
cleavage was performed by reaction for 3–4 hours using 1% (wt/
vol) phenol, 2% H2O, 2.5% (vol/vol) triisopropyl silane (233781:
Sigma Aldrich, UK) and 2% (vol/vol) 2,29 (ethylenedioxy)
diethanethiol (3,6-dioxa-1,8-octanedithiol (DODT)) (465178: Sig-
ma Aldrich, UK) in trifluoroacetic acid (Rathburn Chemicals Ltd.,
UK) [29]. The cleaved peptides were then precipitated in cold
(0uC) peroxide-free diethyl ether (Rathburn Chemicals Ltd., UK),
centrifuged at 2,0006g; the supernatants were discarded and the
precipitation and centrifugation steps were repeated twice. The
peptides were then dried under a stream of anhydrous argon gas
(BOC, UK) before being stored at 280uC.
For purification each peptide was subsequently dissolved in
500 ml of 2,2,2, trifluoroethanol (T63002: Sigma Aldrich, USA),
made to 5.5 ml with 5% (vol/vol) far UV grade acetonitrile
(Rathburn Chemicals Ltd., UK) in H2O containing 0.1% (vol/vol)
trifluoroacetic acid, and then subjected to reversed-phase HPLC
using a 5 ml injection loop, a 5–95% acetonitrile gradient run at
9 ml/min over 30 min through an ACE C18–300 A˚
250621.2 mm preparative column (ACE-231-2520: Advanced
Chromatography Technologies, UK) in a Beckman Gold prepar-
ative HPLC system (Beckman, USA). The main peaks, detected at
a wavelength of 215 nm, were collected and freeze-dried before
storage at 280uC.
Additionally, peptides TSSApep-II/V/VI, chimera TSSApep-
I/-II, and MenTcI were also synthesised commercially (Geno-
sphere Biotechnologies, Paris, France).
Purified peptides were prepared as 1 mg/ml stock solutions in
PBS and the addition of biotin in the last coupling was assessed by
ELISA. For this assay, 10 mg/ml of each peptide was prepared in
16 carbonate-bicarbonate coating buffer (15 mM Na2CO3,
34 mM NaHCO3, pH 9.6) and added at 50 ml/well to 96-well
ELISA plates (735–0465: Immulon 4HBX, VWR, UK). Plates
were covered with an adhesive sheet and incubated overnight at
4uC. Following three washes with PBS containing 0.05% (vol/vol)
Tween 20 (P7949: Sigma Aldrich, UK) (PBS/T), 200 ml/well
blocking buffer (PBS/2% skimmed milk powder (Premier Inter-
national Foods, Spalding, UK) was added and incubated at 37uC
for 2 hrs. Following three washes, a 1:2000 dilution of peroxidase-
labeled streptavidin (S2438: Sigma Aldrich, UK) in PBS/T
containing 2% skimmed milk powder (PBS/T/M) was added at
50 ml/well, and incubated at 37uC for 1 hour. After washing six
Lineage-Specific Serology in Chronic Chagas Disease
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times with PBS/T, 50 mM phosphate/citrate buffer (pH 5.0)
containing 2 mM o-phenylenediamine HCl (P1526: Sigma
Aldrich, UK) and 0.005% (vol/vol) H2O2 (216763: Sigma Aldrich,
UK) was added at 50 ml/well and the plates were incubated in the
dark at room temperature for 10 minutes. The substrate reactions
were then stopped by the addition of 2M H2SO4 (25 ml/well) and
the absorbance values were determined at a wavelength of 490 nm
(MRX, Dynatech, USA).
Production of whole-cell lysate antigen
T. cruzi was cultured as previously described [30]. For
production of lysate antigen, mid-to-late log phase cultures of a
TcII strain (IINF/PY/00/Chaco23cl4) of T. cruzi were centrifuged
at 8006g for 10 mins at 4uC in an Allegra X-15R benchtop
centrifuge (Beckman Coulter, UK). After washing in PBS, cell
pellets were subjected to 3 cycles of flash-freezing in liquid
nitrogen and thawing in a cold water bath. Cell lysates were then
sonicated for 3630 sec, with intervals on ice, using a Soniprep 150
sonicator (MSE), at 12 m amplitude. Sonicated lysates were
centrifuged at 13000 rpm for 1 min, and the supernatant used
as antigen in ELISA. Protein concentration was determined using
the BCA Protein Assay kit (PN23227: Fisher Scientific, UK).
Lineage-specific peptide ELISA
Immulon 4HBX 96-well flat bottomed ELISA plates were
coated with 1 mg/100 ml/well of avidin (A9275: Sigma, UK)
diluted in 16 carbonate-bicarbonate coating buffer for binding to
lineage-specific peptide, and in separate wells coating was with
TcII T. cruzi lysate at 0.2 mg/100 ml/well to act as a serologically
positive control for each sample. Plates were covered with an
adhesive sheet and incubated overnight at 4uC. The following day,
unbound avidin and lysate were removed, the plate washed three
times with wash buffer PBS/T, then wells were blocked with
200 ml blocking buffer PBS/T/M at 37uC for 2 hrs. Following
three washes, 1 mg/100 ml/well TSSA lineage-specific peptide in
PBS/T/M was incubated with the avidin-coated wells at 37uC for
1 hr. Following three washes, 100 ml/well of a 1:200 dilution of
serum in PBS/T/M was added and incubated at 37uC for 1 hr.
Following six washes, 100 ml/well of donkey anti-human IgG (H+
L)-HRP (709-035–149: Jackson Immunoresearch, Pennsylvania,
USA), diluted 1:5,000 in PBS/T/M was added, and incubated at
37uC for 1 hr. Following six washes, plates were developed and
read as described above, except that the volumes were 100 ml for
substrate and 50 ml for 2M H2SO4. Replica plates were run in
duplicate simultaneously.
Statistical analysis
Cut-off values for ELISAs with human sera and peptides were
calculated from the mean plus 3 standard deviations compared to
the endemic healthy controls from Goiaˆnia, Brazil. Statistical
analysis (2-tailed unpaired t-test) on the Brazilian TSSApep-II/V/
VI seropositives and non-responders was performed using
GraphPad Prism version 4.02 for Windows (GraphPad Software,
San Diego, California, USA).
Analysing diversity of the putative TcI epitope
We designed PCR primers MenTcI FOR (59 ATGCCA-
CAATCGAAACCAAG 39) and MenTcI REV (59 TCACAA-
CAAACGTTTGGCTG 39) (synthesised by Eurofins MWG
Operon, Germany) to amplify the whole open reading frame
(ORF) of the putative RNA–binding protein (Tc00.1047
053511837.129) which was described as containing an epitope
and corresponding peptide applicable for TcI serology [26]. T.
cruzi strains, from which genomic DNA was used as amplification
template, are listed in Table 2. Amplification reactions were
performed in a total volume of 20 ml, and comprised of 16NH4
reaction buffer supplemented with 1.5 mM MgCl2 (Bioline, UK),
200 mM dNTPs (New England Biolabs, UK), 10 pmol of each
primer, and 1 U BioTaq DNA polymerase (Bioline). Amplification
conditions were: 1 cycle of 94uC, 3 mins; 25 cycles of 94uC for
30 secs, 55uC for 30 secs, 72uC for 30 secs; 1 cycle of 72uC for
10 mins. Five microliters of the PCR reaction were analysed by
electrophoresis on 1.5% agarose gels (Bioline); amplification
products were purified from the remaining reaction by precipita-
tion with an equal volume of isopropanol at room temperature,
followed by washing with 70% EtOH, air-drying and resuspension
in ddH2O. Bi-directional DNA sequencing, using each PCR
primer separately at 3.2 pmol, was achieved using a BigDye
Figure 1. TSSA provides potential epitopes that are T. cruzi lineage-specific. [A] Components of the peptides synthesised: N-terminal
biotinylation; PEG spacer; Gly; the lineage-specific sequence; C-terminal Cys. [B] Amino acid sequences of the T. cruzi lineage-specific TSSA potential
epitopes in the synthetic peptides (TSSApep-), with polymorphic residues underlined; for the two chimeric peptides the TSSA-II residues are shown in bold.
doi:10.1371/journal.pntd.0002892.g001
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Terminator v3.1 RR-100 kit (Applied Biosystems, UK) according
to standard protocols. Sequence alignment was performed using
BioEdit software [31]. In parallel, the coding region of the TSSA
gene containing lineage-specific sequences was also sequenced, as
described previously [24], to confirm lineage identity.
Linear B-epitope profiling
Computer analysis of the TSSA-I and the TSSA-II/V/VI
common epitope was performed using EpiQuest-B software (v
2.1.17, Matrix B7.1) from Aptum Biologics Ltd (Southampton,
Hampshire, UK). The algorithm of the program allows prediction
of potential linear B-epitopes and their immunogenicity. The data
were used in graphical format.
Accession numbers
Nucleotide sequences derived in this manuscript are available
under GenBank accession numbers KJ395471 - KJ395493.
Results
TSSA provides potential epitopes specific for each T. cruzi
lineage
The structures and sequences of the peptides synthesised,
indicating the lineage-specific amino acids, are shown in Figure 1,
as based on the comparisons of diversity previously described [24].
In addition to the peptides representing single lineages we
synthesised two chimeric peptides, one with TSSA-I residues at
the N terminus and TSSA-II residues at the C terminus, and the
second with TSSA-II at the N terminus and TSSA-I at the C
terminus (Figure 1B).
Consistent with the known extensive genomic divergence
between TcI and TcII, eight residues differed between their
TSSA potential epitopes. Five and six residues separated TSSA-II
from TSSA-III and TSSA-IV, respectively. Four residues distin-
guished TSSA-I from TSSA-III and two residues separated TSSA-
I from TSSA-IV, in accord with their somewhat greater affinity
with TcI. A single residue differed between the TSSA-II haplotype
shared by TcII, TcV and TcVI and the second haplotype present
at the heterozygous locus in the hybrids TcV and TcVI.
Synthetic peptides are recognised by serum antibodies
Sera from mice experimentally infected with biological clones of
TcII, TcV and TcVI strains recognised TSSApep-II/V/VI in
serology by ELISA, and sera from TcIII and TcIV murine
infections reacted with the corresponding TSSA peptides (Bhat-
tacharyya et al, in preparation), encouraging the evaluation
described here of the diagnostic potential of all the synthetic
peptides with sera from patients with chronic Chagas disease.
Figure 2 shows examples of ELISA plates with T. cruzi lysate
and lineage-specific synthetic peptides as antigens. Sera from
normal healthy endemic controls did not react with the T. cruzi
lysate or with any of the synthetic peptides. Without exception all
Table 2. T. cruzi strains used here for comparative analysis of the ORF containing the reported TcI-applicable peptide (GenBank
accession numbers refer to sequences determined here).
Lineage Strain Origin Host/vector Tc00.1047053511837.129 [26]
a
GenBank
E N S A N P P P P D R S L P T P
TcI MHOM/BR/78/Sylvio-X10/1 Bele´m, Brazil Homo sapiens . . . . . . . . . . . . . . . . KJ395471
MHOM/PE/00/SaxP18 Majes, Peru Homo sapiens . . . . . . . . . . . . . . . . KJ395472
MPHI/BO/00/SJM41 Beni, Bolivia Philander opossum . . . . . . . . . . . . . . . . KJ395473
MDID/BO/00/SMA2 Beni, Bolivia Didelphis marsupialis . . . . . . . . . . . . . . . . KJ395474
MDID/BO/00/SJM37 Beni, Bolivia Didelphis marsupialis . . . . . . . . . . . . . . . . KJ395475
MPHT/BO/00/COTMA47 Cotopachi, Bolivia Phyllotis ocilae . . . . . . . . . . . . . . . . KJ395476
TcII MHOM/CL/00/IVV Cuncumen, Chile Homo sapiens . . . . . . . . . . . . . . . . KJ395477
MHOM/BR/00/Y Sa˜o Paulo, Brazil Homo sapiens . . . . . . . . . . . . . . ST. KJ395478
MHOM/CL/00/CBB Region IV, Chile Homo sapiens . . . . . . . . . . . . . . ST. KJ395479
IINF/BO/00/Tu18 Tupiza, Bolivia Triatoma infestans . . . . . . . . . . . . . . . . KJ395480
IINF/PY/00/Chaco23 Chaco, Paraguay Triatoma infestans . . . . . . . . . . . . . . . . KJ395481
IINF/PY/00/T655 Chaco, Paraguay Triatoma infestans . . . . . . . . . . . . . . . . KJ395482
TcIV IINF/AR/00/LHVA Chaco, Argentina Triatoma infestans . . . . . . . . . . . . . . . . KJ395483
TcV IINF/CL/00/Vinch101 Limari, Chile Triatoma infestans . . . . . . . . . . . . . . . . KJ395484
MHOM/BO/00/92:80 Santa Cruz, Bolivia Homo sapiens . . . . . . . . . . . . . . . . KJ395485
IINF/BR/00/Bug2148 Rio Grande do Sul, Brazil Triatoma infestans . . . . . . . . . . . . . . . . KJ395486
IINF/PY/00/Para6 Paraguari, Paraguay Triatoma infestans . . . . . . . . . . . A . . A . KJ395487
TcVI MHOM/BR/00/CL Brener Rio Grande do Sul, Brazil Triatoma infestans . . . . . . . . . . . . . . . . KJ395488
MHOM/BO/00/P251 Cochabamba, Bolivia Homo sapiens . . . . . . . . . . . . . . . . KJ395489
IINF/PY/00/Chaco17 Chaco, Paraguay Triatoma infestans . . . . . . . . . . . . . . . . KJ395490
IINF/PY/00/Chaco9 Chaco, Paraguay Triatoma infestans . . . . . . . . . . . . . . . . KJ395491
IINF/AR/00/EPV20-1 Chaco, Argentina Triatoma infestans . . . . . . . . . . . . . . . . KJ395492
IINF/CL/00/VFRA Francia, Chile Triatoma infestans . . . . . . . . . . . . . . . . KJ395493
a. = no amino acid change.
doi:10.1371/journal.pntd.0002892.t002
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sera from patients with chronic Chagas disease recognised the T.
cruzi TcII lysate antigen preparation. Figure 2 also provides
examples of sera from Brazil, Argentina and Ecuador that
recognised TSSApep-II/V/VI, indicative of infection with
TcII,TcV or TcVI. A positive result for the epitope derived from
the TcV/VI specific haplotype indicates definite infection with
TcV or TcVI. Some of these sera (e.g. B6 & B10) reacted with
both TSSApep-II/V/VI and TSSApep-V/VI representing the
haplotype restricted to TcV and TcVI, indicating infection with a
hybrid strain, possibly in conjunction with a TcII infection.
Recognition of the TcV and TcVI restricted epitope was never
seen in the absence of recognition of the TSSApep-II/V/VI.
A Venezuelan serum (V4 in Figure 2) recognised TSSApep-IV,
consistent with the known presence of TcIV as a secondary agent
of Chagas disease in Venezuela [16]. However, this serum also
bound to TSSApep-III, which only differs by 2 of 16 residues.
An antibody response to TSSApep-I was exceptional, only two
sera were reactive from the entire set of samples (Table 1) of which
one weak reactor (Argentina A3) is shown in Figure 2.
Chimera TSSApep-I/-II and chimera TSSApep-II/-I were
designed to determine whether the antigenic epitope resided at
the N or C terminus of the peptides. Chimera TSSApep-II/-I was
recognised by 71/83 TSSApep-II/V/VI reactive sera, as demon-
strated for example by Argentine patients A1, A2 and A4 (Figure 2).
In comparison, only 11/83 recognised the chimera TSSApep-I/-II,
indicative that, although not precisely mapped, the dominant region
of the epitope lies towards the N terminus of the peptide and that in
some patients the N terminus is adequate to provide a detectable
epitope. A single TSSApep-IV/TSSApep-III positive serum also
recognised the chimera TSSApep-I/-II peptide.
Four of 186 samples responded to all wells containing peptides;
these were demonstrated to bind non-specifically to avidin in the
absence of peptide, but not to cross react with milk proteins (data
not shown).
Rare recognition of the TSSA-II/V/VI common peptide in
northern South America
The 186 sera from patients with chronic Chagas disease spanned
a geographical range from Argentina to Venezuela. Three Southern
Cone countries were included, where TcII, TcV and TcVI have
been reported to be endemic, and three countries from northern
South America, where TcI is considered to predominate. A
summary of the geographical distribution of the antibody responses
to all the lineage-specific synthetic peptides is shown in Table 1. Of
the sera recognizing TSSApep-II/V/VI, 79 out of 83 were from the
Southern Cone countries and four were from Ecuador. Of these 83
sera, 13 sera also recognised TSSApep-V/VI, 12 from Southern
Cone countries and one of the four sera from Ecuador, indicating
presence of TcV or TcVI, possibly with TcII co-infection.
Independently of the lineage-specific peptides, we also examined
the response to two different chimera peptides, each comprising
different combinations of sequences from TSSApep-I and TSSA-
pep-II/V/VI. Of the Bolivian, Ecuadorean and Argentine sera
which reacted with TSSApep-II/V/VI, all reacted with chimera
TSSApep-II/-I, but only two samples (Ecuadorean) also reacted
with chimera TSSApep-I/-II. In the case of Brazilian samples, of
the 67 that reacted with TSSApep-II/V/VI, 55 reacted with
chimera TSSApep-II/-I, and of these 55, 9 also reacted with
chimera TSSApep-I/-II. Only one sample (Venezuelan) reacted
with chimera TSSApep-I/-II but not with TSSApep-II/V/VI or
chimera TSSApep-II/-I. TSSApep-I failed to detect antibodies,
regardless of origin of the chagasic sera, with the exception of two
sera, one each from Brazil and Argentina. Four sera recognised both
TSSApep-IV and TSSApep-III, consistent with cross-reaction due
to the close similarity between these epitopes.
The country by country distribution of antibody recognition of
the peptides is given in Table 1. ELISA cut-offs and absorbance
values for each lineage-specific peptide are shown in Figure 3.
Each data point represents the mean A490 readout of duplicate
assays of the serum sample with the lineage specific peptides. In
Figure 3, the samples giving the highest reading for TSSApep-III
from Colombia and Venezuela are the same samples that
recognised TSSApep-IV.
Antibodies to the TcII/TcV/TcVI peptide are more
frequent among symptomatic Brazilian patients
60/63 of the Brazilian patients with chronic Chagas disease who
were seropositive against TSSApep-II/V/VI had detailed clinical
evaluation, and of these 60 patients, 23 (38%) had ECG
abnormalities typical of Chagas disease. 23/28 patients seroneg-
ative for TSSApep-II/V/VI also had detailed clinical evaluation,
but in contrast only 4 of these latter, different 23 patients had such
ECG abnormalities (p,0.0001).
Novel bioinformatic algorithms predict highly antigenic
residues
The sequences coding for the TSSA proteins containing the
TSSApep-I and TSSApep-II/V/VI epitopes were subjected to a
Figure 2. Chagasic sera recognise TSSA lineage-specific peptides. Lineage-specific peptides or lysate were added to rows of the ELISA plate
as indicated. ELISA plates showing: recognition of TSSApep-II/V/VI and TSSApep-V/VI, among Brazilian, Ecuadorean and Argentine sera; recognition of
TSSApep-I and TSSApep-IV by an Argentine serum and a Venezuelan serum; recognition of chimera TSSApep-II/I by Argentine sera. All patients were
seropositive with T. cruzi lysate. NEHC= non-endemic healthy control.
doi:10.1371/journal.pntd.0002892.g002
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novel bioinformatic analysis using EpiQuest-B program that builds
the immunogenicity profile for linear protein sequences and
predicts the location and potential immunogenicity of the linear B-
cell epitopes (Litvinov et al, in preparation) in order to give an
antigenicity score for the polymorphic region. The algorithm
predicted high scores within the TSSApep-II/V/VI epitope
region, but much lower for TSSApep-I, as shown in Figure 4.
The different antigenicity scores indicate that the N-terminal
TEN in TSSApep-II/V/VI is the dominant epitope, explaining
the frequent recognition of chimera TSSApep-II/-I (Figure 1)
despite the higher scoring C-terminal GEAPS, which provides a
secondary site of recognition for some (Brazilian) sera that respond
to chimera TSSApep-I/-II (Figure 1). Neither the TEN nor
GEAPS is present in TSSApep-I, explaining the rare recognition
of this epitope. The GEAPS, which is also present in TSSApep-III
and TSSApep-IV, gave much lower antigenicity scores in these
peptides, in the absence of the upstream TEN in these sequences
(data not shown).
Comparative diversity of the putative TcI-applicable
peptide reveals high conservation across lineages
Mendes et al [26] used heterozygous loci in the CL Brener
genome to identify candidate lineage-specific epitopes. One
conserved and three potentially lineage-specific peptides were
synthesised, described as deriving from hypothetical protein
Tc00.1047053510421.310 (conserved epitope peptide), putative
RNA-binding protein Tc00.1047053511837.129 (for TcI serolo-
gy), putative ADP-ribosylation factor GTPase activating protein
Tc00.1047053511589.70 (for TcII), and putative DNA-directed
RNA polymerase III subunit Tc00.1047053510359.320 (for TcVI)
that displayed some discriminatory power in ELISAs and affinity-
ELISAs based on differential range of absorbance values. The
putative TcI epitope was described as restricted to TcI and TcVI
and applicable to serological identification of a specific response to
TcI. We examined the diversity in the coding sequence for this
epitope, using a panel of T. cruzi strains across the lineages
(Table 2). A single amplicon of 381bp was produced by PCR from
all strains using primers MenTcI FOR and MenTcI REV.
Examples from TcI and TcII strains are shown in Figure 5.
However, in comparative sequencing across isolates represent-
ing the lineages we found this epitope to be highly conserved
(Table 2). This epitope had the same amino acid sequence across
all the strains and lineages analysed here with the exception of
strains Y and CBB (TcII) and Para 6 (TcV). In strains Y and CBB,
a heterozygous nucleotide (G/C) residue led to the presence of two
predicted amino acids, Ser or Thr.
The region homologous to the reported TcI-applicable epitope,
which was described as specific to a TcII strain, but given only as
amino acid sequence [26], was subject to BLAST against NCBI
and TriTrypDB databases. There were very low stringency
homologies returned by TriTryp BLAST to various T. cruzi
proteins (mainly around the PPP tripeptide), none of which was
described as RNA-binding proteins. On NCBI BLAST, highest-
scoring matches were to various bacteria and fungi, none to
trypanosomes. Furthermore, none of 55 sera from northern
countries of South America, where TcI is highly endemic, bound
to the TcI synthetic peptide reported in Mendes et al in our
ELISA assays (data not shown).
Discussion
Kong et al [32] developed lineage-specific serology for the
protozoan parasite Toxoplasma gondii, which is difficult to isolate
from chronically infected patients, and most isolates of which are
classified into clonal lineages type I, II, or III. Serology with
synthetic peptides based on diversity within the dense granule
proteins GRA6 and GRA7 was able to distinguish type II from
non-type II infections in humans. Using discriminatory serology, it
was possible to demonstrate that the T. gondii lineages had different
Figure 3. Recognition of TSSA lineage-specific peptides shows a disparate geographical distribution. Each data point represents the
mean A490 of the reaction of duplicates of each serum sample with the peptides. Means of each country data set are represented by solid horizontal
lines; cut-offs, derived from the mean +3SD for each peptide with the EHCs, are shown as dotted line on each graph. Circled and boxed values
indicate the same sera. Resolution for the Brazilian responses to TSSApep-II/V/VI is increased by smaller symbols.
doi:10.1371/journal.pntd.0002892.g003
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continental distributions [33], and that adult offspring of type I-
infected mothers had a significantly increased risk for the
development of psychoses [34].
Here we have used detailed comparative analysis of the genetic
diversity of the T. cruzi TSSA gene encoding the protein core of the
mucin TSSA, to design synthetic peptides for lineage-specific
serology of T. cruzi infection history. These epitopes were
presented on an avidin-coated solid phase via an amino terminal
biotin-label linked to a polyethylene glycol-glycine spacer to
increase rotation and ensure that each amino acid side chain could
freely interact with antibodies. We synthesised and tested these
lineage-specific peptides in ELISA with 186 human sera from six
countries, three in the Southern Cone region of South America
and three in northern South America. We have selected these
countries because typing of T. cruzi isolates with multilocus enzyme
electrophoresis (MLEE) [6], multilocus sequence typing (MLST)
[35] and multilocus microsatellite typing (MLMT) [17] has
repeatedly indicated the predominance of TcII, TcV and TcVI
as the agents of Chagas disease in Southern Cone countries yet the
contrasting high prevalence of TcI in patients North of the
Amazon [7,11]. Nevertheless, there have been some reports that
TcII, as identified by genotyping, can be found among isolates
from humans and domestic triatomine bugs in northern endemic
regions, for example in Colombia and Guatemala [36–38].
Lineage-specific serology is therefore of special interest for T.
cruzi, because of the disparate geographical distributions of both
the T. cruzi lineages and clinical manifestations of chronic Chagas
disease. Thus as long ago as 1981, Miles et al proposed that the
presence of chagasic cardiomyopathy with megaoesophagus and
megacolon in Southern Cone countries, yet apparent absence of
associated megasyndromes from Venezuela, may be related to the
comparative predominance of TcI as the agent of Chagas disease
in northern South America [6]. Nevertheless the evidence of a link
between infecting lineage of T. cruzi and prognosis of chronic
Chagas disease remains circumstantial. As with T. gondii, this is
partly due to the difficulty of isolating and genotyping T. cruzi from
chronic chagasic patients. Blood culture and xenodiagnosis have
limited sensitivity and may be selective for faster growing
biological clones. Furthermore, even if parasites or DNA can be
recovered from chronically infected patients, the resultant T. cruzi
isolates may not be representative of the genetic diversity in the
patient, because T. cruzi replicates intracellularly and lineage
genotypes may be sequestered in the tissues but not recoverable
from the circulating blood [14]. Serology with lineage-specific
antigens provides a means of profiling an individual’s history of T.
cruzi infection, to overcome inaccessibility of the parasite to direct
genotyping during chronic infections.
TSSA provides a good candidate for development of synthetic
peptide-based, lineage-specific serology, because no TSSA homo-
logue beyond the species T. cruzi has been detected by genomic
comparisons, and a lineage-specific candidate epitope can be
represented by a single synthetic peptide. Thus such peptides are
unlikely to generate false positive ELISA results with sera from
endemic healthy controls or from patients with other infectious or
autoimmune diseases. In the multiple ELISAs performed here
none of the healthy controls recognised any of the synthetic
peptides, and all were also serologically negative with the T. cruzi
lysate (Figure 2). However, sera from four of the chagasic patients
bound non-specifically to plates coated with avidin alone and thus
Figure 4. Computer-predicted antigenicity score is much
higher for TSSA-II/V/VI sequence than TSSA-I. Polymorphic
sequences of [A] TSSA-I and [B] TSSA-II/V/VI showing regions of high
antigenicity in red, and low antigenicity in blue. A few amino acid
replacements in TSSA-I lead to disappearance of the immunogenic
epitope that is present in TSSA-II/V/VI sequence.
doi:10.1371/journal.pntd.0002892.g004
Figure 5. PCR amplification of the ORF containing the reported TcI-applicable epitope. Only the amplicon of predicted size (381 bp) was
amplified by the reaction conditions. –ve = no template DNA control. Mk = Hyperladder IV (Bioline, UK).
doi:10.1371/journal.pntd.0002892.g005
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spuriously appeared to recognise all peptides; such artifactual
binding to avidin has been observed in other serological studies
[39].
Since the initial report of the sequence and antigenic
dimorphism of TSSA by Di Noia et al [15], E. coli-produced
recombinant TSSA proteins have been used as antigen with
human and animal sera, as summarised in Table 3. Recognition of
only TSSA-II by chronic chagasic sera from the Southern Cone
region was initially interpreted as suggesting that only TcII caused
chronic Chagas disease [15]. However there are many descriptions
of Chagas disease and chronic chagasic cardiomyopathy in TcI
endemic regions. Recognition of recombinant TSSA-I by human
chagasic sera has been reported by western blot but not by ELISA
[18,21]. One western blot study with recombinant TSSA-II and
TSSA-I has recorded an unexpected level of TcII in northern
South America and Mexico [21]. The recombinant TSSA proteins
used as antigens as described encompass up to 26 amino acids
flanking the polymorphic region [15,20,21], which are highly
conserved between TSSA-I and TSSA-II.
The lineage-specific peptide representing the epitope common
to TcII/TcV/TcVI was recognized by a large number of sera
from Brazil; a proportion of these sera also bound to TSSApep-V/
VI. All duplicate separate samples from the same patients gave
indistinguishable results. The Brazilian sera tested here originated
from the states of Goia´s and Minas Gerais, where TcII human
infections are known to be prevalent, TcV and TcVI are also
present and TcI is (relatively) uncommon [11,40,41], although TcI
is well represented among Brazilian sylvatic transmission cycles
[41,42]. However, a substantial minority of the Brazilian serum
samples (31/98 (31.6%)) did not react with TSSApep-II/V/VI.
Thus sensitivity of the TSSApep-II/V/VI ELISA does not appear
to be absolute for TcII/TcV/TcVI T. cruzi infections (Figure 2,
Table 1). It is possible that corresponding antibodies in the TcII/
TcV/TcVI seronegative patients were simply below the threshold
for detection in the ELISA, although this seems unlikely because
such patients remained equally seronegative against the peptides
even when re-tested at the higher serum concentration of 1:100
(data not shown). Alternatively, some patients may fail to generate
an immune response to the epitope or there may be as yet
undiscovered TSSA diversity in some T. cruzi TcII strains.
Elsewhere in the Southern Cone countries 12 of 15 sera from
Bolivia or Argentina were seropositive with TSSApep-II/V/VI, in
accord with the known high prevalence of these lineages in those
countries [23]. All sera from Bolivia, Argentina and Ecuador, and
the great majority of those from Brazil, that recognised TSSApep-
II/V/VI also reacted with chimera TSSApep-II/-I indicating that
crucial residues reside in the N-terminal part of the TSSA-II/V/
VI epitope.
We found that few serum samples from the three countries in
northern South America recognized TSSApep-II/V/VI or
TSSApep-V/VI. This is consistent with the literature on the
geographical distribution of T. cruzi lineages based on genotyping
of isolates from domestic and sylvatic transmission cycles. In fact
only 4 sera from Ecuador were seropositive with TSSApep-II/V/
VI out of 66 from these northern countries. At least 3 of these 4
Ecuadorian serum samples originated from the Loja region in
southern Ecuador, where TcI has been isolated [43], close to the
border with Peru. Risso et al [21] reported the identification of
TcII in Colombia, Venezuela, and Mexico using western blots
with TSSA-II recombinant antigen. However, when the same
Colombian sera samples were tested here using the lineage-specific
peptides we found no TSSApep-II/V/VI seropositive patients.
Thus with our data we are unable to confirm the presence of
TcII/TcV/TcVI in those Colombian patients.
Only four sera, including one from Venezuela where TcIV is
known to sporadically infect humans, recognised TSSApep-IV. All
four sera also recognised TSSApep-III, which shares 14 of 16
residues, presumably due to cross reaction, as we have observed
with experimental murine sera (Bhattacharyya et al, in prepara-
tion).
Apart from one Argentine and one Brazilian serum, no clear
specific reaction with TSSApep-I was observed, even with sera
from known TcI endemic regions in Venezuela, Colombia and
Ecuador. The few TSSApep-II/V/VI seropositive samples from
Brazil that also reacted with chimera TSSApep-I/-II did not react
with TSSApep-I. One possibility is that the TSSA-I protein, if
expressed at all in chagasic patients, is not sufficiently immuno-
genic to generate an antibody response, possibly due to post-
translational glycosylation of the core peptide sequence. Identifi-
cation of the disaccharide Gala(1,3)Galb as the immunodominant
glycotope present in the O-linked mucins, i.e., those glycosylated
on serine or threonine residues of the peptide chain, has been
reported recently [44,45], and both serine and threonine are
represented by one additional residue in TSSApep-I as compared
Table 3. Reports of TSSA recombinant proteins in serological assays.
Reference
rTSSA Tc
lineage Assay Sources of human sera Authors’ reports
[15] I, II ELISA, CL-ELISAa Argentina, Brazil, Chile TSSA dimorphism; chagasic sera only recognise rTSSA-II; TcI or TcII -infected animal sera
recognised the homologous rTSSA form, without cross-reactivity.
[18] I, II/V/VI Western blot Argentina TcII/V/VI and TcI co-infection in cases of chagasic cardiomyopathy; TcII/V/VI also in
indeterminate clinical form.
[19] II ELISA Argentina rTSSA-II recognised by chagasic but not non-chagasic or cutaneous leishmaniasis sera.
rTSSA-II recognised by canine sera from TcVI but not TcI or TcIII infections.
[20] IIb CL-ELISA a Brazil rTSSA-II 98% sensitive; no response to rTSSA-I; minimal cross-reactivity with Leishmania
sera.
[21] I, II Western blot Argentina, Colombia, Mexico,
Paraguay, Venezuela
Recognition of TSSA-II, TSSA-I and TSSA-II/I in northern South America and Mexico;
almost exclusively rTSSA-II in southern South America.
[22] I, II/V/VI Western blot,
ELISA
Argentina, Bolivia, Paraguay TcII/V/VI predominant in pregnant chagasic women; no recognition of TSSA-I reported.
[23] IIb ELISA Argentina TcII and/or TcV/TcVI in the north of Salta province.
aChemiluminescent ELISA; bcalled by authors TSSA VI, but the same as that first described as TSSA-II.
doi:10.1371/journal.pntd.0002892.t003
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with the TSSA-II epitope. However, equally likely, the TSSA I
epitope may be conformational, with a structure that is not
represented by the linear peptide. Also, alternative immunodomi-
nant epitopes elsewhere in TSSA-I may skew the humoral
response away from the sequence represented by TSSApep-I.
We were interested to see whether there was a difference in the
proportions of TSSApep-II/V/VI seropositive and seronegative
patients presenting with clinical symptoms of chronic Chagas
disease. Remarkably, there was a clear statistically significant
difference: 23/60 (38%) of the Brazilian TSSApep-II/V/VI
seropositives had ECG abnormalities typical of Chagas disease,
whereas such abnormalities only occurred in 4/23 (17%) of the
seronegatives (p,0.0001). One possible interpretation of these
data is that TSSApep-II/V/VI seronegative patients may not be
infected with these lineages but with some less pathogenic strains.
Alternatively, such seronegative patients may be infected with
TcII, TcV or TcVI but the absence of an immune response to the
TSSA-II/V/VI common epitope may be an indicator of a long
term better prognosis; however confirmation would require a
more extensive and longitudinal study. However, the frequencies
of megaoesophagus (43% vs 48%) and megacolon (10% vs 8.7%)
were not significantly different between the TSSApep-II/V/VI
seropositive and seronegative groups respectively.
Trypanosoma rangeli is non-pathogenic to humans, is found
sympatric with T. cruzi, particularly in northern South America,
and serological cross-reaction between these species has been
recognised [46]. The divergence of the TSSA epitopes in T. cruzi
and the lack of response to the peptides with sera from northern
South America, indicate that monospecific sera from patients
infected with T. rangeli alone will not recognise these synthetic
peptide epitopes.
A recent paper reported the identification of a TcI epitope for
lineage-specific serology [26]. However, upon analysing the
sequence diversity in the ORF coding for the parent protein
across T. cruzi lineages, in contrast we found a very high degree of
sequence conservation across the lineages. Thus, we were not able
to confirm any TcI-specificity of that peptide epitope.
We have demonstrated that synthetic peptides are able to
provide T. cruzi antigens for lineage-specific serological diagnosis
in chronic Chagas disease. Synthetic-peptide based lineage-specific
serology has also confirmed the disparate geographical distribution
of TcII/TcV/TcVI but found fewer TcII infections in northern
South America than reported with western blots and recombinant
TSSA-II. Further comparisons of recombinant TSSA antigens and
synthetic peptides are indicated. More attempts should be made to
design a TcI specific peptide, and by comparative genomics to seek
alternative antigens to TSSA that may be lineage-specific.
However, such in silico methods will need to incorporate structural
analysis, and if necessary devise linear peptides that represent
conformational epitopes. In a region of Brazil endemic for TcII we
find a higher rate of ECG abnormalities among patients with
TSSApep-II/V/VI seropositivity than among seronegative pa-
tients. Synthetic-peptide antigens clearly have substantial and
versatile potential in studying the relationship between a patient’s
history of infection and clinical status, and they may provide
clinical biomarkers for prognosis of Chagas disease.
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